AGE|AGE_SPECIFIC_CI_LOWER|AGE_SPECIFIC_CI_UPPER|AGE_SPECIFIC_RATE|COUNT|EVENT_TYPE|POPULATION|SITE|YEAR
1-4|2.5|3.0|2.7|418|Mortality|15339782|All Cancer Sites Combined|1999
1-4|19.1|20.5|19.8|2994|Incidence|15136428|All Cancer Sites Combined|1999
1-4|0.6|0.9|0.7|113|Mortality|15339782|Brain and Other Nervous System|1999
1-4|3.7|4.3|4.0|601|Incidence|15136428|Brain and Other Nervous System|1999
1-4|~|~|~|~|Mortality|7493614|Cervix|1999
1-4|~|~|~|~|Incidence|7394181|Cervix|1999
1-4|~|~|~|~|Mortality|15339782|Colon and Rectum|1999
1-4|~|~|~|~|Incidence|15136428|Colon and Rectum|1999
1-4|~|~|~|~|Mortality|7493614|Corpus and Uterus, NOS|1999
1-4|~|~|~|~|Incidence|7394181|Corpus and Uterus, NOS|1999
1-4|~|~|~|~|Mortality|15339782|Esophagus|1999
1-4|~|~|~|~|Incidence|15136428|Esophagus|1999
1-4|~|~|~|~|Mortality|7493614|Female Breast|1999
1-4|~|~|~|~|Incidence|7394181|Female Breast|1999
1-4|~|~|~|~|Incidence|7394181|Female Breast, <i>in situ</i>|1999
1-4|~|~|~|~|Mortality|15339782|Hodgkin Lymphoma|1999
1-4|~|~|~|~|Incidence|15136428|Hodgkin Lymphoma|1999
1-4|.|.|.|.|Mortality|15339782|Kaposi Sarcoma|1999
1-4|~|~|~|~|Incidence|15136428|Kaposi Sarcoma|1999
1-4|0.1|0.2|0.1|19|Mortality|15339782|Kidney and Renal Pelvis|1999
1-4|1.7|2.1|1.9|290|Incidence|15136428|Kidney and Renal Pelvis|1999
1-4|~|~|~|~|Mortality|15339782|Larynx|1999
1-4|~|~|~|~|Incidence|15136428|Larynx|1999
1-4|0.6|0.9|0.8|119|Mortality|15339782|Leukemias|1999
1-4|7.5|8.4|7.9|1201|Incidence|15136428|Leukemias|1999
1-4|0.1|0.3|0.2|29|Mortality|15339782|Liver and Intrahepatic Bile Duct|1999
1-4|0.4|0.6|0.5|69|Incidence|15136428|Liver and Intrahepatic Bile Duct|1999
1-4|~|~|~|~|Mortality|15339782|Lung and Bronchus|1999
1-4|~|~|~|~|Incidence|15136428|Lung and Bronchus|1999
1-4|~|~|~|~|Mortality|7493614|Male and Female Breast|1999
1-4|~|~|~|~|Incidence|7394181|Male and Female Breast|1999
1-4|~|~|~|~|Incidence|7394181|Male and Female Breast, <i>in situ</i>|1999
1-4|~|~|~|~|Mortality|15339782|Melanomas of the Skin|1999
1-4|~|~|~|~|Incidence|15136428|Melanomas of the Skin|1999
1-4|~|~|~|~|Mortality|15339782|Mesothelioma|1999
1-4|~|~|~|~|Incidence|15136428|Mesothelioma|1999
1-4|~|~|~|~|Mortality|15339782|Myeloma|1999
1-4|~|~|~|~|Incidence|15136428|Myeloma|1999
1-4|0.1|0.2|0.1|16|Mortality|15339782|Non-Hodgkin Lymphoma|1999
1-4|0.6|0.8|0.7|105|Incidence|15136428|Non-Hodgkin Lymphoma|1999
1-4|~|~|~|~|Mortality|15339782|Oral Cavity and Pharynx|1999
1-4|~|~|~|~|Incidence|15136428|Oral Cavity and Pharynx|1999
1-4|~|~|~|~|Mortality|7493614|Ovary|1999
1-4|~|~|~|~|Incidence|7394181|Ovary|1999
1-4|~|~|~|~|Mortality|15339782|Pancreas|1999
1-4|~|~|~|~|Incidence|15136428|Pancreas|1999
1-4|~|~|~|~|Mortality|7846168|Prostate|1999
1-4|~|~|~|~|Incidence|7742247|Prostate|1999
1-4|~|~|~|~|Mortality|15339782|Stomach|1999
1-4|~|~|~|~|Incidence|15136428|Stomach|1999
1-4|~|~|~|~|Mortality|7846168|Testis|1999
1-4|0.2|0.5|0.3|27|Incidence|7742247|Testis|1999
1-4|~|~|~|~|Mortality|15339782|Thyroid|1999
1-4|~|~|~|~|Incidence|15136428|Thyroid|1999
1-4|~|~|~|~|Mortality|15339782|Urinary Bladder|1999
1-4|~|~|~|~|Incidence|15136428|Urinary Bladder|1999
10-14|2.3|2.7|2.5|503|Mortality|20213364|All Cancer Sites Combined|1999
10-14|12.0|12.9|12.4|2479|Incidence|19935660|All Cancer Sites Combined|1999
10-14|0.5|0.7|0.6|124|Mortality|20213364|Brain and Other Nervous System|1999
10-14|2.4|2.9|2.7|531|Incidence|19935660|Brain and Other Nervous System|1999
10-14|~|~|~|~|Mortality|9855664|Cervix|1999
10-14|~|~|~|~|Incidence|9719801|Cervix|1999
10-14|~|~|~|~|Mortality|20213364|Colon and Rectum|1999
10-14|~|~|~|~|Incidence|19935660|Colon and Rectum|1999
10-14|~|~|~|~|Mortality|9855664|Corpus and Uterus, NOS|1999
10-14|~|~|~|~|Incidence|9719801|Corpus and Uterus, NOS|1999
10-14|~|~|~|~|Mortality|20213364|Esophagus|1999
10-14|~|~|~|~|Incidence|19935660|Esophagus|1999
10-14|~|~|~|~|Mortality|9855664|Female Breast|1999
10-14|~|~|~|~|Incidence|9719801|Female Breast|1999
10-14|~|~|~|~|Incidence|9719801|Female Breast, <i>in situ</i>|1999
10-14|~|~|~|~|Mortality|20213364|Hodgkin Lymphoma|1999
10-14|1.0|1.3|1.2|231|Incidence|19935660|Hodgkin Lymphoma|1999
10-14|.|.|.|.|Mortality|20213364|Kaposi Sarcoma|1999
10-14|~|~|~|~|Incidence|19935660|Kaposi Sarcoma|1999
10-14|~|~|~|~|Mortality|20213364|Kidney and Renal Pelvis|1999
10-14|0.1|0.2|0.1|25|Incidence|19935660|Kidney and Renal Pelvis|1999
10-14|~|~|~|~|Mortality|20213364|Larynx|1999
10-14|~|~|~|~|Incidence|19935660|Larynx|1999
10-14|0.7|1.0|0.9|175|Mortality|20213364|Leukemias|1999
10-14|2.6|3.1|2.8|566|Incidence|19935660|Leukemias|1999
10-14|~|~|~|~|Mortality|20213364|Liver and Intrahepatic Bile Duct|1999
10-14|0.1|0.1|0.1|18|Incidence|19935660|Liver and Intrahepatic Bile Duct|1999
10-14|~|~|~|~|Mortality|20213364|Lung and Bronchus|1999
10-14|~|~|~|~|Incidence|19935660|Lung and Bronchus|1999
10-14|~|~|~|~|Mortality|9855664|Male and Female Breast|1999
10-14|~|~|~|~|Incidence|9719801|Male and Female Breast|1999
10-14|~|~|~|~|Incidence|9719801|Male and Female Breast, <i>in situ</i>|1999
10-14|~|~|~|~|Mortality|20213364|Melanomas of the Skin|1999
10-14|0.3|0.4|0.3|67|Incidence|19935660|Melanomas of the Skin|1999
10-14|~|~|~|~|Mortality|20213364|Mesothelioma|1999
10-14|~|~|~|~|Incidence|19935660|Mesothelioma|1999
10-14|~|~|~|~|Mortality|20213364|Myeloma|1999
10-14|~|~|~|~|Incidence|19935660|Myeloma|1999
10-14|0.1|0.2|0.1|25|Mortality|20213364|Non-Hodgkin Lymphoma|1999
10-14|1.0|1.3|1.2|235|Incidence|19935660|Non-Hodgkin Lymphoma|1999
10-14|~|~|~|~|Mortality|20213364|Oral Cavity and Pharynx|1999
10-14|0.2|0.4|0.3|55|Incidence|19935660|Oral Cavity and Pharynx|1999
10-14|~|~|~|~|Mortality|9855664|Ovary|1999
10-14|0.5|0.9|0.7|68|Incidence|9719801|Ovary|1999
10-14|~|~|~|~|Mortality|20213364|Pancreas|1999
10-14|~|~|~|~|Incidence|19935660|Pancreas|1999
10-14|~|~|~|~|Mortality|10357700|Prostate|1999
10-14|~|~|~|~|Incidence|10215859|Prostate|1999
10-14|~|~|~|~|Mortality|20213364|Stomach|1999
10-14|~|~|~|~|Incidence|19935660|Stomach|1999
10-14|~|~|~|~|Mortality|10357700|Testis|1999
10-14|~|~|~|~|Incidence|10215859|Testis|1999
10-14|~|~|~|~|Mortality|20213364|Thyroid|1999
10-14|0.3|0.5|0.4|75|Incidence|19935660|Thyroid|1999
10-14|~|~|~|~|Mortality|20213364|Urinary Bladder|1999
10-14|~|~|~|~|Incidence|19935660|Urinary Bladder|1999
15-19|3.4|4.0|3.7|745|Mortality|20084602|All Cancer Sites Combined|1999
15-19|19.1|20.3|19.7|3894|Incidence|19785979|All Cancer Sites Combined|1999
15-19|0.5|0.7|0.6|115|Mortality|20084602|Brain and Other Nervous System|1999
15-19|1.8|2.2|2.0|402|Incidence|19785979|Brain and Other Nervous System|1999
15-19|~|~|~|~|Mortality|9761569|Cervix|1999
15-19|0.2|0.4|0.3|27|Incidence|9615370|Cervix|1999
15-19|~|~|~|~|Mortality|20084602|Colon and Rectum|1999
15-19|0.2|0.3|0.3|50|Incidence|19785979|Colon and Rectum|1999
15-19|~|~|~|~|Mortality|9761569|Corpus and Uterus, NOS|1999
15-19|~|~|~|~|Incidence|9615370|Corpus and Uterus, NOS|1999
15-19|~|~|~|~|Mortality|20084602|Esophagus|1999
15-19|~|~|~|~|Incidence|19785979|Esophagus|1999
15-19|~|~|~|~|Mortality|9761569|Female Breast|1999
15-19|0.1|0.3|0.2|17|Incidence|9615370|Female Breast|1999
15-19|~|~|~|~|Incidence|9615370|Female Breast, <i>in situ</i>|1999
15-19|0.1|0.2|0.2|31|Mortality|20084602|Hodgkin Lymphoma|1999
15-19|2.8|3.3|3.1|610|Incidence|19785979|Hodgkin Lymphoma|1999
15-19|.|.|.|.|Mortality|20084602|Kaposi Sarcoma|1999
15-19|~|~|~|~|Incidence|19785979|Kaposi Sarcoma|1999
15-19|~|~|~|~|Mortality|20084602|Kidney and Renal Pelvis|1999
15-19|0.1|0.2|0.1|29|Incidence|19785979|Kidney and Renal Pelvis|1999
15-19|~|~|~|~|Mortality|20084602|Larynx|1999
15-19|~|~|~|~|Incidence|19785979|Larynx|1999
15-19|1.0|1.3|1.1|221|Mortality|20084602|Leukemias|1999
15-19|2.4|2.9|2.7|526|Incidence|19785979|Leukemias|1999
15-19|0.1|0.1|0.1|19|Mortality|20084602|Liver and Intrahepatic Bile Duct|1999
15-19|0.1|0.2|0.2|35|Incidence|19785979|Liver and Intrahepatic Bile Duct|1999
15-19|~|~|~|~|Mortality|20084602|Lung and Bronchus|1999
15-19|0.1|0.2|0.2|30|Incidence|19785979|Lung and Bronchus|1999
15-19|~|~|~|~|Mortality|9761569|Male and Female Breast|1999
15-19|0.1|0.3|0.2|17|Incidence|9615370|Male and Female Breast|1999
15-19|~|~|~|~|Incidence|9615370|Male and Female Breast, <i>in situ</i>|1999
15-19|~|~|~|~|Mortality|20084602|Melanomas of the Skin|1999
15-19|1.2|1.5|1.3|260|Incidence|19785979|Melanomas of the Skin|1999
15-19|~|~|~|~|Mortality|20084602|Mesothelioma|1999
15-19|~|~|~|~|Incidence|19785979|Mesothelioma|1999
15-19|~|~|~|~|Mortality|20084602|Myeloma|1999
15-19|~|~|~|~|Incidence|19785979|Myeloma|1999
15-19|0.2|0.3|0.3|51|Mortality|20084602|Non-Hodgkin Lymphoma|1999
15-19|1.4|1.8|1.6|311|Incidence|19785979|Non-Hodgkin Lymphoma|1999
15-19|~|~|~|~|Mortality|20084602|Oral Cavity and Pharynx|1999
15-19|0.3|0.5|0.4|71|Incidence|19785979|Oral Cavity and Pharynx|1999
15-19|~|~|~|~|Mortality|9761569|Ovary|1999
15-19|1.1|1.5|1.3|123|Incidence|9615370|Ovary|1999
15-19|~|~|~|~|Mortality|20084602|Pancreas|1999
15-19|~|~|~|~|Incidence|19785979|Pancreas|1999
15-19|~|~|~|~|Mortality|10323033|Prostate|1999
15-19|~|~|~|~|Incidence|10170609|Prostate|1999
15-19|~|~|~|~|Mortality|20084602|Stomach|1999
15-19|~|~|~|~|Incidence|19785979|Stomach|1999
15-19|~|~|~|~|Mortality|10323033|Testis|1999
15-19|2.9|3.6|3.3|331|Incidence|10170609|Testis|1999
15-19|~|~|~|~|Mortality|20084602|Thyroid|1999
15-19|1.6|2.0|1.8|352|Incidence|19785979|Thyroid|1999
15-19|~|~|~|~|Mortality|20084602|Urinary Bladder|1999
15-19|0.1|0.2|0.1|21|Incidence|19785979|Urinary Bladder|1999
5-9|2.3|2.7|2.5|509|Mortality|20606460|All Cancer Sites Combined|1999
5-9|10.6|11.5|11.0|2240|Incidence|20334315|All Cancer Sites Combined|1999
5-9|0.8|1.0|0.9|184|Mortality|20606460|Brain and Other Nervous System|1999
5-9|3.1|3.6|3.3|676|Incidence|20334315|Brain and Other Nervous System|1999
5-9|~|~|~|~|Mortality|10052618|Cervix|1999
5-9|~|~|~|~|Incidence|9919394|Cervix|1999
5-9|~|~|~|~|Mortality|20606460|Colon and Rectum|1999
5-9|~|~|~|~|Incidence|20334315|Colon and Rectum|1999
5-9|~|~|~|~|Mortality|10052618|Corpus and Uterus, NOS|1999
5-9|~|~|~|~|Incidence|9919394|Corpus and Uterus, NOS|1999
5-9|~|~|~|~|Mortality|20606460|Esophagus|1999
5-9|~|~|~|~|Incidence|20334315|Esophagus|1999
5-9|~|~|~|~|Mortality|10052618|Female Breast|1999
5-9|~|~|~|~|Incidence|9919394|Female Breast|1999
5-9|~|~|~|~|Incidence|9919394|Female Breast, <i>in situ</i>|1999
5-9|~|~|~|~|Mortality|20606460|Hodgkin Lymphoma|1999
5-9|0.3|0.5|0.4|80|Incidence|20334315|Hodgkin Lymphoma|1999
5-9|.|.|.|.|Mortality|20606460|Kaposi Sarcoma|1999
5-9|~|~|~|~|Incidence|20334315|Kaposi Sarcoma|1999
5-9|0.1|0.2|0.1|23|Mortality|20606460|Kidney and Renal Pelvis|1999
5-9|0.4|0.7|0.5|110|Incidence|20334315|Kidney and Renal Pelvis|1999
5-9|~|~|~|~|Mortality|20606460|Larynx|1999
5-9|~|~|~|~|Incidence|20334315|Larynx|1999
5-9|0.5|0.7|0.6|130|Mortality|20606460|Leukemias|1999
5-9|3.3|3.9|3.6|731|Incidence|20334315|Leukemias|1999
5-9|~|~|~|~|Mortality|20606460|Liver and Intrahepatic Bile Duct|1999
5-9|~|~|~|~|Incidence|20334315|Liver and Intrahepatic Bile Duct|1999
5-9|~|~|~|~|Mortality|20606460|Lung and Bronchus|1999
5-9|~|~|~|~|Incidence|20334315|Lung and Bronchus|1999
5-9|~|~|~|~|Mortality|10052618|Male and Female Breast|1999
5-9|~|~|~|~|Incidence|9919394|Male and Female Breast|1999
5-9|~|~|~|~|Incidence|9919394|Male and Female Breast, <i>in situ</i>|1999
5-9|~|~|~|~|Mortality|20606460|Melanomas of the Skin|1999
5-9|~|~|~|~|Incidence|20334315|Melanomas of the Skin|1999
5-9|~|~|~|~|Mortality|20606460|Mesothelioma|1999
5-9|~|~|~|~|Incidence|20334315|Mesothelioma|1999
5-9|~|~|~|~|Mortality|20606460|Myeloma|1999
5-9|~|~|~|~|Incidence|20334315|Myeloma|1999
5-9|~|~|~|~|Mortality|20606460|Non-Hodgkin Lymphoma|1999
5-9|0.8|1.0|0.9|178|Incidence|20334315|Non-Hodgkin Lymphoma|1999
5-9|~|~|~|~|Mortality|20606460|Oral Cavity and Pharynx|1999
5-9|0.1|0.1|0.1|18|Incidence|20334315|Oral Cavity and Pharynx|1999
5-9|~|~|~|~|Mortality|10052618|Ovary|1999
5-9|0.1|0.3|0.2|17|Incidence|9919394|Ovary|1999
5-9|~|~|~|~|Mortality|20606460|Pancreas|1999
5-9|~|~|~|~|Incidence|20334315|Pancreas|1999
5-9|~|~|~|~|Mortality|10553842|Prostate|1999
5-9|~|~|~|~|Incidence|10414921|Prostate|1999
5-9|~|~|~|~|Mortality|20606460|Stomach|1999
5-9|~|~|~|~|Incidence|20334315|Stomach|1999
5-9|~|~|~|~|Mortality|10553842|Testis|1999
5-9|~|~|~|~|Incidence|10414921|Testis|1999
5-9|~|~|~|~|Mortality|20606460|Thyroid|1999
5-9|0.1|0.2|0.2|32|Incidence|20334315|Thyroid|1999
5-9|~|~|~|~|Mortality|20606460|Urinary Bladder|1999
5-9|~|~|~|~|Incidence|20334315|Urinary Bladder|1999
<1|1.4|2.3|1.8|68|Mortality|3795762|All Cancer Sites Combined|1999
<1|21.9|25.1|23.4|878|Incidence|3744604|All Cancer Sites Combined|1999
<1|~|~|~|~|Mortality|3795762|Brain and Other Nervous System|1999
<1|3.0|4.2|3.6|134|Incidence|3744604|Brain and Other Nervous System|1999
<1|~|~|~|~|Mortality|1852123|Cervix|1999
<1|~|~|~|~|Incidence|1827171|Cervix|1999
<1|~|~|~|~|Mortality|3795762|Colon and Rectum|1999
<1|~|~|~|~|Incidence|3744604|Colon and Rectum|1999
<1|~|~|~|~|Mortality|1852123|Corpus and Uterus, NOS|1999
<1|~|~|~|~|Incidence|1827171|Corpus and Uterus, NOS|1999
<1|~|~|~|~|Mortality|3795762|Esophagus|1999
<1|~|~|~|~|Incidence|3744604|Esophagus|1999
<1|~|~|~|~|Mortality|1852123|Female Breast|1999
<1|~|~|~|~|Incidence|1827171|Female Breast|1999
<1|~|~|~|~|Incidence|1827171|Female Breast, <i>in situ</i>|1999
<1|~|~|~|~|Mortality|3795762|Hodgkin Lymphoma|1999
<1|~|~|~|~|Incidence|3744604|Hodgkin Lymphoma|1999
<1|.|.|.|.|Mortality|3795762|Kaposi Sarcoma|1999
<1|~|~|~|~|Incidence|3744604|Kaposi Sarcoma|1999
<1|~|~|~|~|Mortality|3795762|Kidney and Renal Pelvis|1999
<1|1.4|2.3|1.8|69|Incidence|3744604|Kidney and Renal Pelvis|1999
<1|~|~|~|~|Mortality|3795762|Larynx|1999
<1|~|~|~|~|Incidence|3744604|Larynx|1999
<1|0.5|1.0|0.7|27|Mortality|3795762|Leukemias|1999
<1|3.7|5.1|4.4|163|Incidence|3744604|Leukemias|1999
<1|~|~|~|~|Mortality|3795762|Liver and Intrahepatic Bile Duct|1999
<1|0.7|1.4|1.0|38|Incidence|3744604|Liver and Intrahepatic Bile Duct|1999
<1|~|~|~|~|Mortality|3795762|Lung and Bronchus|1999
<1|~|~|~|~|Incidence|3744604|Lung and Bronchus|1999
<1|~|~|~|~|Mortality|1852123|Male and Female Breast|1999
<1|~|~|~|~|Incidence|1827171|Male and Female Breast|1999
<1|~|~|~|~|Incidence|1827171|Male and Female Breast, <i>in situ</i>|1999
<1|~|~|~|~|Mortality|3795762|Melanomas of the Skin|1999
<1|~|~|~|~|Incidence|3744604|Melanomas of the Skin|1999
<1|~|~|~|~|Mortality|3795762|Mesothelioma|1999
<1|~|~|~|~|Incidence|3744604|Mesothelioma|1999
<1|~|~|~|~|Mortality|3795762|Myeloma|1999
<1|~|~|~|~|Incidence|3744604|Myeloma|1999
<1|~|~|~|~|Mortality|3795762|Non-Hodgkin Lymphoma|1999
<1|~|~|~|~|Incidence|3744604|Non-Hodgkin Lymphoma|1999
<1|~|~|~|~|Mortality|3795762|Oral Cavity and Pharynx|1999
<1|~|~|~|~|Incidence|3744604|Oral Cavity and Pharynx|1999
<1|~|~|~|~|Mortality|1852123|Ovary|1999
<1|~|~|~|~|Incidence|1827171|Ovary|1999
<1|~|~|~|~|Mortality|3795762|Pancreas|1999
<1|~|~|~|~|Incidence|3744604|Pancreas|1999
<1|~|~|~|~|Mortality|1943639|Prostate|1999
<1|~|~|~|~|Incidence|1917433|Prostate|1999
<1|~|~|~|~|Mortality|3795762|Stomach|1999
<1|~|~|~|~|Incidence|3744604|Stomach|1999
<1|~|~|~|~|Mortality|1943639|Testis|1999
<1|0.6|1.6|1.0|20|Incidence|1917433|Testis|1999
<1|~|~|~|~|Mortality|3795762|Thyroid|1999
<1|~|~|~|~|Incidence|3744604|Thyroid|1999
<1|~|~|~|~|Mortality|3795762|Urinary Bladder|1999
<1|~|~|~|~|Incidence|3744604|Urinary Bladder|1999
1-4|2.5|3.0|2.7|420|Mortality|15322337|All Cancer Sites Combined|2000
1-4|19.9|21.4|20.6|3118|Incidence|15119430|All Cancer Sites Combined|2000
1-4|0.6|0.8|0.7|104|Mortality|15322337|Brain and Other Nervous System|2000
1-4|3.8|4.5|4.1|626|Incidence|15119430|Brain and Other Nervous System|2000
1-4|~|~|~|~|Mortality|7485852|Cervix|2000
1-4|~|~|~|~|Incidence|7386625|Cervix|2000
1-4|~|~|~|~|Mortality|15322337|Colon and Rectum|2000
1-4|~|~|~|~|Incidence|15119430|Colon and Rectum|2000
1-4|~|~|~|~|Mortality|7485852|Corpus and Uterus, NOS|2000
1-4|~|~|~|~|Incidence|7386625|Corpus and Uterus, NOS|2000
1-4|~|~|~|~|Mortality|15322337|Esophagus|2000
1-4|~|~|~|~|Incidence|15119430|Esophagus|2000
1-4|~|~|~|~|Mortality|7485852|Female Breast|2000
1-4|~|~|~|~|Incidence|7386625|Female Breast|2000
1-4|~|~|~|~|Incidence|7386625|Female Breast, <i>in situ</i>|2000
1-4|~|~|~|~|Mortality|15322337|Hodgkin Lymphoma|2000
1-4|0.1|0.2|0.1|16|Incidence|15119430|Hodgkin Lymphoma|2000
1-4|.|.|.|.|Mortality|15322337|Kaposi Sarcoma|2000
1-4|~|~|~|~|Incidence|15119430|Kaposi Sarcoma|2000
1-4|~|~|~|~|Mortality|15322337|Kidney and Renal Pelvis|2000
1-4|1.9|2.4|2.1|325|Incidence|15119430|Kidney and Renal Pelvis|2000
1-4|~|~|~|~|Mortality|15322337|Larynx|2000
1-4|~|~|~|~|Incidence|15119430|Larynx|2000
1-4|0.8|1.1|0.9|137|Mortality|15322337|Leukemias|2000
1-4|8.0|8.9|8.4|1274|Incidence|15119430|Leukemias|2000
1-4|0.1|0.2|0.2|23|Mortality|15322337|Liver and Intrahepatic Bile Duct|2000
1-4|0.4|0.6|0.5|70|Incidence|15119430|Liver and Intrahepatic Bile Duct|2000
1-4|~|~|~|~|Mortality|15322337|Lung and Bronchus|2000
1-4|~|~|~|~|Incidence|15119430|Lung and Bronchus|2000
1-4|~|~|~|~|Mortality|7485852|Male and Female Breast|2000
1-4|~|~|~|~|Incidence|7386625|Male and Female Breast|2000
1-4|~|~|~|~|Incidence|7386625|Male and Female Breast, <i>in situ</i>|2000
1-4|~|~|~|~|Mortality|15322337|Melanomas of the Skin|2000
1-4|~|~|~|~|Incidence|15119430|Melanomas of the Skin|2000
1-4|~|~|~|~|Mortality|15322337|Mesothelioma|2000
1-4|~|~|~|~|Incidence|15119430|Mesothelioma|2000
1-4|~|~|~|~|Mortality|15322337|Myeloma|2000
1-4|~|~|~|~|Incidence|15119430|Myeloma|2000
1-4|~|~|~|~|Mortality|15322337|Non-Hodgkin Lymphoma|2000
1-4|0.5|0.8|0.6|95|Incidence|15119430|Non-Hodgkin Lymphoma|2000
1-4|~|~|~|~|Mortality|15322337|Oral Cavity and Pharynx|2000
1-4|~|~|~|~|Incidence|15119430|Oral Cavity and Pharynx|2000
1-4|~|~|~|~|Mortality|7485852|Ovary|2000
1-4|~|~|~|~|Incidence|7386625|Ovary|2000
1-4|~|~|~|~|Mortality|15322337|Pancreas|2000
1-4|~|~|~|~|Incidence|15119430|Pancreas|2000
1-4|~|~|~|~|Mortality|7836485|Prostate|2000
1-4|~|~|~|~|Incidence|7732805|Prostate|2000
1-4|~|~|~|~|Mortality|15322337|Stomach|2000
1-4|~|~|~|~|Incidence|15119430|Stomach|2000
1-4|~|~|~|~|Mortality|7836485|Testis|2000
1-4|0.1|0.4|0.2|19|Incidence|7732805|Testis|2000
1-4|~|~|~|~|Mortality|15322337|Thyroid|2000
1-4|~|~|~|~|Incidence|15119430|Thyroid|2000
1-4|~|~|~|~|Mortality|15322337|Urinary Bladder|2000
1-4|~|~|~|~|Incidence|15119430|Urinary Bladder|2000
10-14|2.3|2.8|2.5|525|Mortality|20637696|All Cancer Sites Combined|2000
10-14|12.0|13.0|12.5|2542|Incidence|20358437|All Cancer Sites Combined|2000
10-14|0.6|0.9|0.7|150|Mortality|20637696|Brain and Other Nervous System|2000
10-14|2.6|3.0|2.8|568|Incidence|20358437|Brain and Other Nervous System|2000
10-14|~|~|~|~|Mortality|10063054|Cervix|2000
10-14|~|~|~|~|Incidence|9926394|Cervix|2000
10-14|~|~|~|~|Mortality|20637696|Colon and Rectum|2000
10-14|~|~|~|~|Incidence|20358437|Colon and Rectum|2000
10-14|~|~|~|~|Mortality|10063054|Corpus and Uterus, NOS|2000
10-14|~|~|~|~|Incidence|9926394|Corpus and Uterus, NOS|2000
10-14|~|~|~|~|Mortality|20637696|Esophagus|2000
10-14|~|~|~|~|Incidence|20358437|Esophagus|2000
10-14|~|~|~|~|Mortality|10063054|Female Breast|2000
10-14|~|~|~|~|Incidence|9926394|Female Breast|2000
10-14|~|~|~|~|Incidence|9926394|Female Breast, <i>in situ</i>|2000
10-14|~|~|~|~|Mortality|20637696|Hodgkin Lymphoma|2000
10-14|1.1|1.4|1.3|260|Incidence|20358437|Hodgkin Lymphoma|2000
10-14|.|.|.|.|Mortality|20637696|Kaposi Sarcoma|2000
10-14|~|~|~|~|Incidence|20358437|Kaposi Sarcoma|2000
10-14|~|~|~|~|Mortality|20637696|Kidney and Renal Pelvis|2000
10-14|0.1|0.2|0.1|23|Incidence|20358437|Kidney and Renal Pelvis|2000
10-14|~|~|~|~|Mortality|20637696|Larynx|2000
10-14|~|~|~|~|Incidence|20358437|Larynx|2000
10-14|0.7|1.0|0.8|173|Mortality|20637696|Leukemias|2000
10-14|2.3|2.7|2.5|511|Incidence|20358437|Leukemias|2000
10-14|~|~|~|~|Mortality|20637696|Liver and Intrahepatic Bile Duct|2000
10-14|0.1|0.2|0.1|22|Incidence|20358437|Liver and Intrahepatic Bile Duct|2000
10-14|~|~|~|~|Mortality|20637696|Lung and Bronchus|2000
10-14|~|~|~|~|Incidence|20358437|Lung and Bronchus|2000
10-14|~|~|~|~|Mortality|10063054|Male and Female Breast|2000
10-14|~|~|~|~|Incidence|9926394|Male and Female Breast|2000
10-14|~|~|~|~|Incidence|9926394|Male and Female Breast, <i>in situ</i>|2000
10-14|~|~|~|~|Mortality|20637696|Melanomas of the Skin|2000
10-14|0.3|0.4|0.3|67|Incidence|20358437|Melanomas of the Skin|2000
10-14|~|~|~|~|Mortality|20637696|Mesothelioma|2000
10-14|~|~|~|~|Incidence|20358437|Mesothelioma|2000
10-14|~|~|~|~|Mortality|20637696|Myeloma|2000
10-14|~|~|~|~|Incidence|20358437|Myeloma|2000
10-14|0.1|0.2|0.1|24|Mortality|20637696|Non-Hodgkin Lymphoma|2000
10-14|1.0|1.3|1.1|234|Incidence|20358437|Non-Hodgkin Lymphoma|2000
10-14|~|~|~|~|Mortality|20637696|Oral Cavity and Pharynx|2000
10-14|0.2|0.3|0.2|49|Incidence|20358437|Oral Cavity and Pharynx|2000
10-14|~|~|~|~|Mortality|10063054|Ovary|2000
10-14|0.6|0.9|0.7|72|Incidence|9926394|Ovary|2000
10-14|~|~|~|~|Mortality|20637696|Pancreas|2000
10-14|~|~|~|~|Incidence|20358437|Pancreas|2000
10-14|~|~|~|~|Mortality|10574642|Prostate|2000
10-14|~|~|~|~|Incidence|10432043|Prostate|2000
10-14|~|~|~|~|Mortality|20637696|Stomach|2000
10-14|~|~|~|~|Incidence|20358437|Stomach|2000
10-14|~|~|~|~|Mortality|10574642|Testis|2000
10-14|0.1|0.3|0.2|20|Incidence|10432043|Testis|2000
10-14|~|~|~|~|Mortality|20637696|Thyroid|2000
10-14|0.4|0.6|0.5|93|Incidence|20358437|Thyroid|2000
10-14|~|~|~|~|Mortality|20637696|Urinary Bladder|2000
10-14|~|~|~|~|Incidence|20358437|Urinary Bladder|2000
15-19|3.4|3.9|3.7|745|Mortality|20294955|All Cancer Sites Combined|2000
15-19|19.9|21.2|20.5|4106|Incidence|19998739|All Cancer Sites Combined|2000
15-19|0.4|0.6|0.5|105|Mortality|20294955|Brain and Other Nervous System|2000
15-19|2.0|2.4|2.2|438|Incidence|19998739|Brain and Other Nervous System|2000
15-19|~|~|~|~|Mortality|9854932|Cervix|2000
15-19|0.2|0.4|0.2|23|Incidence|9710015|Cervix|2000
15-19|~|~|~|~|Mortality|20294955|Colon and Rectum|2000
15-19|0.2|0.3|0.3|53|Incidence|19998739|Colon and Rectum|2000
15-19|~|~|~|~|Mortality|9854932|Corpus and Uterus, NOS|2000
15-19|~|~|~|~|Incidence|9710015|Corpus and Uterus, NOS|2000
15-19|~|~|~|~|Mortality|20294955|Esophagus|2000
15-19|~|~|~|~|Incidence|19998739|Esophagus|2000
15-19|~|~|~|~|Mortality|9854932|Female Breast|2000
15-19|~|~|~|~|Incidence|9710015|Female Breast|2000
15-19|~|~|~|~|Incidence|9710015|Female Breast, <i>in situ</i>|2000
15-19|0.1|0.2|0.1|21|Mortality|20294955|Hodgkin Lymphoma|2000
15-19|2.9|3.4|3.2|632|Incidence|19998739|Hodgkin Lymphoma|2000
15-19|.|.|.|.|Mortality|20294955|Kaposi Sarcoma|2000
15-19|~|~|~|~|Incidence|19998739|Kaposi Sarcoma|2000
15-19|~|~|~|~|Mortality|20294955|Kidney and Renal Pelvis|2000
15-19|0.1|0.2|0.1|28|Incidence|19998739|Kidney and Renal Pelvis|2000
15-19|~|~|~|~|Mortality|20294955|Larynx|2000
15-19|~|~|~|~|Incidence|19998739|Larynx|2000
15-19|1.0|1.4|1.2|242|Mortality|20294955|Leukemias|2000
15-19|2.5|3.0|2.7|548|Incidence|19998739|Leukemias|2000
15-19|~|~|~|~|Mortality|20294955|Liver and Intrahepatic Bile Duct|2000
15-19|0.1|0.1|0.1|18|Incidence|19998739|Liver and Intrahepatic Bile Duct|2000
15-19|~|~|~|~|Mortality|20294955|Lung and Bronchus|2000
15-19|0.1|0.2|0.1|28|Incidence|19998739|Lung and Bronchus|2000
15-19|~|~|~|~|Mortality|9854932|Male and Female Breast|2000
15-19|~|~|~|~|Incidence|9710015|Male and Female Breast|2000
15-19|~|~|~|~|Incidence|9710015|Male and Female Breast, <i>in situ</i>|2000
15-19|~|~|~|~|Mortality|20294955|Melanomas of the Skin|2000
15-19|1.3|1.7|1.5|298|Incidence|19998739|Melanomas of the Skin|2000
15-19|~|~|~|~|Mortality|20294955|Mesothelioma|2000
15-19|~|~|~|~|Incidence|19998739|Mesothelioma|2000
15-19|~|~|~|~|Mortality|20294955|Myeloma|2000
15-19|~|~|~|~|Incidence|19998739|Myeloma|2000
15-19|0.2|0.4|0.3|60|Mortality|20294955|Non-Hodgkin Lymphoma|2000
15-19|1.6|2.0|1.8|352|Incidence|19998739|Non-Hodgkin Lymphoma|2000
15-19|~|~|~|~|Mortality|20294955|Oral Cavity and Pharynx|2000
15-19|0.3|0.5|0.4|82|Incidence|19998739|Oral Cavity and Pharynx|2000
15-19|~|~|~|~|Mortality|9854932|Ovary|2000
15-19|1.1|1.6|1.3|128|Incidence|9710015|Ovary|2000
15-19|~|~|~|~|Mortality|20294955|Pancreas|2000
15-19|~|~|~|~|Incidence|19998739|Pancreas|2000
15-19|~|~|~|~|Mortality|10440023|Prostate|2000
15-19|~|~|~|~|Incidence|10288724|Prostate|2000
15-19|~|~|~|~|Mortality|20294955|Stomach|2000
15-19|~|~|~|~|Incidence|19998739|Stomach|2000
15-19|~|~|~|~|Mortality|10440023|Testis|2000
15-19|3.1|3.9|3.5|359|Incidence|10288724|Testis|2000
15-19|~|~|~|~|Mortality|20294955|Thyroid|2000
15-19|1.5|1.9|1.7|338|Incidence|19998739|Thyroid|2000
15-19|~|~|~|~|Mortality|20294955|Urinary Bladder|2000
15-19|0.1|0.2|0.1|26|Incidence|19998739|Urinary Bladder|2000
5-9|2.2|2.6|2.4|489|Mortality|20463852|All Cancer Sites Combined|2000
5-9|11.0|12.0|11.5|2320|Incidence|20194272|All Cancer Sites Combined|2000
5-9|0.7|0.9|0.8|166|Mortality|20463852|Brain and Other Nervous System|2000
5-9|3.1|3.6|3.4|683|Incidence|20194272|Brain and Other Nervous System|2000
5-9|~|~|~|~|Mortality|9984495|Cervix|2000
5-9|~|~|~|~|Incidence|9852526|Cervix|2000
5-9|~|~|~|~|Mortality|20463852|Colon and Rectum|2000
5-9|~|~|~|~|Incidence|20194272|Colon and Rectum|2000
5-9|~|~|~|~|Mortality|9984495|Corpus and Uterus, NOS|2000
5-9|~|~|~|~|Incidence|9852526|Corpus and Uterus, NOS|2000
5-9|~|~|~|~|Mortality|20463852|Esophagus|2000
5-9|~|~|~|~|Incidence|20194272|Esophagus|2000
5-9|~|~|~|~|Mortality|9984495|Female Breast|2000
5-9|~|~|~|~|Incidence|9852526|Female Breast|2000
5-9|~|~|~|~|Incidence|9852526|Female Breast, <i>in situ</i>|2000
5-9|~|~|~|~|Mortality|20463852|Hodgkin Lymphoma|2000
5-9|0.3|0.4|0.4|72|Incidence|20194272|Hodgkin Lymphoma|2000
5-9|.|.|.|.|Mortality|20463852|Kaposi Sarcoma|2000
5-9|~|~|~|~|Incidence|20194272|Kaposi Sarcoma|2000
5-9|0.1|0.2|0.1|21|Mortality|20463852|Kidney and Renal Pelvis|2000
5-9|0.5|0.7|0.6|126|Incidence|20194272|Kidney and Renal Pelvis|2000
5-9|~|~|~|~|Mortality|20463852|Larynx|2000
5-9|~|~|~|~|Incidence|20194272|Larynx|2000
5-9|0.6|0.8|0.7|142|Mortality|20463852|Leukemias|2000
5-9|3.5|4.0|3.8|758|Incidence|20194272|Leukemias|2000
5-9|~|~|~|~|Mortality|20463852|Liver and Intrahepatic Bile Duct|2000
5-9|~|~|~|~|Incidence|20194272|Liver and Intrahepatic Bile Duct|2000
5-9|~|~|~|~|Mortality|20463852|Lung and Bronchus|2000
5-9|~|~|~|~|Incidence|20194272|Lung and Bronchus|2000
5-9|~|~|~|~|Mortality|9984495|Male and Female Breast|2000
5-9|~|~|~|~|Incidence|9852526|Male and Female Breast|2000
5-9|~|~|~|~|Incidence|9852526|Male and Female Breast, <i>in situ</i>|2000
5-9|~|~|~|~|Mortality|20463852|Melanomas of the Skin|2000
5-9|0.0|0.1|0.1|17|Incidence|20194272|Melanomas of the Skin|2000
5-9|~|~|~|~|Mortality|20463852|Mesothelioma|2000
5-9|~|~|~|~|Incidence|20194272|Mesothelioma|2000
5-9|~|~|~|~|Mortality|20463852|Myeloma|2000
5-9|~|~|~|~|Incidence|20194272|Myeloma|2000
5-9|0.1|0.2|0.1|23|Mortality|20463852|Non-Hodgkin Lymphoma|2000
5-9|1.0|1.3|1.1|223|Incidence|20194272|Non-Hodgkin Lymphoma|2000
5-9|~|~|~|~|Mortality|20463852|Oral Cavity and Pharynx|2000
5-9|0.1|0.1|0.1|19|Incidence|20194272|Oral Cavity and Pharynx|2000
5-9|~|~|~|~|Mortality|9984495|Ovary|2000
5-9|0.1|0.4|0.2|23|Incidence|9852526|Ovary|2000
5-9|~|~|~|~|Mortality|20463852|Pancreas|2000
5-9|~|~|~|~|Incidence|20194272|Pancreas|2000
5-9|~|~|~|~|Mortality|10479357|Prostate|2000
5-9|~|~|~|~|Incidence|10341746|Prostate|2000
5-9|~|~|~|~|Mortality|20463852|Stomach|2000
5-9|~|~|~|~|Incidence|20194272|Stomach|2000
5-9|~|~|~|~|Mortality|10479357|Testis|2000
5-9|~|~|~|~|Incidence|10341746|Testis|2000
5-9|~|~|~|~|Mortality|20463852|Thyroid|2000
5-9|0.1|0.2|0.1|20|Incidence|20194272|Thyroid|2000
5-9|~|~|~|~|Mortality|20463852|Urinary Bladder|2000
5-9|~|~|~|~|Incidence|20194272|Urinary Bladder|2000
<1|1.9|2.9|2.4|92|Mortality|3855956|All Cancer Sites Combined|2000
<1|22.2|25.3|23.7|901|Incidence|3804065|All Cancer Sites Combined|2000
<1|0.3|0.8|0.5|20|Mortality|3855956|Brain and Other Nervous System|2000
<1|3.5|4.8|4.1|156|Incidence|3804065|Brain and Other Nervous System|2000
<1|~|~|~|~|Mortality|1881822|Cervix|2000
<1|~|~|~|~|Incidence|1856559|Cervix|2000
<1|~|~|~|~|Mortality|3855956|Colon and Rectum|2000
<1|~|~|~|~|Incidence|3804065|Colon and Rectum|2000
<1|~|~|~|~|Mortality|1881822|Corpus and Uterus, NOS|2000
<1|~|~|~|~|Incidence|1856559|Corpus and Uterus, NOS|2000
<1|~|~|~|~|Mortality|3855956|Esophagus|2000
<1|~|~|~|~|Incidence|3804065|Esophagus|2000
<1|~|~|~|~|Mortality|1881822|Female Breast|2000
<1|~|~|~|~|Incidence|1856559|Female Breast|2000
<1|~|~|~|~|Incidence|1856559|Female Breast, <i>in situ</i>|2000
<1|~|~|~|~|Mortality|3855956|Hodgkin Lymphoma|2000
<1|~|~|~|~|Incidence|3804065|Hodgkin Lymphoma|2000
<1|.|.|.|.|Mortality|3855956|Kaposi Sarcoma|2000
<1|~|~|~|~|Incidence|3804065|Kaposi Sarcoma|2000
<1|~|~|~|~|Mortality|3855956|Kidney and Renal Pelvis|2000
<1|1.2|2.0|1.5|58|Incidence|3804065|Kidney and Renal Pelvis|2000
<1|~|~|~|~|Mortality|3855956|Larynx|2000
<1|~|~|~|~|Incidence|3804065|Larynx|2000
<1|0.7|1.4|1.0|38|Mortality|3855956|Leukemias|2000
<1|4.0|5.4|4.7|178|Incidence|3804065|Leukemias|2000
<1|~|~|~|~|Mortality|3855956|Liver and Intrahepatic Bile Duct|2000
<1|0.8|1.6|1.2|44|Incidence|3804065|Liver and Intrahepatic Bile Duct|2000
<1|~|~|~|~|Mortality|3855956|Lung and Bronchus|2000
<1|~|~|~|~|Incidence|3804065|Lung and Bronchus|2000
<1|~|~|~|~|Mortality|1881822|Male and Female Breast|2000
<1|~|~|~|~|Incidence|1856559|Male and Female Breast|2000
<1|~|~|~|~|Incidence|1856559|Male and Female Breast, <i>in situ</i>|2000
<1|~|~|~|~|Mortality|3855956|Melanomas of the Skin|2000
<1|~|~|~|~|Incidence|3804065|Melanomas of the Skin|2000
<1|~|~|~|~|Mortality|3855956|Mesothelioma|2000
<1|~|~|~|~|Incidence|3804065|Mesothelioma|2000
<1|~|~|~|~|Mortality|3855956|Myeloma|2000
<1|~|~|~|~|Incidence|3804065|Myeloma|2000
<1|~|~|~|~|Mortality|3855956|Non-Hodgkin Lymphoma|2000
<1|~|~|~|~|Incidence|3804065|Non-Hodgkin Lymphoma|2000
<1|~|~|~|~|Mortality|3855956|Oral Cavity and Pharynx|2000
<1|~|~|~|~|Incidence|3804065|Oral Cavity and Pharynx|2000
<1|~|~|~|~|Mortality|1881822|Ovary|2000
<1|~|~|~|~|Incidence|1856559|Ovary|2000
<1|~|~|~|~|Mortality|3855956|Pancreas|2000
<1|~|~|~|~|Incidence|3804065|Pancreas|2000
<1|~|~|~|~|Mortality|1974134|Prostate|2000
<1|~|~|~|~|Incidence|1947506|Prostate|2000
<1|~|~|~|~|Mortality|3855956|Stomach|2000
<1|~|~|~|~|Incidence|3804065|Stomach|2000
<1|~|~|~|~|Mortality|1974134|Testis|2000
<1|~|~|~|~|Incidence|1947506|Testis|2000
<1|~|~|~|~|Mortality|3855956|Thyroid|2000
<1|~|~|~|~|Incidence|3804065|Thyroid|2000
<1|~|~|~|~|Mortality|3855956|Urinary Bladder|2000
<1|~|~|~|~|Incidence|3804065|Urinary Bladder|2000
1-4|2.5|3.0|2.7|420|Mortality|15285559|All Cancer Sites Combined|2001
1-4|21.0|22.5|21.7|3286|Incidence|15123657|All Cancer Sites Combined|2001
1-4|0.5|0.8|0.7|100|Mortality|15285559|Brain and Other Nervous System|2001
1-4|3.7|4.4|4.0|612|Incidence|15123657|Brain and Other Nervous System|2001
1-4|~|~|~|~|Mortality|7468536|Cervix|2001
1-4|~|~|~|~|Incidence|7389458|Cervix|2001
1-4|~|~|~|~|Mortality|15285559|Colon and Rectum|2001
1-4|~|~|~|~|Incidence|15123657|Colon and Rectum|2001
1-4|~|~|~|~|Mortality|7468536|Corpus and Uterus, NOS|2001
1-4|~|~|~|~|Incidence|7389458|Corpus and Uterus, NOS|2001
1-4|~|~|~|~|Mortality|15285559|Esophagus|2001
1-4|~|~|~|~|Incidence|15123657|Esophagus|2001
1-4|~|~|~|~|Mortality|7468536|Female Breast|2001
1-4|~|~|~|~|Incidence|7389458|Female Breast|2001
1-4|~|~|~|~|Incidence|7389458|Female Breast, <i>in situ</i>|2001
1-4|~|~|~|~|Mortality|15285559|Hodgkin Lymphoma|2001
1-4|0.1|0.2|0.1|20|Incidence|15123657|Hodgkin Lymphoma|2001
1-4|.|.|.|.|Mortality|15285559|Kaposi Sarcoma|2001
1-4|~|~|~|~|Incidence|15123657|Kaposi Sarcoma|2001
1-4|0.1|0.2|0.1|22|Mortality|15285559|Kidney and Renal Pelvis|2001
1-4|1.9|2.4|2.1|319|Incidence|15123657|Kidney and Renal Pelvis|2001
1-4|~|~|~|~|Mortality|15285559|Larynx|2001
1-4|~|~|~|~|Incidence|15123657|Larynx|2001
1-4|0.9|1.2|1.0|155|Mortality|15285559|Leukemias|2001
1-4|8.5|9.4|9.0|1355|Incidence|15123657|Leukemias|2001
1-4|0.1|0.2|0.1|18|Mortality|15285559|Liver and Intrahepatic Bile Duct|2001
1-4|0.3|0.5|0.4|63|Incidence|15123657|Liver and Intrahepatic Bile Duct|2001
1-4|~|~|~|~|Mortality|15285559|Lung and Bronchus|2001
1-4|~|~|~|~|Incidence|15123657|Lung and Bronchus|2001
1-4|~|~|~|~|Mortality|7468536|Male and Female Breast|2001
1-4|~|~|~|~|Incidence|7389458|Male and Female Breast|2001
1-4|~|~|~|~|Incidence|7389458|Male and Female Breast, <i>in situ</i>|2001
1-4|~|~|~|~|Mortality|15285559|Melanomas of the Skin|2001
1-4|~|~|~|~|Incidence|15123657|Melanomas of the Skin|2001
1-4|~|~|~|~|Mortality|15285559|Mesothelioma|2001
1-4|~|~|~|~|Incidence|15123657|Mesothelioma|2001
1-4|~|~|~|~|Mortality|15285559|Myeloma|2001
1-4|~|~|~|~|Incidence|15123657|Myeloma|2001
1-4|~|~|~|~|Mortality|15285559|Non-Hodgkin Lymphoma|2001
1-4|0.5|0.7|0.6|90|Incidence|15123657|Non-Hodgkin Lymphoma|2001
1-4|~|~|~|~|Mortality|15285559|Oral Cavity and Pharynx|2001
1-4|0.1|0.2|0.1|17|Incidence|15123657|Oral Cavity and Pharynx|2001
1-4|~|~|~|~|Mortality|7468536|Ovary|2001
1-4|~|~|~|~|Incidence|7389458|Ovary|2001
1-4|~|~|~|~|Mortality|15285559|Pancreas|2001
1-4|~|~|~|~|Incidence|15123657|Pancreas|2001
1-4|~|~|~|~|Mortality|7817023|Prostate|2001
1-4|~|~|~|~|Incidence|7734199|Prostate|2001
1-4|~|~|~|~|Mortality|15285559|Stomach|2001
1-4|~|~|~|~|Incidence|15123657|Stomach|2001
1-4|~|~|~|~|Mortality|7817023|Testis|2001
1-4|0.3|0.6|0.4|32|Incidence|7734199|Testis|2001
1-4|~|~|~|~|Mortality|15285559|Thyroid|2001
1-4|~|~|~|~|Incidence|15123657|Thyroid|2001
1-4|~|~|~|~|Mortality|15285559|Urinary Bladder|2001
1-4|~|~|~|~|Incidence|15123657|Urinary Bladder|2001
10-14|2.2|2.7|2.5|515|Mortality|20978678|All Cancer Sites Combined|2001
10-14|12.8|13.8|13.3|2753|Incidence|20758808|All Cancer Sites Combined|2001
10-14|0.5|0.7|0.6|130|Mortality|20978678|Brain and Other Nervous System|2001
10-14|2.5|3.0|2.7|565|Incidence|20758808|Brain and Other Nervous System|2001
10-14|~|~|~|~|Mortality|10231469|Cervix|2001
10-14|~|~|~|~|Incidence|10123827|Cervix|2001
10-14|~|~|~|~|Mortality|20978678|Colon and Rectum|2001
10-14|~|~|~|~|Incidence|20758808|Colon and Rectum|2001
10-14|~|~|~|~|Mortality|10231469|Corpus and Uterus, NOS|2001
10-14|~|~|~|~|Incidence|10123827|Corpus and Uterus, NOS|2001
10-14|~|~|~|~|Mortality|20978678|Esophagus|2001
10-14|~|~|~|~|Incidence|20758808|Esophagus|2001
10-14|~|~|~|~|Mortality|10231469|Female Breast|2001
10-14|~|~|~|~|Incidence|10123827|Female Breast|2001
10-14|~|~|~|~|Incidence|10123827|Female Breast, <i>in situ</i>|2001
10-14|~|~|~|~|Mortality|20978678|Hodgkin Lymphoma|2001
10-14|1.1|1.4|1.2|252|Incidence|20758808|Hodgkin Lymphoma|2001
10-14|.|.|.|.|Mortality|20978678|Kaposi Sarcoma|2001
10-14|~|~|~|~|Incidence|20758808|Kaposi Sarcoma|2001
10-14|~|~|~|~|Mortality|20978678|Kidney and Renal Pelvis|2001
10-14|0.1|0.2|0.1|31|Incidence|20758808|Kidney and Renal Pelvis|2001
10-14|~|~|~|~|Mortality|20978678|Larynx|2001
10-14|~|~|~|~|Incidence|20758808|Larynx|2001
10-14|0.7|0.9|0.8|170|Mortality|20978678|Leukemias|2001
10-14|2.7|3.2|3.0|618|Incidence|20758808|Leukemias|2001
10-14|~|~|~|~|Mortality|20978678|Liver and Intrahepatic Bile Duct|2001
10-14|0.1|0.1|0.1|19|Incidence|20758808|Liver and Intrahepatic Bile Duct|2001
10-14|~|~|~|~|Mortality|20978678|Lung and Bronchus|2001
10-14|~|~|~|~|Incidence|20758808|Lung and Bronchus|2001
10-14|~|~|~|~|Mortality|10231469|Male and Female Breast|2001
10-14|~|~|~|~|Incidence|10123827|Male and Female Breast|2001
10-14|~|~|~|~|Incidence|10123827|Male and Female Breast, <i>in situ</i>|2001
10-14|~|~|~|~|Mortality|20978678|Melanomas of the Skin|2001
10-14|0.3|0.5|0.4|78|Incidence|20758808|Melanomas of the Skin|2001
10-14|~|~|~|~|Mortality|20978678|Mesothelioma|2001
10-14|~|~|~|~|Incidence|20758808|Mesothelioma|2001
10-14|~|~|~|~|Mortality|20978678|Myeloma|2001
10-14|~|~|~|~|Incidence|20758808|Myeloma|2001
10-14|0.1|0.2|0.1|27|Mortality|20978678|Non-Hodgkin Lymphoma|2001
10-14|1.1|1.4|1.3|263|Incidence|20758808|Non-Hodgkin Lymphoma|2001
10-14|~|~|~|~|Mortality|20978678|Oral Cavity and Pharynx|2001
10-14|0.2|0.4|0.3|60|Incidence|20758808|Oral Cavity and Pharynx|2001
10-14|~|~|~|~|Mortality|10231469|Ovary|2001
10-14|0.4|0.8|0.6|59|Incidence|10123827|Ovary|2001
10-14|~|~|~|~|Mortality|20978678|Pancreas|2001
10-14|~|~|~|~|Incidence|20758808|Pancreas|2001
10-14|~|~|~|~|Mortality|10747209|Prostate|2001
10-14|~|~|~|~|Incidence|10634981|Prostate|2001
10-14|~|~|~|~|Mortality|20978678|Stomach|2001
10-14|~|~|~|~|Incidence|20758808|Stomach|2001
10-14|~|~|~|~|Mortality|10747209|Testis|2001
10-14|0.1|0.3|0.2|17|Incidence|10634981|Testis|2001
10-14|~|~|~|~|Mortality|20978678|Thyroid|2001
10-14|0.5|0.7|0.6|117|Incidence|20758808|Thyroid|2001
10-14|~|~|~|~|Mortality|20978678|Urinary Bladder|2001
10-14|~|~|~|~|Incidence|20758808|Urinary Bladder|2001
15-19|3.3|3.8|3.6|732|Mortality|20456284|All Cancer Sites Combined|2001
15-19|20.7|21.9|21.3|4307|Incidence|20227701|All Cancer Sites Combined|2001
15-19|0.4|0.6|0.5|104|Mortality|20456284|Brain and Other Nervous System|2001
15-19|2.0|2.4|2.2|438|Incidence|20227701|Brain and Other Nervous System|2001
15-19|~|~|~|~|Mortality|9908897|Cervix|2001
15-19|0.1|0.3|0.2|21|Incidence|9797025|Cervix|2001
15-19|~|~|~|~|Mortality|20456284|Colon and Rectum|2001
15-19|0.2|0.4|0.3|56|Incidence|20227701|Colon and Rectum|2001
15-19|~|~|~|~|Mortality|9908897|Corpus and Uterus, NOS|2001
15-19|~|~|~|~|Incidence|9797025|Corpus and Uterus, NOS|2001
15-19|~|~|~|~|Mortality|20456284|Esophagus|2001
15-19|~|~|~|~|Incidence|20227701|Esophagus|2001
15-19|~|~|~|~|Mortality|9908897|Female Breast|2001
15-19|0.1|0.3|0.2|22|Incidence|9797025|Female Breast|2001
15-19|~|~|~|~|Incidence|9797025|Female Breast, <i>in situ</i>|2001
15-19|0.1|0.2|0.1|25|Mortality|20456284|Hodgkin Lymphoma|2001
15-19|3.0|3.5|3.2|650|Incidence|20227701|Hodgkin Lymphoma|2001
15-19|.|.|.|.|Mortality|20456284|Kaposi Sarcoma|2001
15-19|~|~|~|~|Incidence|20227701|Kaposi Sarcoma|2001
15-19|~|~|~|~|Mortality|20456284|Kidney and Renal Pelvis|2001
15-19|0.1|0.2|0.2|33|Incidence|20227701|Kidney and Renal Pelvis|2001
15-19|~|~|~|~|Mortality|20456284|Larynx|2001
15-19|~|~|~|~|Incidence|20227701|Larynx|2001
15-19|1.0|1.3|1.1|225|Mortality|20456284|Leukemias|2001
15-19|2.6|3.1|2.9|578|Incidence|20227701|Leukemias|2001
15-19|~|~|~|~|Mortality|20456284|Liver and Intrahepatic Bile Duct|2001
15-19|0.1|0.2|0.1|28|Incidence|20227701|Liver and Intrahepatic Bile Duct|2001
15-19|~|~|~|~|Mortality|20456284|Lung and Bronchus|2001
15-19|0.1|0.2|0.2|33|Incidence|20227701|Lung and Bronchus|2001
15-19|~|~|~|~|Mortality|9908897|Male and Female Breast|2001
15-19|0.1|0.3|0.2|22|Incidence|9797025|Male and Female Breast|2001
15-19|~|~|~|~|Incidence|9797025|Male and Female Breast, <i>in situ</i>|2001
15-19|~|~|~|~|Mortality|20456284|Melanomas of the Skin|2001
15-19|1.5|1.8|1.6|330|Incidence|20227701|Melanomas of the Skin|2001
15-19|~|~|~|~|Mortality|20456284|Mesothelioma|2001
15-19|~|~|~|~|Incidence|20227701|Mesothelioma|2001
15-19|~|~|~|~|Mortality|20456284|Myeloma|2001
15-19|~|~|~|~|Incidence|20227701|Myeloma|2001
15-19|0.2|0.4|0.3|61|Mortality|20456284|Non-Hodgkin Lymphoma|2001
15-19|1.6|2.0|1.8|357|Incidence|20227701|Non-Hodgkin Lymphoma|2001
15-19|~|~|~|~|Mortality|20456284|Oral Cavity and Pharynx|2001
15-19|0.3|0.4|0.4|72|Incidence|20227701|Oral Cavity and Pharynx|2001
15-19|~|~|~|~|Mortality|9908897|Ovary|2001
15-19|0.9|1.4|1.1|112|Incidence|9797025|Ovary|2001
15-19|~|~|~|~|Mortality|20456284|Pancreas|2001
15-19|~|~|~|~|Incidence|20227701|Pancreas|2001
15-19|~|~|~|~|Mortality|10547387|Prostate|2001
15-19|~|~|~|~|Incidence|10430676|Prostate|2001
15-19|~|~|~|~|Mortality|20456284|Stomach|2001
15-19|~|~|~|~|Incidence|20227701|Stomach|2001
15-19|~|~|~|~|Mortality|10547387|Testis|2001
15-19|2.9|3.7|3.3|343|Incidence|10430676|Testis|2001
15-19|~|~|~|~|Mortality|20456284|Thyroid|2001
15-19|1.5|1.8|1.6|328|Incidence|20227701|Thyroid|2001
15-19|~|~|~|~|Mortality|20456284|Urinary Bladder|2001
15-19|0.1|0.2|0.1|25|Incidence|20227701|Urinary Bladder|2001
5-9|2.2|2.7|2.4|493|Mortality|20173362|All Cancer Sites Combined|2001
5-9|11.1|12.0|11.5|2303|Incidence|19962452|All Cancer Sites Combined|2001
5-9|0.7|1.0|0.8|170|Mortality|20173362|Brain and Other Nervous System|2001
5-9|3.1|3.6|3.4|673|Incidence|19962452|Brain and Other Nervous System|2001
5-9|~|~|~|~|Mortality|9844298|Cervix|2001
5-9|~|~|~|~|Incidence|9740654|Cervix|2001
5-9|~|~|~|~|Mortality|20173362|Colon and Rectum|2001
5-9|~|~|~|~|Incidence|19962452|Colon and Rectum|2001
5-9|~|~|~|~|Mortality|9844298|Corpus and Uterus, NOS|2001
5-9|~|~|~|~|Incidence|9740654|Corpus and Uterus, NOS|2001
5-9|~|~|~|~|Mortality|20173362|Esophagus|2001
5-9|~|~|~|~|Incidence|19962452|Esophagus|2001
5-9|~|~|~|~|Mortality|9844298|Female Breast|2001
5-9|~|~|~|~|Incidence|9740654|Female Breast|2001
5-9|~|~|~|~|Incidence|9740654|Female Breast, <i>in situ</i>|2001
5-9|~|~|~|~|Mortality|20173362|Hodgkin Lymphoma|2001
5-9|0.3|0.5|0.4|84|Incidence|19962452|Hodgkin Lymphoma|2001
5-9|.|.|.|.|Mortality|20173362|Kaposi Sarcoma|2001
5-9|~|~|~|~|Incidence|19962452|Kaposi Sarcoma|2001
5-9|0.1|0.2|0.1|30|Mortality|20173362|Kidney and Renal Pelvis|2001
5-9|0.4|0.6|0.5|102|Incidence|19962452|Kidney and Renal Pelvis|2001
5-9|~|~|~|~|Mortality|20173362|Larynx|2001
5-9|~|~|~|~|Incidence|19962452|Larynx|2001
5-9|0.6|0.9|0.8|153|Mortality|20173362|Leukemias|2001
5-9|3.5|4.0|3.8|750|Incidence|19962452|Leukemias|2001
5-9|~|~|~|~|Mortality|20173362|Liver and Intrahepatic Bile Duct|2001
5-9|0.1|0.2|0.1|20|Incidence|19962452|Liver and Intrahepatic Bile Duct|2001
5-9|~|~|~|~|Mortality|20173362|Lung and Bronchus|2001
5-9|~|~|~|~|Incidence|19962452|Lung and Bronchus|2001
5-9|~|~|~|~|Mortality|9844298|Male and Female Breast|2001
5-9|~|~|~|~|Incidence|9740654|Male and Female Breast|2001
5-9|~|~|~|~|Incidence|9740654|Male and Female Breast, <i>in situ</i>|2001
5-9|~|~|~|~|Mortality|20173362|Melanomas of the Skin|2001
5-9|0.1|0.2|0.1|24|Incidence|19962452|Melanomas of the Skin|2001
5-9|~|~|~|~|Mortality|20173362|Mesothelioma|2001
5-9|~|~|~|~|Incidence|19962452|Mesothelioma|2001
5-9|~|~|~|~|Mortality|20173362|Myeloma|2001
5-9|~|~|~|~|Incidence|19962452|Myeloma|2001
5-9|~|~|~|~|Mortality|20173362|Non-Hodgkin Lymphoma|2001
5-9|0.8|1.1|0.9|187|Incidence|19962452|Non-Hodgkin Lymphoma|2001
5-9|~|~|~|~|Mortality|20173362|Oral Cavity and Pharynx|2001
5-9|0.1|0.2|0.1|20|Incidence|19962452|Oral Cavity and Pharynx|2001
5-9|~|~|~|~|Mortality|9844298|Ovary|2001
5-9|0.1|0.3|0.2|20|Incidence|9740654|Ovary|2001
5-9|~|~|~|~|Mortality|20173362|Pancreas|2001
5-9|~|~|~|~|Incidence|19962452|Pancreas|2001
5-9|~|~|~|~|Mortality|10329064|Prostate|2001
5-9|~|~|~|~|Incidence|10221798|Prostate|2001
5-9|~|~|~|~|Mortality|20173362|Stomach|2001
5-9|~|~|~|~|Incidence|19962452|Stomach|2001
5-9|~|~|~|~|Mortality|10329064|Testis|2001
5-9|~|~|~|~|Incidence|10221798|Testis|2001
5-9|~|~|~|~|Mortality|20173362|Thyroid|2001
5-9|0.1|0.2|0.1|21|Incidence|19962452|Thyroid|2001
5-9|~|~|~|~|Mortality|20173362|Urinary Bladder|2001
5-9|~|~|~|~|Incidence|19962452|Urinary Bladder|2001
<1|1.3|2.1|1.6|66|Mortality|4012658|All Cancer Sites Combined|2001
<1|23.1|26.2|24.6|978|Incidence|3970113|All Cancer Sites Combined|2001
<1|0.2|0.6|0.4|16|Mortality|4012658|Brain and Other Nervous System|2001
<1|3.2|4.4|3.7|148|Incidence|3970113|Brain and Other Nervous System|2001
<1|~|~|~|~|Mortality|1962905|Cervix|2001
<1|~|~|~|~|Incidence|1942094|Cervix|2001
<1|~|~|~|~|Mortality|4012658|Colon and Rectum|2001
<1|~|~|~|~|Incidence|3970113|Colon and Rectum|2001
<1|~|~|~|~|Mortality|1962905|Corpus and Uterus, NOS|2001
<1|~|~|~|~|Incidence|1942094|Corpus and Uterus, NOS|2001
<1|~|~|~|~|Mortality|4012658|Esophagus|2001
<1|~|~|~|~|Incidence|3970113|Esophagus|2001
<1|~|~|~|~|Mortality|1962905|Female Breast|2001
<1|~|~|~|~|Incidence|1942094|Female Breast|2001
<1|~|~|~|~|Incidence|1942094|Female Breast, <i>in situ</i>|2001
<1|~|~|~|~|Mortality|4012658|Hodgkin Lymphoma|2001
<1|~|~|~|~|Incidence|3970113|Hodgkin Lymphoma|2001
<1|.|.|.|.|Mortality|4012658|Kaposi Sarcoma|2001
<1|~|~|~|~|Incidence|3970113|Kaposi Sarcoma|2001
<1|~|~|~|~|Mortality|4012658|Kidney and Renal Pelvis|2001
<1|1.5|2.4|1.9|75|Incidence|3970113|Kidney and Renal Pelvis|2001
<1|~|~|~|~|Mortality|4012658|Larynx|2001
<1|~|~|~|~|Incidence|3970113|Larynx|2001
<1|0.4|0.9|0.6|25|Mortality|4012658|Leukemias|2001
<1|3.5|4.7|4.1|161|Incidence|3970113|Leukemias|2001
<1|~|~|~|~|Mortality|4012658|Liver and Intrahepatic Bile Duct|2001
<1|0.8|1.4|1.1|42|Incidence|3970113|Liver and Intrahepatic Bile Duct|2001
<1|~|~|~|~|Mortality|4012658|Lung and Bronchus|2001
<1|~|~|~|~|Incidence|3970113|Lung and Bronchus|2001
<1|~|~|~|~|Mortality|1962905|Male and Female Breast|2001
<1|~|~|~|~|Incidence|1942094|Male and Female Breast|2001
<1|~|~|~|~|Incidence|1942094|Male and Female Breast, <i>in situ</i>|2001
<1|~|~|~|~|Mortality|4012658|Melanomas of the Skin|2001
<1|~|~|~|~|Incidence|3970113|Melanomas of the Skin|2001
<1|~|~|~|~|Mortality|4012658|Mesothelioma|2001
<1|~|~|~|~|Incidence|3970113|Mesothelioma|2001
<1|~|~|~|~|Mortality|4012658|Myeloma|2001
<1|~|~|~|~|Incidence|3970113|Myeloma|2001
<1|~|~|~|~|Mortality|4012658|Non-Hodgkin Lymphoma|2001
<1|~|~|~|~|Incidence|3970113|Non-Hodgkin Lymphoma|2001
<1|~|~|~|~|Mortality|4012658|Oral Cavity and Pharynx|2001
<1|~|~|~|~|Incidence|3970113|Oral Cavity and Pharynx|2001
<1|~|~|~|~|Mortality|1962905|Ovary|2001
<1|~|~|~|~|Incidence|1942094|Ovary|2001
<1|~|~|~|~|Mortality|4012658|Pancreas|2001
<1|~|~|~|~|Incidence|3970113|Pancreas|2001
<1|~|~|~|~|Mortality|2049753|Prostate|2001
<1|~|~|~|~|Incidence|2028019|Prostate|2001
<1|~|~|~|~|Mortality|4012658|Stomach|2001
<1|~|~|~|~|Incidence|3970113|Stomach|2001
<1|~|~|~|~|Mortality|2049753|Testis|2001
<1|0.6|1.6|1.0|21|Incidence|2028019|Testis|2001
<1|~|~|~|~|Mortality|4012658|Thyroid|2001
<1|~|~|~|~|Incidence|3970113|Thyroid|2001
<1|~|~|~|~|Mortality|4012658|Urinary Bladder|2001
<1|~|~|~|~|Incidence|3970113|Urinary Bladder|2001
1-4|2.3|2.9|2.6|402|Mortality|15477731|All Cancer Sites Combined|2002
1-4|20.6|22.1|21.3|3266|Incidence|15313864|All Cancer Sites Combined|2002
1-4|0.6|0.9|0.7|114|Mortality|15477731|Brain and Other Nervous System|2002
1-4|4.1|4.8|4.5|685|Incidence|15313864|Brain and Other Nervous System|2002
1-4|~|~|~|~|Mortality|7564711|Cervix|2002
1-4|~|~|~|~|Incidence|7484518|Cervix|2002
1-4|~|~|~|~|Mortality|15477731|Colon and Rectum|2002
1-4|~|~|~|~|Incidence|15313864|Colon and Rectum|2002
1-4|~|~|~|~|Mortality|7564711|Corpus and Uterus, NOS|2002
1-4|~|~|~|~|Incidence|7484518|Corpus and Uterus, NOS|2002
1-4|~|~|~|~|Mortality|15477731|Esophagus|2002
1-4|~|~|~|~|Incidence|15313864|Esophagus|2002
1-4|~|~|~|~|Mortality|7564711|Female Breast|2002
1-4|~|~|~|~|Incidence|7484518|Female Breast|2002
1-4|~|~|~|~|Incidence|7484518|Female Breast, <i>in situ</i>|2002
1-4|~|~|~|~|Mortality|15477731|Hodgkin Lymphoma|2002
1-4|~|~|~|~|Incidence|15313864|Hodgkin Lymphoma|2002
1-4|.|.|.|.|Mortality|15477731|Kaposi Sarcoma|2002
1-4|~|~|~|~|Incidence|15313864|Kaposi Sarcoma|2002
1-4|~|~|~|~|Mortality|15477731|Kidney and Renal Pelvis|2002
1-4|1.8|2.3|2.0|312|Incidence|15313864|Kidney and Renal Pelvis|2002
1-4|~|~|~|~|Mortality|15477731|Larynx|2002
1-4|~|~|~|~|Incidence|15313864|Larynx|2002
1-4|0.5|0.8|0.7|104|Mortality|15477731|Leukemias|2002
1-4|8.1|9.1|8.6|1315|Incidence|15313864|Leukemias|2002
1-4|0.1|0.3|0.2|28|Mortality|15477731|Liver and Intrahepatic Bile Duct|2002
1-4|0.3|0.6|0.4|67|Incidence|15313864|Liver and Intrahepatic Bile Duct|2002
1-4|~|~|~|~|Mortality|15477731|Lung and Bronchus|2002
1-4|~|~|~|~|Incidence|15313864|Lung and Bronchus|2002
1-4|~|~|~|~|Mortality|7564711|Male and Female Breast|2002
1-4|~|~|~|~|Incidence|7484518|Male and Female Breast|2002
1-4|~|~|~|~|Incidence|7484518|Male and Female Breast, <i>in situ</i>|2002
1-4|~|~|~|~|Mortality|15477731|Melanomas of the Skin|2002
1-4|0.1|0.2|0.1|16|Incidence|15313864|Melanomas of the Skin|2002
1-4|~|~|~|~|Mortality|15477731|Mesothelioma|2002
1-4|~|~|~|~|Incidence|15313864|Mesothelioma|2002
1-4|~|~|~|~|Mortality|15477731|Myeloma|2002
1-4|~|~|~|~|Incidence|15313864|Myeloma|2002
1-4|~|~|~|~|Mortality|15477731|Non-Hodgkin Lymphoma|2002
1-4|0.6|0.9|0.7|109|Incidence|15313864|Non-Hodgkin Lymphoma|2002
1-4|~|~|~|~|Mortality|15477731|Oral Cavity and Pharynx|2002
1-4|~|~|~|~|Incidence|15313864|Oral Cavity and Pharynx|2002
1-4|~|~|~|~|Mortality|7564711|Ovary|2002
1-4|~|~|~|~|Incidence|7484518|Ovary|2002
1-4|~|~|~|~|Mortality|15477731|Pancreas|2002
1-4|~|~|~|~|Incidence|15313864|Pancreas|2002
1-4|~|~|~|~|Mortality|7913020|Prostate|2002
1-4|~|~|~|~|Incidence|7829346|Prostate|2002
1-4|~|~|~|~|Mortality|15477731|Stomach|2002
1-4|~|~|~|~|Incidence|15313864|Stomach|2002
1-4|~|~|~|~|Mortality|7913020|Testis|2002
1-4|0.2|0.5|0.3|27|Incidence|7829346|Testis|2002
1-4|~|~|~|~|Mortality|15477731|Thyroid|2002
1-4|~|~|~|~|Incidence|15313864|Thyroid|2002
1-4|~|~|~|~|Mortality|15477731|Urinary Bladder|2002
1-4|~|~|~|~|Incidence|15313864|Urinary Bladder|2002
10-14|2.3|2.7|2.5|535|Mortality|21261421|All Cancer Sites Combined|2002
10-14|12.2|13.2|12.7|2671|Incidence|21040663|All Cancer Sites Combined|2002
10-14|0.5|0.8|0.6|135|Mortality|21261421|Brain and Other Nervous System|2002
10-14|2.4|2.9|2.7|560|Incidence|21040663|Brain and Other Nervous System|2002
10-14|~|~|~|~|Mortality|10371422|Cervix|2002
10-14|~|~|~|~|Incidence|10263170|Cervix|2002
10-14|~|~|~|~|Mortality|21261421|Colon and Rectum|2002
10-14|0.1|0.1|0.1|19|Incidence|21040663|Colon and Rectum|2002
10-14|~|~|~|~|Mortality|10371422|Corpus and Uterus, NOS|2002
10-14|~|~|~|~|Incidence|10263170|Corpus and Uterus, NOS|2002
10-14|~|~|~|~|Mortality|21261421|Esophagus|2002
10-14|~|~|~|~|Incidence|21040663|Esophagus|2002
10-14|~|~|~|~|Mortality|10371422|Female Breast|2002
10-14|~|~|~|~|Incidence|10263170|Female Breast|2002
10-14|~|~|~|~|Incidence|10263170|Female Breast, <i>in situ</i>|2002
10-14|~|~|~|~|Mortality|21261421|Hodgkin Lymphoma|2002
10-14|1.1|1.4|1.2|259|Incidence|21040663|Hodgkin Lymphoma|2002
10-14|.|.|.|.|Mortality|21261421|Kaposi Sarcoma|2002
10-14|~|~|~|~|Incidence|21040663|Kaposi Sarcoma|2002
10-14|~|~|~|~|Mortality|21261421|Kidney and Renal Pelvis|2002
10-14|0.1|0.2|0.1|26|Incidence|21040663|Kidney and Renal Pelvis|2002
10-14|~|~|~|~|Mortality|21261421|Larynx|2002
10-14|~|~|~|~|Incidence|21040663|Larynx|2002
10-14|0.7|0.9|0.8|168|Mortality|21261421|Leukemias|2002
10-14|2.6|3.0|2.8|583|Incidence|21040663|Leukemias|2002
10-14|~|~|~|~|Mortality|21261421|Liver and Intrahepatic Bile Duct|2002
10-14|0.0|0.1|0.1|17|Incidence|21040663|Liver and Intrahepatic Bile Duct|2002
10-14|~|~|~|~|Mortality|21261421|Lung and Bronchus|2002
10-14|~|~|~|~|Incidence|21040663|Lung and Bronchus|2002
10-14|~|~|~|~|Mortality|10371422|Male and Female Breast|2002
10-14|~|~|~|~|Incidence|10263170|Male and Female Breast|2002
10-14|~|~|~|~|Incidence|10263170|Male and Female Breast, <i>in situ</i>|2002
10-14|~|~|~|~|Mortality|21261421|Melanomas of the Skin|2002
10-14|0.3|0.5|0.4|76|Incidence|21040663|Melanomas of the Skin|2002
10-14|~|~|~|~|Mortality|21261421|Mesothelioma|2002
10-14|~|~|~|~|Incidence|21040663|Mesothelioma|2002
10-14|~|~|~|~|Mortality|21261421|Myeloma|2002
10-14|~|~|~|~|Incidence|21040663|Myeloma|2002
10-14|0.1|0.3|0.2|42|Mortality|21261421|Non-Hodgkin Lymphoma|2002
10-14|1.0|1.3|1.1|236|Incidence|21040663|Non-Hodgkin Lymphoma|2002
10-14|~|~|~|~|Mortality|21261421|Oral Cavity and Pharynx|2002
10-14|0.2|0.3|0.3|54|Incidence|21040663|Oral Cavity and Pharynx|2002
10-14|~|~|~|~|Mortality|10371422|Ovary|2002
10-14|0.4|0.7|0.6|57|Incidence|10263170|Ovary|2002
10-14|~|~|~|~|Mortality|21261421|Pancreas|2002
10-14|~|~|~|~|Incidence|21040663|Pancreas|2002
10-14|~|~|~|~|Mortality|10889999|Prostate|2002
10-14|~|~|~|~|Incidence|10777493|Prostate|2002
10-14|~|~|~|~|Mortality|21261421|Stomach|2002
10-14|~|~|~|~|Incidence|21040663|Stomach|2002
10-14|~|~|~|~|Mortality|10889999|Testis|2002
10-14|0.1|0.3|0.2|24|Incidence|10777493|Testis|2002
10-14|~|~|~|~|Mortality|21261421|Thyroid|2002
10-14|0.4|0.6|0.5|96|Incidence|21040663|Thyroid|2002
10-14|~|~|~|~|Mortality|21261421|Urinary Bladder|2002
10-14|~|~|~|~|Incidence|21040663|Urinary Bladder|2002
15-19|3.3|3.8|3.5|723|Mortality|20610370|All Cancer Sites Combined|2002
15-19|21.1|22.4|21.7|4428|Incidence|20386049|All Cancer Sites Combined|2002
15-19|0.4|0.6|0.5|108|Mortality|20610370|Brain and Other Nervous System|2002
15-19|2.0|2.4|2.2|452|Incidence|20386049|Brain and Other Nervous System|2002
15-19|~|~|~|~|Mortality|9981879|Cervix|2002
15-19|0.1|0.3|0.2|23|Incidence|9872299|Cervix|2002
15-19|~|~|~|~|Mortality|20610370|Colon and Rectum|2002
15-19|0.2|0.3|0.2|47|Incidence|20386049|Colon and Rectum|2002
15-19|~|~|~|~|Mortality|9981879|Corpus and Uterus, NOS|2002
15-19|~|~|~|~|Incidence|9872299|Corpus and Uterus, NOS|2002
15-19|~|~|~|~|Mortality|20610370|Esophagus|2002
15-19|~|~|~|~|Incidence|20386049|Esophagus|2002
15-19|~|~|~|~|Mortality|9981879|Female Breast|2002
15-19|0.1|0.3|0.2|19|Incidence|9872299|Female Breast|2002
15-19|~|~|~|~|Incidence|9872299|Female Breast, <i>in situ</i>|2002
15-19|0.1|0.2|0.1|27|Mortality|20610370|Hodgkin Lymphoma|2002
15-19|3.0|3.5|3.3|669|Incidence|20386049|Hodgkin Lymphoma|2002
15-19|.|.|.|.|Mortality|20610370|Kaposi Sarcoma|2002
15-19|~|~|~|~|Incidence|20386049|Kaposi Sarcoma|2002
15-19|~|~|~|~|Mortality|20610370|Kidney and Renal Pelvis|2002
15-19|0.1|0.2|0.1|28|Incidence|20386049|Kidney and Renal Pelvis|2002
15-19|~|~|~|~|Mortality|20610370|Larynx|2002
15-19|~|~|~|~|Incidence|20386049|Larynx|2002
15-19|1.0|1.3|1.1|237|Mortality|20610370|Leukemias|2002
15-19|2.6|3.1|2.8|576|Incidence|20386049|Leukemias|2002
15-19|~|~|~|~|Mortality|20610370|Liver and Intrahepatic Bile Duct|2002
15-19|0.1|0.2|0.1|25|Incidence|20386049|Liver and Intrahepatic Bile Duct|2002
15-19|~|~|~|~|Mortality|20610370|Lung and Bronchus|2002
15-19|0.1|0.2|0.2|32|Incidence|20386049|Lung and Bronchus|2002
15-19|~|~|~|~|Mortality|9981879|Male and Female Breast|2002
15-19|0.1|0.3|0.2|19|Incidence|9872299|Male and Female Breast|2002
15-19|~|~|~|~|Incidence|9872299|Male and Female Breast, <i>in situ</i>|2002
15-19|~|~|~|~|Mortality|20610370|Melanomas of the Skin|2002
15-19|1.6|2.0|1.8|371|Incidence|20386049|Melanomas of the Skin|2002
15-19|~|~|~|~|Mortality|20610370|Mesothelioma|2002
15-19|~|~|~|~|Incidence|20386049|Mesothelioma|2002
15-19|~|~|~|~|Mortality|20610370|Myeloma|2002
15-19|~|~|~|~|Incidence|20386049|Myeloma|2002
15-19|0.2|0.3|0.2|44|Mortality|20610370|Non-Hodgkin Lymphoma|2002
15-19|1.6|2.0|1.8|371|Incidence|20386049|Non-Hodgkin Lymphoma|2002
15-19|~|~|~|~|Mortality|20610370|Oral Cavity and Pharynx|2002
15-19|0.3|0.5|0.4|86|Incidence|20386049|Oral Cavity and Pharynx|2002
15-19|~|~|~|~|Mortality|9981879|Ovary|2002
15-19|1.2|1.6|1.4|136|Incidence|9872299|Ovary|2002
15-19|~|~|~|~|Mortality|20610370|Pancreas|2002
15-19|~|~|~|~|Incidence|20386049|Pancreas|2002
15-19|~|~|~|~|Mortality|10628491|Prostate|2002
15-19|~|~|~|~|Incidence|10513750|Prostate|2002
15-19|~|~|~|~|Mortality|20610370|Stomach|2002
15-19|~|~|~|~|Incidence|20386049|Stomach|2002
15-19|~|~|~|~|Mortality|10628491|Testis|2002
15-19|3.1|3.8|3.5|363|Incidence|10513750|Testis|2002
15-19|~|~|~|~|Mortality|20610370|Thyroid|2002
15-19|1.6|1.9|1.7|353|Incidence|20386049|Thyroid|2002
15-19|~|~|~|~|Mortality|20610370|Urinary Bladder|2002
15-19|0.1|0.1|0.1|19|Incidence|20386049|Urinary Bladder|2002
5-9|2.5|2.9|2.7|537|Mortality|19872417|All Cancer Sites Combined|2002
5-9|11.6|12.6|12.1|2383|Incidence|19665950|All Cancer Sites Combined|2002
5-9|0.9|1.2|1.0|202|Mortality|19872417|Brain and Other Nervous System|2002
5-9|3.4|3.9|3.6|714|Incidence|19665950|Brain and Other Nervous System|2002
5-9|~|~|~|~|Mortality|9699735|Cervix|2002
5-9|~|~|~|~|Incidence|9598433|Cervix|2002
5-9|~|~|~|~|Mortality|19872417|Colon and Rectum|2002
5-9|~|~|~|~|Incidence|19665950|Colon and Rectum|2002
5-9|~|~|~|~|Mortality|9699735|Corpus and Uterus, NOS|2002
5-9|~|~|~|~|Incidence|9598433|Corpus and Uterus, NOS|2002
5-9|~|~|~|~|Mortality|19872417|Esophagus|2002
5-9|~|~|~|~|Incidence|19665950|Esophagus|2002
5-9|~|~|~|~|Mortality|9699735|Female Breast|2002
5-9|~|~|~|~|Incidence|9598433|Female Breast|2002
5-9|~|~|~|~|Incidence|9598433|Female Breast, <i>in situ</i>|2002
5-9|~|~|~|~|Mortality|19872417|Hodgkin Lymphoma|2002
5-9|0.3|0.4|0.4|69|Incidence|19665950|Hodgkin Lymphoma|2002
5-9|.|.|.|.|Mortality|19872417|Kaposi Sarcoma|2002
5-9|~|~|~|~|Incidence|19665950|Kaposi Sarcoma|2002
5-9|0.1|0.2|0.1|23|Mortality|19872417|Kidney and Renal Pelvis|2002
5-9|0.4|0.6|0.5|96|Incidence|19665950|Kidney and Renal Pelvis|2002
5-9|~|~|~|~|Mortality|19872417|Larynx|2002
5-9|~|~|~|~|Incidence|19665950|Larynx|2002
5-9|0.6|0.9|0.7|148|Mortality|19872417|Leukemias|2002
5-9|3.6|4.2|3.9|763|Incidence|19665950|Leukemias|2002
5-9|~|~|~|~|Mortality|19872417|Liver and Intrahepatic Bile Duct|2002
5-9|0.1|0.1|0.1|18|Incidence|19665950|Liver and Intrahepatic Bile Duct|2002
5-9|~|~|~|~|Mortality|19872417|Lung and Bronchus|2002
5-9|~|~|~|~|Incidence|19665950|Lung and Bronchus|2002
5-9|~|~|~|~|Mortality|9699735|Male and Female Breast|2002
5-9|~|~|~|~|Incidence|9598433|Male and Female Breast|2002
5-9|~|~|~|~|Incidence|9598433|Male and Female Breast, <i>in situ</i>|2002
5-9|~|~|~|~|Mortality|19872417|Melanomas of the Skin|2002
5-9|0.1|0.2|0.2|32|Incidence|19665950|Melanomas of the Skin|2002
5-9|~|~|~|~|Mortality|19872417|Mesothelioma|2002
5-9|~|~|~|~|Incidence|19665950|Mesothelioma|2002
5-9|~|~|~|~|Mortality|19872417|Myeloma|2002
5-9|~|~|~|~|Incidence|19665950|Myeloma|2002
5-9|~|~|~|~|Mortality|19872417|Non-Hodgkin Lymphoma|2002
5-9|0.8|1.1|0.9|184|Incidence|19665950|Non-Hodgkin Lymphoma|2002
5-9|~|~|~|~|Mortality|19872417|Oral Cavity and Pharynx|2002
5-9|0.1|0.1|0.1|17|Incidence|19665950|Oral Cavity and Pharynx|2002
5-9|~|~|~|~|Mortality|9699735|Ovary|2002
5-9|0.2|0.4|0.3|26|Incidence|9598433|Ovary|2002
5-9|~|~|~|~|Mortality|19872417|Pancreas|2002
5-9|~|~|~|~|Incidence|19665950|Pancreas|2002
5-9|~|~|~|~|Mortality|10172682|Prostate|2002
5-9|~|~|~|~|Incidence|10067517|Prostate|2002
5-9|~|~|~|~|Mortality|19872417|Stomach|2002
5-9|~|~|~|~|Incidence|19665950|Stomach|2002
5-9|~|~|~|~|Mortality|10172682|Testis|2002
5-9|~|~|~|~|Incidence|10067517|Testis|2002
5-9|~|~|~|~|Mortality|19872417|Thyroid|2002
5-9|0.1|0.2|0.1|21|Incidence|19665950|Thyroid|2002
5-9|~|~|~|~|Mortality|19872417|Urinary Bladder|2002
5-9|~|~|~|~|Incidence|19665950|Urinary Bladder|2002
<1|1.5|2.4|1.9|74|Mortality|3951461|All Cancer Sites Combined|2002
<1|23.1|26.3|24.6|964|Incidence|3910837|All Cancer Sites Combined|2002
<1|~|~|~|~|Mortality|3951461|Brain and Other Nervous System|2002
<1|3.3|4.5|3.9|151|Incidence|3910837|Brain and Other Nervous System|2002
<1|~|~|~|~|Mortality|1932939|Cervix|2002
<1|~|~|~|~|Incidence|1913004|Cervix|2002
<1|~|~|~|~|Mortality|3951461|Colon and Rectum|2002
<1|~|~|~|~|Incidence|3910837|Colon and Rectum|2002
<1|~|~|~|~|Mortality|1932939|Corpus and Uterus, NOS|2002
<1|~|~|~|~|Incidence|1913004|Corpus and Uterus, NOS|2002
<1|~|~|~|~|Mortality|3951461|Esophagus|2002
<1|~|~|~|~|Incidence|3910837|Esophagus|2002
<1|~|~|~|~|Mortality|1932939|Female Breast|2002
<1|~|~|~|~|Incidence|1913004|Female Breast|2002
<1|~|~|~|~|Incidence|1913004|Female Breast, <i>in situ</i>|2002
<1|~|~|~|~|Mortality|3951461|Hodgkin Lymphoma|2002
<1|~|~|~|~|Incidence|3910837|Hodgkin Lymphoma|2002
<1|.|.|.|.|Mortality|3951461|Kaposi Sarcoma|2002
<1|~|~|~|~|Incidence|3910837|Kaposi Sarcoma|2002
<1|~|~|~|~|Mortality|3951461|Kidney and Renal Pelvis|2002
<1|1.5|2.4|1.9|75|Incidence|3910837|Kidney and Renal Pelvis|2002
<1|~|~|~|~|Mortality|3951461|Larynx|2002
<1|~|~|~|~|Incidence|3910837|Larynx|2002
<1|0.3|0.8|0.5|21|Mortality|3951461|Leukemias|2002
<1|3.6|5.0|4.3|167|Incidence|3910837|Leukemias|2002
<1|~|~|~|~|Mortality|3951461|Liver and Intrahepatic Bile Duct|2002
<1|0.6|1.2|0.8|33|Incidence|3910837|Liver and Intrahepatic Bile Duct|2002
<1|~|~|~|~|Mortality|3951461|Lung and Bronchus|2002
<1|~|~|~|~|Incidence|3910837|Lung and Bronchus|2002
<1|~|~|~|~|Mortality|1932939|Male and Female Breast|2002
<1|~|~|~|~|Incidence|1913004|Male and Female Breast|2002
<1|~|~|~|~|Incidence|1913004|Male and Female Breast, <i>in situ</i>|2002
<1|~|~|~|~|Mortality|3951461|Melanomas of the Skin|2002
<1|~|~|~|~|Incidence|3910837|Melanomas of the Skin|2002
<1|~|~|~|~|Mortality|3951461|Mesothelioma|2002
<1|~|~|~|~|Incidence|3910837|Mesothelioma|2002
<1|~|~|~|~|Mortality|3951461|Myeloma|2002
<1|~|~|~|~|Incidence|3910837|Myeloma|2002
<1|~|~|~|~|Mortality|3951461|Non-Hodgkin Lymphoma|2002
<1|~|~|~|~|Incidence|3910837|Non-Hodgkin Lymphoma|2002
<1|~|~|~|~|Mortality|3951461|Oral Cavity and Pharynx|2002
<1|~|~|~|~|Incidence|3910837|Oral Cavity and Pharynx|2002
<1|~|~|~|~|Mortality|1932939|Ovary|2002
<1|~|~|~|~|Incidence|1913004|Ovary|2002
<1|~|~|~|~|Mortality|3951461|Pancreas|2002
<1|~|~|~|~|Incidence|3910837|Pancreas|2002
<1|~|~|~|~|Mortality|2018522|Prostate|2002
<1|~|~|~|~|Incidence|1997833|Prostate|2002
<1|~|~|~|~|Mortality|3951461|Stomach|2002
<1|~|~|~|~|Incidence|3910837|Stomach|2002
<1|~|~|~|~|Mortality|2018522|Testis|2002
<1|0.7|1.7|1.1|22|Incidence|1997833|Testis|2002
<1|~|~|~|~|Mortality|3951461|Thyroid|2002
<1|~|~|~|~|Incidence|3910837|Thyroid|2002
<1|~|~|~|~|Mortality|3951461|Urinary Bladder|2002
<1|~|~|~|~|Incidence|3910837|Urinary Bladder|2002
1-4|2.3|2.8|2.5|392|Mortality|15616575|All Cancer Sites Combined|2003
1-4|20.1|21.5|20.8|3248|Incidence|15616575|All Cancer Sites Combined|2003
1-4|0.5|0.8|0.7|104|Mortality|15616575|Brain and Other Nervous System|2003
1-4|3.9|4.5|4.2|654|Incidence|15616575|Brain and Other Nervous System|2003
1-4|~|~|~|~|Mortality|7636693|Cervix|2003
1-4|~|~|~|~|Incidence|7636693|Cervix|2003
1-4|~|~|~|~|Mortality|15616575|Colon and Rectum|2003
1-4|~|~|~|~|Incidence|15616575|Colon and Rectum|2003
1-4|~|~|~|~|Mortality|7636693|Corpus and Uterus, NOS|2003
1-4|~|~|~|~|Incidence|7636693|Corpus and Uterus, NOS|2003
1-4|~|~|~|~|Mortality|15616575|Esophagus|2003
1-4|~|~|~|~|Incidence|15616575|Esophagus|2003
1-4|~|~|~|~|Mortality|7636693|Female Breast|2003
1-4|~|~|~|~|Incidence|7636693|Female Breast|2003
1-4|~|~|~|~|Incidence|7636693|Female Breast, <i>in situ</i>|2003
1-4|~|~|~|~|Mortality|15616575|Hodgkin Lymphoma|2003
1-4|0.1|0.2|0.1|18|Incidence|15616575|Hodgkin Lymphoma|2003
1-4|.|.|.|.|Mortality|15616575|Kaposi Sarcoma|2003
1-4|~|~|~|~|Incidence|15616575|Kaposi Sarcoma|2003
1-4|~|~|~|~|Mortality|15616575|Kidney and Renal Pelvis|2003
1-4|1.8|2.3|2.0|315|Incidence|15616575|Kidney and Renal Pelvis|2003
1-4|~|~|~|~|Mortality|15616575|Larynx|2003
1-4|~|~|~|~|Incidence|15616575|Larynx|2003
1-4|0.7|1.0|0.9|133|Mortality|15616575|Leukemias|2003
1-4|7.7|8.6|8.1|1266|Incidence|15616575|Leukemias|2003
1-4|0.1|0.2|0.1|23|Mortality|15616575|Liver and Intrahepatic Bile Duct|2003
1-4|0.4|0.6|0.5|72|Incidence|15616575|Liver and Intrahepatic Bile Duct|2003
1-4|~|~|~|~|Mortality|15616575|Lung and Bronchus|2003
1-4|~|~|~|~|Incidence|15616575|Lung and Bronchus|2003
1-4|~|~|~|~|Mortality|7636693|Male and Female Breast|2003
1-4|~|~|~|~|Incidence|7636693|Male and Female Breast|2003
1-4|~|~|~|~|Incidence|7636693|Male and Female Breast, <i>in situ</i>|2003
1-4|~|~|~|~|Mortality|15616575|Melanomas of the Skin|2003
1-4|~|~|~|~|Incidence|15616575|Melanomas of the Skin|2003
1-4|~|~|~|~|Mortality|15616575|Mesothelioma|2003
1-4|~|~|~|~|Incidence|15616575|Mesothelioma|2003
1-4|~|~|~|~|Mortality|15616575|Myeloma|2003
1-4|~|~|~|~|Incidence|15616575|Myeloma|2003
1-4|~|~|~|~|Mortality|15616575|Non-Hodgkin Lymphoma|2003
1-4|0.6|0.9|0.7|115|Incidence|15616575|Non-Hodgkin Lymphoma|2003
1-4|~|~|~|~|Mortality|15616575|Oral Cavity and Pharynx|2003
1-4|~|~|~|~|Incidence|15616575|Oral Cavity and Pharynx|2003
1-4|~|~|~|~|Mortality|7636693|Ovary|2003
1-4|~|~|~|~|Incidence|7636693|Ovary|2003
1-4|~|~|~|~|Mortality|15616575|Pancreas|2003
1-4|~|~|~|~|Incidence|15616575|Pancreas|2003
1-4|~|~|~|~|Mortality|7979882|Prostate|2003
1-4|~|~|~|~|Incidence|7979882|Prostate|2003
1-4|~|~|~|~|Mortality|15616575|Stomach|2003
1-4|~|~|~|~|Incidence|15616575|Stomach|2003
1-4|~|~|~|~|Mortality|7979882|Testis|2003
1-4|0.2|0.4|0.3|24|Incidence|7979882|Testis|2003
1-4|~|~|~|~|Mortality|15616575|Thyroid|2003
1-4|~|~|~|~|Incidence|15616575|Thyroid|2003
1-4|~|~|~|~|Mortality|15616575|Urinary Bladder|2003
1-4|~|~|~|~|Incidence|15616575|Urinary Bladder|2003
10-14|2.4|2.8|2.6|560|Mortality|21415353|All Cancer Sites Combined|2003
10-14|12.3|13.3|12.8|2736|Incidence|21415353|All Cancer Sites Combined|2003
10-14|0.6|0.9|0.8|161|Mortality|21415353|Brain and Other Nervous System|2003
10-14|2.5|2.9|2.7|580|Incidence|21415353|Brain and Other Nervous System|2003
10-14|~|~|~|~|Mortality|10444875|Cervix|2003
10-14|~|~|~|~|Incidence|10444875|Cervix|2003
10-14|~|~|~|~|Mortality|21415353|Colon and Rectum|2003
10-14|0.0|0.1|0.1|18|Incidence|21415353|Colon and Rectum|2003
10-14|~|~|~|~|Mortality|10444875|Corpus and Uterus, NOS|2003
10-14|~|~|~|~|Incidence|10444875|Corpus and Uterus, NOS|2003
10-14|~|~|~|~|Mortality|21415353|Esophagus|2003
10-14|~|~|~|~|Incidence|21415353|Esophagus|2003
10-14|~|~|~|~|Mortality|10444875|Female Breast|2003
10-14|~|~|~|~|Incidence|10444875|Female Breast|2003
10-14|~|~|~|~|Incidence|10444875|Female Breast, <i>in situ</i>|2003
10-14|~|~|~|~|Mortality|21415353|Hodgkin Lymphoma|2003
10-14|1.0|1.3|1.2|254|Incidence|21415353|Hodgkin Lymphoma|2003
10-14|.|.|.|.|Mortality|21415353|Kaposi Sarcoma|2003
10-14|~|~|~|~|Incidence|21415353|Kaposi Sarcoma|2003
10-14|~|~|~|~|Mortality|21415353|Kidney and Renal Pelvis|2003
10-14|0.1|0.2|0.2|34|Incidence|21415353|Kidney and Renal Pelvis|2003
10-14|~|~|~|~|Mortality|21415353|Larynx|2003
10-14|~|~|~|~|Incidence|21415353|Larynx|2003
10-14|0.7|1.0|0.9|186|Mortality|21415353|Leukemias|2003
10-14|2.3|2.8|2.6|548|Incidence|21415353|Leukemias|2003
10-14|~|~|~|~|Mortality|21415353|Liver and Intrahepatic Bile Duct|2003
10-14|0.1|0.2|0.1|29|Incidence|21415353|Liver and Intrahepatic Bile Duct|2003
10-14|~|~|~|~|Mortality|21415353|Lung and Bronchus|2003
10-14|~|~|~|~|Incidence|21415353|Lung and Bronchus|2003
10-14|~|~|~|~|Mortality|10444875|Male and Female Breast|2003
10-14|~|~|~|~|Incidence|10444875|Male and Female Breast|2003
10-14|~|~|~|~|Incidence|10444875|Male and Female Breast, <i>in situ</i>|2003
10-14|~|~|~|~|Mortality|21415353|Melanomas of the Skin|2003
10-14|0.3|0.5|0.4|78|Incidence|21415353|Melanomas of the Skin|2003
10-14|~|~|~|~|Mortality|21415353|Mesothelioma|2003
10-14|~|~|~|~|Incidence|21415353|Mesothelioma|2003
10-14|~|~|~|~|Mortality|21415353|Myeloma|2003
10-14|~|~|~|~|Incidence|21415353|Myeloma|2003
10-14|0.1|0.2|0.1|28|Mortality|21415353|Non-Hodgkin Lymphoma|2003
10-14|0.9|1.2|1.0|219|Incidence|21415353|Non-Hodgkin Lymphoma|2003
10-14|~|~|~|~|Mortality|21415353|Oral Cavity and Pharynx|2003
10-14|0.2|0.4|0.3|58|Incidence|21415353|Oral Cavity and Pharynx|2003
10-14|~|~|~|~|Mortality|10444875|Ovary|2003
10-14|0.6|0.9|0.7|76|Incidence|10444875|Ovary|2003
10-14|~|~|~|~|Mortality|21415353|Pancreas|2003
10-14|~|~|~|~|Incidence|21415353|Pancreas|2003
10-14|~|~|~|~|Mortality|10970478|Prostate|2003
10-14|~|~|~|~|Incidence|10970478|Prostate|2003
10-14|~|~|~|~|Mortality|21415353|Stomach|2003
10-14|~|~|~|~|Incidence|21415353|Stomach|2003
10-14|~|~|~|~|Mortality|10970478|Testis|2003
10-14|0.2|0.3|0.2|26|Incidence|10970478|Testis|2003
10-14|~|~|~|~|Mortality|21415353|Thyroid|2003
10-14|0.4|0.6|0.5|113|Incidence|21415353|Thyroid|2003
10-14|~|~|~|~|Mortality|21415353|Urinary Bladder|2003
10-14|~|~|~|~|Incidence|21415353|Urinary Bladder|2003
15-19|3.1|3.6|3.3|690|Mortality|20797166|All Cancer Sites Combined|2003
15-19|20.8|22.0|21.4|4448|Incidence|20797166|All Cancer Sites Combined|2003
15-19|0.5|0.7|0.6|119|Mortality|20797166|Brain and Other Nervous System|2003
15-19|2.0|2.4|2.2|465|Incidence|20797166|Brain and Other Nervous System|2003
15-19|~|~|~|~|Mortality|10086567|Cervix|2003
15-19|0.1|0.3|0.2|20|Incidence|10086567|Cervix|2003
15-19|~|~|~|~|Mortality|20797166|Colon and Rectum|2003
15-19|0.2|0.3|0.3|54|Incidence|20797166|Colon and Rectum|2003
15-19|~|~|~|~|Mortality|10086567|Corpus and Uterus, NOS|2003
15-19|~|~|~|~|Incidence|10086567|Corpus and Uterus, NOS|2003
15-19|~|~|~|~|Mortality|20797166|Esophagus|2003
15-19|~|~|~|~|Incidence|20797166|Esophagus|2003
15-19|~|~|~|~|Mortality|10086567|Female Breast|2003
15-19|0.1|0.3|0.2|17|Incidence|10086567|Female Breast|2003
15-19|~|~|~|~|Incidence|10086567|Female Breast, <i>in situ</i>|2003
15-19|0.0|0.1|0.1|16|Mortality|20797166|Hodgkin Lymphoma|2003
15-19|3.0|3.4|3.2|664|Incidence|20797166|Hodgkin Lymphoma|2003
15-19|.|.|.|.|Mortality|20797166|Kaposi Sarcoma|2003
15-19|~|~|~|~|Incidence|20797166|Kaposi Sarcoma|2003
15-19|~|~|~|~|Mortality|20797166|Kidney and Renal Pelvis|2003
15-19|0.1|0.2|0.1|31|Incidence|20797166|Kidney and Renal Pelvis|2003
15-19|~|~|~|~|Mortality|20797166|Larynx|2003
15-19|~|~|~|~|Incidence|20797166|Larynx|2003
15-19|0.8|1.0|0.9|183|Mortality|20797166|Leukemias|2003
15-19|2.5|3.0|2.7|568|Incidence|20797166|Leukemias|2003
15-19|~|~|~|~|Mortality|20797166|Liver and Intrahepatic Bile Duct|2003
15-19|0.1|0.2|0.1|24|Incidence|20797166|Liver and Intrahepatic Bile Duct|2003
15-19|~|~|~|~|Mortality|20797166|Lung and Bronchus|2003
15-19|0.1|0.2|0.1|26|Incidence|20797166|Lung and Bronchus|2003
15-19|~|~|~|~|Mortality|10086567|Male and Female Breast|2003
15-19|0.1|0.3|0.2|17|Incidence|10086567|Male and Female Breast|2003
15-19|~|~|~|~|Incidence|10086567|Male and Female Breast, <i>in situ</i>|2003
15-19|~|~|~|~|Mortality|20797166|Melanomas of the Skin|2003
15-19|1.6|1.9|1.7|363|Incidence|20797166|Melanomas of the Skin|2003
15-19|~|~|~|~|Mortality|20797166|Mesothelioma|2003
15-19|~|~|~|~|Incidence|20797166|Mesothelioma|2003
15-19|~|~|~|~|Mortality|20797166|Myeloma|2003
15-19|~|~|~|~|Incidence|20797166|Myeloma|2003
15-19|0.2|0.3|0.3|53|Mortality|20797166|Non-Hodgkin Lymphoma|2003
15-19|1.4|1.8|1.6|334|Incidence|20797166|Non-Hodgkin Lymphoma|2003
15-19|~|~|~|~|Mortality|20797166|Oral Cavity and Pharynx|2003
15-19|0.4|0.6|0.5|108|Incidence|20797166|Oral Cavity and Pharynx|2003
15-19|~|~|~|~|Mortality|10086567|Ovary|2003
15-19|1.0|1.5|1.3|127|Incidence|10086567|Ovary|2003
15-19|~|~|~|~|Mortality|20797166|Pancreas|2003
15-19|~|~|~|~|Incidence|20797166|Pancreas|2003
15-19|~|~|~|~|Mortality|10710599|Prostate|2003
15-19|~|~|~|~|Incidence|10710599|Prostate|2003
15-19|~|~|~|~|Mortality|20797166|Stomach|2003
15-19|~|~|~|~|Incidence|20797166|Stomach|2003
15-19|~|~|~|~|Mortality|10710599|Testis|2003
15-19|3.0|3.7|3.3|356|Incidence|10710599|Testis|2003
15-19|~|~|~|~|Mortality|20797166|Thyroid|2003
15-19|1.6|2.0|1.8|379|Incidence|20797166|Thyroid|2003
15-19|~|~|~|~|Mortality|20797166|Urinary Bladder|2003
15-19|0.1|0.2|0.1|22|Incidence|20797166|Urinary Bladder|2003
5-9|2.4|2.9|2.6|516|Mortality|19620851|All Cancer Sites Combined|2003
5-9|11.0|12.0|11.5|2250|Incidence|19620851|All Cancer Sites Combined|2003
5-9|0.8|1.0|0.9|175|Mortality|19620851|Brain and Other Nervous System|2003
5-9|3.0|3.5|3.3|643|Incidence|19620851|Brain and Other Nervous System|2003
5-9|~|~|~|~|Mortality|9581247|Cervix|2003
5-9|~|~|~|~|Incidence|9581247|Cervix|2003
5-9|~|~|~|~|Mortality|19620851|Colon and Rectum|2003
5-9|~|~|~|~|Incidence|19620851|Colon and Rectum|2003
5-9|~|~|~|~|Mortality|9581247|Corpus and Uterus, NOS|2003
5-9|~|~|~|~|Incidence|9581247|Corpus and Uterus, NOS|2003
5-9|~|~|~|~|Mortality|19620851|Esophagus|2003
5-9|~|~|~|~|Incidence|19620851|Esophagus|2003
5-9|~|~|~|~|Mortality|9581247|Female Breast|2003
5-9|~|~|~|~|Incidence|9581247|Female Breast|2003
5-9|~|~|~|~|Incidence|9581247|Female Breast, <i>in situ</i>|2003
5-9|~|~|~|~|Mortality|19620851|Hodgkin Lymphoma|2003
5-9|0.4|0.5|0.4|87|Incidence|19620851|Hodgkin Lymphoma|2003
5-9|.|.|.|.|Mortality|19620851|Kaposi Sarcoma|2003
5-9|~|~|~|~|Incidence|19620851|Kaposi Sarcoma|2003
5-9|0.1|0.2|0.1|28|Mortality|19620851|Kidney and Renal Pelvis|2003
5-9|0.4|0.6|0.5|104|Incidence|19620851|Kidney and Renal Pelvis|2003
5-9|~|~|~|~|Mortality|19620851|Larynx|2003
5-9|~|~|~|~|Incidence|19620851|Larynx|2003
5-9|0.7|0.9|0.8|156|Mortality|19620851|Leukemias|2003
5-9|3.6|4.1|3.9|757|Incidence|19620851|Leukemias|2003
5-9|~|~|~|~|Mortality|19620851|Liver and Intrahepatic Bile Duct|2003
5-9|0.1|0.1|0.1|17|Incidence|19620851|Liver and Intrahepatic Bile Duct|2003
5-9|~|~|~|~|Mortality|19620851|Lung and Bronchus|2003
5-9|~|~|~|~|Incidence|19620851|Lung and Bronchus|2003
5-9|~|~|~|~|Mortality|9581247|Male and Female Breast|2003
5-9|~|~|~|~|Incidence|9581247|Male and Female Breast|2003
5-9|~|~|~|~|Incidence|9581247|Male and Female Breast, <i>in situ</i>|2003
5-9|~|~|~|~|Mortality|19620851|Melanomas of the Skin|2003
5-9|~|~|~|~|Incidence|19620851|Melanomas of the Skin|2003
5-9|~|~|~|~|Mortality|19620851|Mesothelioma|2003
5-9|~|~|~|~|Incidence|19620851|Mesothelioma|2003
5-9|~|~|~|~|Mortality|19620851|Myeloma|2003
5-9|~|~|~|~|Incidence|19620851|Myeloma|2003
5-9|0.1|0.1|0.1|17|Mortality|19620851|Non-Hodgkin Lymphoma|2003
5-9|0.9|1.2|1.0|203|Incidence|19620851|Non-Hodgkin Lymphoma|2003
5-9|~|~|~|~|Mortality|19620851|Oral Cavity and Pharynx|2003
5-9|0.1|0.2|0.2|31|Incidence|19620851|Oral Cavity and Pharynx|2003
5-9|~|~|~|~|Mortality|9581247|Ovary|2003
5-9|~|~|~|~|Incidence|9581247|Ovary|2003
5-9|~|~|~|~|Mortality|19620851|Pancreas|2003
5-9|~|~|~|~|Incidence|19620851|Pancreas|2003
5-9|~|~|~|~|Mortality|10039604|Prostate|2003
5-9|~|~|~|~|Incidence|10039604|Prostate|2003
5-9|~|~|~|~|Mortality|19620851|Stomach|2003
5-9|~|~|~|~|Incidence|19620851|Stomach|2003
5-9|~|~|~|~|Mortality|10039604|Testis|2003
5-9|~|~|~|~|Incidence|10039604|Testis|2003
5-9|~|~|~|~|Mortality|19620851|Thyroid|2003
5-9|~|~|~|~|Incidence|19620851|Thyroid|2003
5-9|~|~|~|~|Mortality|19620851|Urinary Bladder|2003
5-9|~|~|~|~|Incidence|19620851|Urinary Bladder|2003
<1|1.5|2.4|1.9|75|Mortality|3975871|All Cancer Sites Combined|2003
<1|23.6|26.7|25.1|999|Incidence|3975871|All Cancer Sites Combined|2003
<1|0.3|0.7|0.5|18|Mortality|3975871|Brain and Other Nervous System|2003
<1|3.2|4.4|3.7|149|Incidence|3975871|Brain and Other Nervous System|2003
<1|~|~|~|~|Mortality|1942634|Cervix|2003
<1|~|~|~|~|Incidence|1942634|Cervix|2003
<1|~|~|~|~|Mortality|3975871|Colon and Rectum|2003
<1|~|~|~|~|Incidence|3975871|Colon and Rectum|2003
<1|~|~|~|~|Mortality|1942634|Corpus and Uterus, NOS|2003
<1|~|~|~|~|Incidence|1942634|Corpus and Uterus, NOS|2003
<1|~|~|~|~|Mortality|3975871|Esophagus|2003
<1|~|~|~|~|Incidence|3975871|Esophagus|2003
<1|~|~|~|~|Mortality|1942634|Female Breast|2003
<1|~|~|~|~|Incidence|1942634|Female Breast|2003
<1|~|~|~|~|Incidence|1942634|Female Breast, <i>in situ</i>|2003
<1|~|~|~|~|Mortality|3975871|Hodgkin Lymphoma|2003
<1|~|~|~|~|Incidence|3975871|Hodgkin Lymphoma|2003
<1|.|.|.|.|Mortality|3975871|Kaposi Sarcoma|2003
<1|~|~|~|~|Incidence|3975871|Kaposi Sarcoma|2003
<1|~|~|~|~|Mortality|3975871|Kidney and Renal Pelvis|2003
<1|1.5|2.3|1.9|74|Incidence|3975871|Kidney and Renal Pelvis|2003
<1|~|~|~|~|Mortality|3975871|Larynx|2003
<1|~|~|~|~|Incidence|3975871|Larynx|2003
<1|0.5|1.1|0.8|30|Mortality|3975871|Leukemias|2003
<1|3.8|5.1|4.4|176|Incidence|3975871|Leukemias|2003
<1|~|~|~|~|Mortality|3975871|Liver and Intrahepatic Bile Duct|2003
<1|1.0|1.8|1.4|54|Incidence|3975871|Liver and Intrahepatic Bile Duct|2003
<1|~|~|~|~|Mortality|3975871|Lung and Bronchus|2003
<1|~|~|~|~|Incidence|3975871|Lung and Bronchus|2003
<1|~|~|~|~|Mortality|1942634|Male and Female Breast|2003
<1|~|~|~|~|Incidence|1942634|Male and Female Breast|2003
<1|~|~|~|~|Incidence|1942634|Male and Female Breast, <i>in situ</i>|2003
<1|~|~|~|~|Mortality|3975871|Melanomas of the Skin|2003
<1|~|~|~|~|Incidence|3975871|Melanomas of the Skin|2003
<1|~|~|~|~|Mortality|3975871|Mesothelioma|2003
<1|~|~|~|~|Incidence|3975871|Mesothelioma|2003
<1|~|~|~|~|Mortality|3975871|Myeloma|2003
<1|~|~|~|~|Incidence|3975871|Myeloma|2003
<1|~|~|~|~|Mortality|3975871|Non-Hodgkin Lymphoma|2003
<1|~|~|~|~|Incidence|3975871|Non-Hodgkin Lymphoma|2003
<1|~|~|~|~|Mortality|3975871|Oral Cavity and Pharynx|2003
<1|~|~|~|~|Incidence|3975871|Oral Cavity and Pharynx|2003
<1|~|~|~|~|Mortality|1942634|Ovary|2003
<1|~|~|~|~|Incidence|1942634|Ovary|2003
<1|~|~|~|~|Mortality|3975871|Pancreas|2003
<1|~|~|~|~|Incidence|3975871|Pancreas|2003
<1|~|~|~|~|Mortality|2033237|Prostate|2003
<1|~|~|~|~|Incidence|2033237|Prostate|2003
<1|~|~|~|~|Mortality|3975871|Stomach|2003
<1|~|~|~|~|Incidence|3975871|Stomach|2003
<1|~|~|~|~|Mortality|2033237|Testis|2003
<1|0.4|1.3|0.8|16|Incidence|2033237|Testis|2003
<1|~|~|~|~|Mortality|3975871|Thyroid|2003
<1|~|~|~|~|Incidence|3975871|Thyroid|2003
<1|~|~|~|~|Mortality|3975871|Urinary Bladder|2003
<1|~|~|~|~|Incidence|3975871|Urinary Bladder|2003
1-4|2.3|2.8|2.5|399|Mortality|15771627|All Cancer Sites Combined|2004
1-4|21.6|23.1|22.3|3524|Incidence|15771627|All Cancer Sites Combined|2004
1-4|0.5|0.8|0.6|102|Mortality|15771627|Brain and Other Nervous System|2004
1-4|4.3|5.0|4.6|728|Incidence|15771627|Brain and Other Nervous System|2004
1-4|~|~|~|~|Mortality|7713175|Cervix|2004
1-4|~|~|~|~|Incidence|7713175|Cervix|2004
1-4|~|~|~|~|Mortality|15771627|Colon and Rectum|2004
1-4|~|~|~|~|Incidence|15771627|Colon and Rectum|2004
1-4|~|~|~|~|Mortality|7713175|Corpus and Uterus, NOS|2004
1-4|~|~|~|~|Incidence|7713175|Corpus and Uterus, NOS|2004
1-4|~|~|~|~|Mortality|15771627|Esophagus|2004
1-4|~|~|~|~|Incidence|15771627|Esophagus|2004
1-4|~|~|~|~|Mortality|7713175|Female Breast|2004
1-4|~|~|~|~|Incidence|7713175|Female Breast|2004
1-4|~|~|~|~|Incidence|7713175|Female Breast, <i>in situ</i>|2004
1-4|~|~|~|~|Mortality|15771627|Hodgkin Lymphoma|2004
1-4|~|~|~|~|Incidence|15771627|Hodgkin Lymphoma|2004
1-4|.|.|.|.|Mortality|15771627|Kaposi Sarcoma|2004
1-4|~|~|~|~|Incidence|15771627|Kaposi Sarcoma|2004
1-4|0.1|0.2|0.1|18|Mortality|15771627|Kidney and Renal Pelvis|2004
1-4|1.8|2.3|2.0|323|Incidence|15771627|Kidney and Renal Pelvis|2004
1-4|~|~|~|~|Mortality|15771627|Larynx|2004
1-4|~|~|~|~|Incidence|15771627|Larynx|2004
1-4|0.6|0.9|0.8|120|Mortality|15771627|Leukemias|2004
1-4|8.7|9.7|9.2|1446|Incidence|15771627|Leukemias|2004
1-4|0.1|0.2|0.1|22|Mortality|15771627|Liver and Intrahepatic Bile Duct|2004
1-4|0.5|0.7|0.6|94|Incidence|15771627|Liver and Intrahepatic Bile Duct|2004
1-4|~|~|~|~|Mortality|15771627|Lung and Bronchus|2004
1-4|~|~|~|~|Incidence|15771627|Lung and Bronchus|2004
1-4|~|~|~|~|Mortality|7713175|Male and Female Breast|2004
1-4|~|~|~|~|Incidence|7713175|Male and Female Breast|2004
1-4|~|~|~|~|Incidence|7713175|Male and Female Breast, <i>in situ</i>|2004
1-4|~|~|~|~|Mortality|15771627|Melanomas of the Skin|2004
1-4|0.1|0.2|0.1|19|Incidence|15771627|Melanomas of the Skin|2004
1-4|~|~|~|~|Mortality|15771627|Mesothelioma|2004
1-4|~|~|~|~|Incidence|15771627|Mesothelioma|2004
1-4|~|~|~|~|Mortality|15771627|Myeloma|2004
1-4|~|~|~|~|Incidence|15771627|Myeloma|2004
1-4|~|~|~|~|Mortality|15771627|Non-Hodgkin Lymphoma|2004
1-4|0.6|0.8|0.7|109|Incidence|15771627|Non-Hodgkin Lymphoma|2004
1-4|~|~|~|~|Mortality|15771627|Oral Cavity and Pharynx|2004
1-4|~|~|~|~|Incidence|15771627|Oral Cavity and Pharynx|2004
1-4|~|~|~|~|Mortality|7713175|Ovary|2004
1-4|~|~|~|~|Incidence|7713175|Ovary|2004
1-4|~|~|~|~|Mortality|15771627|Pancreas|2004
1-4|~|~|~|~|Incidence|15771627|Pancreas|2004
1-4|~|~|~|~|Mortality|8058452|Prostate|2004
1-4|~|~|~|~|Incidence|8058452|Prostate|2004
1-4|~|~|~|~|Mortality|15771627|Stomach|2004
1-4|~|~|~|~|Incidence|15771627|Stomach|2004
1-4|~|~|~|~|Mortality|8058452|Testis|2004
1-4|0.2|0.4|0.3|21|Incidence|8058452|Testis|2004
1-4|~|~|~|~|Mortality|15771627|Thyroid|2004
1-4|~|~|~|~|Incidence|15771627|Thyroid|2004
1-4|~|~|~|~|Mortality|15771627|Urinary Bladder|2004
1-4|~|~|~|~|Incidence|15771627|Urinary Bladder|2004
10-14|2.1|2.5|2.3|493|Mortality|21411680|All Cancer Sites Combined|2004
10-14|12.9|13.9|13.4|2865|Incidence|21411680|All Cancer Sites Combined|2004
10-14|0.5|0.8|0.6|139|Mortality|21411680|Brain and Other Nervous System|2004
10-14|2.5|2.9|2.7|580|Incidence|21411680|Brain and Other Nervous System|2004
10-14|~|~|~|~|Mortality|10443706|Cervix|2004
10-14|~|~|~|~|Incidence|10443706|Cervix|2004
10-14|~|~|~|~|Mortality|21411680|Colon and Rectum|2004
10-14|~|~|~|~|Incidence|21411680|Colon and Rectum|2004
10-14|~|~|~|~|Mortality|10443706|Corpus and Uterus, NOS|2004
10-14|~|~|~|~|Incidence|10443706|Corpus and Uterus, NOS|2004
10-14|~|~|~|~|Mortality|21411680|Esophagus|2004
10-14|~|~|~|~|Incidence|21411680|Esophagus|2004
10-14|~|~|~|~|Mortality|10443706|Female Breast|2004
10-14|~|~|~|~|Incidence|10443706|Female Breast|2004
10-14|~|~|~|~|Incidence|10443706|Female Breast, <i>in situ</i>|2004
10-14|~|~|~|~|Mortality|21411680|Hodgkin Lymphoma|2004
10-14|1.0|1.3|1.1|242|Incidence|21411680|Hodgkin Lymphoma|2004
10-14|.|.|.|.|Mortality|21411680|Kaposi Sarcoma|2004
10-14|~|~|~|~|Incidence|21411680|Kaposi Sarcoma|2004
10-14|~|~|~|~|Mortality|21411680|Kidney and Renal Pelvis|2004
10-14|0.1|0.2|0.2|39|Incidence|21411680|Kidney and Renal Pelvis|2004
10-14|~|~|~|~|Mortality|21411680|Larynx|2004
10-14|~|~|~|~|Incidence|21411680|Larynx|2004
10-14|0.6|0.9|0.7|156|Mortality|21411680|Leukemias|2004
10-14|2.6|3.1|2.8|604|Incidence|21411680|Leukemias|2004
10-14|~|~|~|~|Mortality|21411680|Liver and Intrahepatic Bile Duct|2004
10-14|~|~|~|~|Incidence|21411680|Liver and Intrahepatic Bile Duct|2004
10-14|~|~|~|~|Mortality|21411680|Lung and Bronchus|2004
10-14|~|~|~|~|Incidence|21411680|Lung and Bronchus|2004
10-14|~|~|~|~|Mortality|10443706|Male and Female Breast|2004
10-14|~|~|~|~|Incidence|10443706|Male and Female Breast|2004
10-14|~|~|~|~|Incidence|10443706|Male and Female Breast, <i>in situ</i>|2004
10-14|~|~|~|~|Mortality|21411680|Melanomas of the Skin|2004
10-14|0.3|0.5|0.4|84|Incidence|21411680|Melanomas of the Skin|2004
10-14|~|~|~|~|Mortality|21411680|Mesothelioma|2004
10-14|~|~|~|~|Incidence|21411680|Mesothelioma|2004
10-14|~|~|~|~|Mortality|21411680|Myeloma|2004
10-14|~|~|~|~|Incidence|21411680|Myeloma|2004
10-14|0.1|0.1|0.1|19|Mortality|21411680|Non-Hodgkin Lymphoma|2004
10-14|1.1|1.5|1.3|276|Incidence|21411680|Non-Hodgkin Lymphoma|2004
10-14|~|~|~|~|Mortality|21411680|Oral Cavity and Pharynx|2004
10-14|0.2|0.3|0.3|55|Incidence|21411680|Oral Cavity and Pharynx|2004
10-14|~|~|~|~|Mortality|10443706|Ovary|2004
10-14|0.7|1.1|0.9|92|Incidence|10443706|Ovary|2004
10-14|~|~|~|~|Mortality|21411680|Pancreas|2004
10-14|~|~|~|~|Incidence|21411680|Pancreas|2004
10-14|~|~|~|~|Mortality|10967974|Prostate|2004
10-14|~|~|~|~|Incidence|10967974|Prostate|2004
10-14|~|~|~|~|Mortality|21411680|Stomach|2004
10-14|~|~|~|~|Incidence|21411680|Stomach|2004
10-14|~|~|~|~|Mortality|10967974|Testis|2004
10-14|0.2|0.4|0.3|31|Incidence|10967974|Testis|2004
10-14|~|~|~|~|Mortality|21411680|Thyroid|2004
10-14|0.5|0.7|0.5|117|Incidence|21411680|Thyroid|2004
10-14|~|~|~|~|Mortality|21411680|Urinary Bladder|2004
10-14|~|~|~|~|Incidence|21411680|Urinary Bladder|2004
15-19|3.2|3.7|3.5|731|Mortality|21102552|All Cancer Sites Combined|2004
15-19|21.1|22.4|21.7|4589|Incidence|21102552|All Cancer Sites Combined|2004
15-19|0.4|0.6|0.5|109|Mortality|21102552|Brain and Other Nervous System|2004
15-19|2.1|2.6|2.3|495|Incidence|21102552|Brain and Other Nervous System|2004
15-19|~|~|~|~|Mortality|10242793|Cervix|2004
15-19|0.1|0.3|0.2|17|Incidence|10242793|Cervix|2004
15-19|~|~|~|~|Mortality|21102552|Colon and Rectum|2004
15-19|0.2|0.3|0.3|54|Incidence|21102552|Colon and Rectum|2004
15-19|~|~|~|~|Mortality|10242793|Corpus and Uterus, NOS|2004
15-19|~|~|~|~|Incidence|10242793|Corpus and Uterus, NOS|2004
15-19|~|~|~|~|Mortality|21102552|Esophagus|2004
15-19|~|~|~|~|Incidence|21102552|Esophagus|2004
15-19|~|~|~|~|Mortality|10242793|Female Breast|2004
15-19|0.1|0.3|0.2|17|Incidence|10242793|Female Breast|2004
15-19|~|~|~|~|Incidence|10242793|Female Breast, <i>in situ</i>|2004
15-19|0.0|0.1|0.1|17|Mortality|21102552|Hodgkin Lymphoma|2004
15-19|2.9|3.4|3.2|667|Incidence|21102552|Hodgkin Lymphoma|2004
15-19|.|.|.|.|Mortality|21102552|Kaposi Sarcoma|2004
15-19|~|~|~|~|Incidence|21102552|Kaposi Sarcoma|2004
15-19|~|~|~|~|Mortality|21102552|Kidney and Renal Pelvis|2004
15-19|0.1|0.3|0.2|42|Incidence|21102552|Kidney and Renal Pelvis|2004
15-19|~|~|~|~|Mortality|21102552|Larynx|2004
15-19|~|~|~|~|Incidence|21102552|Larynx|2004
15-19|0.9|1.1|1.0|210|Mortality|21102552|Leukemias|2004
15-19|2.6|3.1|2.9|606|Incidence|21102552|Leukemias|2004
15-19|0.0|0.1|0.1|16|Mortality|21102552|Liver and Intrahepatic Bile Duct|2004
15-19|0.1|0.3|0.2|39|Incidence|21102552|Liver and Intrahepatic Bile Duct|2004
15-19|~|~|~|~|Mortality|21102552|Lung and Bronchus|2004
15-19|0.1|0.2|0.1|23|Incidence|21102552|Lung and Bronchus|2004
15-19|~|~|~|~|Mortality|10242793|Male and Female Breast|2004
15-19|0.1|0.3|0.2|17|Incidence|10242793|Male and Female Breast|2004
15-19|~|~|~|~|Incidence|10242793|Male and Female Breast, <i>in situ</i>|2004
15-19|~|~|~|~|Mortality|21102552|Melanomas of the Skin|2004
15-19|1.6|2.0|1.8|379|Incidence|21102552|Melanomas of the Skin|2004
15-19|~|~|~|~|Mortality|21102552|Mesothelioma|2004
15-19|~|~|~|~|Incidence|21102552|Mesothelioma|2004
15-19|~|~|~|~|Mortality|21102552|Myeloma|2004
15-19|~|~|~|~|Incidence|21102552|Myeloma|2004
15-19|0.2|0.3|0.3|56|Mortality|21102552|Non-Hodgkin Lymphoma|2004
15-19|1.5|1.8|1.6|345|Incidence|21102552|Non-Hodgkin Lymphoma|2004
15-19|~|~|~|~|Mortality|21102552|Oral Cavity and Pharynx|2004
15-19|0.3|0.5|0.4|85|Incidence|21102552|Oral Cavity and Pharynx|2004
15-19|~|~|~|~|Mortality|10242793|Ovary|2004
15-19|1.0|1.5|1.2|126|Incidence|10242793|Ovary|2004
15-19|~|~|~|~|Mortality|21102552|Pancreas|2004
15-19|~|~|~|~|Incidence|21102552|Pancreas|2004
15-19|~|~|~|~|Mortality|10859759|Prostate|2004
15-19|~|~|~|~|Incidence|10859759|Prostate|2004
15-19|~|~|~|~|Mortality|21102552|Stomach|2004
15-19|~|~|~|~|Incidence|21102552|Stomach|2004
15-19|~|~|~|~|Mortality|10859759|Testis|2004
15-19|3.2|3.9|3.5|383|Incidence|10859759|Testis|2004
15-19|~|~|~|~|Mortality|21102552|Thyroid|2004
15-19|1.8|2.1|1.9|409|Incidence|21102552|Thyroid|2004
15-19|~|~|~|~|Mortality|21102552|Urinary Bladder|2004
15-19|0.1|0.2|0.1|23|Incidence|21102552|Urinary Bladder|2004
5-9|2.5|2.9|2.7|526|Mortality|19454237|All Cancer Sites Combined|2004
5-9|11.5|12.5|12.0|2327|Incidence|19454237|All Cancer Sites Combined|2004
5-9|0.8|1.1|1.0|186|Mortality|19454237|Brain and Other Nervous System|2004
5-9|3.3|3.9|3.6|696|Incidence|19454237|Brain and Other Nervous System|2004
5-9|~|~|~|~|Mortality|9503231|Cervix|2004
5-9|~|~|~|~|Incidence|9503231|Cervix|2004
5-9|~|~|~|~|Mortality|19454237|Colon and Rectum|2004
5-9|~|~|~|~|Incidence|19454237|Colon and Rectum|2004
5-9|~|~|~|~|Mortality|9503231|Corpus and Uterus, NOS|2004
5-9|~|~|~|~|Incidence|9503231|Corpus and Uterus, NOS|2004
5-9|~|~|~|~|Mortality|19454237|Esophagus|2004
5-9|~|~|~|~|Incidence|19454237|Esophagus|2004
5-9|~|~|~|~|Mortality|9503231|Female Breast|2004
5-9|~|~|~|~|Incidence|9503231|Female Breast|2004
5-9|~|~|~|~|Incidence|9503231|Female Breast, <i>in situ</i>|2004
5-9|~|~|~|~|Mortality|19454237|Hodgkin Lymphoma|2004
5-9|0.3|0.4|0.3|68|Incidence|19454237|Hodgkin Lymphoma|2004
5-9|.|.|.|.|Mortality|19454237|Kaposi Sarcoma|2004
5-9|~|~|~|~|Incidence|19454237|Kaposi Sarcoma|2004
5-9|0.1|0.2|0.1|23|Mortality|19454237|Kidney and Renal Pelvis|2004
5-9|0.4|0.6|0.5|92|Incidence|19454237|Kidney and Renal Pelvis|2004
5-9|~|~|~|~|Mortality|19454237|Larynx|2004
5-9|~|~|~|~|Incidence|19454237|Larynx|2004
5-9|0.7|0.9|0.8|156|Mortality|19454237|Leukemias|2004
5-9|3.7|4.3|4.0|772|Incidence|19454237|Leukemias|2004
5-9|~|~|~|~|Mortality|19454237|Liver and Intrahepatic Bile Duct|2004
5-9|0.1|0.2|0.1|19|Incidence|19454237|Liver and Intrahepatic Bile Duct|2004
5-9|~|~|~|~|Mortality|19454237|Lung and Bronchus|2004
5-9|~|~|~|~|Incidence|19454237|Lung and Bronchus|2004
5-9|~|~|~|~|Mortality|9503231|Male and Female Breast|2004
5-9|~|~|~|~|Incidence|9503231|Male and Female Breast|2004
5-9|~|~|~|~|Incidence|9503231|Male and Female Breast, <i>in situ</i>|2004
5-9|~|~|~|~|Mortality|19454237|Melanomas of the Skin|2004
5-9|0.1|0.2|0.2|31|Incidence|19454237|Melanomas of the Skin|2004
5-9|~|~|~|~|Mortality|19454237|Mesothelioma|2004
5-9|~|~|~|~|Incidence|19454237|Mesothelioma|2004
5-9|~|~|~|~|Mortality|19454237|Myeloma|2004
5-9|~|~|~|~|Incidence|19454237|Myeloma|2004
5-9|0.1|0.2|0.1|22|Mortality|19454237|Non-Hodgkin Lymphoma|2004
5-9|0.8|1.1|0.9|183|Incidence|19454237|Non-Hodgkin Lymphoma|2004
5-9|~|~|~|~|Mortality|19454237|Oral Cavity and Pharynx|2004
5-9|~|~|~|~|Incidence|19454237|Oral Cavity and Pharynx|2004
5-9|~|~|~|~|Mortality|9503231|Ovary|2004
5-9|0.1|0.3|0.2|21|Incidence|9503231|Ovary|2004
5-9|~|~|~|~|Mortality|19454237|Pancreas|2004
5-9|~|~|~|~|Incidence|19454237|Pancreas|2004
5-9|~|~|~|~|Mortality|9951006|Prostate|2004
5-9|~|~|~|~|Incidence|9951006|Prostate|2004
5-9|~|~|~|~|Mortality|19454237|Stomach|2004
5-9|~|~|~|~|Incidence|19454237|Stomach|2004
5-9|~|~|~|~|Mortality|9951006|Testis|2004
5-9|~|~|~|~|Incidence|9951006|Testis|2004
5-9|~|~|~|~|Mortality|19454237|Thyroid|2004
5-9|0.1|0.3|0.2|40|Incidence|19454237|Thyroid|2004
5-9|~|~|~|~|Mortality|19454237|Urinary Bladder|2004
5-9|~|~|~|~|Incidence|19454237|Urinary Bladder|2004
<1|1.4|2.3|1.8|74|Mortality|4014258|All Cancer Sites Combined|2004
<1|23.8|26.9|25.3|1017|Incidence|4014258|All Cancer Sites Combined|2004
<1|0.3|0.7|0.5|19|Mortality|4014258|Brain and Other Nervous System|2004
<1|3.6|4.9|4.2|170|Incidence|4014258|Brain and Other Nervous System|2004
<1|~|~|~|~|Mortality|1962216|Cervix|2004
<1|~|~|~|~|Incidence|1962216|Cervix|2004
<1|~|~|~|~|Mortality|4014258|Colon and Rectum|2004
<1|~|~|~|~|Incidence|4014258|Colon and Rectum|2004
<1|~|~|~|~|Mortality|1962216|Corpus and Uterus, NOS|2004
<1|~|~|~|~|Incidence|1962216|Corpus and Uterus, NOS|2004
<1|~|~|~|~|Mortality|4014258|Esophagus|2004
<1|~|~|~|~|Incidence|4014258|Esophagus|2004
<1|~|~|~|~|Mortality|1962216|Female Breast|2004
<1|~|~|~|~|Incidence|1962216|Female Breast|2004
<1|~|~|~|~|Incidence|1962216|Female Breast, <i>in situ</i>|2004
<1|~|~|~|~|Mortality|4014258|Hodgkin Lymphoma|2004
<1|~|~|~|~|Incidence|4014258|Hodgkin Lymphoma|2004
<1|.|.|.|.|Mortality|4014258|Kaposi Sarcoma|2004
<1|~|~|~|~|Incidence|4014258|Kaposi Sarcoma|2004
<1|~|~|~|~|Mortality|4014258|Kidney and Renal Pelvis|2004
<1|1.0|1.7|1.3|52|Incidence|4014258|Kidney and Renal Pelvis|2004
<1|~|~|~|~|Mortality|4014258|Larynx|2004
<1|~|~|~|~|Incidence|4014258|Larynx|2004
<1|0.4|0.9|0.6|23|Mortality|4014258|Leukemias|2004
<1|3.8|5.1|4.4|178|Incidence|4014258|Leukemias|2004
<1|~|~|~|~|Mortality|4014258|Liver and Intrahepatic Bile Duct|2004
<1|1.1|1.9|1.4|58|Incidence|4014258|Liver and Intrahepatic Bile Duct|2004
<1|~|~|~|~|Mortality|4014258|Lung and Bronchus|2004
<1|~|~|~|~|Incidence|4014258|Lung and Bronchus|2004
<1|~|~|~|~|Mortality|1962216|Male and Female Breast|2004
<1|~|~|~|~|Incidence|1962216|Male and Female Breast|2004
<1|~|~|~|~|Incidence|1962216|Male and Female Breast, <i>in situ</i>|2004
<1|~|~|~|~|Mortality|4014258|Melanomas of the Skin|2004
<1|~|~|~|~|Incidence|4014258|Melanomas of the Skin|2004
<1|~|~|~|~|Mortality|4014258|Mesothelioma|2004
<1|~|~|~|~|Incidence|4014258|Mesothelioma|2004
<1|~|~|~|~|Mortality|4014258|Myeloma|2004
<1|~|~|~|~|Incidence|4014258|Myeloma|2004
<1|~|~|~|~|Mortality|4014258|Non-Hodgkin Lymphoma|2004
<1|~|~|~|~|Incidence|4014258|Non-Hodgkin Lymphoma|2004
<1|~|~|~|~|Mortality|4014258|Oral Cavity and Pharynx|2004
<1|~|~|~|~|Incidence|4014258|Oral Cavity and Pharynx|2004
<1|~|~|~|~|Mortality|1962216|Ovary|2004
<1|~|~|~|~|Incidence|1962216|Ovary|2004
<1|~|~|~|~|Mortality|4014258|Pancreas|2004
<1|~|~|~|~|Incidence|4014258|Pancreas|2004
<1|~|~|~|~|Mortality|2052042|Prostate|2004
<1|~|~|~|~|Incidence|2052042|Prostate|2004
<1|~|~|~|~|Mortality|4014258|Stomach|2004
<1|~|~|~|~|Incidence|4014258|Stomach|2004
<1|~|~|~|~|Mortality|2052042|Testis|2004
<1|~|~|~|~|Incidence|2052042|Testis|2004
<1|~|~|~|~|Mortality|4014258|Thyroid|2004
<1|~|~|~|~|Incidence|4014258|Thyroid|2004
<1|~|~|~|~|Mortality|4014258|Urinary Bladder|2004
<1|~|~|~|~|Incidence|4014258|Urinary Bladder|2004
1-4|2.1|2.6|2.4|377|Mortality|15913007|All Cancer Sites Combined|2005
1-4|20.8|22.2|21.5|3422|Incidence|15913007|All Cancer Sites Combined|2005
1-4|0.4|0.7|0.5|84|Mortality|15913007|Brain and Other Nervous System|2005
1-4|4.0|4.6|4.3|683|Incidence|15913007|Brain and Other Nervous System|2005
1-4|~|~|~|~|Mortality|7785123|Cervix|2005
1-4|~|~|~|~|Incidence|7785123|Cervix|2005
1-4|~|~|~|~|Mortality|15913007|Colon and Rectum|2005
1-4|~|~|~|~|Incidence|15913007|Colon and Rectum|2005
1-4|~|~|~|~|Mortality|7785123|Corpus and Uterus, NOS|2005
1-4|~|~|~|~|Incidence|7785123|Corpus and Uterus, NOS|2005
1-4|~|~|~|~|Mortality|15913007|Esophagus|2005
1-4|~|~|~|~|Incidence|15913007|Esophagus|2005
1-4|~|~|~|~|Mortality|7785123|Female Breast|2005
1-4|~|~|~|~|Incidence|7785123|Female Breast|2005
1-4|~|~|~|~|Incidence|7785123|Female Breast, <i>in situ</i>|2005
1-4|~|~|~|~|Mortality|15913007|Hodgkin Lymphoma|2005
1-4|0.1|0.2|0.1|16|Incidence|15913007|Hodgkin Lymphoma|2005
1-4|.|.|.|.|Mortality|15913007|Kaposi Sarcoma|2005
1-4|~|~|~|~|Incidence|15913007|Kaposi Sarcoma|2005
1-4|0.1|0.2|0.1|16|Mortality|15913007|Kidney and Renal Pelvis|2005
1-4|1.8|2.3|2.0|326|Incidence|15913007|Kidney and Renal Pelvis|2005
1-4|~|~|~|~|Mortality|15913007|Larynx|2005
1-4|~|~|~|~|Incidence|15913007|Larynx|2005
1-4|0.6|0.9|0.8|120|Mortality|15913007|Leukemias|2005
1-4|8.2|9.1|8.7|1379|Incidence|15913007|Leukemias|2005
1-4|0.1|0.2|0.1|21|Mortality|15913007|Liver and Intrahepatic Bile Duct|2005
1-4|0.4|0.6|0.5|79|Incidence|15913007|Liver and Intrahepatic Bile Duct|2005
1-4|~|~|~|~|Mortality|15913007|Lung and Bronchus|2005
1-4|~|~|~|~|Incidence|15913007|Lung and Bronchus|2005
1-4|~|~|~|~|Mortality|7785123|Male and Female Breast|2005
1-4|~|~|~|~|Incidence|7785123|Male and Female Breast|2005
1-4|~|~|~|~|Incidence|7785123|Male and Female Breast, <i>in situ</i>|2005
1-4|~|~|~|~|Mortality|15913007|Melanomas of the Skin|2005
1-4|0.1|0.2|0.1|18|Incidence|15913007|Melanomas of the Skin|2005
1-4|~|~|~|~|Mortality|15913007|Mesothelioma|2005
1-4|~|~|~|~|Incidence|15913007|Mesothelioma|2005
1-4|~|~|~|~|Mortality|15913007|Myeloma|2005
1-4|~|~|~|~|Incidence|15913007|Myeloma|2005
1-4|~|~|~|~|Mortality|15913007|Non-Hodgkin Lymphoma|2005
1-4|0.5|0.8|0.7|105|Incidence|15913007|Non-Hodgkin Lymphoma|2005
1-4|~|~|~|~|Mortality|15913007|Oral Cavity and Pharynx|2005
1-4|~|~|~|~|Incidence|15913007|Oral Cavity and Pharynx|2005
1-4|~|~|~|~|Mortality|7785123|Ovary|2005
1-4|~|~|~|~|Incidence|7785123|Ovary|2005
1-4|~|~|~|~|Mortality|15913007|Pancreas|2005
1-4|~|~|~|~|Incidence|15913007|Pancreas|2005
1-4|~|~|~|~|Mortality|8127884|Prostate|2005
1-4|~|~|~|~|Incidence|8127884|Prostate|2005
1-4|~|~|~|~|Mortality|15913007|Stomach|2005
1-4|~|~|~|~|Incidence|15913007|Stomach|2005
1-4|~|~|~|~|Mortality|8127884|Testis|2005
1-4|0.3|0.5|0.4|31|Incidence|8127884|Testis|2005
1-4|~|~|~|~|Mortality|15913007|Thyroid|2005
1-4|~|~|~|~|Incidence|15913007|Thyroid|2005
1-4|~|~|~|~|Mortality|15913007|Urinary Bladder|2005
1-4|~|~|~|~|Incidence|15913007|Urinary Bladder|2005
10-14|2.2|2.6|2.4|515|Mortality|21212579|All Cancer Sites Combined|2005
10-14|12.6|13.5|13.0|2766|Incidence|21212579|All Cancer Sites Combined|2005
10-14|0.5|0.8|0.6|136|Mortality|21212579|Brain and Other Nervous System|2005
10-14|2.5|2.9|2.7|567|Incidence|21212579|Brain and Other Nervous System|2005
10-14|~|~|~|~|Mortality|10348382|Cervix|2005
10-14|~|~|~|~|Incidence|10348382|Cervix|2005
10-14|~|~|~|~|Mortality|21212579|Colon and Rectum|2005
10-14|~|~|~|~|Incidence|21212579|Colon and Rectum|2005
10-14|~|~|~|~|Mortality|10348382|Corpus and Uterus, NOS|2005
10-14|~|~|~|~|Incidence|10348382|Corpus and Uterus, NOS|2005
10-14|~|~|~|~|Mortality|21212579|Esophagus|2005
10-14|~|~|~|~|Incidence|21212579|Esophagus|2005
10-14|~|~|~|~|Mortality|10348382|Female Breast|2005
10-14|~|~|~|~|Incidence|10348382|Female Breast|2005
10-14|~|~|~|~|Incidence|10348382|Female Breast, <i>in situ</i>|2005
10-14|~|~|~|~|Mortality|21212579|Hodgkin Lymphoma|2005
10-14|1.1|1.4|1.3|267|Incidence|21212579|Hodgkin Lymphoma|2005
10-14|.|.|.|.|Mortality|21212579|Kaposi Sarcoma|2005
10-14|~|~|~|~|Incidence|21212579|Kaposi Sarcoma|2005
10-14|~|~|~|~|Mortality|21212579|Kidney and Renal Pelvis|2005
10-14|0.1|0.2|0.1|26|Incidence|21212579|Kidney and Renal Pelvis|2005
10-14|~|~|~|~|Mortality|21212579|Larynx|2005
10-14|~|~|~|~|Incidence|21212579|Larynx|2005
10-14|0.6|0.8|0.7|150|Mortality|21212579|Leukemias|2005
10-14|2.6|3.1|2.8|603|Incidence|21212579|Leukemias|2005
10-14|~|~|~|~|Mortality|21212579|Liver and Intrahepatic Bile Duct|2005
10-14|0.1|0.2|0.1|26|Incidence|21212579|Liver and Intrahepatic Bile Duct|2005
10-14|~|~|~|~|Mortality|21212579|Lung and Bronchus|2005
10-14|~|~|~|~|Incidence|21212579|Lung and Bronchus|2005
10-14|~|~|~|~|Mortality|10348382|Male and Female Breast|2005
10-14|~|~|~|~|Incidence|10348382|Male and Female Breast|2005
10-14|~|~|~|~|Incidence|10348382|Male and Female Breast, <i>in situ</i>|2005
10-14|~|~|~|~|Mortality|21212579|Melanomas of the Skin|2005
10-14|0.3|0.4|0.3|72|Incidence|21212579|Melanomas of the Skin|2005
10-14|~|~|~|~|Mortality|21212579|Mesothelioma|2005
10-14|~|~|~|~|Incidence|21212579|Mesothelioma|2005
10-14|~|~|~|~|Mortality|21212579|Myeloma|2005
10-14|~|~|~|~|Incidence|21212579|Myeloma|2005
10-14|0.1|0.2|0.1|29|Mortality|21212579|Non-Hodgkin Lymphoma|2005
10-14|1.1|1.4|1.2|261|Incidence|21212579|Non-Hodgkin Lymphoma|2005
10-14|~|~|~|~|Mortality|21212579|Oral Cavity and Pharynx|2005
10-14|0.3|0.4|0.3|73|Incidence|21212579|Oral Cavity and Pharynx|2005
10-14|~|~|~|~|Mortality|10348382|Ovary|2005
10-14|0.5|0.9|0.7|71|Incidence|10348382|Ovary|2005
10-14|~|~|~|~|Mortality|21212579|Pancreas|2005
10-14|~|~|~|~|Incidence|21212579|Pancreas|2005
10-14|~|~|~|~|Mortality|10864197|Prostate|2005
10-14|~|~|~|~|Incidence|10864197|Prostate|2005
10-14|~|~|~|~|Mortality|21212579|Stomach|2005
10-14|~|~|~|~|Incidence|21212579|Stomach|2005
10-14|~|~|~|~|Mortality|10864197|Testis|2005
10-14|0.1|0.3|0.2|25|Incidence|10864197|Testis|2005
10-14|~|~|~|~|Mortality|21212579|Thyroid|2005
10-14|0.4|0.7|0.5|115|Incidence|21212579|Thyroid|2005
10-14|~|~|~|~|Mortality|21212579|Urinary Bladder|2005
10-14|~|~|~|~|Incidence|21212579|Urinary Bladder|2005
15-19|3.2|3.7|3.4|731|Mortality|21486214|All Cancer Sites Combined|2005
15-19|21.6|22.8|22.2|4771|Incidence|21486214|All Cancer Sites Combined|2005
15-19|0.5|0.7|0.5|118|Mortality|21486214|Brain and Other Nervous System|2005
15-19|2.0|2.4|2.2|476|Incidence|21486214|Brain and Other Nervous System|2005
15-19|~|~|~|~|Mortality|10434789|Cervix|2005
15-19|0.1|0.3|0.2|18|Incidence|10434789|Cervix|2005
15-19|~|~|~|~|Mortality|21486214|Colon and Rectum|2005
15-19|0.3|0.4|0.3|70|Incidence|21486214|Colon and Rectum|2005
15-19|~|~|~|~|Mortality|10434789|Corpus and Uterus, NOS|2005
15-19|~|~|~|~|Incidence|10434789|Corpus and Uterus, NOS|2005
15-19|~|~|~|~|Mortality|21486214|Esophagus|2005
15-19|~|~|~|~|Incidence|21486214|Esophagus|2005
15-19|~|~|~|~|Mortality|10434789|Female Breast|2005
15-19|~|~|~|~|Incidence|10434789|Female Breast|2005
15-19|~|~|~|~|Incidence|10434789|Female Breast, <i>in situ</i>|2005
15-19|~|~|~|~|Mortality|21486214|Hodgkin Lymphoma|2005
15-19|3.1|3.6|3.3|710|Incidence|21486214|Hodgkin Lymphoma|2005
15-19|.|.|.|.|Mortality|21486214|Kaposi Sarcoma|2005
15-19|~|~|~|~|Incidence|21486214|Kaposi Sarcoma|2005
15-19|~|~|~|~|Mortality|21486214|Kidney and Renal Pelvis|2005
15-19|0.2|0.3|0.2|49|Incidence|21486214|Kidney and Renal Pelvis|2005
15-19|~|~|~|~|Mortality|21486214|Larynx|2005
15-19|~|~|~|~|Incidence|21486214|Larynx|2005
15-19|0.9|1.2|1.0|223|Mortality|21486214|Leukemias|2005
15-19|2.6|3.0|2.8|595|Incidence|21486214|Leukemias|2005
15-19|~|~|~|~|Mortality|21486214|Liver and Intrahepatic Bile Duct|2005
15-19|0.1|0.2|0.1|26|Incidence|21486214|Liver and Intrahepatic Bile Duct|2005
15-19|~|~|~|~|Mortality|21486214|Lung and Bronchus|2005
15-19|0.1|0.2|0.1|31|Incidence|21486214|Lung and Bronchus|2005
15-19|~|~|~|~|Mortality|10434789|Male and Female Breast|2005
15-19|~|~|~|~|Incidence|10434789|Male and Female Breast|2005
15-19|~|~|~|~|Incidence|10434789|Male and Female Breast, <i>in situ</i>|2005
15-19|~|~|~|~|Mortality|21486214|Melanomas of the Skin|2005
15-19|1.7|2.0|1.8|396|Incidence|21486214|Melanomas of the Skin|2005
15-19|~|~|~|~|Mortality|21486214|Mesothelioma|2005
15-19|~|~|~|~|Incidence|21486214|Mesothelioma|2005
15-19|~|~|~|~|Mortality|21486214|Myeloma|2005
15-19|~|~|~|~|Incidence|21486214|Myeloma|2005
15-19|0.2|0.3|0.2|47|Mortality|21486214|Non-Hodgkin Lymphoma|2005
15-19|1.8|2.1|1.9|417|Incidence|21486214|Non-Hodgkin Lymphoma|2005
15-19|~|~|~|~|Mortality|21486214|Oral Cavity and Pharynx|2005
15-19|0.4|0.5|0.4|96|Incidence|21486214|Oral Cavity and Pharynx|2005
15-19|~|~|~|~|Mortality|10434789|Ovary|2005
15-19|1.3|1.8|1.5|157|Incidence|10434789|Ovary|2005
15-19|~|~|~|~|Mortality|21486214|Pancreas|2005
15-19|~|~|~|~|Incidence|21486214|Pancreas|2005
15-19|~|~|~|~|Mortality|11051425|Prostate|2005
15-19|~|~|~|~|Incidence|11051425|Prostate|2005
15-19|~|~|~|~|Mortality|21486214|Stomach|2005
15-19|~|~|~|~|Incidence|21486214|Stomach|2005
15-19|~|~|~|~|Mortality|11051425|Testis|2005
15-19|3.3|4.0|3.6|398|Incidence|11051425|Testis|2005
15-19|~|~|~|~|Mortality|21486214|Thyroid|2005
15-19|1.6|2.0|1.8|387|Incidence|21486214|Thyroid|2005
15-19|~|~|~|~|Mortality|21486214|Urinary Bladder|2005
15-19|0.1|0.2|0.1|26|Incidence|21486214|Urinary Bladder|2005
5-9|2.3|2.7|2.5|485|Mortality|19389067|All Cancer Sites Combined|2005
5-9|11.4|12.4|11.9|2305|Incidence|19389067|All Cancer Sites Combined|2005
5-9|0.8|1.1|1.0|188|Mortality|19389067|Brain and Other Nervous System|2005
5-9|3.2|3.7|3.5|671|Incidence|19389067|Brain and Other Nervous System|2005
5-9|~|~|~|~|Mortality|9473900|Cervix|2005
5-9|~|~|~|~|Incidence|9473900|Cervix|2005
5-9|~|~|~|~|Mortality|19389067|Colon and Rectum|2005
5-9|~|~|~|~|Incidence|19389067|Colon and Rectum|2005
5-9|~|~|~|~|Mortality|9473900|Corpus and Uterus, NOS|2005
5-9|~|~|~|~|Incidence|9473900|Corpus and Uterus, NOS|2005
5-9|~|~|~|~|Mortality|19389067|Esophagus|2005
5-9|~|~|~|~|Incidence|19389067|Esophagus|2005
5-9|~|~|~|~|Mortality|9473900|Female Breast|2005
5-9|~|~|~|~|Incidence|9473900|Female Breast|2005
5-9|~|~|~|~|Incidence|9473900|Female Breast, <i>in situ</i>|2005
5-9|~|~|~|~|Mortality|19389067|Hodgkin Lymphoma|2005
5-9|0.3|0.5|0.4|77|Incidence|19389067|Hodgkin Lymphoma|2005
5-9|.|.|.|.|Mortality|19389067|Kaposi Sarcoma|2005
5-9|~|~|~|~|Incidence|19389067|Kaposi Sarcoma|2005
5-9|0.1|0.2|0.1|20|Mortality|19389067|Kidney and Renal Pelvis|2005
5-9|0.4|0.6|0.5|100|Incidence|19389067|Kidney and Renal Pelvis|2005
5-9|~|~|~|~|Mortality|19389067|Larynx|2005
5-9|~|~|~|~|Incidence|19389067|Larynx|2005
5-9|0.5|0.8|0.6|125|Mortality|19389067|Leukemias|2005
5-9|3.5|4.0|3.8|730|Incidence|19389067|Leukemias|2005
5-9|~|~|~|~|Mortality|19389067|Liver and Intrahepatic Bile Duct|2005
5-9|0.0|0.1|0.1|16|Incidence|19389067|Liver and Intrahepatic Bile Duct|2005
5-9|~|~|~|~|Mortality|19389067|Lung and Bronchus|2005
5-9|~|~|~|~|Incidence|19389067|Lung and Bronchus|2005
5-9|~|~|~|~|Mortality|9473900|Male and Female Breast|2005
5-9|~|~|~|~|Incidence|9473900|Male and Female Breast|2005
5-9|~|~|~|~|Incidence|9473900|Male and Female Breast, <i>in situ</i>|2005
5-9|~|~|~|~|Mortality|19389067|Melanomas of the Skin|2005
5-9|0.1|0.3|0.2|38|Incidence|19389067|Melanomas of the Skin|2005
5-9|~|~|~|~|Mortality|19389067|Mesothelioma|2005
5-9|~|~|~|~|Incidence|19389067|Mesothelioma|2005
5-9|~|~|~|~|Mortality|19389067|Myeloma|2005
5-9|~|~|~|~|Incidence|19389067|Myeloma|2005
5-9|0.1|0.2|0.1|19|Mortality|19389067|Non-Hodgkin Lymphoma|2005
5-9|0.8|1.1|0.9|176|Incidence|19389067|Non-Hodgkin Lymphoma|2005
5-9|~|~|~|~|Mortality|19389067|Oral Cavity and Pharynx|2005
5-9|0.1|0.2|0.1|23|Incidence|19389067|Oral Cavity and Pharynx|2005
5-9|~|~|~|~|Mortality|9473900|Ovary|2005
5-9|0.1|0.3|0.2|18|Incidence|9473900|Ovary|2005
5-9|~|~|~|~|Mortality|19389067|Pancreas|2005
5-9|~|~|~|~|Incidence|19389067|Pancreas|2005
5-9|~|~|~|~|Mortality|9915167|Prostate|2005
5-9|~|~|~|~|Incidence|9915167|Prostate|2005
5-9|~|~|~|~|Mortality|19389067|Stomach|2005
5-9|~|~|~|~|Incidence|19389067|Stomach|2005
5-9|~|~|~|~|Mortality|9915167|Testis|2005
5-9|~|~|~|~|Incidence|9915167|Testis|2005
5-9|~|~|~|~|Mortality|19389067|Thyroid|2005
5-9|0.1|0.1|0.1|18|Incidence|19389067|Thyroid|2005
5-9|~|~|~|~|Mortality|19389067|Urinary Bladder|2005
5-9|~|~|~|~|Incidence|19389067|Urinary Bladder|2005
<1|1.5|2.3|1.9|75|Mortality|4004393|All Cancer Sites Combined|2005
<1|23.2|26.3|24.7|990|Incidence|4004393|All Cancer Sites Combined|2005
<1|0.3|0.7|0.4|18|Mortality|4004393|Brain and Other Nervous System|2005
<1|3.1|4.3|3.6|145|Incidence|4004393|Brain and Other Nervous System|2005
<1|~|~|~|~|Mortality|1956682|Cervix|2005
<1|~|~|~|~|Incidence|1956682|Cervix|2005
<1|~|~|~|~|Mortality|4004393|Colon and Rectum|2005
<1|~|~|~|~|Incidence|4004393|Colon and Rectum|2005
<1|~|~|~|~|Mortality|1956682|Corpus and Uterus, NOS|2005
<1|~|~|~|~|Incidence|1956682|Corpus and Uterus, NOS|2005
<1|~|~|~|~|Mortality|4004393|Esophagus|2005
<1|~|~|~|~|Incidence|4004393|Esophagus|2005
<1|~|~|~|~|Mortality|1956682|Female Breast|2005
<1|~|~|~|~|Incidence|1956682|Female Breast|2005
<1|~|~|~|~|Incidence|1956682|Female Breast, <i>in situ</i>|2005
<1|~|~|~|~|Mortality|4004393|Hodgkin Lymphoma|2005
<1|~|~|~|~|Incidence|4004393|Hodgkin Lymphoma|2005
<1|.|.|.|.|Mortality|4004393|Kaposi Sarcoma|2005
<1|~|~|~|~|Incidence|4004393|Kaposi Sarcoma|2005
<1|~|~|~|~|Mortality|4004393|Kidney and Renal Pelvis|2005
<1|1.3|2.1|1.7|67|Incidence|4004393|Kidney and Renal Pelvis|2005
<1|~|~|~|~|Mortality|4004393|Larynx|2005
<1|~|~|~|~|Incidence|4004393|Larynx|2005
<1|0.3|0.8|0.5|22|Mortality|4004393|Leukemias|2005
<1|3.7|5.0|4.3|173|Incidence|4004393|Leukemias|2005
<1|~|~|~|~|Mortality|4004393|Liver and Intrahepatic Bile Duct|2005
<1|0.8|1.4|1.0|42|Incidence|4004393|Liver and Intrahepatic Bile Duct|2005
<1|~|~|~|~|Mortality|4004393|Lung and Bronchus|2005
<1|~|~|~|~|Incidence|4004393|Lung and Bronchus|2005
<1|~|~|~|~|Mortality|1956682|Male and Female Breast|2005
<1|~|~|~|~|Incidence|1956682|Male and Female Breast|2005
<1|~|~|~|~|Incidence|1956682|Male and Female Breast, <i>in situ</i>|2005
<1|~|~|~|~|Mortality|4004393|Melanomas of the Skin|2005
<1|~|~|~|~|Incidence|4004393|Melanomas of the Skin|2005
<1|~|~|~|~|Mortality|4004393|Mesothelioma|2005
<1|~|~|~|~|Incidence|4004393|Mesothelioma|2005
<1|~|~|~|~|Mortality|4004393|Myeloma|2005
<1|~|~|~|~|Incidence|4004393|Myeloma|2005
<1|~|~|~|~|Mortality|4004393|Non-Hodgkin Lymphoma|2005
<1|~|~|~|~|Incidence|4004393|Non-Hodgkin Lymphoma|2005
<1|~|~|~|~|Mortality|4004393|Oral Cavity and Pharynx|2005
<1|~|~|~|~|Incidence|4004393|Oral Cavity and Pharynx|2005
<1|~|~|~|~|Mortality|1956682|Ovary|2005
<1|~|~|~|~|Incidence|1956682|Ovary|2005
<1|~|~|~|~|Mortality|4004393|Pancreas|2005
<1|~|~|~|~|Incidence|4004393|Pancreas|2005
<1|~|~|~|~|Mortality|2047711|Prostate|2005
<1|~|~|~|~|Incidence|2047711|Prostate|2005
<1|~|~|~|~|Mortality|4004393|Stomach|2005
<1|~|~|~|~|Incidence|4004393|Stomach|2005
<1|~|~|~|~|Mortality|2047711|Testis|2005
<1|0.6|1.5|1.0|20|Incidence|2047711|Testis|2005
<1|~|~|~|~|Mortality|4004393|Thyroid|2005
<1|~|~|~|~|Incidence|4004393|Thyroid|2005
<1|~|~|~|~|Mortality|4004393|Urinary Bladder|2005
<1|~|~|~|~|Incidence|4004393|Urinary Bladder|2005
1-4|2.1|2.6|2.4|377|Mortality|15897145|All Cancer Sites Combined|2006
1-4|20.7|22.1|21.4|3400|Incidence|15897145|All Cancer Sites Combined|2006
1-4|0.5|0.8|0.6|101|Mortality|15897145|Brain and Other Nervous System|2006
1-4|4.3|5.0|4.7|740|Incidence|15897145|Brain and Other Nervous System|2006
1-4|~|~|~|~|Mortality|7775092|Cervix|2006
1-4|~|~|~|~|Incidence|7775092|Cervix|2006
1-4|~|~|~|~|Mortality|15897145|Colon and Rectum|2006
1-4|~|~|~|~|Incidence|15897145|Colon and Rectum|2006
1-4|~|~|~|~|Mortality|7775092|Corpus and Uterus, NOS|2006
1-4|~|~|~|~|Incidence|7775092|Corpus and Uterus, NOS|2006
1-4|~|~|~|~|Mortality|15897145|Esophagus|2006
1-4|~|~|~|~|Incidence|15897145|Esophagus|2006
1-4|~|~|~|~|Mortality|7775092|Female Breast|2006
1-4|~|~|~|~|Incidence|7775092|Female Breast|2006
1-4|~|~|~|~|Incidence|7775092|Female Breast, <i>in situ</i>|2006
1-4|~|~|~|~|Mortality|15897145|Hodgkin Lymphoma|2006
1-4|0.1|0.2|0.1|17|Incidence|15897145|Hodgkin Lymphoma|2006
1-4|.|.|.|.|Mortality|15897145|Kaposi Sarcoma|2006
1-4|~|~|~|~|Incidence|15897145|Kaposi Sarcoma|2006
1-4|~|~|~|~|Mortality|15897145|Kidney and Renal Pelvis|2006
1-4|1.8|2.3|2.0|321|Incidence|15897145|Kidney and Renal Pelvis|2006
1-4|~|~|~|~|Mortality|15897145|Larynx|2006
1-4|~|~|~|~|Incidence|15897145|Larynx|2006
1-4|0.6|0.9|0.8|124|Mortality|15897145|Leukemias|2006
1-4|8.2|9.2|8.7|1381|Incidence|15897145|Leukemias|2006
1-4|~|~|~|~|Mortality|15897145|Liver and Intrahepatic Bile Duct|2006
1-4|0.4|0.6|0.5|83|Incidence|15897145|Liver and Intrahepatic Bile Duct|2006
1-4|~|~|~|~|Mortality|15897145|Lung and Bronchus|2006
1-4|~|~|~|~|Incidence|15897145|Lung and Bronchus|2006
1-4|~|~|~|~|Mortality|7775092|Male and Female Breast|2006
1-4|~|~|~|~|Incidence|7775092|Male and Female Breast|2006
1-4|~|~|~|~|Incidence|7775092|Male and Female Breast, <i>in situ</i>|2006
1-4|~|~|~|~|Mortality|15897145|Melanomas of the Skin|2006
1-4|~|~|~|~|Incidence|15897145|Melanomas of the Skin|2006
1-4|~|~|~|~|Mortality|15897145|Mesothelioma|2006
1-4|~|~|~|~|Incidence|15897145|Mesothelioma|2006
1-4|~|~|~|~|Mortality|15897145|Myeloma|2006
1-4|~|~|~|~|Incidence|15897145|Myeloma|2006
1-4|~|~|~|~|Mortality|15897145|Non-Hodgkin Lymphoma|2006
1-4|0.5|0.8|0.6|98|Incidence|15897145|Non-Hodgkin Lymphoma|2006
1-4|~|~|~|~|Mortality|15897145|Oral Cavity and Pharynx|2006
1-4|~|~|~|~|Incidence|15897145|Oral Cavity and Pharynx|2006
1-4|~|~|~|~|Mortality|7775092|Ovary|2006
1-4|~|~|~|~|Incidence|7775092|Ovary|2006
1-4|~|~|~|~|Mortality|15897145|Pancreas|2006
1-4|~|~|~|~|Incidence|15897145|Pancreas|2006
1-4|~|~|~|~|Mortality|8122053|Prostate|2006
1-4|~|~|~|~|Incidence|8122053|Prostate|2006
1-4|~|~|~|~|Mortality|15897145|Stomach|2006
1-4|~|~|~|~|Incidence|15897145|Stomach|2006
1-4|~|~|~|~|Mortality|8122053|Testis|2006
1-4|0.1|0.4|0.2|19|Incidence|8122053|Testis|2006
1-4|~|~|~|~|Mortality|15897145|Thyroid|2006
1-4|~|~|~|~|Incidence|15897145|Thyroid|2006
1-4|~|~|~|~|Mortality|15897145|Urinary Bladder|2006
1-4|~|~|~|~|Incidence|15897145|Urinary Bladder|2006
10-14|1.9|2.3|2.1|448|Mortality|21033138|All Cancer Sites Combined|2006
10-14|13.0|14.0|13.5|2845|Incidence|21033138|All Cancer Sites Combined|2006
10-14|0.5|0.7|0.6|129|Mortality|21033138|Brain and Other Nervous System|2006
10-14|2.5|2.9|2.7|569|Incidence|21033138|Brain and Other Nervous System|2006
10-14|~|~|~|~|Mortality|10261944|Cervix|2006
10-14|~|~|~|~|Incidence|10261944|Cervix|2006
10-14|~|~|~|~|Mortality|21033138|Colon and Rectum|2006
10-14|0.1|0.1|0.1|18|Incidence|21033138|Colon and Rectum|2006
10-14|~|~|~|~|Mortality|10261944|Corpus and Uterus, NOS|2006
10-14|~|~|~|~|Incidence|10261944|Corpus and Uterus, NOS|2006
10-14|~|~|~|~|Mortality|21033138|Esophagus|2006
10-14|~|~|~|~|Incidence|21033138|Esophagus|2006
10-14|~|~|~|~|Mortality|10261944|Female Breast|2006
10-14|~|~|~|~|Incidence|10261944|Female Breast|2006
10-14|~|~|~|~|Incidence|10261944|Female Breast, <i>in situ</i>|2006
10-14|~|~|~|~|Mortality|21033138|Hodgkin Lymphoma|2006
10-14|1.1|1.4|1.3|265|Incidence|21033138|Hodgkin Lymphoma|2006
10-14|.|.|.|.|Mortality|21033138|Kaposi Sarcoma|2006
10-14|~|~|~|~|Incidence|21033138|Kaposi Sarcoma|2006
10-14|~|~|~|~|Mortality|21033138|Kidney and Renal Pelvis|2006
10-14|0.1|0.2|0.1|26|Incidence|21033138|Kidney and Renal Pelvis|2006
10-14|~|~|~|~|Mortality|21033138|Larynx|2006
10-14|~|~|~|~|Incidence|21033138|Larynx|2006
10-14|0.6|0.8|0.7|152|Mortality|21033138|Leukemias|2006
10-14|3.0|3.5|3.2|677|Incidence|21033138|Leukemias|2006
10-14|~|~|~|~|Mortality|21033138|Liver and Intrahepatic Bile Duct|2006
10-14|0.1|0.2|0.1|21|Incidence|21033138|Liver and Intrahepatic Bile Duct|2006
10-14|~|~|~|~|Mortality|21033138|Lung and Bronchus|2006
10-14|~|~|~|~|Incidence|21033138|Lung and Bronchus|2006
10-14|~|~|~|~|Mortality|10261944|Male and Female Breast|2006
10-14|~|~|~|~|Incidence|10261944|Male and Female Breast|2006
10-14|~|~|~|~|Incidence|10261944|Male and Female Breast, <i>in situ</i>|2006
10-14|~|~|~|~|Mortality|21033138|Melanomas of the Skin|2006
10-14|0.3|0.5|0.4|90|Incidence|21033138|Melanomas of the Skin|2006
10-14|~|~|~|~|Mortality|21033138|Mesothelioma|2006
10-14|~|~|~|~|Incidence|21033138|Mesothelioma|2006
10-14|~|~|~|~|Mortality|21033138|Myeloma|2006
10-14|~|~|~|~|Incidence|21033138|Myeloma|2006
10-14|0.1|0.2|0.1|25|Mortality|21033138|Non-Hodgkin Lymphoma|2006
10-14|1.1|1.4|1.2|260|Incidence|21033138|Non-Hodgkin Lymphoma|2006
10-14|~|~|~|~|Mortality|21033138|Oral Cavity and Pharynx|2006
10-14|0.2|0.4|0.3|61|Incidence|21033138|Oral Cavity and Pharynx|2006
10-14|~|~|~|~|Mortality|10261944|Ovary|2006
10-14|0.6|0.9|0.7|76|Incidence|10261944|Ovary|2006
10-14|~|~|~|~|Mortality|21033138|Pancreas|2006
10-14|~|~|~|~|Incidence|21033138|Pancreas|2006
10-14|~|~|~|~|Mortality|10771194|Prostate|2006
10-14|~|~|~|~|Incidence|10771194|Prostate|2006
10-14|~|~|~|~|Mortality|21033138|Stomach|2006
10-14|~|~|~|~|Incidence|21033138|Stomach|2006
10-14|~|~|~|~|Mortality|10771194|Testis|2006
10-14|~|~|~|~|Incidence|10771194|Testis|2006
10-14|~|~|~|~|Mortality|21033138|Thyroid|2006
10-14|0.5|0.7|0.6|128|Incidence|21033138|Thyroid|2006
10-14|~|~|~|~|Mortality|21033138|Urinary Bladder|2006
10-14|~|~|~|~|Incidence|21033138|Urinary Bladder|2006
15-19|2.9|3.3|3.1|675|Mortality|21807709|All Cancer Sites Combined|2006
15-19|21.0|22.2|21.6|4707|Incidence|21807709|All Cancer Sites Combined|2006
15-19|0.4|0.6|0.5|102|Mortality|21807709|Brain and Other Nervous System|2006
15-19|2.1|2.6|2.3|510|Incidence|21807709|Brain and Other Nervous System|2006
15-19|~|~|~|~|Mortality|10597293|Cervix|2006
15-19|0.1|0.3|0.2|24|Incidence|10597293|Cervix|2006
15-19|~|~|~|~|Mortality|21807709|Colon and Rectum|2006
15-19|0.2|0.4|0.3|62|Incidence|21807709|Colon and Rectum|2006
15-19|~|~|~|~|Mortality|10597293|Corpus and Uterus, NOS|2006
15-19|~|~|~|~|Incidence|10597293|Corpus and Uterus, NOS|2006
15-19|~|~|~|~|Mortality|21807709|Esophagus|2006
15-19|~|~|~|~|Incidence|21807709|Esophagus|2006
15-19|~|~|~|~|Mortality|10597293|Female Breast|2006
15-19|0.1|0.3|0.2|20|Incidence|10597293|Female Breast|2006
15-19|~|~|~|~|Incidence|10597293|Female Breast, <i>in situ</i>|2006
15-19|0.0|0.1|0.1|18|Mortality|21807709|Hodgkin Lymphoma|2006
15-19|2.9|3.4|3.1|683|Incidence|21807709|Hodgkin Lymphoma|2006
15-19|.|.|.|.|Mortality|21807709|Kaposi Sarcoma|2006
15-19|~|~|~|~|Incidence|21807709|Kaposi Sarcoma|2006
15-19|~|~|~|~|Mortality|21807709|Kidney and Renal Pelvis|2006
15-19|0.2|0.3|0.2|48|Incidence|21807709|Kidney and Renal Pelvis|2006
15-19|~|~|~|~|Mortality|21807709|Larynx|2006
15-19|~|~|~|~|Incidence|21807709|Larynx|2006
15-19|0.8|1.1|0.9|207|Mortality|21807709|Leukemias|2006
15-19|2.8|3.2|3.0|656|Incidence|21807709|Leukemias|2006
15-19|~|~|~|~|Mortality|21807709|Liver and Intrahepatic Bile Duct|2006
15-19|0.1|0.2|0.2|34|Incidence|21807709|Liver and Intrahepatic Bile Duct|2006
15-19|~|~|~|~|Mortality|21807709|Lung and Bronchus|2006
15-19|0.1|0.2|0.1|28|Incidence|21807709|Lung and Bronchus|2006
15-19|~|~|~|~|Mortality|10597293|Male and Female Breast|2006
15-19|0.1|0.3|0.2|20|Incidence|10597293|Male and Female Breast|2006
15-19|~|~|~|~|Incidence|10597293|Male and Female Breast, <i>in situ</i>|2006
15-19|~|~|~|~|Mortality|21807709|Melanomas of the Skin|2006
15-19|1.3|1.6|1.4|306|Incidence|21807709|Melanomas of the Skin|2006
15-19|~|~|~|~|Mortality|21807709|Mesothelioma|2006
15-19|~|~|~|~|Incidence|21807709|Mesothelioma|2006
15-19|~|~|~|~|Mortality|21807709|Myeloma|2006
15-19|~|~|~|~|Incidence|21807709|Myeloma|2006
15-19|0.2|0.3|0.2|45|Mortality|21807709|Non-Hodgkin Lymphoma|2006
15-19|1.6|2.0|1.8|395|Incidence|21807709|Non-Hodgkin Lymphoma|2006
15-19|~|~|~|~|Mortality|21807709|Oral Cavity and Pharynx|2006
15-19|0.4|0.6|0.5|107|Incidence|21807709|Oral Cavity and Pharynx|2006
15-19|~|~|~|~|Mortality|10597293|Ovary|2006
15-19|1.2|1.7|1.4|149|Incidence|10597293|Ovary|2006
15-19|~|~|~|~|Mortality|21807709|Pancreas|2006
15-19|~|~|~|~|Incidence|21807709|Pancreas|2006
15-19|~|~|~|~|Mortality|11210416|Prostate|2006
15-19|~|~|~|~|Incidence|11210416|Prostate|2006
15-19|~|~|~|~|Mortality|21807709|Stomach|2006
15-19|~|~|~|~|Incidence|21807709|Stomach|2006
15-19|~|~|~|~|Mortality|11210416|Testis|2006
15-19|2.7|3.4|3.0|339|Incidence|11210416|Testis|2006
15-19|~|~|~|~|Mortality|21807709|Thyroid|2006
15-19|1.7|2.1|1.9|417|Incidence|21807709|Thyroid|2006
15-19|~|~|~|~|Mortality|21807709|Urinary Bladder|2006
15-19|0.1|0.2|0.1|22|Incidence|21807709|Urinary Bladder|2006
5-9|2.1|2.6|2.3|459|Mortality|19544688|All Cancer Sites Combined|2006
5-9|11.7|12.6|12.1|2374|Incidence|19544688|All Cancer Sites Combined|2006
5-9|0.8|1.0|0.9|176|Mortality|19544688|Brain and Other Nervous System|2006
5-9|3.1|3.6|3.4|659|Incidence|19544688|Brain and Other Nervous System|2006
5-9|~|~|~|~|Mortality|9555173|Cervix|2006
5-9|~|~|~|~|Incidence|9555173|Cervix|2006
5-9|~|~|~|~|Mortality|19544688|Colon and Rectum|2006
5-9|~|~|~|~|Incidence|19544688|Colon and Rectum|2006
5-9|~|~|~|~|Mortality|9555173|Corpus and Uterus, NOS|2006
5-9|~|~|~|~|Incidence|9555173|Corpus and Uterus, NOS|2006
5-9|~|~|~|~|Mortality|19544688|Esophagus|2006
5-9|~|~|~|~|Incidence|19544688|Esophagus|2006
5-9|~|~|~|~|Mortality|9555173|Female Breast|2006
5-9|~|~|~|~|Incidence|9555173|Female Breast|2006
5-9|~|~|~|~|Incidence|9555173|Female Breast, <i>in situ</i>|2006
5-9|~|~|~|~|Mortality|19544688|Hodgkin Lymphoma|2006
5-9|0.4|0.6|0.5|92|Incidence|19544688|Hodgkin Lymphoma|2006
5-9|.|.|.|.|Mortality|19544688|Kaposi Sarcoma|2006
5-9|~|~|~|~|Incidence|19544688|Kaposi Sarcoma|2006
5-9|0.1|0.2|0.1|23|Mortality|19544688|Kidney and Renal Pelvis|2006
5-9|0.5|0.7|0.6|109|Incidence|19544688|Kidney and Renal Pelvis|2006
5-9|~|~|~|~|Mortality|19544688|Larynx|2006
5-9|~|~|~|~|Incidence|19544688|Larynx|2006
5-9|0.4|0.6|0.5|104|Mortality|19544688|Leukemias|2006
5-9|3.6|4.2|3.9|756|Incidence|19544688|Leukemias|2006
5-9|~|~|~|~|Mortality|19544688|Liver and Intrahepatic Bile Duct|2006
5-9|0.1|0.2|0.1|20|Incidence|19544688|Liver and Intrahepatic Bile Duct|2006
5-9|~|~|~|~|Mortality|19544688|Lung and Bronchus|2006
5-9|~|~|~|~|Incidence|19544688|Lung and Bronchus|2006
5-9|~|~|~|~|Mortality|9555173|Male and Female Breast|2006
5-9|~|~|~|~|Incidence|9555173|Male and Female Breast|2006
5-9|~|~|~|~|Incidence|9555173|Male and Female Breast, <i>in situ</i>|2006
5-9|~|~|~|~|Mortality|19544688|Melanomas of the Skin|2006
5-9|0.1|0.2|0.2|31|Incidence|19544688|Melanomas of the Skin|2006
5-9|~|~|~|~|Mortality|19544688|Mesothelioma|2006
5-9|~|~|~|~|Incidence|19544688|Mesothelioma|2006
5-9|~|~|~|~|Mortality|19544688|Myeloma|2006
5-9|~|~|~|~|Incidence|19544688|Myeloma|2006
5-9|~|~|~|~|Mortality|19544688|Non-Hodgkin Lymphoma|2006
5-9|0.8|1.1|0.9|178|Incidence|19544688|Non-Hodgkin Lymphoma|2006
5-9|~|~|~|~|Mortality|19544688|Oral Cavity and Pharynx|2006
5-9|0.1|0.2|0.2|30|Incidence|19544688|Oral Cavity and Pharynx|2006
5-9|~|~|~|~|Mortality|9555173|Ovary|2006
5-9|0.2|0.4|0.3|25|Incidence|9555173|Ovary|2006
5-9|~|~|~|~|Mortality|19544688|Pancreas|2006
5-9|~|~|~|~|Incidence|19544688|Pancreas|2006
5-9|~|~|~|~|Mortality|9989515|Prostate|2006
5-9|~|~|~|~|Incidence|9989515|Prostate|2006
5-9|~|~|~|~|Mortality|19544688|Stomach|2006
5-9|~|~|~|~|Incidence|19544688|Stomach|2006
5-9|~|~|~|~|Mortality|9989515|Testis|2006
5-9|~|~|~|~|Incidence|9989515|Testis|2006
5-9|~|~|~|~|Mortality|19544688|Thyroid|2006
5-9|0.1|0.2|0.2|30|Incidence|19544688|Thyroid|2006
5-9|~|~|~|~|Mortality|19544688|Urinary Bladder|2006
5-9|~|~|~|~|Incidence|19544688|Urinary Bladder|2006
<1|1.5|2.4|1.9|76|Mortality|4041738|All Cancer Sites Combined|2006
<1|24.7|27.9|26.2|1060|Incidence|4041738|All Cancer Sites Combined|2006
<1|0.2|0.6|0.4|16|Mortality|4041738|Brain and Other Nervous System|2006
<1|3.3|4.5|3.8|155|Incidence|4041738|Brain and Other Nervous System|2006
<1|~|~|~|~|Mortality|1975919|Cervix|2006
<1|~|~|~|~|Incidence|1975919|Cervix|2006
<1|~|~|~|~|Mortality|4041738|Colon and Rectum|2006
<1|~|~|~|~|Incidence|4041738|Colon and Rectum|2006
<1|~|~|~|~|Mortality|1975919|Corpus and Uterus, NOS|2006
<1|~|~|~|~|Incidence|1975919|Corpus and Uterus, NOS|2006
<1|~|~|~|~|Mortality|4041738|Esophagus|2006
<1|~|~|~|~|Incidence|4041738|Esophagus|2006
<1|~|~|~|~|Mortality|1975919|Female Breast|2006
<1|~|~|~|~|Incidence|1975919|Female Breast|2006
<1|~|~|~|~|Incidence|1975919|Female Breast, <i>in situ</i>|2006
<1|~|~|~|~|Mortality|4041738|Hodgkin Lymphoma|2006
<1|~|~|~|~|Incidence|4041738|Hodgkin Lymphoma|2006
<1|.|.|.|.|Mortality|4041738|Kaposi Sarcoma|2006
<1|~|~|~|~|Incidence|4041738|Kaposi Sarcoma|2006
<1|~|~|~|~|Mortality|4041738|Kidney and Renal Pelvis|2006
<1|1.3|2.1|1.7|68|Incidence|4041738|Kidney and Renal Pelvis|2006
<1|~|~|~|~|Mortality|4041738|Larynx|2006
<1|~|~|~|~|Incidence|4041738|Larynx|2006
<1|0.5|1.1|0.8|31|Mortality|4041738|Leukemias|2006
<1|4.2|5.6|4.8|195|Incidence|4041738|Leukemias|2006
<1|~|~|~|~|Mortality|4041738|Liver and Intrahepatic Bile Duct|2006
<1|1.2|2.0|1.6|64|Incidence|4041738|Liver and Intrahepatic Bile Duct|2006
<1|~|~|~|~|Mortality|4041738|Lung and Bronchus|2006
<1|~|~|~|~|Incidence|4041738|Lung and Bronchus|2006
<1|~|~|~|~|Mortality|1975919|Male and Female Breast|2006
<1|~|~|~|~|Incidence|1975919|Male and Female Breast|2006
<1|~|~|~|~|Incidence|1975919|Male and Female Breast, <i>in situ</i>|2006
<1|~|~|~|~|Mortality|4041738|Melanomas of the Skin|2006
<1|~|~|~|~|Incidence|4041738|Melanomas of the Skin|2006
<1|~|~|~|~|Mortality|4041738|Mesothelioma|2006
<1|~|~|~|~|Incidence|4041738|Mesothelioma|2006
<1|~|~|~|~|Mortality|4041738|Myeloma|2006
<1|~|~|~|~|Incidence|4041738|Myeloma|2006
<1|~|~|~|~|Mortality|4041738|Non-Hodgkin Lymphoma|2006
<1|~|~|~|~|Incidence|4041738|Non-Hodgkin Lymphoma|2006
<1|~|~|~|~|Mortality|4041738|Oral Cavity and Pharynx|2006
<1|~|~|~|~|Incidence|4041738|Oral Cavity and Pharynx|2006
<1|~|~|~|~|Mortality|1975919|Ovary|2006
<1|~|~|~|~|Incidence|1975919|Ovary|2006
<1|~|~|~|~|Mortality|4041738|Pancreas|2006
<1|~|~|~|~|Incidence|4041738|Pancreas|2006
<1|~|~|~|~|Mortality|2065819|Prostate|2006
<1|~|~|~|~|Incidence|2065819|Prostate|2006
<1|~|~|~|~|Mortality|4041738|Stomach|2006
<1|~|~|~|~|Incidence|4041738|Stomach|2006
<1|~|~|~|~|Mortality|2065819|Testis|2006
<1|~|~|~|~|Incidence|2065819|Testis|2006
<1|~|~|~|~|Mortality|4041738|Thyroid|2006
<1|~|~|~|~|Incidence|4041738|Thyroid|2006
<1|~|~|~|~|Mortality|4041738|Urinary Bladder|2006
<1|~|~|~|~|Incidence|4041738|Urinary Bladder|2006
1-4|2.1|2.5|2.3|364|Mortality|15977965|All Cancer Sites Combined|2007
1-4|21.9|23.4|22.6|3614|Incidence|15977965|All Cancer Sites Combined|2007
1-4|0.6|0.8|0.7|109|Mortality|15977965|Brain and Other Nervous System|2007
1-4|4.3|5.0|4.6|739|Incidence|15977965|Brain and Other Nervous System|2007
1-4|~|~|~|~|Mortality|7813088|Cervix|2007
1-4|~|~|~|~|Incidence|7813088|Cervix|2007
1-4|~|~|~|~|Mortality|15977965|Colon and Rectum|2007
1-4|~|~|~|~|Incidence|15977965|Colon and Rectum|2007
1-4|~|~|~|~|Mortality|7813088|Corpus and Uterus, NOS|2007
1-4|~|~|~|~|Incidence|7813088|Corpus and Uterus, NOS|2007
1-4|~|~|~|~|Mortality|15977965|Esophagus|2007
1-4|~|~|~|~|Incidence|15977965|Esophagus|2007
1-4|~|~|~|~|Mortality|7813088|Female Breast|2007
1-4|~|~|~|~|Incidence|7813088|Female Breast|2007
1-4|~|~|~|~|Incidence|7813088|Female Breast, <i>in situ</i>|2007
1-4|~|~|~|~|Mortality|15977965|Hodgkin Lymphoma|2007
1-4|~|~|~|~|Incidence|15977965|Hodgkin Lymphoma|2007
1-4|.|.|.|.|Mortality|15977965|Kaposi Sarcoma|2007
1-4|~|~|~|~|Incidence|15977965|Kaposi Sarcoma|2007
1-4|~|~|~|~|Mortality|15977965|Kidney and Renal Pelvis|2007
1-4|1.8|2.2|2.0|314|Incidence|15977965|Kidney and Renal Pelvis|2007
1-4|~|~|~|~|Mortality|15977965|Larynx|2007
1-4|~|~|~|~|Incidence|15977965|Larynx|2007
1-4|0.5|0.8|0.7|106|Mortality|15977965|Leukemias|2007
1-4|8.8|9.8|9.3|1482|Incidence|15977965|Leukemias|2007
1-4|0.1|0.2|0.1|19|Mortality|15977965|Liver and Intrahepatic Bile Duct|2007
1-4|0.5|0.7|0.6|92|Incidence|15977965|Liver and Intrahepatic Bile Duct|2007
1-4|~|~|~|~|Mortality|15977965|Lung and Bronchus|2007
1-4|~|~|~|~|Incidence|15977965|Lung and Bronchus|2007
1-4|~|~|~|~|Mortality|7813088|Male and Female Breast|2007
1-4|~|~|~|~|Incidence|7813088|Male and Female Breast|2007
1-4|~|~|~|~|Incidence|7813088|Male and Female Breast, <i>in situ</i>|2007
1-4|~|~|~|~|Mortality|15977965|Melanomas of the Skin|2007
1-4|~|~|~|~|Incidence|15977965|Melanomas of the Skin|2007
1-4|~|~|~|~|Mortality|15977965|Mesothelioma|2007
1-4|~|~|~|~|Incidence|15977965|Mesothelioma|2007
1-4|~|~|~|~|Mortality|15977965|Myeloma|2007
1-4|~|~|~|~|Incidence|15977965|Myeloma|2007
1-4|~|~|~|~|Mortality|15977965|Non-Hodgkin Lymphoma|2007
1-4|0.5|0.7|0.6|93|Incidence|15977965|Non-Hodgkin Lymphoma|2007
1-4|~|~|~|~|Mortality|15977965|Oral Cavity and Pharynx|2007
1-4|~|~|~|~|Incidence|15977965|Oral Cavity and Pharynx|2007
1-4|~|~|~|~|Mortality|7813088|Ovary|2007
1-4|~|~|~|~|Incidence|7813088|Ovary|2007
1-4|~|~|~|~|Mortality|15977965|Pancreas|2007
1-4|~|~|~|~|Incidence|15977965|Pancreas|2007
1-4|~|~|~|~|Mortality|8164877|Prostate|2007
1-4|~|~|~|~|Incidence|8164877|Prostate|2007
1-4|~|~|~|~|Mortality|15977965|Stomach|2007
1-4|~|~|~|~|Incidence|15977965|Stomach|2007
1-4|~|~|~|~|Mortality|8164877|Testis|2007
1-4|0.2|0.5|0.3|28|Incidence|8164877|Testis|2007
1-4|~|~|~|~|Mortality|15977965|Thyroid|2007
1-4|~|~|~|~|Incidence|15977965|Thyroid|2007
1-4|~|~|~|~|Mortality|15977965|Urinary Bladder|2007
1-4|~|~|~|~|Incidence|15977965|Urinary Bladder|2007
10-14|2.1|2.5|2.3|479|Mortality|20841042|All Cancer Sites Combined|2007
10-14|12.8|13.8|13.3|2778|Incidence|20841042|All Cancer Sites Combined|2007
10-14|0.5|0.7|0.6|130|Mortality|20841042|Brain and Other Nervous System|2007
10-14|2.7|3.2|2.9|609|Incidence|20841042|Brain and Other Nervous System|2007
10-14|~|~|~|~|Mortality|10170082|Cervix|2007
10-14|~|~|~|~|Incidence|10170082|Cervix|2007
10-14|~|~|~|~|Mortality|20841042|Colon and Rectum|2007
10-14|0.0|0.1|0.1|16|Incidence|20841042|Colon and Rectum|2007
10-14|~|~|~|~|Mortality|10170082|Corpus and Uterus, NOS|2007
10-14|~|~|~|~|Incidence|10170082|Corpus and Uterus, NOS|2007
10-14|~|~|~|~|Mortality|20841042|Esophagus|2007
10-14|~|~|~|~|Incidence|20841042|Esophagus|2007
10-14|~|~|~|~|Mortality|10170082|Female Breast|2007
10-14|~|~|~|~|Incidence|10170082|Female Breast|2007
10-14|~|~|~|~|Incidence|10170082|Female Breast, <i>in situ</i>|2007
10-14|~|~|~|~|Mortality|20841042|Hodgkin Lymphoma|2007
10-14|1.1|1.4|1.2|249|Incidence|20841042|Hodgkin Lymphoma|2007
10-14|.|.|.|.|Mortality|20841042|Kaposi Sarcoma|2007
10-14|~|~|~|~|Incidence|20841042|Kaposi Sarcoma|2007
10-14|~|~|~|~|Mortality|20841042|Kidney and Renal Pelvis|2007
10-14|0.1|0.2|0.2|33|Incidence|20841042|Kidney and Renal Pelvis|2007
10-14|~|~|~|~|Mortality|20841042|Larynx|2007
10-14|~|~|~|~|Incidence|20841042|Larynx|2007
10-14|0.7|1.0|0.8|175|Mortality|20841042|Leukemias|2007
10-14|2.7|3.1|2.9|606|Incidence|20841042|Leukemias|2007
10-14|~|~|~|~|Mortality|20841042|Liver and Intrahepatic Bile Duct|2007
10-14|0.0|0.1|0.1|17|Incidence|20841042|Liver and Intrahepatic Bile Duct|2007
10-14|~|~|~|~|Mortality|20841042|Lung and Bronchus|2007
10-14|0.0|0.1|0.1|17|Incidence|20841042|Lung and Bronchus|2007
10-14|~|~|~|~|Mortality|10170082|Male and Female Breast|2007
10-14|~|~|~|~|Incidence|10170082|Male and Female Breast|2007
10-14|~|~|~|~|Incidence|10170082|Male and Female Breast, <i>in situ</i>|2007
10-14|~|~|~|~|Mortality|20841042|Melanomas of the Skin|2007
10-14|0.2|0.4|0.3|67|Incidence|20841042|Melanomas of the Skin|2007
10-14|~|~|~|~|Mortality|20841042|Mesothelioma|2007
10-14|~|~|~|~|Incidence|20841042|Mesothelioma|2007
10-14|~|~|~|~|Mortality|20841042|Myeloma|2007
10-14|~|~|~|~|Incidence|20841042|Myeloma|2007
10-14|0.1|0.1|0.1|20|Mortality|20841042|Non-Hodgkin Lymphoma|2007
10-14|1.2|1.5|1.3|279|Incidence|20841042|Non-Hodgkin Lymphoma|2007
10-14|~|~|~|~|Mortality|20841042|Oral Cavity and Pharynx|2007
10-14|0.2|0.3|0.2|47|Incidence|20841042|Oral Cavity and Pharynx|2007
10-14|~|~|~|~|Mortality|10170082|Ovary|2007
10-14|0.6|0.9|0.7|72|Incidence|10170082|Ovary|2007
10-14|~|~|~|~|Mortality|20841042|Pancreas|2007
10-14|~|~|~|~|Incidence|20841042|Pancreas|2007
10-14|~|~|~|~|Mortality|10670960|Prostate|2007
10-14|~|~|~|~|Incidence|10670960|Prostate|2007
10-14|~|~|~|~|Mortality|20841042|Stomach|2007
10-14|~|~|~|~|Incidence|20841042|Stomach|2007
10-14|~|~|~|~|Mortality|10670960|Testis|2007
10-14|0.2|0.4|0.3|33|Incidence|10670960|Testis|2007
10-14|~|~|~|~|Mortality|20841042|Thyroid|2007
10-14|0.5|0.7|0.6|120|Incidence|20841042|Thyroid|2007
10-14|~|~|~|~|Mortality|20841042|Urinary Bladder|2007
10-14|~|~|~|~|Incidence|20841042|Urinary Bladder|2007
15-19|2.8|3.3|3.0|673|Mortality|22067816|All Cancer Sites Combined|2007
15-19|21.6|22.8|22.2|4896|Incidence|22067816|All Cancer Sites Combined|2007
15-19|0.3|0.5|0.4|95|Mortality|22067816|Brain and Other Nervous System|2007
15-19|2.1|2.5|2.3|502|Incidence|22067816|Brain and Other Nervous System|2007
15-19|~|~|~|~|Mortality|10731326|Cervix|2007
15-19|0.1|0.3|0.2|21|Incidence|10731326|Cervix|2007
15-19|~|~|~|~|Mortality|22067816|Colon and Rectum|2007
15-19|0.2|0.4|0.3|63|Incidence|22067816|Colon and Rectum|2007
15-19|~|~|~|~|Mortality|10731326|Corpus and Uterus, NOS|2007
15-19|~|~|~|~|Incidence|10731326|Corpus and Uterus, NOS|2007
15-19|~|~|~|~|Mortality|22067816|Esophagus|2007
15-19|~|~|~|~|Incidence|22067816|Esophagus|2007
15-19|~|~|~|~|Mortality|10731326|Female Breast|2007
15-19|0.1|0.3|0.2|21|Incidence|10731326|Female Breast|2007
15-19|~|~|~|~|Incidence|10731326|Female Breast, <i>in situ</i>|2007
15-19|0.0|0.1|0.1|16|Mortality|22067816|Hodgkin Lymphoma|2007
15-19|3.0|3.4|3.2|706|Incidence|22067816|Hodgkin Lymphoma|2007
15-19|.|.|.|.|Mortality|22067816|Kaposi Sarcoma|2007
15-19|~|~|~|~|Incidence|22067816|Kaposi Sarcoma|2007
15-19|~|~|~|~|Mortality|22067816|Kidney and Renal Pelvis|2007
15-19|0.1|0.3|0.2|43|Incidence|22067816|Kidney and Renal Pelvis|2007
15-19|~|~|~|~|Mortality|22067816|Larynx|2007
15-19|~|~|~|~|Incidence|22067816|Larynx|2007
15-19|0.8|1.1|0.9|202|Mortality|22067816|Leukemias|2007
15-19|2.7|3.2|3.0|654|Incidence|22067816|Leukemias|2007
15-19|~|~|~|~|Mortality|22067816|Liver and Intrahepatic Bile Duct|2007
15-19|0.1|0.2|0.2|38|Incidence|22067816|Liver and Intrahepatic Bile Duct|2007
15-19|~|~|~|~|Mortality|22067816|Lung and Bronchus|2007
15-19|0.1|0.2|0.1|27|Incidence|22067816|Lung and Bronchus|2007
15-19|~|~|~|~|Mortality|10731326|Male and Female Breast|2007
15-19|0.1|0.3|0.2|21|Incidence|10731326|Male and Female Breast|2007
15-19|~|~|~|~|Incidence|10731326|Male and Female Breast, <i>in situ</i>|2007
15-19|~|~|~|~|Mortality|22067816|Melanomas of the Skin|2007
15-19|1.3|1.7|1.5|327|Incidence|22067816|Melanomas of the Skin|2007
15-19|~|~|~|~|Mortality|22067816|Mesothelioma|2007
15-19|~|~|~|~|Incidence|22067816|Mesothelioma|2007
15-19|~|~|~|~|Mortality|22067816|Myeloma|2007
15-19|~|~|~|~|Incidence|22067816|Myeloma|2007
15-19|0.2|0.3|0.2|47|Mortality|22067816|Non-Hodgkin Lymphoma|2007
15-19|1.6|1.9|1.7|382|Incidence|22067816|Non-Hodgkin Lymphoma|2007
15-19|~|~|~|~|Mortality|22067816|Oral Cavity and Pharynx|2007
15-19|0.4|0.6|0.5|105|Incidence|22067816|Oral Cavity and Pharynx|2007
15-19|~|~|~|~|Mortality|10731326|Ovary|2007
15-19|1.0|1.4|1.2|129|Incidence|10731326|Ovary|2007
15-19|~|~|~|~|Mortality|22067816|Pancreas|2007
15-19|~|~|~|~|Incidence|22067816|Pancreas|2007
15-19|~|~|~|~|Mortality|11336490|Prostate|2007
15-19|~|~|~|~|Incidence|11336490|Prostate|2007
15-19|~|~|~|~|Mortality|22067816|Stomach|2007
15-19|~|~|~|~|Incidence|22067816|Stomach|2007
15-19|~|~|~|~|Mortality|11336490|Testis|2007
15-19|3.3|4.0|3.7|416|Incidence|11336490|Testis|2007
15-19|~|~|~|~|Mortality|22067816|Thyroid|2007
15-19|2.1|2.5|2.3|500|Incidence|22067816|Thyroid|2007
15-19|~|~|~|~|Mortality|22067816|Urinary Bladder|2007
15-19|0.0|0.1|0.1|17|Incidence|22067816|Urinary Bladder|2007
5-9|2.2|2.7|2.4|480|Mortality|19714611|All Cancer Sites Combined|2007
5-9|11.9|12.9|12.4|2443|Incidence|19714611|All Cancer Sites Combined|2007
5-9|0.7|1.0|0.9|172|Mortality|19714611|Brain and Other Nervous System|2007
5-9|3.3|3.8|3.5|693|Incidence|19714611|Brain and Other Nervous System|2007
5-9|~|~|~|~|Mortality|9640683|Cervix|2007
5-9|~|~|~|~|Incidence|9640683|Cervix|2007
5-9|~|~|~|~|Mortality|19714611|Colon and Rectum|2007
5-9|~|~|~|~|Incidence|19714611|Colon and Rectum|2007
5-9|~|~|~|~|Mortality|9640683|Corpus and Uterus, NOS|2007
5-9|~|~|~|~|Incidence|9640683|Corpus and Uterus, NOS|2007
5-9|~|~|~|~|Mortality|19714611|Esophagus|2007
5-9|~|~|~|~|Incidence|19714611|Esophagus|2007
5-9|~|~|~|~|Mortality|9640683|Female Breast|2007
5-9|~|~|~|~|Incidence|9640683|Female Breast|2007
5-9|~|~|~|~|Incidence|9640683|Female Breast, <i>in situ</i>|2007
5-9|~|~|~|~|Mortality|19714611|Hodgkin Lymphoma|2007
5-9|0.3|0.4|0.3|69|Incidence|19714611|Hodgkin Lymphoma|2007
5-9|.|.|.|.|Mortality|19714611|Kaposi Sarcoma|2007
5-9|~|~|~|~|Incidence|19714611|Kaposi Sarcoma|2007
5-9|0.1|0.1|0.1|17|Mortality|19714611|Kidney and Renal Pelvis|2007
5-9|0.5|0.7|0.6|124|Incidence|19714611|Kidney and Renal Pelvis|2007
5-9|~|~|~|~|Mortality|19714611|Larynx|2007
5-9|~|~|~|~|Incidence|19714611|Larynx|2007
5-9|0.6|0.8|0.7|139|Mortality|19714611|Leukemias|2007
5-9|3.8|4.3|4.0|798|Incidence|19714611|Leukemias|2007
5-9|~|~|~|~|Mortality|19714611|Liver and Intrahepatic Bile Duct|2007
5-9|0.1|0.2|0.1|21|Incidence|19714611|Liver and Intrahepatic Bile Duct|2007
5-9|~|~|~|~|Mortality|19714611|Lung and Bronchus|2007
5-9|~|~|~|~|Incidence|19714611|Lung and Bronchus|2007
5-9|~|~|~|~|Mortality|9640683|Male and Female Breast|2007
5-9|~|~|~|~|Incidence|9640683|Male and Female Breast|2007
5-9|~|~|~|~|Incidence|9640683|Male and Female Breast, <i>in situ</i>|2007
5-9|~|~|~|~|Mortality|19714611|Melanomas of the Skin|2007
5-9|0.1|0.2|0.2|31|Incidence|19714611|Melanomas of the Skin|2007
5-9|~|~|~|~|Mortality|19714611|Mesothelioma|2007
5-9|~|~|~|~|Incidence|19714611|Mesothelioma|2007
5-9|~|~|~|~|Mortality|19714611|Myeloma|2007
5-9|~|~|~|~|Incidence|19714611|Myeloma|2007
5-9|~|~|~|~|Mortality|19714611|Non-Hodgkin Lymphoma|2007
5-9|0.9|1.2|1.1|209|Incidence|19714611|Non-Hodgkin Lymphoma|2007
5-9|~|~|~|~|Mortality|19714611|Oral Cavity and Pharynx|2007
5-9|0.1|0.2|0.1|22|Incidence|19714611|Oral Cavity and Pharynx|2007
5-9|~|~|~|~|Mortality|9640683|Ovary|2007
5-9|0.2|0.4|0.3|29|Incidence|9640683|Ovary|2007
5-9|~|~|~|~|Mortality|19714611|Pancreas|2007
5-9|~|~|~|~|Incidence|19714611|Pancreas|2007
5-9|~|~|~|~|Mortality|10073928|Prostate|2007
5-9|~|~|~|~|Incidence|10073928|Prostate|2007
5-9|~|~|~|~|Mortality|19714611|Stomach|2007
5-9|~|~|~|~|Incidence|19714611|Stomach|2007
5-9|~|~|~|~|Mortality|10073928|Testis|2007
5-9|~|~|~|~|Incidence|10073928|Testis|2007
5-9|~|~|~|~|Mortality|19714611|Thyroid|2007
5-9|0.1|0.2|0.1|19|Incidence|19714611|Thyroid|2007
5-9|~|~|~|~|Mortality|19714611|Urinary Bladder|2007
5-9|~|~|~|~|Incidence|19714611|Urinary Bladder|2007
<1|1.4|2.2|1.7|72|Mortality|4147997|All Cancer Sites Combined|2007
<1|24.8|27.9|26.3|1091|Incidence|4147997|All Cancer Sites Combined|2007
<1|~|~|~|~|Mortality|4147997|Brain and Other Nervous System|2007
<1|3.6|4.9|4.2|176|Incidence|4147997|Brain and Other Nervous System|2007
<1|~|~|~|~|Mortality|2027181|Cervix|2007
<1|~|~|~|~|Incidence|2027181|Cervix|2007
<1|~|~|~|~|Mortality|4147997|Colon and Rectum|2007
<1|~|~|~|~|Incidence|4147997|Colon and Rectum|2007
<1|~|~|~|~|Mortality|2027181|Corpus and Uterus, NOS|2007
<1|~|~|~|~|Incidence|2027181|Corpus and Uterus, NOS|2007
<1|~|~|~|~|Mortality|4147997|Esophagus|2007
<1|~|~|~|~|Incidence|4147997|Esophagus|2007
<1|~|~|~|~|Mortality|2027181|Female Breast|2007
<1|~|~|~|~|Incidence|2027181|Female Breast|2007
<1|~|~|~|~|Incidence|2027181|Female Breast, <i>in situ</i>|2007
<1|~|~|~|~|Mortality|4147997|Hodgkin Lymphoma|2007
<1|~|~|~|~|Incidence|4147997|Hodgkin Lymphoma|2007
<1|.|.|.|.|Mortality|4147997|Kaposi Sarcoma|2007
<1|~|~|~|~|Incidence|4147997|Kaposi Sarcoma|2007
<1|~|~|~|~|Mortality|4147997|Kidney and Renal Pelvis|2007
<1|1.4|2.2|1.8|73|Incidence|4147997|Kidney and Renal Pelvis|2007
<1|~|~|~|~|Mortality|4147997|Larynx|2007
<1|~|~|~|~|Incidence|4147997|Larynx|2007
<1|0.3|0.8|0.5|21|Mortality|4147997|Leukemias|2007
<1|3.7|5.0|4.3|179|Incidence|4147997|Leukemias|2007
<1|~|~|~|~|Mortality|4147997|Liver and Intrahepatic Bile Duct|2007
<1|0.9|1.5|1.2|48|Incidence|4147997|Liver and Intrahepatic Bile Duct|2007
<1|~|~|~|~|Mortality|4147997|Lung and Bronchus|2007
<1|~|~|~|~|Incidence|4147997|Lung and Bronchus|2007
<1|~|~|~|~|Mortality|2027181|Male and Female Breast|2007
<1|~|~|~|~|Incidence|2027181|Male and Female Breast|2007
<1|~|~|~|~|Incidence|2027181|Male and Female Breast, <i>in situ</i>|2007
<1|~|~|~|~|Mortality|4147997|Melanomas of the Skin|2007
<1|~|~|~|~|Incidence|4147997|Melanomas of the Skin|2007
<1|~|~|~|~|Mortality|4147997|Mesothelioma|2007
<1|~|~|~|~|Incidence|4147997|Mesothelioma|2007
<1|~|~|~|~|Mortality|4147997|Myeloma|2007
<1|~|~|~|~|Incidence|4147997|Myeloma|2007
<1|~|~|~|~|Mortality|4147997|Non-Hodgkin Lymphoma|2007
<1|~|~|~|~|Incidence|4147997|Non-Hodgkin Lymphoma|2007
<1|~|~|~|~|Mortality|4147997|Oral Cavity and Pharynx|2007
<1|~|~|~|~|Incidence|4147997|Oral Cavity and Pharynx|2007
<1|~|~|~|~|Mortality|2027181|Ovary|2007
<1|~|~|~|~|Incidence|2027181|Ovary|2007
<1|~|~|~|~|Mortality|4147997|Pancreas|2007
<1|~|~|~|~|Incidence|4147997|Pancreas|2007
<1|~|~|~|~|Mortality|2120816|Prostate|2007
<1|~|~|~|~|Incidence|2120816|Prostate|2007
<1|~|~|~|~|Mortality|4147997|Stomach|2007
<1|~|~|~|~|Incidence|4147997|Stomach|2007
<1|~|~|~|~|Mortality|2120816|Testis|2007
<1|0.6|1.5|1.0|21|Incidence|2120816|Testis|2007
<1|~|~|~|~|Mortality|4147997|Thyroid|2007
<1|~|~|~|~|Incidence|4147997|Thyroid|2007
<1|~|~|~|~|Mortality|4147997|Urinary Bladder|2007
<1|~|~|~|~|Incidence|4147997|Urinary Bladder|2007
1-4|2.2|2.7|2.4|394|Mortality|16138392|All Cancer Sites Combined|2008
1-4|22.0|23.5|22.7|3668|Incidence|16138392|All Cancer Sites Combined|2008
1-4|0.6|0.9|0.7|119|Mortality|16138392|Brain and Other Nervous System|2008
1-4|4.4|5.1|4.7|764|Incidence|16138392|Brain and Other Nervous System|2008
1-4|~|~|~|~|Mortality|7891294|Cervix|2008
1-4|~|~|~|~|Incidence|7891294|Cervix|2008
1-4|~|~|~|~|Mortality|16138392|Colon and Rectum|2008
1-4|~|~|~|~|Incidence|16138392|Colon and Rectum|2008
1-4|~|~|~|~|Mortality|7891294|Corpus and Uterus, NOS|2008
1-4|~|~|~|~|Incidence|7891294|Corpus and Uterus, NOS|2008
1-4|~|~|~|~|Mortality|16138392|Esophagus|2008
1-4|~|~|~|~|Incidence|16138392|Esophagus|2008
1-4|~|~|~|~|Mortality|7891294|Female Breast|2008
1-4|~|~|~|~|Incidence|7891294|Female Breast|2008
1-4|~|~|~|~|Incidence|7891294|Female Breast, <i>in situ</i>|2008
1-4|~|~|~|~|Mortality|16138392|Hodgkin Lymphoma|2008
1-4|0.1|0.2|0.1|16|Incidence|16138392|Hodgkin Lymphoma|2008
1-4|.|.|.|.|Mortality|16138392|Kaposi Sarcoma|2008
1-4|~|~|~|~|Incidence|16138392|Kaposi Sarcoma|2008
1-4|~|~|~|~|Mortality|16138392|Kidney and Renal Pelvis|2008
1-4|2.0|2.4|2.2|354|Incidence|16138392|Kidney and Renal Pelvis|2008
1-4|~|~|~|~|Mortality|16138392|Larynx|2008
1-4|~|~|~|~|Incidence|16138392|Larynx|2008
1-4|0.6|0.9|0.8|123|Mortality|16138392|Leukemias|2008
1-4|8.8|9.7|9.2|1488|Incidence|16138392|Leukemias|2008
1-4|0.1|0.2|0.1|20|Mortality|16138392|Liver and Intrahepatic Bile Duct|2008
1-4|0.5|0.7|0.6|91|Incidence|16138392|Liver and Intrahepatic Bile Duct|2008
1-4|~|~|~|~|Mortality|16138392|Lung and Bronchus|2008
1-4|~|~|~|~|Incidence|16138392|Lung and Bronchus|2008
1-4|~|~|~|~|Mortality|7891294|Male and Female Breast|2008
1-4|~|~|~|~|Incidence|7891294|Male and Female Breast|2008
1-4|~|~|~|~|Incidence|7891294|Male and Female Breast, <i>in situ</i>|2008
1-4|~|~|~|~|Mortality|16138392|Melanomas of the Skin|2008
1-4|~|~|~|~|Incidence|16138392|Melanomas of the Skin|2008
1-4|~|~|~|~|Mortality|16138392|Mesothelioma|2008
1-4|~|~|~|~|Incidence|16138392|Mesothelioma|2008
1-4|~|~|~|~|Mortality|16138392|Myeloma|2008
1-4|~|~|~|~|Incidence|16138392|Myeloma|2008
1-4|~|~|~|~|Mortality|16138392|Non-Hodgkin Lymphoma|2008
1-4|0.6|0.8|0.7|114|Incidence|16138392|Non-Hodgkin Lymphoma|2008
1-4|~|~|~|~|Mortality|16138392|Oral Cavity and Pharynx|2008
1-4|~|~|~|~|Incidence|16138392|Oral Cavity and Pharynx|2008
1-4|~|~|~|~|Mortality|7891294|Ovary|2008
1-4|~|~|~|~|Incidence|7891294|Ovary|2008
1-4|~|~|~|~|Mortality|16138392|Pancreas|2008
1-4|~|~|~|~|Incidence|16138392|Pancreas|2008
1-4|~|~|~|~|Mortality|8247098|Prostate|2008
1-4|~|~|~|~|Incidence|8247098|Prostate|2008
1-4|~|~|~|~|Mortality|16138392|Stomach|2008
1-4|~|~|~|~|Incidence|16138392|Stomach|2008
1-4|~|~|~|~|Mortality|8247098|Testis|2008
1-4|0.2|0.5|0.3|28|Incidence|8247098|Testis|2008
1-4|~|~|~|~|Mortality|16138392|Thyroid|2008
1-4|~|~|~|~|Incidence|16138392|Thyroid|2008
1-4|~|~|~|~|Mortality|16138392|Urinary Bladder|2008
1-4|~|~|~|~|Incidence|16138392|Urinary Bladder|2008
10-14|1.9|2.3|2.1|433|Mortality|20706655|All Cancer Sites Combined|2008
10-14|12.9|13.9|13.4|2775|Incidence|20706655|All Cancer Sites Combined|2008
10-14|0.5|0.7|0.6|125|Mortality|20706655|Brain and Other Nervous System|2008
10-14|2.5|2.9|2.7|561|Incidence|20706655|Brain and Other Nervous System|2008
10-14|~|~|~|~|Mortality|10108474|Cervix|2008
10-14|~|~|~|~|Incidence|10108474|Cervix|2008
10-14|~|~|~|~|Mortality|20706655|Colon and Rectum|2008
10-14|~|~|~|~|Incidence|20706655|Colon and Rectum|2008
10-14|~|~|~|~|Mortality|10108474|Corpus and Uterus, NOS|2008
10-14|~|~|~|~|Incidence|10108474|Corpus and Uterus, NOS|2008
10-14|~|~|~|~|Mortality|20706655|Esophagus|2008
10-14|~|~|~|~|Incidence|20706655|Esophagus|2008
10-14|~|~|~|~|Mortality|10108474|Female Breast|2008
10-14|~|~|~|~|Incidence|10108474|Female Breast|2008
10-14|~|~|~|~|Incidence|10108474|Female Breast, <i>in situ</i>|2008
10-14|~|~|~|~|Mortality|20706655|Hodgkin Lymphoma|2008
10-14|1.2|1.5|1.3|276|Incidence|20706655|Hodgkin Lymphoma|2008
10-14|.|.|.|.|Mortality|20706655|Kaposi Sarcoma|2008
10-14|~|~|~|~|Incidence|20706655|Kaposi Sarcoma|2008
10-14|~|~|~|~|Mortality|20706655|Kidney and Renal Pelvis|2008
10-14|0.1|0.2|0.1|25|Incidence|20706655|Kidney and Renal Pelvis|2008
10-14|~|~|~|~|Mortality|20706655|Larynx|2008
10-14|~|~|~|~|Incidence|20706655|Larynx|2008
10-14|0.6|0.9|0.7|152|Mortality|20706655|Leukemias|2008
10-14|2.9|3.4|3.2|657|Incidence|20706655|Leukemias|2008
10-14|~|~|~|~|Mortality|20706655|Liver and Intrahepatic Bile Duct|2008
10-14|0.1|0.1|0.1|18|Incidence|20706655|Liver and Intrahepatic Bile Duct|2008
10-14|~|~|~|~|Mortality|20706655|Lung and Bronchus|2008
10-14|~|~|~|~|Incidence|20706655|Lung and Bronchus|2008
10-14|~|~|~|~|Mortality|10108474|Male and Female Breast|2008
10-14|~|~|~|~|Incidence|10108474|Male and Female Breast|2008
10-14|~|~|~|~|Incidence|10108474|Male and Female Breast, <i>in situ</i>|2008
10-14|~|~|~|~|Mortality|20706655|Melanomas of the Skin|2008
10-14|0.3|0.4|0.4|74|Incidence|20706655|Melanomas of the Skin|2008
10-14|~|~|~|~|Mortality|20706655|Mesothelioma|2008
10-14|~|~|~|~|Incidence|20706655|Mesothelioma|2008
10-14|~|~|~|~|Mortality|20706655|Myeloma|2008
10-14|~|~|~|~|Incidence|20706655|Myeloma|2008
10-14|~|~|~|~|Mortality|20706655|Non-Hodgkin Lymphoma|2008
10-14|1.0|1.3|1.2|244|Incidence|20706655|Non-Hodgkin Lymphoma|2008
10-14|~|~|~|~|Mortality|20706655|Oral Cavity and Pharynx|2008
10-14|0.2|0.4|0.3|60|Incidence|20706655|Oral Cavity and Pharynx|2008
10-14|~|~|~|~|Mortality|10108474|Ovary|2008
10-14|0.5|0.9|0.7|69|Incidence|10108474|Ovary|2008
10-14|~|~|~|~|Mortality|20706655|Pancreas|2008
10-14|~|~|~|~|Incidence|20706655|Pancreas|2008
10-14|~|~|~|~|Mortality|10598181|Prostate|2008
10-14|~|~|~|~|Incidence|10598181|Prostate|2008
10-14|~|~|~|~|Mortality|20706655|Stomach|2008
10-14|~|~|~|~|Incidence|20706655|Stomach|2008
10-14|~|~|~|~|Mortality|10598181|Testis|2008
10-14|0.1|0.3|0.2|19|Incidence|10598181|Testis|2008
10-14|~|~|~|~|Mortality|20706655|Thyroid|2008
10-14|0.5|0.7|0.6|126|Incidence|20706655|Thyroid|2008
10-14|~|~|~|~|Mortality|20706655|Urinary Bladder|2008
10-14|~|~|~|~|Incidence|20706655|Urinary Bladder|2008
15-19|2.9|3.3|3.1|685|Mortality|22210880|All Cancer Sites Combined|2008
15-19|21.6|22.8|22.2|4934|Incidence|22210880|All Cancer Sites Combined|2008
15-19|0.4|0.6|0.5|104|Mortality|22210880|Brain and Other Nervous System|2008
15-19|2.2|2.6|2.4|525|Incidence|22210880|Brain and Other Nervous System|2008
15-19|~|~|~|~|Mortality|10805148|Cervix|2008
15-19|0.1|0.3|0.2|22|Incidence|10805148|Cervix|2008
15-19|~|~|~|~|Mortality|22210880|Colon and Rectum|2008
15-19|0.2|0.4|0.3|66|Incidence|22210880|Colon and Rectum|2008
15-19|~|~|~|~|Mortality|10805148|Corpus and Uterus, NOS|2008
15-19|~|~|~|~|Incidence|10805148|Corpus and Uterus, NOS|2008
15-19|~|~|~|~|Mortality|22210880|Esophagus|2008
15-19|~|~|~|~|Incidence|22210880|Esophagus|2008
15-19|~|~|~|~|Mortality|10805148|Female Breast|2008
15-19|0.1|0.2|0.1|16|Incidence|10805148|Female Breast|2008
15-19|~|~|~|~|Incidence|10805148|Female Breast, <i>in situ</i>|2008
15-19|~|~|~|~|Mortality|22210880|Hodgkin Lymphoma|2008
15-19|3.0|3.5|3.3|722|Incidence|22210880|Hodgkin Lymphoma|2008
15-19|.|.|.|.|Mortality|22210880|Kaposi Sarcoma|2008
15-19|~|~|~|~|Incidence|22210880|Kaposi Sarcoma|2008
15-19|~|~|~|~|Mortality|22210880|Kidney and Renal Pelvis|2008
15-19|0.2|0.3|0.2|49|Incidence|22210880|Kidney and Renal Pelvis|2008
15-19|~|~|~|~|Mortality|22210880|Larynx|2008
15-19|~|~|~|~|Incidence|22210880|Larynx|2008
15-19|0.8|1.0|0.9|196|Mortality|22210880|Leukemias|2008
15-19|2.8|3.3|3.1|683|Incidence|22210880|Leukemias|2008
15-19|0.0|0.1|0.1|16|Mortality|22210880|Liver and Intrahepatic Bile Duct|2008
15-19|0.1|0.2|0.1|28|Incidence|22210880|Liver and Intrahepatic Bile Duct|2008
15-19|~|~|~|~|Mortality|22210880|Lung and Bronchus|2008
15-19|0.1|0.3|0.2|41|Incidence|22210880|Lung and Bronchus|2008
15-19|~|~|~|~|Mortality|10805148|Male and Female Breast|2008
15-19|0.1|0.2|0.1|16|Incidence|10805148|Male and Female Breast|2008
15-19|~|~|~|~|Incidence|10805148|Male and Female Breast, <i>in situ</i>|2008
15-19|~|~|~|~|Mortality|22210880|Melanomas of the Skin|2008
15-19|1.1|1.4|1.2|276|Incidence|22210880|Melanomas of the Skin|2008
15-19|~|~|~|~|Mortality|22210880|Mesothelioma|2008
15-19|~|~|~|~|Incidence|22210880|Mesothelioma|2008
15-19|~|~|~|~|Mortality|22210880|Myeloma|2008
15-19|~|~|~|~|Incidence|22210880|Myeloma|2008
15-19|0.2|0.3|0.2|54|Mortality|22210880|Non-Hodgkin Lymphoma|2008
15-19|1.6|1.9|1.7|385|Incidence|22210880|Non-Hodgkin Lymphoma|2008
15-19|~|~|~|~|Mortality|22210880|Oral Cavity and Pharynx|2008
15-19|0.4|0.6|0.5|102|Incidence|22210880|Oral Cavity and Pharynx|2008
15-19|~|~|~|~|Mortality|10805148|Ovary|2008
15-19|1.0|1.4|1.1|124|Incidence|10805148|Ovary|2008
15-19|~|~|~|~|Mortality|22210880|Pancreas|2008
15-19|~|~|~|~|Incidence|22210880|Pancreas|2008
15-19|~|~|~|~|Mortality|11405732|Prostate|2008
15-19|~|~|~|~|Incidence|11405732|Prostate|2008
15-19|~|~|~|~|Mortality|22210880|Stomach|2008
15-19|0.0|0.1|0.1|16|Incidence|22210880|Stomach|2008
15-19|~|~|~|~|Mortality|11405732|Testis|2008
15-19|3.3|4.0|3.6|415|Incidence|11405732|Testis|2008
15-19|~|~|~|~|Mortality|22210880|Thyroid|2008
15-19|2.3|2.7|2.5|548|Incidence|22210880|Thyroid|2008
15-19|~|~|~|~|Mortality|22210880|Urinary Bladder|2008
15-19|0.0|0.1|0.1|18|Incidence|22210880|Urinary Bladder|2008
5-9|2.1|2.5|2.3|457|Mortality|19929602|All Cancer Sites Combined|2008
5-9|12.4|13.4|12.9|2571|Incidence|19929602|All Cancer Sites Combined|2008
5-9|0.7|1.0|0.9|174|Mortality|19929602|Brain and Other Nervous System|2008
5-9|3.4|4.0|3.7|736|Incidence|19929602|Brain and Other Nervous System|2008
5-9|~|~|~|~|Mortality|9748488|Cervix|2008
5-9|~|~|~|~|Incidence|9748488|Cervix|2008
5-9|~|~|~|~|Mortality|19929602|Colon and Rectum|2008
5-9|~|~|~|~|Incidence|19929602|Colon and Rectum|2008
5-9|~|~|~|~|Mortality|9748488|Corpus and Uterus, NOS|2008
5-9|~|~|~|~|Incidence|9748488|Corpus and Uterus, NOS|2008
5-9|~|~|~|~|Mortality|19929602|Esophagus|2008
5-9|~|~|~|~|Incidence|19929602|Esophagus|2008
5-9|~|~|~|~|Mortality|9748488|Female Breast|2008
5-9|~|~|~|~|Incidence|9748488|Female Breast|2008
5-9|~|~|~|~|Incidence|9748488|Female Breast, <i>in situ</i>|2008
5-9|~|~|~|~|Mortality|19929602|Hodgkin Lymphoma|2008
5-9|0.4|0.5|0.4|89|Incidence|19929602|Hodgkin Lymphoma|2008
5-9|.|.|.|.|Mortality|19929602|Kaposi Sarcoma|2008
5-9|~|~|~|~|Incidence|19929602|Kaposi Sarcoma|2008
5-9|0.1|0.2|0.1|26|Mortality|19929602|Kidney and Renal Pelvis|2008
5-9|0.5|0.7|0.6|115|Incidence|19929602|Kidney and Renal Pelvis|2008
5-9|~|~|~|~|Mortality|19929602|Larynx|2008
5-9|~|~|~|~|Incidence|19929602|Larynx|2008
5-9|0.4|0.6|0.5|100|Mortality|19929602|Leukemias|2008
5-9|3.9|4.5|4.2|834|Incidence|19929602|Leukemias|2008
5-9|~|~|~|~|Mortality|19929602|Liver and Intrahepatic Bile Duct|2008
5-9|0.1|0.2|0.1|20|Incidence|19929602|Liver and Intrahepatic Bile Duct|2008
5-9|~|~|~|~|Mortality|19929602|Lung and Bronchus|2008
5-9|~|~|~|~|Incidence|19929602|Lung and Bronchus|2008
5-9|~|~|~|~|Mortality|9748488|Male and Female Breast|2008
5-9|~|~|~|~|Incidence|9748488|Male and Female Breast|2008
5-9|~|~|~|~|Incidence|9748488|Male and Female Breast, <i>in situ</i>|2008
5-9|~|~|~|~|Mortality|19929602|Melanomas of the Skin|2008
5-9|0.1|0.2|0.1|25|Incidence|19929602|Melanomas of the Skin|2008
5-9|~|~|~|~|Mortality|19929602|Mesothelioma|2008
5-9|~|~|~|~|Incidence|19929602|Mesothelioma|2008
5-9|~|~|~|~|Mortality|19929602|Myeloma|2008
5-9|~|~|~|~|Incidence|19929602|Myeloma|2008
5-9|0.1|0.2|0.1|20|Mortality|19929602|Non-Hodgkin Lymphoma|2008
5-9|0.9|1.2|1.1|212|Incidence|19929602|Non-Hodgkin Lymphoma|2008
5-9|~|~|~|~|Mortality|19929602|Oral Cavity and Pharynx|2008
5-9|0.0|0.1|0.1|17|Incidence|19929602|Oral Cavity and Pharynx|2008
5-9|~|~|~|~|Mortality|9748488|Ovary|2008
5-9|0.1|0.4|0.2|23|Incidence|9748488|Ovary|2008
5-9|~|~|~|~|Mortality|19929602|Pancreas|2008
5-9|~|~|~|~|Incidence|19929602|Pancreas|2008
5-9|~|~|~|~|Mortality|10181114|Prostate|2008
5-9|~|~|~|~|Incidence|10181114|Prostate|2008
5-9|~|~|~|~|Mortality|19929602|Stomach|2008
5-9|~|~|~|~|Incidence|19929602|Stomach|2008
5-9|~|~|~|~|Mortality|10181114|Testis|2008
5-9|~|~|~|~|Incidence|10181114|Testis|2008
5-9|~|~|~|~|Mortality|19929602|Thyroid|2008
5-9|0.1|0.2|0.1|25|Incidence|19929602|Thyroid|2008
5-9|~|~|~|~|Mortality|19929602|Urinary Bladder|2008
5-9|~|~|~|~|Incidence|19929602|Urinary Bladder|2008
<1|1.3|2.1|1.7|70|Mortality|4132735|All Cancer Sites Combined|2008
<1|25.2|28.4|26.8|1107|Incidence|4132735|All Cancer Sites Combined|2008
<1|~|~|~|~|Mortality|4132735|Brain and Other Nervous System|2008
<1|3.5|4.8|4.1|169|Incidence|4132735|Brain and Other Nervous System|2008
<1|~|~|~|~|Mortality|2022889|Cervix|2008
<1|~|~|~|~|Incidence|2022889|Cervix|2008
<1|~|~|~|~|Mortality|4132735|Colon and Rectum|2008
<1|~|~|~|~|Incidence|4132735|Colon and Rectum|2008
<1|~|~|~|~|Mortality|2022889|Corpus and Uterus, NOS|2008
<1|~|~|~|~|Incidence|2022889|Corpus and Uterus, NOS|2008
<1|~|~|~|~|Mortality|4132735|Esophagus|2008
<1|~|~|~|~|Incidence|4132735|Esophagus|2008
<1|~|~|~|~|Mortality|2022889|Female Breast|2008
<1|~|~|~|~|Incidence|2022889|Female Breast|2008
<1|~|~|~|~|Incidence|2022889|Female Breast, <i>in situ</i>|2008
<1|~|~|~|~|Mortality|4132735|Hodgkin Lymphoma|2008
<1|~|~|~|~|Incidence|4132735|Hodgkin Lymphoma|2008
<1|.|.|.|.|Mortality|4132735|Kaposi Sarcoma|2008
<1|~|~|~|~|Incidence|4132735|Kaposi Sarcoma|2008
<1|~|~|~|~|Mortality|4132735|Kidney and Renal Pelvis|2008
<1|1.4|2.3|1.8|75|Incidence|4132735|Kidney and Renal Pelvis|2008
<1|~|~|~|~|Mortality|4132735|Larynx|2008
<1|~|~|~|~|Incidence|4132735|Larynx|2008
<1|0.4|1.0|0.7|27|Mortality|4132735|Leukemias|2008
<1|3.9|5.2|4.5|188|Incidence|4132735|Leukemias|2008
<1|~|~|~|~|Mortality|4132735|Liver and Intrahepatic Bile Duct|2008
<1|0.9|1.6|1.2|49|Incidence|4132735|Liver and Intrahepatic Bile Duct|2008
<1|~|~|~|~|Mortality|4132735|Lung and Bronchus|2008
<1|~|~|~|~|Incidence|4132735|Lung and Bronchus|2008
<1|~|~|~|~|Mortality|2022889|Male and Female Breast|2008
<1|~|~|~|~|Incidence|2022889|Male and Female Breast|2008
<1|~|~|~|~|Incidence|2022889|Male and Female Breast, <i>in situ</i>|2008
<1|~|~|~|~|Mortality|4132735|Melanomas of the Skin|2008
<1|0.2|0.6|0.4|16|Incidence|4132735|Melanomas of the Skin|2008
<1|~|~|~|~|Mortality|4132735|Mesothelioma|2008
<1|~|~|~|~|Incidence|4132735|Mesothelioma|2008
<1|~|~|~|~|Mortality|4132735|Myeloma|2008
<1|~|~|~|~|Incidence|4132735|Myeloma|2008
<1|~|~|~|~|Mortality|4132735|Non-Hodgkin Lymphoma|2008
<1|~|~|~|~|Incidence|4132735|Non-Hodgkin Lymphoma|2008
<1|~|~|~|~|Mortality|4132735|Oral Cavity and Pharynx|2008
<1|~|~|~|~|Incidence|4132735|Oral Cavity and Pharynx|2008
<1|~|~|~|~|Mortality|2022889|Ovary|2008
<1|~|~|~|~|Incidence|2022889|Ovary|2008
<1|~|~|~|~|Mortality|4132735|Pancreas|2008
<1|~|~|~|~|Incidence|4132735|Pancreas|2008
<1|~|~|~|~|Mortality|2109846|Prostate|2008
<1|~|~|~|~|Incidence|2109846|Prostate|2008
<1|~|~|~|~|Mortality|4132735|Stomach|2008
<1|~|~|~|~|Incidence|4132735|Stomach|2008
<1|~|~|~|~|Mortality|2109846|Testis|2008
<1|0.7|1.6|1.1|23|Incidence|2109846|Testis|2008
<1|~|~|~|~|Mortality|4132735|Thyroid|2008
<1|~|~|~|~|Incidence|4132735|Thyroid|2008
<1|~|~|~|~|Mortality|4132735|Urinary Bladder|2008
<1|~|~|~|~|Incidence|4132735|Urinary Bladder|2008
1-4|1.9|2.4|2.2|350|Mortality|16240931|All Cancer Sites Combined|2009
1-4|21.6|23.1|22.3|3628|Incidence|16240931|All Cancer Sites Combined|2009
1-4|0.4|0.6|0.5|84|Mortality|16240931|Brain and Other Nervous System|2009
1-4|4.2|4.8|4.5|730|Incidence|16240931|Brain and Other Nervous System|2009
1-4|~|~|~|~|Mortality|7943260|Cervix|2009
1-4|~|~|~|~|Incidence|7943260|Cervix|2009
1-4|~|~|~|~|Mortality|16240931|Colon and Rectum|2009
1-4|~|~|~|~|Incidence|16240931|Colon and Rectum|2009
1-4|~|~|~|~|Mortality|7943260|Corpus and Uterus, NOS|2009
1-4|~|~|~|~|Incidence|7943260|Corpus and Uterus, NOS|2009
1-4|~|~|~|~|Mortality|16240931|Esophagus|2009
1-4|~|~|~|~|Incidence|16240931|Esophagus|2009
1-4|~|~|~|~|Mortality|7943260|Female Breast|2009
1-4|~|~|~|~|Incidence|7943260|Female Breast|2009
1-4|~|~|~|~|Incidence|7943260|Female Breast, <i>in situ</i>|2009
1-4|~|~|~|~|Mortality|16240931|Hodgkin Lymphoma|2009
1-4|0.1|0.2|0.1|22|Incidence|16240931|Hodgkin Lymphoma|2009
1-4|.|.|.|.|Mortality|16240931|Kaposi Sarcoma|2009
1-4|~|~|~|~|Incidence|16240931|Kaposi Sarcoma|2009
1-4|~|~|~|~|Mortality|16240931|Kidney and Renal Pelvis|2009
1-4|2.0|2.4|2.2|355|Incidence|16240931|Kidney and Renal Pelvis|2009
1-4|~|~|~|~|Mortality|16240931|Larynx|2009
1-4|~|~|~|~|Incidence|16240931|Larynx|2009
1-4|0.6|0.9|0.7|118|Mortality|16240931|Leukemias|2009
1-4|8.8|9.7|9.2|1498|Incidence|16240931|Leukemias|2009
1-4|~|~|~|~|Mortality|16240931|Liver and Intrahepatic Bile Duct|2009
1-4|0.4|0.6|0.5|80|Incidence|16240931|Liver and Intrahepatic Bile Duct|2009
1-4|~|~|~|~|Mortality|16240931|Lung and Bronchus|2009
1-4|~|~|~|~|Incidence|16240931|Lung and Bronchus|2009
1-4|~|~|~|~|Mortality|7943260|Male and Female Breast|2009
1-4|~|~|~|~|Incidence|7943260|Male and Female Breast|2009
1-4|~|~|~|~|Incidence|7943260|Male and Female Breast, <i>in situ</i>|2009
1-4|~|~|~|~|Mortality|16240931|Melanomas of the Skin|2009
1-4|~|~|~|~|Incidence|16240931|Melanomas of the Skin|2009
1-4|~|~|~|~|Mortality|16240931|Mesothelioma|2009
1-4|~|~|~|~|Incidence|16240931|Mesothelioma|2009
1-4|~|~|~|~|Mortality|16240931|Myeloma|2009
1-4|~|~|~|~|Incidence|16240931|Myeloma|2009
1-4|~|~|~|~|Mortality|16240931|Non-Hodgkin Lymphoma|2009
1-4|0.5|0.8|0.6|105|Incidence|16240931|Non-Hodgkin Lymphoma|2009
1-4|~|~|~|~|Mortality|16240931|Oral Cavity and Pharynx|2009
1-4|~|~|~|~|Incidence|16240931|Oral Cavity and Pharynx|2009
1-4|~|~|~|~|Mortality|7943260|Ovary|2009
1-4|~|~|~|~|Incidence|7943260|Ovary|2009
1-4|~|~|~|~|Mortality|16240931|Pancreas|2009
1-4|~|~|~|~|Incidence|16240931|Pancreas|2009
1-4|~|~|~|~|Mortality|8297671|Prostate|2009
1-4|~|~|~|~|Incidence|8297671|Prostate|2009
1-4|~|~|~|~|Mortality|16240931|Stomach|2009
1-4|~|~|~|~|Incidence|16240931|Stomach|2009
1-4|~|~|~|~|Mortality|8297671|Testis|2009
1-4|0.3|0.6|0.4|33|Incidence|8297671|Testis|2009
1-4|~|~|~|~|Mortality|16240931|Thyroid|2009
1-4|~|~|~|~|Incidence|16240931|Thyroid|2009
1-4|~|~|~|~|Mortality|16240931|Urinary Bladder|2009
1-4|~|~|~|~|Incidence|16240931|Urinary Bladder|2009
10-14|1.8|2.2|2.0|419|Mortality|20660564|All Cancer Sites Combined|2009
10-14|13.2|14.2|13.7|2828|Incidence|20660564|All Cancer Sites Combined|2009
10-14|0.5|0.7|0.5|113|Mortality|20660564|Brain and Other Nervous System|2009
10-14|2.6|3.1|2.8|585|Incidence|20660564|Brain and Other Nervous System|2009
10-14|~|~|~|~|Mortality|10088732|Cervix|2009
10-14|~|~|~|~|Incidence|10088732|Cervix|2009
10-14|~|~|~|~|Mortality|20660564|Colon and Rectum|2009
10-14|0.0|0.1|0.1|17|Incidence|20660564|Colon and Rectum|2009
10-14|~|~|~|~|Mortality|10088732|Corpus and Uterus, NOS|2009
10-14|~|~|~|~|Incidence|10088732|Corpus and Uterus, NOS|2009
10-14|~|~|~|~|Mortality|20660564|Esophagus|2009
10-14|~|~|~|~|Incidence|20660564|Esophagus|2009
10-14|~|~|~|~|Mortality|10088732|Female Breast|2009
10-14|~|~|~|~|Incidence|10088732|Female Breast|2009
10-14|~|~|~|~|Incidence|10088732|Female Breast, <i>in situ</i>|2009
10-14|~|~|~|~|Mortality|20660564|Hodgkin Lymphoma|2009
10-14|1.0|1.3|1.2|240|Incidence|20660564|Hodgkin Lymphoma|2009
10-14|.|.|.|.|Mortality|20660564|Kaposi Sarcoma|2009
10-14|~|~|~|~|Incidence|20660564|Kaposi Sarcoma|2009
10-14|~|~|~|~|Mortality|20660564|Kidney and Renal Pelvis|2009
10-14|0.1|0.2|0.2|32|Incidence|20660564|Kidney and Renal Pelvis|2009
10-14|~|~|~|~|Mortality|20660564|Larynx|2009
10-14|~|~|~|~|Incidence|20660564|Larynx|2009
10-14|0.5|0.7|0.6|127|Mortality|20660564|Leukemias|2009
10-14|2.8|3.3|3.1|635|Incidence|20660564|Leukemias|2009
10-14|~|~|~|~|Mortality|20660564|Liver and Intrahepatic Bile Duct|2009
10-14|0.1|0.2|0.1|25|Incidence|20660564|Liver and Intrahepatic Bile Duct|2009
10-14|~|~|~|~|Mortality|20660564|Lung and Bronchus|2009
10-14|~|~|~|~|Incidence|20660564|Lung and Bronchus|2009
10-14|~|~|~|~|Mortality|10088732|Male and Female Breast|2009
10-14|~|~|~|~|Incidence|10088732|Male and Female Breast|2009
10-14|~|~|~|~|Incidence|10088732|Male and Female Breast, <i>in situ</i>|2009
10-14|~|~|~|~|Mortality|20660564|Melanomas of the Skin|2009
10-14|0.2|0.3|0.2|48|Incidence|20660564|Melanomas of the Skin|2009
10-14|~|~|~|~|Mortality|20660564|Mesothelioma|2009
10-14|~|~|~|~|Incidence|20660564|Mesothelioma|2009
10-14|~|~|~|~|Mortality|20660564|Myeloma|2009
10-14|~|~|~|~|Incidence|20660564|Myeloma|2009
10-14|0.1|0.1|0.1|20|Mortality|20660564|Non-Hodgkin Lymphoma|2009
10-14|1.1|1.4|1.3|259|Incidence|20660564|Non-Hodgkin Lymphoma|2009
10-14|~|~|~|~|Mortality|20660564|Oral Cavity and Pharynx|2009
10-14|0.3|0.4|0.3|71|Incidence|20660564|Oral Cavity and Pharynx|2009
10-14|~|~|~|~|Mortality|10088732|Ovary|2009
10-14|0.6|0.9|0.7|73|Incidence|10088732|Ovary|2009
10-14|~|~|~|~|Mortality|20660564|Pancreas|2009
10-14|~|~|~|~|Incidence|20660564|Pancreas|2009
10-14|~|~|~|~|Mortality|10571832|Prostate|2009
10-14|~|~|~|~|Incidence|10571832|Prostate|2009
10-14|~|~|~|~|Mortality|20660564|Stomach|2009
10-14|~|~|~|~|Incidence|20660564|Stomach|2009
10-14|~|~|~|~|Mortality|10571832|Testis|2009
10-14|0.2|0.3|0.2|25|Incidence|10571832|Testis|2009
10-14|~|~|~|~|Mortality|20660564|Thyroid|2009
10-14|0.6|0.8|0.7|147|Incidence|20660564|Thyroid|2009
10-14|~|~|~|~|Mortality|20660564|Urinary Bladder|2009
10-14|~|~|~|~|Incidence|20660564|Urinary Bladder|2009
15-19|2.7|3.1|2.9|644|Mortality|22192810|All Cancer Sites Combined|2009
15-19|21.6|22.9|22.2|4935|Incidence|22192810|All Cancer Sites Combined|2009
15-19|0.4|0.6|0.5|120|Mortality|22192810|Brain and Other Nervous System|2009
15-19|2.1|2.5|2.3|500|Incidence|22192810|Brain and Other Nervous System|2009
15-19|~|~|~|~|Mortality|10804571|Cervix|2009
15-19|0.1|0.3|0.2|24|Incidence|10804571|Cervix|2009
15-19|~|~|~|~|Mortality|22192810|Colon and Rectum|2009
15-19|0.2|0.3|0.2|54|Incidence|22192810|Colon and Rectum|2009
15-19|~|~|~|~|Mortality|10804571|Corpus and Uterus, NOS|2009
15-19|~|~|~|~|Incidence|10804571|Corpus and Uterus, NOS|2009
15-19|~|~|~|~|Mortality|22192810|Esophagus|2009
15-19|~|~|~|~|Incidence|22192810|Esophagus|2009
15-19|~|~|~|~|Mortality|10804571|Female Breast|2009
15-19|0.1|0.3|0.2|19|Incidence|10804571|Female Breast|2009
15-19|~|~|~|~|Incidence|10804571|Female Breast, <i>in situ</i>|2009
15-19|~|~|~|~|Mortality|22192810|Hodgkin Lymphoma|2009
15-19|3.1|3.5|3.3|732|Incidence|22192810|Hodgkin Lymphoma|2009
15-19|.|.|.|.|Mortality|22192810|Kaposi Sarcoma|2009
15-19|~|~|~|~|Incidence|22192810|Kaposi Sarcoma|2009
15-19|~|~|~|~|Mortality|22192810|Kidney and Renal Pelvis|2009
15-19|0.1|0.3|0.2|44|Incidence|22192810|Kidney and Renal Pelvis|2009
15-19|~|~|~|~|Mortality|22192810|Larynx|2009
15-19|~|~|~|~|Incidence|22192810|Larynx|2009
15-19|0.7|0.9|0.8|172|Mortality|22192810|Leukemias|2009
15-19|2.6|3.1|2.8|628|Incidence|22192810|Leukemias|2009
15-19|0.0|0.1|0.1|16|Mortality|22192810|Liver and Intrahepatic Bile Duct|2009
15-19|0.1|0.2|0.1|31|Incidence|22192810|Liver and Intrahepatic Bile Duct|2009
15-19|~|~|~|~|Mortality|22192810|Lung and Bronchus|2009
15-19|0.1|0.3|0.2|41|Incidence|22192810|Lung and Bronchus|2009
15-19|~|~|~|~|Mortality|10804571|Male and Female Breast|2009
15-19|0.1|0.3|0.2|19|Incidence|10804571|Male and Female Breast|2009
15-19|~|~|~|~|Incidence|10804571|Male and Female Breast, <i>in situ</i>|2009
15-19|~|~|~|~|Mortality|22192810|Melanomas of the Skin|2009
15-19|1.1|1.4|1.2|272|Incidence|22192810|Melanomas of the Skin|2009
15-19|~|~|~|~|Mortality|22192810|Mesothelioma|2009
15-19|~|~|~|~|Incidence|22192810|Mesothelioma|2009
15-19|~|~|~|~|Mortality|22192810|Myeloma|2009
15-19|~|~|~|~|Incidence|22192810|Myeloma|2009
15-19|0.1|0.2|0.2|37|Mortality|22192810|Non-Hodgkin Lymphoma|2009
15-19|1.5|1.9|1.7|373|Incidence|22192810|Non-Hodgkin Lymphoma|2009
15-19|~|~|~|~|Mortality|22192810|Oral Cavity and Pharynx|2009
15-19|0.4|0.6|0.5|118|Incidence|22192810|Oral Cavity and Pharynx|2009
15-19|~|~|~|~|Mortality|10804571|Ovary|2009
15-19|1.3|1.8|1.5|165|Incidence|10804571|Ovary|2009
15-19|~|~|~|~|Mortality|22192810|Pancreas|2009
15-19|~|~|~|~|Incidence|22192810|Pancreas|2009
15-19|~|~|~|~|Mortality|11388239|Prostate|2009
15-19|~|~|~|~|Incidence|11388239|Prostate|2009
15-19|~|~|~|~|Mortality|22192810|Stomach|2009
15-19|~|~|~|~|Incidence|22192810|Stomach|2009
15-19|~|~|~|~|Mortality|11388239|Testis|2009
15-19|3.2|3.9|3.6|408|Incidence|11388239|Testis|2009
15-19|~|~|~|~|Mortality|22192810|Thyroid|2009
15-19|2.3|2.7|2.5|547|Incidence|22192810|Thyroid|2009
15-19|~|~|~|~|Mortality|22192810|Urinary Bladder|2009
15-19|~|~|~|~|Incidence|22192810|Urinary Bladder|2009
5-9|2.2|2.6|2.4|477|Mortality|20182499|All Cancer Sites Combined|2009
5-9|12.1|13.1|12.6|2536|Incidence|20182499|All Cancer Sites Combined|2009
5-9|0.8|1.1|1.0|193|Mortality|20182499|Brain and Other Nervous System|2009
5-9|3.4|3.9|3.6|732|Incidence|20182499|Brain and Other Nervous System|2009
5-9|~|~|~|~|Mortality|9874744|Cervix|2009
5-9|~|~|~|~|Incidence|9874744|Cervix|2009
5-9|~|~|~|~|Mortality|20182499|Colon and Rectum|2009
5-9|~|~|~|~|Incidence|20182499|Colon and Rectum|2009
5-9|~|~|~|~|Mortality|9874744|Corpus and Uterus, NOS|2009
5-9|~|~|~|~|Incidence|9874744|Corpus and Uterus, NOS|2009
5-9|~|~|~|~|Mortality|20182499|Esophagus|2009
5-9|~|~|~|~|Incidence|20182499|Esophagus|2009
5-9|~|~|~|~|Mortality|9874744|Female Breast|2009
5-9|~|~|~|~|Incidence|9874744|Female Breast|2009
5-9|~|~|~|~|Incidence|9874744|Female Breast, <i>in situ</i>|2009
5-9|~|~|~|~|Mortality|20182499|Hodgkin Lymphoma|2009
5-9|0.3|0.5|0.4|86|Incidence|20182499|Hodgkin Lymphoma|2009
5-9|.|.|.|.|Mortality|20182499|Kaposi Sarcoma|2009
5-9|~|~|~|~|Incidence|20182499|Kaposi Sarcoma|2009
5-9|0.0|0.1|0.1|17|Mortality|20182499|Kidney and Renal Pelvis|2009
5-9|0.5|0.7|0.6|123|Incidence|20182499|Kidney and Renal Pelvis|2009
5-9|~|~|~|~|Mortality|20182499|Larynx|2009
5-9|~|~|~|~|Incidence|20182499|Larynx|2009
5-9|0.5|0.7|0.6|117|Mortality|20182499|Leukemias|2009
5-9|3.9|4.5|4.2|840|Incidence|20182499|Leukemias|2009
5-9|~|~|~|~|Mortality|20182499|Liver and Intrahepatic Bile Duct|2009
5-9|~|~|~|~|Incidence|20182499|Liver and Intrahepatic Bile Duct|2009
5-9|~|~|~|~|Mortality|20182499|Lung and Bronchus|2009
5-9|~|~|~|~|Incidence|20182499|Lung and Bronchus|2009
5-9|~|~|~|~|Mortality|9874744|Male and Female Breast|2009
5-9|~|~|~|~|Incidence|9874744|Male and Female Breast|2009
5-9|~|~|~|~|Incidence|9874744|Male and Female Breast, <i>in situ</i>|2009
5-9|~|~|~|~|Mortality|20182499|Melanomas of the Skin|2009
5-9|0.1|0.2|0.1|25|Incidence|20182499|Melanomas of the Skin|2009
5-9|~|~|~|~|Mortality|20182499|Mesothelioma|2009
5-9|~|~|~|~|Incidence|20182499|Mesothelioma|2009
5-9|~|~|~|~|Mortality|20182499|Myeloma|2009
5-9|~|~|~|~|Incidence|20182499|Myeloma|2009
5-9|~|~|~|~|Mortality|20182499|Non-Hodgkin Lymphoma|2009
5-9|0.8|1.1|1.0|197|Incidence|20182499|Non-Hodgkin Lymphoma|2009
5-9|~|~|~|~|Mortality|20182499|Oral Cavity and Pharynx|2009
5-9|0.1|0.2|0.1|27|Incidence|20182499|Oral Cavity and Pharynx|2009
5-9|~|~|~|~|Mortality|9874744|Ovary|2009
5-9|0.1|0.3|0.2|23|Incidence|9874744|Ovary|2009
5-9|~|~|~|~|Mortality|20182499|Pancreas|2009
5-9|~|~|~|~|Incidence|20182499|Pancreas|2009
5-9|~|~|~|~|Mortality|10307755|Prostate|2009
5-9|~|~|~|~|Incidence|10307755|Prostate|2009
5-9|~|~|~|~|Mortality|20182499|Stomach|2009
5-9|~|~|~|~|Incidence|20182499|Stomach|2009
5-9|~|~|~|~|Mortality|10307755|Testis|2009
5-9|~|~|~|~|Incidence|10307755|Testis|2009
5-9|~|~|~|~|Mortality|20182499|Thyroid|2009
5-9|0.1|0.2|0.1|28|Incidence|20182499|Thyroid|2009
5-9|~|~|~|~|Mortality|20182499|Urinary Bladder|2009
5-9|~|~|~|~|Incidence|20182499|Urinary Bladder|2009
<1|1.5|2.3|1.8|74|Mortality|4003587|All Cancer Sites Combined|2009
<1|24.9|28.1|26.5|1060|Incidence|4003587|All Cancer Sites Combined|2009
<1|~|~|~|~|Mortality|4003587|Brain and Other Nervous System|2009
<1|3.8|5.1|4.4|177|Incidence|4003587|Brain and Other Nervous System|2009
<1|~|~|~|~|Mortality|1959169|Cervix|2009
<1|~|~|~|~|Incidence|1959169|Cervix|2009
<1|~|~|~|~|Mortality|4003587|Colon and Rectum|2009
<1|~|~|~|~|Incidence|4003587|Colon and Rectum|2009
<1|~|~|~|~|Mortality|1959169|Corpus and Uterus, NOS|2009
<1|~|~|~|~|Incidence|1959169|Corpus and Uterus, NOS|2009
<1|~|~|~|~|Mortality|4003587|Esophagus|2009
<1|~|~|~|~|Incidence|4003587|Esophagus|2009
<1|~|~|~|~|Mortality|1959169|Female Breast|2009
<1|~|~|~|~|Incidence|1959169|Female Breast|2009
<1|~|~|~|~|Incidence|1959169|Female Breast, <i>in situ</i>|2009
<1|~|~|~|~|Mortality|4003587|Hodgkin Lymphoma|2009
<1|~|~|~|~|Incidence|4003587|Hodgkin Lymphoma|2009
<1|.|.|.|.|Mortality|4003587|Kaposi Sarcoma|2009
<1|~|~|~|~|Incidence|4003587|Kaposi Sarcoma|2009
<1|~|~|~|~|Mortality|4003587|Kidney and Renal Pelvis|2009
<1|1.6|2.5|2.0|81|Incidence|4003587|Kidney and Renal Pelvis|2009
<1|~|~|~|~|Mortality|4003587|Larynx|2009
<1|~|~|~|~|Incidence|4003587|Larynx|2009
<1|0.4|1.0|0.7|27|Mortality|4003587|Leukemias|2009
<1|3.4|4.7|4.0|162|Incidence|4003587|Leukemias|2009
<1|~|~|~|~|Mortality|4003587|Liver and Intrahepatic Bile Duct|2009
<1|0.7|1.3|1.0|39|Incidence|4003587|Liver and Intrahepatic Bile Duct|2009
<1|~|~|~|~|Mortality|4003587|Lung and Bronchus|2009
<1|~|~|~|~|Incidence|4003587|Lung and Bronchus|2009
<1|~|~|~|~|Mortality|1959169|Male and Female Breast|2009
<1|~|~|~|~|Incidence|1959169|Male and Female Breast|2009
<1|~|~|~|~|Incidence|1959169|Male and Female Breast, <i>in situ</i>|2009
<1|~|~|~|~|Mortality|4003587|Melanomas of the Skin|2009
<1|~|~|~|~|Incidence|4003587|Melanomas of the Skin|2009
<1|~|~|~|~|Mortality|4003587|Mesothelioma|2009
<1|~|~|~|~|Incidence|4003587|Mesothelioma|2009
<1|~|~|~|~|Mortality|4003587|Myeloma|2009
<1|~|~|~|~|Incidence|4003587|Myeloma|2009
<1|~|~|~|~|Mortality|4003587|Non-Hodgkin Lymphoma|2009
<1|~|~|~|~|Incidence|4003587|Non-Hodgkin Lymphoma|2009
<1|~|~|~|~|Mortality|4003587|Oral Cavity and Pharynx|2009
<1|~|~|~|~|Incidence|4003587|Oral Cavity and Pharynx|2009
<1|~|~|~|~|Mortality|1959169|Ovary|2009
<1|~|~|~|~|Incidence|1959169|Ovary|2009
<1|~|~|~|~|Mortality|4003587|Pancreas|2009
<1|~|~|~|~|Incidence|4003587|Pancreas|2009
<1|~|~|~|~|Mortality|2044418|Prostate|2009
<1|~|~|~|~|Incidence|2044418|Prostate|2009
<1|~|~|~|~|Mortality|4003587|Stomach|2009
<1|~|~|~|~|Incidence|4003587|Stomach|2009
<1|~|~|~|~|Mortality|2044418|Testis|2009
<1|0.8|1.8|1.2|25|Incidence|2044418|Testis|2009
<1|~|~|~|~|Mortality|4003587|Thyroid|2009
<1|~|~|~|~|Incidence|4003587|Thyroid|2009
<1|~|~|~|~|Mortality|4003587|Urinary Bladder|2009
<1|~|~|~|~|Incidence|4003587|Urinary Bladder|2009
1-4|1.9|2.4|2.1|346|Mortality|16238083|All Cancer Sites Combined|2010
1-4|22.7|24.2|23.5|3812|Incidence|16238083|All Cancer Sites Combined|2010
1-4|0.5|0.8|0.6|101|Mortality|16238083|Brain and Other Nervous System|2010
1-4|4.5|5.2|4.9|788|Incidence|16238083|Brain and Other Nervous System|2010
1-4|~|~|~|~|Mortality|7943589|Cervix|2010
1-4|~|~|~|~|Incidence|7943589|Cervix|2010
1-4|~|~|~|~|Mortality|16238083|Colon and Rectum|2010
1-4|~|~|~|~|Incidence|16238083|Colon and Rectum|2010
1-4|~|~|~|~|Mortality|7943589|Corpus and Uterus, NOS|2010
1-4|~|~|~|~|Incidence|7943589|Corpus and Uterus, NOS|2010
1-4|~|~|~|~|Mortality|16238083|Esophagus|2010
1-4|~|~|~|~|Incidence|16238083|Esophagus|2010
1-4|~|~|~|~|Mortality|7943589|Female Breast|2010
1-4|~|~|~|~|Incidence|7943589|Female Breast|2010
1-4|~|~|~|~|Incidence|7943589|Female Breast, <i>in situ</i>|2010
1-4|~|~|~|~|Mortality|16238083|Hodgkin Lymphoma|2010
1-4|~|~|~|~|Incidence|16238083|Hodgkin Lymphoma|2010
1-4|.|.|.|.|Mortality|16238083|Kaposi Sarcoma|2010
1-4|~|~|~|~|Incidence|16238083|Kaposi Sarcoma|2010
1-4|0.1|0.2|0.1|16|Mortality|16238083|Kidney and Renal Pelvis|2010
1-4|1.9|2.3|2.1|339|Incidence|16238083|Kidney and Renal Pelvis|2010
1-4|~|~|~|~|Mortality|16238083|Larynx|2010
1-4|~|~|~|~|Incidence|16238083|Larynx|2010
1-4|0.6|0.8|0.7|112|Mortality|16238083|Leukemias|2010
1-4|8.5|9.5|9.0|1458|Incidence|16238083|Leukemias|2010
1-4|0.1|0.2|0.1|19|Mortality|16238083|Liver and Intrahepatic Bile Duct|2010
1-4|0.5|0.8|0.6|103|Incidence|16238083|Liver and Intrahepatic Bile Duct|2010
1-4|~|~|~|~|Mortality|16238083|Lung and Bronchus|2010
1-4|~|~|~|~|Incidence|16238083|Lung and Bronchus|2010
1-4|~|~|~|~|Mortality|7943589|Male and Female Breast|2010
1-4|~|~|~|~|Incidence|7943589|Male and Female Breast|2010
1-4|~|~|~|~|Incidence|7943589|Male and Female Breast, <i>in situ</i>|2010
1-4|~|~|~|~|Mortality|16238083|Melanomas of the Skin|2010
1-4|~|~|~|~|Incidence|16238083|Melanomas of the Skin|2010
1-4|~|~|~|~|Mortality|16238083|Mesothelioma|2010
1-4|~|~|~|~|Incidence|16238083|Mesothelioma|2010
1-4|~|~|~|~|Mortality|16238083|Myeloma|2010
1-4|~|~|~|~|Incidence|16238083|Myeloma|2010
1-4|~|~|~|~|Mortality|16238083|Non-Hodgkin Lymphoma|2010
1-4|0.6|0.8|0.7|114|Incidence|16238083|Non-Hodgkin Lymphoma|2010
1-4|~|~|~|~|Mortality|16238083|Oral Cavity and Pharynx|2010
1-4|~|~|~|~|Incidence|16238083|Oral Cavity and Pharynx|2010
1-4|~|~|~|~|Mortality|7943589|Ovary|2010
1-4|~|~|~|~|Incidence|7943589|Ovary|2010
1-4|~|~|~|~|Mortality|16238083|Pancreas|2010
1-4|~|~|~|~|Incidence|16238083|Pancreas|2010
1-4|~|~|~|~|Mortality|8294494|Prostate|2010
1-4|~|~|~|~|Incidence|8294494|Prostate|2010
1-4|~|~|~|~|Mortality|16238083|Stomach|2010
1-4|~|~|~|~|Incidence|16238083|Stomach|2010
1-4|~|~|~|~|Mortality|8294494|Testis|2010
1-4|0.2|0.5|0.3|29|Incidence|8294494|Testis|2010
1-4|~|~|~|~|Mortality|16238083|Thyroid|2010
1-4|~|~|~|~|Incidence|16238083|Thyroid|2010
1-4|~|~|~|~|Mortality|16238083|Urinary Bladder|2010
1-4|~|~|~|~|Incidence|16238083|Urinary Bladder|2010
10-14|2.1|2.5|2.3|477|Mortality|20681024|All Cancer Sites Combined|2010
10-14|13.7|14.7|14.2|2939|Incidence|20681024|All Cancer Sites Combined|2010
10-14|0.5|0.7|0.6|129|Mortality|20681024|Brain and Other Nervous System|2010
10-14|2.7|3.2|2.9|610|Incidence|20681024|Brain and Other Nervous System|2010
10-14|~|~|~|~|Mortality|10102606|Cervix|2010
10-14|~|~|~|~|Incidence|10102606|Cervix|2010
10-14|~|~|~|~|Mortality|20681024|Colon and Rectum|2010
10-14|0.0|0.1|0.1|16|Incidence|20681024|Colon and Rectum|2010
10-14|~|~|~|~|Mortality|10102606|Corpus and Uterus, NOS|2010
10-14|~|~|~|~|Incidence|10102606|Corpus and Uterus, NOS|2010
10-14|~|~|~|~|Mortality|20681024|Esophagus|2010
10-14|~|~|~|~|Incidence|20681024|Esophagus|2010
10-14|~|~|~|~|Mortality|10102606|Female Breast|2010
10-14|~|~|~|~|Incidence|10102606|Female Breast|2010
10-14|~|~|~|~|Incidence|10102606|Female Breast, <i>in situ</i>|2010
10-14|~|~|~|~|Mortality|20681024|Hodgkin Lymphoma|2010
10-14|1.0|1.3|1.1|232|Incidence|20681024|Hodgkin Lymphoma|2010
10-14|.|.|.|.|Mortality|20681024|Kaposi Sarcoma|2010
10-14|~|~|~|~|Incidence|20681024|Kaposi Sarcoma|2010
10-14|~|~|~|~|Mortality|20681024|Kidney and Renal Pelvis|2010
10-14|0.1|0.2|0.1|26|Incidence|20681024|Kidney and Renal Pelvis|2010
10-14|~|~|~|~|Mortality|20681024|Larynx|2010
10-14|~|~|~|~|Incidence|20681024|Larynx|2010
10-14|0.6|0.8|0.7|142|Mortality|20681024|Leukemias|2010
10-14|3.0|3.5|3.2|667|Incidence|20681024|Leukemias|2010
10-14|~|~|~|~|Mortality|20681024|Liver and Intrahepatic Bile Duct|2010
10-14|0.1|0.2|0.1|29|Incidence|20681024|Liver and Intrahepatic Bile Duct|2010
10-14|~|~|~|~|Mortality|20681024|Lung and Bronchus|2010
10-14|~|~|~|~|Incidence|20681024|Lung and Bronchus|2010
10-14|~|~|~|~|Mortality|10102606|Male and Female Breast|2010
10-14|~|~|~|~|Incidence|10102606|Male and Female Breast|2010
10-14|~|~|~|~|Incidence|10102606|Male and Female Breast, <i>in situ</i>|2010
10-14|~|~|~|~|Mortality|20681024|Melanomas of the Skin|2010
10-14|0.2|0.3|0.2|49|Incidence|20681024|Melanomas of the Skin|2010
10-14|~|~|~|~|Mortality|20681024|Mesothelioma|2010
10-14|~|~|~|~|Incidence|20681024|Mesothelioma|2010
10-14|~|~|~|~|Mortality|20681024|Myeloma|2010
10-14|~|~|~|~|Incidence|20681024|Myeloma|2010
10-14|0.1|0.1|0.1|19|Mortality|20681024|Non-Hodgkin Lymphoma|2010
10-14|1.0|1.3|1.2|240|Incidence|20681024|Non-Hodgkin Lymphoma|2010
10-14|~|~|~|~|Mortality|20681024|Oral Cavity and Pharynx|2010
10-14|0.3|0.4|0.3|68|Incidence|20681024|Oral Cavity and Pharynx|2010
10-14|~|~|~|~|Mortality|10102606|Ovary|2010
10-14|0.6|0.9|0.8|76|Incidence|10102606|Ovary|2010
10-14|~|~|~|~|Mortality|20681024|Pancreas|2010
10-14|~|~|~|~|Incidence|20681024|Pancreas|2010
10-14|~|~|~|~|Mortality|10578418|Prostate|2010
10-14|~|~|~|~|Incidence|10578418|Prostate|2010
10-14|~|~|~|~|Mortality|20681024|Stomach|2010
10-14|~|~|~|~|Incidence|20681024|Stomach|2010
10-14|~|~|~|~|Mortality|10578418|Testis|2010
10-14|0.1|0.3|0.2|23|Incidence|10578418|Testis|2010
10-14|~|~|~|~|Mortality|20681024|Thyroid|2010
10-14|0.6|0.9|0.7|150|Incidence|20681024|Thyroid|2010
10-14|~|~|~|~|Mortality|20681024|Urinary Bladder|2010
10-14|~|~|~|~|Incidence|20681024|Urinary Bladder|2010
15-19|2.5|3.0|2.7|601|Mortality|21981869|All Cancer Sites Combined|2010
15-19|21.2|22.4|21.8|4787|Incidence|21981869|All Cancer Sites Combined|2010
15-19|0.3|0.5|0.4|88|Mortality|21981869|Brain and Other Nervous System|2010
15-19|2.0|2.4|2.2|479|Incidence|21981869|Brain and Other Nervous System|2010
15-19|~|~|~|~|Mortality|10703592|Cervix|2010
15-19|~|~|~|~|Incidence|10703592|Cervix|2010
15-19|~|~|~|~|Mortality|21981869|Colon and Rectum|2010
15-19|0.3|0.5|0.4|84|Incidence|21981869|Colon and Rectum|2010
15-19|~|~|~|~|Mortality|10703592|Corpus and Uterus, NOS|2010
15-19|~|~|~|~|Incidence|10703592|Corpus and Uterus, NOS|2010
15-19|~|~|~|~|Mortality|21981869|Esophagus|2010
15-19|~|~|~|~|Incidence|21981869|Esophagus|2010
15-19|~|~|~|~|Mortality|10703592|Female Breast|2010
15-19|0.1|0.3|0.2|22|Incidence|10703592|Female Breast|2010
15-19|~|~|~|~|Incidence|10703592|Female Breast, <i>in situ</i>|2010
15-19|~|~|~|~|Mortality|21981869|Hodgkin Lymphoma|2010
15-19|3.0|3.5|3.2|712|Incidence|21981869|Hodgkin Lymphoma|2010
15-19|.|.|.|.|Mortality|21981869|Kaposi Sarcoma|2010
15-19|~|~|~|~|Incidence|21981869|Kaposi Sarcoma|2010
15-19|~|~|~|~|Mortality|21981869|Kidney and Renal Pelvis|2010
15-19|0.1|0.2|0.2|34|Incidence|21981869|Kidney and Renal Pelvis|2010
15-19|~|~|~|~|Mortality|21981869|Larynx|2010
15-19|~|~|~|~|Incidence|21981869|Larynx|2010
15-19|0.6|0.9|0.7|163|Mortality|21981869|Leukemias|2010
15-19|2.7|3.2|2.9|645|Incidence|21981869|Leukemias|2010
15-19|~|~|~|~|Mortality|21981869|Liver and Intrahepatic Bile Duct|2010
15-19|0.1|0.2|0.2|39|Incidence|21981869|Liver and Intrahepatic Bile Duct|2010
15-19|~|~|~|~|Mortality|21981869|Lung and Bronchus|2010
15-19|0.1|0.2|0.1|31|Incidence|21981869|Lung and Bronchus|2010
15-19|~|~|~|~|Mortality|10703592|Male and Female Breast|2010
15-19|0.1|0.3|0.2|22|Incidence|10703592|Male and Female Breast|2010
15-19|~|~|~|~|Incidence|10703592|Male and Female Breast, <i>in situ</i>|2010
15-19|~|~|~|~|Mortality|21981869|Melanomas of the Skin|2010
15-19|0.9|1.2|1.0|228|Incidence|21981869|Melanomas of the Skin|2010
15-19|~|~|~|~|Mortality|21981869|Mesothelioma|2010
15-19|~|~|~|~|Incidence|21981869|Mesothelioma|2010
15-19|~|~|~|~|Mortality|21981869|Myeloma|2010
15-19|~|~|~|~|Incidence|21981869|Myeloma|2010
15-19|0.1|0.2|0.2|40|Mortality|21981869|Non-Hodgkin Lymphoma|2010
15-19|1.5|1.8|1.6|356|Incidence|21981869|Non-Hodgkin Lymphoma|2010
15-19|~|~|~|~|Mortality|21981869|Oral Cavity and Pharynx|2010
15-19|0.4|0.6|0.5|111|Incidence|21981869|Oral Cavity and Pharynx|2010
15-19|~|~|~|~|Mortality|10703592|Ovary|2010
15-19|1.1|1.5|1.3|138|Incidence|10703592|Ovary|2010
15-19|~|~|~|~|Mortality|21981869|Pancreas|2010
15-19|~|~|~|~|Incidence|21981869|Pancreas|2010
15-19|~|~|~|~|Mortality|11278277|Prostate|2010
15-19|~|~|~|~|Incidence|11278277|Prostate|2010
15-19|~|~|~|~|Mortality|21981869|Stomach|2010
15-19|0.1|0.1|0.1|19|Incidence|21981869|Stomach|2010
15-19|~|~|~|~|Mortality|11278277|Testis|2010
15-19|3.2|3.9|3.5|400|Incidence|11278277|Testis|2010
15-19|~|~|~|~|Mortality|21981869|Thyroid|2010
15-19|2.4|2.8|2.6|570|Incidence|21981869|Thyroid|2010
15-19|~|~|~|~|Mortality|21981869|Urinary Bladder|2010
15-19|0.1|0.1|0.1|19|Incidence|21981869|Urinary Bladder|2010
5-9|2.0|2.4|2.2|439|Mortality|20331821|All Cancer Sites Combined|2010
5-9|12.8|13.8|13.3|2705|Incidence|20331821|All Cancer Sites Combined|2010
5-9|0.7|1.0|0.8|167|Mortality|20331821|Brain and Other Nervous System|2010
5-9|3.5|4.0|3.7|761|Incidence|20331821|Brain and Other Nervous System|2010
5-9|~|~|~|~|Mortality|9951198|Cervix|2010
5-9|~|~|~|~|Incidence|9951198|Cervix|2010
5-9|~|~|~|~|Mortality|20331821|Colon and Rectum|2010
5-9|~|~|~|~|Incidence|20331821|Colon and Rectum|2010
5-9|~|~|~|~|Mortality|9951198|Corpus and Uterus, NOS|2010
5-9|~|~|~|~|Incidence|9951198|Corpus and Uterus, NOS|2010
5-9|~|~|~|~|Mortality|20331821|Esophagus|2010
5-9|~|~|~|~|Incidence|20331821|Esophagus|2010
5-9|~|~|~|~|Mortality|9951198|Female Breast|2010
5-9|~|~|~|~|Incidence|9951198|Female Breast|2010
5-9|~|~|~|~|Incidence|9951198|Female Breast, <i>in situ</i>|2010
5-9|~|~|~|~|Mortality|20331821|Hodgkin Lymphoma|2010
5-9|0.3|0.5|0.4|77|Incidence|20331821|Hodgkin Lymphoma|2010
5-9|.|.|.|.|Mortality|20331821|Kaposi Sarcoma|2010
5-9|~|~|~|~|Incidence|20331821|Kaposi Sarcoma|2010
5-9|0.1|0.1|0.1|19|Mortality|20331821|Kidney and Renal Pelvis|2010
5-9|0.5|0.7|0.6|115|Incidence|20331821|Kidney and Renal Pelvis|2010
5-9|~|~|~|~|Mortality|20331821|Larynx|2010
5-9|~|~|~|~|Incidence|20331821|Larynx|2010
5-9|0.4|0.7|0.5|111|Mortality|20331821|Leukemias|2010
5-9|4.0|4.6|4.3|866|Incidence|20331821|Leukemias|2010
5-9|~|~|~|~|Mortality|20331821|Liver and Intrahepatic Bile Duct|2010
5-9|0.1|0.2|0.1|25|Incidence|20331821|Liver and Intrahepatic Bile Duct|2010
5-9|~|~|~|~|Mortality|20331821|Lung and Bronchus|2010
5-9|~|~|~|~|Incidence|20331821|Lung and Bronchus|2010
5-9|~|~|~|~|Mortality|9951198|Male and Female Breast|2010
5-9|~|~|~|~|Incidence|9951198|Male and Female Breast|2010
5-9|~|~|~|~|Incidence|9951198|Male and Female Breast, <i>in situ</i>|2010
5-9|~|~|~|~|Mortality|20331821|Melanomas of the Skin|2010
5-9|0.1|0.2|0.1|30|Incidence|20331821|Melanomas of the Skin|2010
5-9|~|~|~|~|Mortality|20331821|Mesothelioma|2010
5-9|~|~|~|~|Incidence|20331821|Mesothelioma|2010
5-9|~|~|~|~|Mortality|20331821|Myeloma|2010
5-9|~|~|~|~|Incidence|20331821|Myeloma|2010
5-9|~|~|~|~|Mortality|20331821|Non-Hodgkin Lymphoma|2010
5-9|1.0|1.3|1.1|229|Incidence|20331821|Non-Hodgkin Lymphoma|2010
5-9|~|~|~|~|Mortality|20331821|Oral Cavity and Pharynx|2010
5-9|0.1|0.2|0.1|21|Incidence|20331821|Oral Cavity and Pharynx|2010
5-9|~|~|~|~|Mortality|9951198|Ovary|2010
5-9|0.1|0.3|0.2|22|Incidence|9951198|Ovary|2010
5-9|~|~|~|~|Mortality|20331821|Pancreas|2010
5-9|~|~|~|~|Incidence|20331821|Pancreas|2010
5-9|~|~|~|~|Mortality|10380623|Prostate|2010
5-9|~|~|~|~|Incidence|10380623|Prostate|2010
5-9|~|~|~|~|Mortality|20331821|Stomach|2010
5-9|~|~|~|~|Incidence|20331821|Stomach|2010
5-9|~|~|~|~|Mortality|10380623|Testis|2010
5-9|~|~|~|~|Incidence|10380623|Testis|2010
5-9|~|~|~|~|Mortality|20331821|Thyroid|2010
5-9|0.1|0.2|0.1|24|Incidence|20331821|Thyroid|2010
5-9|~|~|~|~|Mortality|20331821|Urinary Bladder|2010
5-9|~|~|~|~|Incidence|20331821|Urinary Bladder|2010
<1|1.2|2.0|1.6|62|Mortality|3951495|All Cancer Sites Combined|2010
<1|24.8|28.0|26.3|1041|Incidence|3951495|All Cancer Sites Combined|2010
<1|~|~|~|~|Mortality|3951495|Brain and Other Nervous System|2010
<1|3.1|4.3|3.7|146|Incidence|3951495|Brain and Other Nervous System|2010
<1|~|~|~|~|Mortality|1932979|Cervix|2010
<1|~|~|~|~|Incidence|1932979|Cervix|2010
<1|~|~|~|~|Mortality|3951495|Colon and Rectum|2010
<1|~|~|~|~|Incidence|3951495|Colon and Rectum|2010
<1|~|~|~|~|Mortality|1932979|Corpus and Uterus, NOS|2010
<1|~|~|~|~|Incidence|1932979|Corpus and Uterus, NOS|2010
<1|~|~|~|~|Mortality|3951495|Esophagus|2010
<1|~|~|~|~|Incidence|3951495|Esophagus|2010
<1|~|~|~|~|Mortality|1932979|Female Breast|2010
<1|~|~|~|~|Incidence|1932979|Female Breast|2010
<1|~|~|~|~|Incidence|1932979|Female Breast, <i>in situ</i>|2010
<1|~|~|~|~|Mortality|3951495|Hodgkin Lymphoma|2010
<1|~|~|~|~|Incidence|3951495|Hodgkin Lymphoma|2010
<1|.|.|.|.|Mortality|3951495|Kaposi Sarcoma|2010
<1|~|~|~|~|Incidence|3951495|Kaposi Sarcoma|2010
<1|~|~|~|~|Mortality|3951495|Kidney and Renal Pelvis|2010
<1|1.2|2.0|1.5|61|Incidence|3951495|Kidney and Renal Pelvis|2010
<1|~|~|~|~|Mortality|3951495|Larynx|2010
<1|~|~|~|~|Incidence|3951495|Larynx|2010
<1|0.4|0.9|0.6|25|Mortality|3951495|Leukemias|2010
<1|3.7|5.0|4.3|169|Incidence|3951495|Leukemias|2010
<1|~|~|~|~|Mortality|3951495|Liver and Intrahepatic Bile Duct|2010
<1|1.2|2.0|1.5|60|Incidence|3951495|Liver and Intrahepatic Bile Duct|2010
<1|~|~|~|~|Mortality|3951495|Lung and Bronchus|2010
<1|~|~|~|~|Incidence|3951495|Lung and Bronchus|2010
<1|~|~|~|~|Mortality|1932979|Male and Female Breast|2010
<1|~|~|~|~|Incidence|1932979|Male and Female Breast|2010
<1|~|~|~|~|Incidence|1932979|Male and Female Breast, <i>in situ</i>|2010
<1|~|~|~|~|Mortality|3951495|Melanomas of the Skin|2010
<1|~|~|~|~|Incidence|3951495|Melanomas of the Skin|2010
<1|~|~|~|~|Mortality|3951495|Mesothelioma|2010
<1|~|~|~|~|Incidence|3951495|Mesothelioma|2010
<1|~|~|~|~|Mortality|3951495|Myeloma|2010
<1|~|~|~|~|Incidence|3951495|Myeloma|2010
<1|~|~|~|~|Mortality|3951495|Non-Hodgkin Lymphoma|2010
<1|~|~|~|~|Incidence|3951495|Non-Hodgkin Lymphoma|2010
<1|~|~|~|~|Mortality|3951495|Oral Cavity and Pharynx|2010
<1|~|~|~|~|Incidence|3951495|Oral Cavity and Pharynx|2010
<1|~|~|~|~|Mortality|1932979|Ovary|2010
<1|~|~|~|~|Incidence|1932979|Ovary|2010
<1|~|~|~|~|Mortality|3951495|Pancreas|2010
<1|~|~|~|~|Incidence|3951495|Pancreas|2010
<1|~|~|~|~|Mortality|2018516|Prostate|2010
<1|~|~|~|~|Incidence|2018516|Prostate|2010
<1|~|~|~|~|Mortality|3951495|Stomach|2010
<1|~|~|~|~|Incidence|3951495|Stomach|2010
<1|~|~|~|~|Mortality|2018516|Testis|2010
<1|1.0|2.1|1.5|30|Incidence|2018516|Testis|2010
<1|~|~|~|~|Mortality|3951495|Thyroid|2010
<1|~|~|~|~|Incidence|3951495|Thyroid|2010
<1|~|~|~|~|Mortality|3951495|Urinary Bladder|2010
<1|~|~|~|~|Incidence|3951495|Urinary Bladder|2010
1-4|2.0|2.4|2.2|353|Mortality|16162947|All Cancer Sites Combined|2011
1-4|22.8|24.3|23.5|3797|Incidence|16162947|All Cancer Sites Combined|2011
1-4|0.6|0.8|0.7|111|Mortality|16162947|Brain and Other Nervous System|2011
1-4|4.3|5.0|4.7|755|Incidence|16162947|Brain and Other Nervous System|2011
1-4|~|~|~|~|Mortality|7910126|Cervix|2011
1-4|~|~|~|~|Incidence|7910126|Cervix|2011
1-4|~|~|~|~|Mortality|16162947|Colon and Rectum|2011
1-4|~|~|~|~|Incidence|16162947|Colon and Rectum|2011
1-4|~|~|~|~|Mortality|7910126|Corpus and Uterus, NOS|2011
1-4|~|~|~|~|Incidence|7910126|Corpus and Uterus, NOS|2011
1-4|~|~|~|~|Mortality|16162947|Esophagus|2011
1-4|~|~|~|~|Incidence|16162947|Esophagus|2011
1-4|~|~|~|~|Mortality|7910126|Female Breast|2011
1-4|~|~|~|~|Incidence|7910126|Female Breast|2011
1-4|~|~|~|~|Incidence|7910126|Female Breast, <i>in situ</i>|2011
1-4|~|~|~|~|Mortality|16162947|Hodgkin Lymphoma|2011
1-4|~|~|~|~|Incidence|16162947|Hodgkin Lymphoma|2011
1-4|.|.|.|.|Mortality|16162947|Kaposi Sarcoma|2011
1-4|~|~|~|~|Incidence|16162947|Kaposi Sarcoma|2011
1-4|~|~|~|~|Mortality|16162947|Kidney and Renal Pelvis|2011
1-4|2.0|2.5|2.2|358|Incidence|16162947|Kidney and Renal Pelvis|2011
1-4|~|~|~|~|Mortality|16162947|Larynx|2011
1-4|~|~|~|~|Incidence|16162947|Larynx|2011
1-4|0.5|0.7|0.6|95|Mortality|16162947|Leukemias|2011
1-4|8.7|9.6|9.2|1482|Incidence|16162947|Leukemias|2011
1-4|0.1|0.2|0.2|27|Mortality|16162947|Liver and Intrahepatic Bile Duct|2011
1-4|0.6|0.8|0.7|112|Incidence|16162947|Liver and Intrahepatic Bile Duct|2011
1-4|~|~|~|~|Mortality|16162947|Lung and Bronchus|2011
1-4|~|~|~|~|Incidence|16162947|Lung and Bronchus|2011
1-4|~|~|~|~|Mortality|7910126|Male and Female Breast|2011
1-4|~|~|~|~|Incidence|7910126|Male and Female Breast|2011
1-4|~|~|~|~|Incidence|7910126|Male and Female Breast, <i>in situ</i>|2011
1-4|~|~|~|~|Mortality|16162947|Melanomas of the Skin|2011
1-4|~|~|~|~|Incidence|16162947|Melanomas of the Skin|2011
1-4|~|~|~|~|Mortality|16162947|Mesothelioma|2011
1-4|~|~|~|~|Incidence|16162947|Mesothelioma|2011
1-4|~|~|~|~|Mortality|16162947|Myeloma|2011
1-4|~|~|~|~|Incidence|16162947|Myeloma|2011
1-4|~|~|~|~|Mortality|16162947|Non-Hodgkin Lymphoma|2011
1-4|0.5|0.8|0.6|105|Incidence|16162947|Non-Hodgkin Lymphoma|2011
1-4|~|~|~|~|Mortality|16162947|Oral Cavity and Pharynx|2011
1-4|~|~|~|~|Incidence|16162947|Oral Cavity and Pharynx|2011
1-4|~|~|~|~|Mortality|7910126|Ovary|2011
1-4|~|~|~|~|Incidence|7910126|Ovary|2011
1-4|~|~|~|~|Mortality|16162947|Pancreas|2011
1-4|~|~|~|~|Incidence|16162947|Pancreas|2011
1-4|~|~|~|~|Mortality|8252821|Prostate|2011
1-4|~|~|~|~|Incidence|8252821|Prostate|2011
1-4|~|~|~|~|Mortality|16162947|Stomach|2011
1-4|~|~|~|~|Incidence|16162947|Stomach|2011
1-4|~|~|~|~|Mortality|8252821|Testis|2011
1-4|0.2|0.4|0.3|24|Incidence|8252821|Testis|2011
1-4|~|~|~|~|Mortality|16162947|Thyroid|2011
1-4|~|~|~|~|Incidence|16162947|Thyroid|2011
1-4|~|~|~|~|Mortality|16162947|Urinary Bladder|2011
1-4|~|~|~|~|Incidence|16162947|Urinary Bladder|2011
10-14|1.8|2.2|2.0|419|Mortality|20715026|All Cancer Sites Combined|2011
10-14|13.7|14.7|14.2|2934|Incidence|20715026|All Cancer Sites Combined|2011
10-14|0.5|0.7|0.6|116|Mortality|20715026|Brain and Other Nervous System|2011
10-14|2.7|3.2|2.9|609|Incidence|20715026|Brain and Other Nervous System|2011
10-14|~|~|~|~|Mortality|10127110|Cervix|2011
10-14|~|~|~|~|Incidence|10127110|Cervix|2011
10-14|~|~|~|~|Mortality|20715026|Colon and Rectum|2011
10-14|0.1|0.2|0.1|25|Incidence|20715026|Colon and Rectum|2011
10-14|~|~|~|~|Mortality|10127110|Corpus and Uterus, NOS|2011
10-14|~|~|~|~|Incidence|10127110|Corpus and Uterus, NOS|2011
10-14|~|~|~|~|Mortality|20715026|Esophagus|2011
10-14|~|~|~|~|Incidence|20715026|Esophagus|2011
10-14|~|~|~|~|Mortality|10127110|Female Breast|2011
10-14|~|~|~|~|Incidence|10127110|Female Breast|2011
10-14|~|~|~|~|Incidence|10127110|Female Breast, <i>in situ</i>|2011
10-14|~|~|~|~|Mortality|20715026|Hodgkin Lymphoma|2011
10-14|1.0|1.3|1.1|228|Incidence|20715026|Hodgkin Lymphoma|2011
10-14|.|.|.|.|Mortality|20715026|Kaposi Sarcoma|2011
10-14|~|~|~|~|Incidence|20715026|Kaposi Sarcoma|2011
10-14|~|~|~|~|Mortality|20715026|Kidney and Renal Pelvis|2011
10-14|0.1|0.2|0.2|34|Incidence|20715026|Kidney and Renal Pelvis|2011
10-14|~|~|~|~|Mortality|20715026|Larynx|2011
10-14|~|~|~|~|Incidence|20715026|Larynx|2011
10-14|0.5|0.7|0.6|127|Mortality|20715026|Leukemias|2011
10-14|2.9|3.4|3.1|647|Incidence|20715026|Leukemias|2011
10-14|~|~|~|~|Mortality|20715026|Liver and Intrahepatic Bile Duct|2011
10-14|0.1|0.2|0.1|31|Incidence|20715026|Liver and Intrahepatic Bile Duct|2011
10-14|~|~|~|~|Mortality|20715026|Lung and Bronchus|2011
10-14|~|~|~|~|Incidence|20715026|Lung and Bronchus|2011
10-14|~|~|~|~|Mortality|10127110|Male and Female Breast|2011
10-14|~|~|~|~|Incidence|10127110|Male and Female Breast|2011
10-14|~|~|~|~|Incidence|10127110|Male and Female Breast, <i>in situ</i>|2011
10-14|~|~|~|~|Mortality|20715026|Melanomas of the Skin|2011
10-14|0.2|0.4|0.3|64|Incidence|20715026|Melanomas of the Skin|2011
10-14|~|~|~|~|Mortality|20715026|Mesothelioma|2011
10-14|~|~|~|~|Incidence|20715026|Mesothelioma|2011
10-14|~|~|~|~|Mortality|20715026|Myeloma|2011
10-14|~|~|~|~|Incidence|20715026|Myeloma|2011
10-14|0.0|0.1|0.1|16|Mortality|20715026|Non-Hodgkin Lymphoma|2011
10-14|1.0|1.3|1.1|235|Incidence|20715026|Non-Hodgkin Lymphoma|2011
10-14|~|~|~|~|Mortality|20715026|Oral Cavity and Pharynx|2011
10-14|0.2|0.3|0.3|53|Incidence|20715026|Oral Cavity and Pharynx|2011
10-14|~|~|~|~|Mortality|10127110|Ovary|2011
10-14|0.5|0.8|0.7|66|Incidence|10127110|Ovary|2011
10-14|~|~|~|~|Mortality|20715026|Pancreas|2011
10-14|~|~|~|~|Incidence|20715026|Pancreas|2011
10-14|~|~|~|~|Mortality|10587916|Prostate|2011
10-14|~|~|~|~|Incidence|10587916|Prostate|2011
10-14|~|~|~|~|Mortality|20715026|Stomach|2011
10-14|~|~|~|~|Incidence|20715026|Stomach|2011
10-14|~|~|~|~|Mortality|10587916|Testis|2011
10-14|0.1|0.3|0.2|19|Incidence|10587916|Testis|2011
10-14|~|~|~|~|Mortality|20715026|Thyroid|2011
10-14|0.7|1.0|0.8|172|Incidence|20715026|Thyroid|2011
10-14|~|~|~|~|Mortality|20715026|Urinary Bladder|2011
10-14|~|~|~|~|Incidence|20715026|Urinary Bladder|2011
15-19|2.7|3.2|2.9|639|Mortality|21661743|All Cancer Sites Combined|2011
15-19|22.0|23.2|22.6|4894|Incidence|21661743|All Cancer Sites Combined|2011
15-19|0.4|0.6|0.5|111|Mortality|21661743|Brain and Other Nervous System|2011
15-19|2.4|2.8|2.6|562|Incidence|21661743|Brain and Other Nervous System|2011
15-19|~|~|~|~|Mortality|10540730|Cervix|2011
15-19|~|~|~|~|Incidence|10540730|Cervix|2011
15-19|~|~|~|~|Mortality|21661743|Colon and Rectum|2011
15-19|0.3|0.4|0.3|75|Incidence|21661743|Colon and Rectum|2011
15-19|~|~|~|~|Mortality|10540730|Corpus and Uterus, NOS|2011
15-19|~|~|~|~|Incidence|10540730|Corpus and Uterus, NOS|2011
15-19|~|~|~|~|Mortality|21661743|Esophagus|2011
15-19|~|~|~|~|Incidence|21661743|Esophagus|2011
15-19|~|~|~|~|Mortality|10540730|Female Breast|2011
15-19|~|~|~|~|Incidence|10540730|Female Breast|2011
15-19|~|~|~|~|Incidence|10540730|Female Breast, <i>in situ</i>|2011
15-19|0.0|0.1|0.1|16|Mortality|21661743|Hodgkin Lymphoma|2011
15-19|2.9|3.4|3.2|688|Incidence|21661743|Hodgkin Lymphoma|2011
15-19|.|.|.|.|Mortality|21661743|Kaposi Sarcoma|2011
15-19|~|~|~|~|Incidence|21661743|Kaposi Sarcoma|2011
15-19|~|~|~|~|Mortality|21661743|Kidney and Renal Pelvis|2011
15-19|0.1|0.3|0.2|44|Incidence|21661743|Kidney and Renal Pelvis|2011
15-19|~|~|~|~|Mortality|21661743|Larynx|2011
15-19|~|~|~|~|Incidence|21661743|Larynx|2011
15-19|0.7|0.9|0.8|177|Mortality|21661743|Leukemias|2011
15-19|2.9|3.4|3.1|680|Incidence|21661743|Leukemias|2011
15-19|~|~|~|~|Mortality|21661743|Liver and Intrahepatic Bile Duct|2011
15-19|0.1|0.2|0.1|24|Incidence|21661743|Liver and Intrahepatic Bile Duct|2011
15-19|~|~|~|~|Mortality|21661743|Lung and Bronchus|2011
15-19|0.1|0.2|0.1|26|Incidence|21661743|Lung and Bronchus|2011
15-19|~|~|~|~|Mortality|10540730|Male and Female Breast|2011
15-19|~|~|~|~|Incidence|10540730|Male and Female Breast|2011
15-19|~|~|~|~|Incidence|10540730|Male and Female Breast, <i>in situ</i>|2011
15-19|~|~|~|~|Mortality|21661743|Melanomas of the Skin|2011
15-19|0.9|1.2|1.0|224|Incidence|21661743|Melanomas of the Skin|2011
15-19|~|~|~|~|Mortality|21661743|Mesothelioma|2011
15-19|~|~|~|~|Incidence|21661743|Mesothelioma|2011
15-19|~|~|~|~|Mortality|21661743|Myeloma|2011
15-19|~|~|~|~|Incidence|21661743|Myeloma|2011
15-19|0.1|0.2|0.1|32|Mortality|21661743|Non-Hodgkin Lymphoma|2011
15-19|1.6|1.9|1.7|374|Incidence|21661743|Non-Hodgkin Lymphoma|2011
15-19|~|~|~|~|Mortality|21661743|Oral Cavity and Pharynx|2011
15-19|0.4|0.6|0.5|104|Incidence|21661743|Oral Cavity and Pharynx|2011
15-19|~|~|~|~|Mortality|10540730|Ovary|2011
15-19|1.0|1.4|1.2|127|Incidence|10540730|Ovary|2011
15-19|~|~|~|~|Mortality|21661743|Pancreas|2011
15-19|0.1|0.1|0.1|21|Incidence|21661743|Pancreas|2011
15-19|~|~|~|~|Mortality|11121013|Prostate|2011
15-19|~|~|~|~|Incidence|11121013|Prostate|2011
15-19|~|~|~|~|Mortality|21661743|Stomach|2011
15-19|0.0|0.1|0.1|16|Incidence|21661743|Stomach|2011
15-19|~|~|~|~|Mortality|11121013|Testis|2011
15-19|3.3|4.0|3.6|405|Incidence|11121013|Testis|2011
15-19|~|~|~|~|Mortality|21661743|Thyroid|2011
15-19|2.5|3.0|2.8|597|Incidence|21661743|Thyroid|2011
15-19|~|~|~|~|Mortality|21661743|Urinary Bladder|2011
15-19|0.1|0.2|0.1|27|Incidence|21661743|Urinary Bladder|2011
5-9|2.0|2.4|2.2|441|Mortality|20335489|All Cancer Sites Combined|2011
5-9|13.0|14.0|13.5|2736|Incidence|20335489|All Cancer Sites Combined|2011
5-9|0.8|1.1|1.0|198|Mortality|20335489|Brain and Other Nervous System|2011
5-9|3.4|3.9|3.7|747|Incidence|20335489|Brain and Other Nervous System|2011
5-9|~|~|~|~|Mortality|9952601|Cervix|2011
5-9|~|~|~|~|Incidence|9952601|Cervix|2011
5-9|~|~|~|~|Mortality|20335489|Colon and Rectum|2011
5-9|~|~|~|~|Incidence|20335489|Colon and Rectum|2011
5-9|~|~|~|~|Mortality|9952601|Corpus and Uterus, NOS|2011
5-9|~|~|~|~|Incidence|9952601|Corpus and Uterus, NOS|2011
5-9|~|~|~|~|Mortality|20335489|Esophagus|2011
5-9|~|~|~|~|Incidence|20335489|Esophagus|2011
5-9|~|~|~|~|Mortality|9952601|Female Breast|2011
5-9|~|~|~|~|Incidence|9952601|Female Breast|2011
5-9|~|~|~|~|Incidence|9952601|Female Breast, <i>in situ</i>|2011
5-9|~|~|~|~|Mortality|20335489|Hodgkin Lymphoma|2011
5-9|0.3|0.5|0.4|74|Incidence|20335489|Hodgkin Lymphoma|2011
5-9|.|.|.|.|Mortality|20335489|Kaposi Sarcoma|2011
5-9|~|~|~|~|Incidence|20335489|Kaposi Sarcoma|2011
5-9|0.1|0.2|0.1|21|Mortality|20335489|Kidney and Renal Pelvis|2011
5-9|0.5|0.7|0.6|119|Incidence|20335489|Kidney and Renal Pelvis|2011
5-9|~|~|~|~|Mortality|20335489|Larynx|2011
5-9|~|~|~|~|Incidence|20335489|Larynx|2011
5-9|0.4|0.6|0.5|98|Mortality|20335489|Leukemias|2011
5-9|4.2|4.8|4.5|906|Incidence|20335489|Leukemias|2011
5-9|~|~|~|~|Mortality|20335489|Liver and Intrahepatic Bile Duct|2011
5-9|0.1|0.2|0.1|21|Incidence|20335489|Liver and Intrahepatic Bile Duct|2011
5-9|~|~|~|~|Mortality|20335489|Lung and Bronchus|2011
5-9|~|~|~|~|Incidence|20335489|Lung and Bronchus|2011
5-9|~|~|~|~|Mortality|9952601|Male and Female Breast|2011
5-9|~|~|~|~|Incidence|9952601|Male and Female Breast|2011
5-9|~|~|~|~|Incidence|9952601|Male and Female Breast, <i>in situ</i>|2011
5-9|~|~|~|~|Mortality|20335489|Melanomas of the Skin|2011
5-9|0.1|0.2|0.2|35|Incidence|20335489|Melanomas of the Skin|2011
5-9|~|~|~|~|Mortality|20335489|Mesothelioma|2011
5-9|~|~|~|~|Incidence|20335489|Mesothelioma|2011
5-9|~|~|~|~|Mortality|20335489|Myeloma|2011
5-9|~|~|~|~|Incidence|20335489|Myeloma|2011
5-9|~|~|~|~|Mortality|20335489|Non-Hodgkin Lymphoma|2011
5-9|0.9|1.2|1.0|213|Incidence|20335489|Non-Hodgkin Lymphoma|2011
5-9|~|~|~|~|Mortality|20335489|Oral Cavity and Pharynx|2011
5-9|0.1|0.1|0.1|19|Incidence|20335489|Oral Cavity and Pharynx|2011
5-9|~|~|~|~|Mortality|9952601|Ovary|2011
5-9|0.2|0.4|0.3|31|Incidence|9952601|Ovary|2011
5-9|~|~|~|~|Mortality|20335489|Pancreas|2011
5-9|~|~|~|~|Incidence|20335489|Pancreas|2011
5-9|~|~|~|~|Mortality|10382888|Prostate|2011
5-9|~|~|~|~|Incidence|10382888|Prostate|2011
5-9|~|~|~|~|Mortality|20335489|Stomach|2011
5-9|~|~|~|~|Incidence|20335489|Stomach|2011
5-9|~|~|~|~|Mortality|10382888|Testis|2011
5-9|~|~|~|~|Incidence|10382888|Testis|2011
5-9|~|~|~|~|Mortality|20335489|Thyroid|2011
5-9|0.1|0.2|0.1|29|Incidence|20335489|Thyroid|2011
5-9|~|~|~|~|Mortality|20335489|Urinary Bladder|2011
5-9|~|~|~|~|Incidence|20335489|Urinary Bladder|2011
<1|1.4|2.2|1.8|70|Mortality|3963264|All Cancer Sites Combined|2011
<1|24.0|27.2|25.6|1013|Incidence|3963264|All Cancer Sites Combined|2011
<1|~|~|~|~|Mortality|3963264|Brain and Other Nervous System|2011
<1|3.3|4.6|3.9|156|Incidence|3963264|Brain and Other Nervous System|2011
<1|~|~|~|~|Mortality|1934746|Cervix|2011
<1|~|~|~|~|Incidence|1934746|Cervix|2011
<1|~|~|~|~|Mortality|3963264|Colon and Rectum|2011
<1|~|~|~|~|Incidence|3963264|Colon and Rectum|2011
<1|~|~|~|~|Mortality|1934746|Corpus and Uterus, NOS|2011
<1|~|~|~|~|Incidence|1934746|Corpus and Uterus, NOS|2011
<1|~|~|~|~|Mortality|3963264|Esophagus|2011
<1|~|~|~|~|Incidence|3963264|Esophagus|2011
<1|~|~|~|~|Mortality|1934746|Female Breast|2011
<1|~|~|~|~|Incidence|1934746|Female Breast|2011
<1|~|~|~|~|Incidence|1934746|Female Breast, <i>in situ</i>|2011
<1|~|~|~|~|Mortality|3963264|Hodgkin Lymphoma|2011
<1|~|~|~|~|Incidence|3963264|Hodgkin Lymphoma|2011
<1|.|.|.|.|Mortality|3963264|Kaposi Sarcoma|2011
<1|~|~|~|~|Incidence|3963264|Kaposi Sarcoma|2011
<1|~|~|~|~|Mortality|3963264|Kidney and Renal Pelvis|2011
<1|1.2|2.0|1.6|63|Incidence|3963264|Kidney and Renal Pelvis|2011
<1|~|~|~|~|Mortality|3963264|Larynx|2011
<1|~|~|~|~|Incidence|3963264|Larynx|2011
<1|0.3|0.8|0.6|22|Mortality|3963264|Leukemias|2011
<1|3.6|4.9|4.2|167|Incidence|3963264|Leukemias|2011
<1|~|~|~|~|Mortality|3963264|Liver and Intrahepatic Bile Duct|2011
<1|1.0|1.8|1.4|55|Incidence|3963264|Liver and Intrahepatic Bile Duct|2011
<1|~|~|~|~|Mortality|3963264|Lung and Bronchus|2011
<1|~|~|~|~|Incidence|3963264|Lung and Bronchus|2011
<1|~|~|~|~|Mortality|1934746|Male and Female Breast|2011
<1|~|~|~|~|Incidence|1934746|Male and Female Breast|2011
<1|~|~|~|~|Incidence|1934746|Male and Female Breast, <i>in situ</i>|2011
<1|~|~|~|~|Mortality|3963264|Melanomas of the Skin|2011
<1|~|~|~|~|Incidence|3963264|Melanomas of the Skin|2011
<1|~|~|~|~|Mortality|3963264|Mesothelioma|2011
<1|~|~|~|~|Incidence|3963264|Mesothelioma|2011
<1|~|~|~|~|Mortality|3963264|Myeloma|2011
<1|~|~|~|~|Incidence|3963264|Myeloma|2011
<1|~|~|~|~|Mortality|3963264|Non-Hodgkin Lymphoma|2011
<1|~|~|~|~|Incidence|3963264|Non-Hodgkin Lymphoma|2011
<1|~|~|~|~|Mortality|3963264|Oral Cavity and Pharynx|2011
<1|~|~|~|~|Incidence|3963264|Oral Cavity and Pharynx|2011
<1|~|~|~|~|Mortality|1934746|Ovary|2011
<1|~|~|~|~|Incidence|1934746|Ovary|2011
<1|~|~|~|~|Mortality|3963264|Pancreas|2011
<1|~|~|~|~|Incidence|3963264|Pancreas|2011
<1|~|~|~|~|Mortality|2028518|Prostate|2011
<1|~|~|~|~|Incidence|2028518|Prostate|2011
<1|~|~|~|~|Mortality|3963264|Stomach|2011
<1|~|~|~|~|Incidence|3963264|Stomach|2011
<1|~|~|~|~|Mortality|2028518|Testis|2011
<1|~|~|~|~|Incidence|2028518|Testis|2011
<1|~|~|~|~|Mortality|3963264|Thyroid|2011
<1|~|~|~|~|Incidence|3963264|Thyroid|2011
<1|~|~|~|~|Mortality|3963264|Urinary Bladder|2011
<1|~|~|~|~|Incidence|3963264|Urinary Bladder|2011
1-4|2.2|2.7|2.4|392|Mortality|16054205|All Cancer Sites Combined|2012
1-4|22.9|24.4|23.6|3793|Incidence|16054205|All Cancer Sites Combined|2012
1-4|0.6|0.8|0.7|108|Mortality|16054205|Brain and Other Nervous System|2012
1-4|4.6|5.3|4.9|787|Incidence|16054205|Brain and Other Nervous System|2012
1-4|~|~|~|~|Mortality|7855136|Cervix|2012
1-4|~|~|~|~|Incidence|7855136|Cervix|2012
1-4|~|~|~|~|Mortality|16054205|Colon and Rectum|2012
1-4|~|~|~|~|Incidence|16054205|Colon and Rectum|2012
1-4|~|~|~|~|Mortality|7855136|Corpus and Uterus, NOS|2012
1-4|~|~|~|~|Incidence|7855136|Corpus and Uterus, NOS|2012
1-4|~|~|~|~|Mortality|16054205|Esophagus|2012
1-4|~|~|~|~|Incidence|16054205|Esophagus|2012
1-4|~|~|~|~|Mortality|7855136|Female Breast|2012
1-4|~|~|~|~|Incidence|7855136|Female Breast|2012
1-4|~|~|~|~|Incidence|7855136|Female Breast, <i>in situ</i>|2012
1-4|~|~|~|~|Mortality|16054205|Hodgkin Lymphoma|2012
1-4|0.1|0.2|0.1|21|Incidence|16054205|Hodgkin Lymphoma|2012
1-4|.|.|.|.|Mortality|16054205|Kaposi Sarcoma|2012
1-4|~|~|~|~|Incidence|16054205|Kaposi Sarcoma|2012
1-4|~|~|~|~|Mortality|16054205|Kidney and Renal Pelvis|2012
1-4|1.8|2.3|2.0|326|Incidence|16054205|Kidney and Renal Pelvis|2012
1-4|~|~|~|~|Mortality|16054205|Larynx|2012
1-4|~|~|~|~|Incidence|16054205|Larynx|2012
1-4|0.7|1.0|0.8|136|Mortality|16054205|Leukemias|2012
1-4|8.6|9.5|9.0|1452|Incidence|16054205|Leukemias|2012
1-4|0.1|0.2|0.1|17|Mortality|16054205|Liver and Intrahepatic Bile Duct|2012
1-4|0.6|0.9|0.7|118|Incidence|16054205|Liver and Intrahepatic Bile Duct|2012
1-4|~|~|~|~|Mortality|16054205|Lung and Bronchus|2012
1-4|~|~|~|~|Incidence|16054205|Lung and Bronchus|2012
1-4|~|~|~|~|Mortality|7855136|Male and Female Breast|2012
1-4|~|~|~|~|Incidence|7855136|Male and Female Breast|2012
1-4|~|~|~|~|Incidence|7855136|Male and Female Breast, <i>in situ</i>|2012
1-4|~|~|~|~|Mortality|16054205|Melanomas of the Skin|2012
1-4|0.1|0.2|0.1|18|Incidence|16054205|Melanomas of the Skin|2012
1-4|~|~|~|~|Mortality|16054205|Mesothelioma|2012
1-4|~|~|~|~|Incidence|16054205|Mesothelioma|2012
1-4|~|~|~|~|Mortality|16054205|Myeloma|2012
1-4|~|~|~|~|Incidence|16054205|Myeloma|2012
1-4|~|~|~|~|Mortality|16054205|Non-Hodgkin Lymphoma|2012
1-4|0.5|0.8|0.6|103|Incidence|16054205|Non-Hodgkin Lymphoma|2012
1-4|~|~|~|~|Mortality|16054205|Oral Cavity and Pharynx|2012
1-4|~|~|~|~|Incidence|16054205|Oral Cavity and Pharynx|2012
1-4|~|~|~|~|Mortality|7855136|Ovary|2012
1-4|~|~|~|~|Incidence|7855136|Ovary|2012
1-4|~|~|~|~|Mortality|16054205|Pancreas|2012
1-4|~|~|~|~|Incidence|16054205|Pancreas|2012
1-4|~|~|~|~|Mortality|8199069|Prostate|2012
1-4|~|~|~|~|Incidence|8199069|Prostate|2012
1-4|~|~|~|~|Mortality|16054205|Stomach|2012
1-4|~|~|~|~|Incidence|16054205|Stomach|2012
1-4|~|~|~|~|Mortality|8199069|Testis|2012
1-4|0.2|0.4|0.3|22|Incidence|8199069|Testis|2012
1-4|~|~|~|~|Mortality|16054205|Thyroid|2012
1-4|~|~|~|~|Incidence|16054205|Thyroid|2012
1-4|~|~|~|~|Mortality|16054205|Urinary Bladder|2012
1-4|~|~|~|~|Incidence|16054205|Urinary Bladder|2012
10-14|2.1|2.5|2.3|472|Mortality|20673843|All Cancer Sites Combined|2012
10-14|13.9|15.0|14.4|2982|Incidence|20673843|All Cancer Sites Combined|2012
10-14|0.6|0.9|0.7|151|Mortality|20673843|Brain and Other Nervous System|2012
10-14|2.7|3.1|2.9|597|Incidence|20673843|Brain and Other Nervous System|2012
10-14|~|~|~|~|Mortality|10111589|Cervix|2012
10-14|~|~|~|~|Incidence|10111589|Cervix|2012
10-14|~|~|~|~|Mortality|20673843|Colon and Rectum|2012
10-14|0.1|0.2|0.1|29|Incidence|20673843|Colon and Rectum|2012
10-14|~|~|~|~|Mortality|10111589|Corpus and Uterus, NOS|2012
10-14|~|~|~|~|Incidence|10111589|Corpus and Uterus, NOS|2012
10-14|~|~|~|~|Mortality|20673843|Esophagus|2012
10-14|~|~|~|~|Incidence|20673843|Esophagus|2012
10-14|~|~|~|~|Mortality|10111589|Female Breast|2012
10-14|~|~|~|~|Incidence|10111589|Female Breast|2012
10-14|~|~|~|~|Incidence|10111589|Female Breast, <i>in situ</i>|2012
10-14|~|~|~|~|Mortality|20673843|Hodgkin Lymphoma|2012
10-14|1.1|1.4|1.3|262|Incidence|20673843|Hodgkin Lymphoma|2012
10-14|.|.|.|.|Mortality|20673843|Kaposi Sarcoma|2012
10-14|~|~|~|~|Incidence|20673843|Kaposi Sarcoma|2012
10-14|~|~|~|~|Mortality|20673843|Kidney and Renal Pelvis|2012
10-14|0.1|0.2|0.2|34|Incidence|20673843|Kidney and Renal Pelvis|2012
10-14|~|~|~|~|Mortality|20673843|Larynx|2012
10-14|~|~|~|~|Incidence|20673843|Larynx|2012
10-14|0.5|0.7|0.6|126|Mortality|20673843|Leukemias|2012
10-14|2.7|3.2|3.0|614|Incidence|20673843|Leukemias|2012
10-14|~|~|~|~|Mortality|20673843|Liver and Intrahepatic Bile Duct|2012
10-14|0.1|0.2|0.1|26|Incidence|20673843|Liver and Intrahepatic Bile Duct|2012
10-14|~|~|~|~|Mortality|20673843|Lung and Bronchus|2012
10-14|~|~|~|~|Incidence|20673843|Lung and Bronchus|2012
10-14|~|~|~|~|Mortality|10111589|Male and Female Breast|2012
10-14|~|~|~|~|Incidence|10111589|Male and Female Breast|2012
10-14|~|~|~|~|Incidence|10111589|Male and Female Breast, <i>in situ</i>|2012
10-14|~|~|~|~|Mortality|20673843|Melanomas of the Skin|2012
10-14|0.2|0.3|0.2|44|Incidence|20673843|Melanomas of the Skin|2012
10-14|~|~|~|~|Mortality|20673843|Mesothelioma|2012
10-14|~|~|~|~|Incidence|20673843|Mesothelioma|2012
10-14|~|~|~|~|Mortality|20673843|Myeloma|2012
10-14|~|~|~|~|Incidence|20673843|Myeloma|2012
10-14|0.1|0.1|0.1|18|Mortality|20673843|Non-Hodgkin Lymphoma|2012
10-14|1.2|1.5|1.4|285|Incidence|20673843|Non-Hodgkin Lymphoma|2012
10-14|~|~|~|~|Mortality|20673843|Oral Cavity and Pharynx|2012
10-14|0.2|0.3|0.3|55|Incidence|20673843|Oral Cavity and Pharynx|2012
10-14|~|~|~|~|Mortality|10111589|Ovary|2012
10-14|0.6|1.0|0.8|77|Incidence|10111589|Ovary|2012
10-14|~|~|~|~|Mortality|20673843|Pancreas|2012
10-14|~|~|~|~|Incidence|20673843|Pancreas|2012
10-14|~|~|~|~|Mortality|10562254|Prostate|2012
10-14|~|~|~|~|Incidence|10562254|Prostate|2012
10-14|~|~|~|~|Mortality|20673843|Stomach|2012
10-14|~|~|~|~|Incidence|20673843|Stomach|2012
10-14|~|~|~|~|Mortality|10562254|Testis|2012
10-14|~|~|~|~|Incidence|10562254|Testis|2012
10-14|~|~|~|~|Mortality|20673843|Thyroid|2012
10-14|0.7|0.9|0.8|165|Incidence|20673843|Thyroid|2012
10-14|~|~|~|~|Mortality|20673843|Urinary Bladder|2012
10-14|~|~|~|~|Incidence|20673843|Urinary Bladder|2012
15-19|2.7|3.2|2.9|628|Mortality|21374020|All Cancer Sites Combined|2012
15-19|22.7|24.0|23.3|4987|Incidence|21374020|All Cancer Sites Combined|2012
15-19|0.5|0.7|0.5|117|Mortality|21374020|Brain and Other Nervous System|2012
15-19|2.2|2.6|2.4|507|Incidence|21374020|Brain and Other Nervous System|2012
15-19|~|~|~|~|Mortality|10411033|Cervix|2012
15-19|~|~|~|~|Incidence|10411033|Cervix|2012
15-19|~|~|~|~|Mortality|21374020|Colon and Rectum|2012
15-19|0.4|0.6|0.5|109|Incidence|21374020|Colon and Rectum|2012
15-19|~|~|~|~|Mortality|10411033|Corpus and Uterus, NOS|2012
15-19|~|~|~|~|Incidence|10411033|Corpus and Uterus, NOS|2012
15-19|~|~|~|~|Mortality|21374020|Esophagus|2012
15-19|~|~|~|~|Incidence|21374020|Esophagus|2012
15-19|~|~|~|~|Mortality|10411033|Female Breast|2012
15-19|0.1|0.3|0.2|17|Incidence|10411033|Female Breast|2012
15-19|~|~|~|~|Incidence|10411033|Female Breast, <i>in situ</i>|2012
15-19|~|~|~|~|Mortality|21374020|Hodgkin Lymphoma|2012
15-19|3.0|3.5|3.3|700|Incidence|21374020|Hodgkin Lymphoma|2012
15-19|.|.|.|.|Mortality|21374020|Kaposi Sarcoma|2012
15-19|~|~|~|~|Incidence|21374020|Kaposi Sarcoma|2012
15-19|~|~|~|~|Mortality|21374020|Kidney and Renal Pelvis|2012
15-19|0.2|0.3|0.3|55|Incidence|21374020|Kidney and Renal Pelvis|2012
15-19|~|~|~|~|Mortality|21374020|Larynx|2012
15-19|~|~|~|~|Incidence|21374020|Larynx|2012
15-19|0.6|0.9|0.7|156|Mortality|21374020|Leukemias|2012
15-19|2.8|3.2|3.0|641|Incidence|21374020|Leukemias|2012
15-19|~|~|~|~|Mortality|21374020|Liver and Intrahepatic Bile Duct|2012
15-19|0.1|0.2|0.1|28|Incidence|21374020|Liver and Intrahepatic Bile Duct|2012
15-19|~|~|~|~|Mortality|21374020|Lung and Bronchus|2012
15-19|0.1|0.2|0.1|30|Incidence|21374020|Lung and Bronchus|2012
15-19|~|~|~|~|Mortality|10411033|Male and Female Breast|2012
15-19|0.1|0.3|0.2|17|Incidence|10411033|Male and Female Breast|2012
15-19|~|~|~|~|Incidence|10411033|Male and Female Breast, <i>in situ</i>|2012
15-19|~|~|~|~|Mortality|21374020|Melanomas of the Skin|2012
15-19|0.9|1.2|1.1|226|Incidence|21374020|Melanomas of the Skin|2012
15-19|~|~|~|~|Mortality|21374020|Mesothelioma|2012
15-19|~|~|~|~|Incidence|21374020|Mesothelioma|2012
15-19|~|~|~|~|Mortality|21374020|Myeloma|2012
15-19|~|~|~|~|Incidence|21374020|Myeloma|2012
15-19|0.1|0.2|0.1|24|Mortality|21374020|Non-Hodgkin Lymphoma|2012
15-19|1.8|2.2|2.0|421|Incidence|21374020|Non-Hodgkin Lymphoma|2012
15-19|~|~|~|~|Mortality|21374020|Oral Cavity and Pharynx|2012
15-19|0.4|0.6|0.5|106|Incidence|21374020|Oral Cavity and Pharynx|2012
15-19|~|~|~|~|Mortality|10411033|Ovary|2012
15-19|1.3|1.8|1.5|161|Incidence|10411033|Ovary|2012
15-19|~|~|~|~|Mortality|21374020|Pancreas|2012
15-19|0.0|0.1|0.1|18|Incidence|21374020|Pancreas|2012
15-19|~|~|~|~|Mortality|10962987|Prostate|2012
15-19|~|~|~|~|Incidence|10962987|Prostate|2012
15-19|~|~|~|~|Mortality|21374020|Stomach|2012
15-19|~|~|~|~|Incidence|21374020|Stomach|2012
15-19|~|~|~|~|Mortality|10962987|Testis|2012
15-19|3.4|4.2|3.8|417|Incidence|10962987|Testis|2012
15-19|~|~|~|~|Mortality|21374020|Thyroid|2012
15-19|2.7|3.2|2.9|623|Incidence|21374020|Thyroid|2012
15-19|~|~|~|~|Mortality|21374020|Urinary Bladder|2012
15-19|0.1|0.2|0.1|24|Incidence|21374020|Urinary Bladder|2012
5-9|2.0|2.4|2.1|440|Mortality|20472679|All Cancer Sites Combined|2012
5-9|12.1|13.1|12.6|2586|Incidence|20472679|All Cancer Sites Combined|2012
5-9|0.8|1.0|0.9|185|Mortality|20472679|Brain and Other Nervous System|2012
5-9|3.2|3.7|3.5|707|Incidence|20472679|Brain and Other Nervous System|2012
5-9|~|~|~|~|Mortality|10018115|Cervix|2012
5-9|~|~|~|~|Incidence|10018115|Cervix|2012
5-9|~|~|~|~|Mortality|20472679|Colon and Rectum|2012
5-9|~|~|~|~|Incidence|20472679|Colon and Rectum|2012
5-9|~|~|~|~|Mortality|10018115|Corpus and Uterus, NOS|2012
5-9|~|~|~|~|Incidence|10018115|Corpus and Uterus, NOS|2012
5-9|~|~|~|~|Mortality|20472679|Esophagus|2012
5-9|~|~|~|~|Incidence|20472679|Esophagus|2012
5-9|~|~|~|~|Mortality|10018115|Female Breast|2012
5-9|~|~|~|~|Incidence|10018115|Female Breast|2012
5-9|~|~|~|~|Incidence|10018115|Female Breast, <i>in situ</i>|2012
5-9|~|~|~|~|Mortality|20472679|Hodgkin Lymphoma|2012
5-9|0.2|0.4|0.3|66|Incidence|20472679|Hodgkin Lymphoma|2012
5-9|.|.|.|.|Mortality|20472679|Kaposi Sarcoma|2012
5-9|~|~|~|~|Incidence|20472679|Kaposi Sarcoma|2012
5-9|~|~|~|~|Mortality|20472679|Kidney and Renal Pelvis|2012
5-9|0.5|0.7|0.6|113|Incidence|20472679|Kidney and Renal Pelvis|2012
5-9|~|~|~|~|Mortality|20472679|Larynx|2012
5-9|~|~|~|~|Incidence|20472679|Larynx|2012
5-9|0.4|0.6|0.5|97|Mortality|20472679|Leukemias|2012
5-9|3.8|4.3|4.0|823|Incidence|20472679|Leukemias|2012
5-9|~|~|~|~|Mortality|20472679|Liver and Intrahepatic Bile Duct|2012
5-9|0.1|0.2|0.1|21|Incidence|20472679|Liver and Intrahepatic Bile Duct|2012
5-9|~|~|~|~|Mortality|20472679|Lung and Bronchus|2012
5-9|~|~|~|~|Incidence|20472679|Lung and Bronchus|2012
5-9|~|~|~|~|Mortality|10018115|Male and Female Breast|2012
5-9|~|~|~|~|Incidence|10018115|Male and Female Breast|2012
5-9|~|~|~|~|Incidence|10018115|Male and Female Breast, <i>in situ</i>|2012
5-9|~|~|~|~|Mortality|20472679|Melanomas of the Skin|2012
5-9|0.1|0.3|0.2|38|Incidence|20472679|Melanomas of the Skin|2012
5-9|~|~|~|~|Mortality|20472679|Mesothelioma|2012
5-9|~|~|~|~|Incidence|20472679|Mesothelioma|2012
5-9|~|~|~|~|Mortality|20472679|Myeloma|2012
5-9|~|~|~|~|Incidence|20472679|Myeloma|2012
5-9|~|~|~|~|Mortality|20472679|Non-Hodgkin Lymphoma|2012
5-9|0.9|1.2|1.1|216|Incidence|20472679|Non-Hodgkin Lymphoma|2012
5-9|~|~|~|~|Mortality|20472679|Oral Cavity and Pharynx|2012
5-9|0.0|0.1|0.1|16|Incidence|20472679|Oral Cavity and Pharynx|2012
5-9|~|~|~|~|Mortality|10018115|Ovary|2012
5-9|0.2|0.4|0.2|25|Incidence|10018115|Ovary|2012
5-9|~|~|~|~|Mortality|20472679|Pancreas|2012
5-9|~|~|~|~|Incidence|20472679|Pancreas|2012
5-9|~|~|~|~|Mortality|10454564|Prostate|2012
5-9|~|~|~|~|Incidence|10454564|Prostate|2012
5-9|~|~|~|~|Mortality|20472679|Stomach|2012
5-9|~|~|~|~|Incidence|20472679|Stomach|2012
5-9|~|~|~|~|Mortality|10454564|Testis|2012
5-9|~|~|~|~|Incidence|10454564|Testis|2012
5-9|~|~|~|~|Mortality|20472679|Thyroid|2012
5-9|0.1|0.2|0.1|27|Incidence|20472679|Thyroid|2012
5-9|~|~|~|~|Mortality|20472679|Urinary Bladder|2012
5-9|~|~|~|~|Incidence|20472679|Urinary Bladder|2012
<1|1.2|2.1|1.6|63|Mortality|3926731|All Cancer Sites Combined|2012
<1|25.3|28.6|26.9|1058|Incidence|3926731|All Cancer Sites Combined|2012
<1|~|~|~|~|Mortality|3926731|Brain and Other Nervous System|2012
<1|3.2|4.5|3.8|149|Incidence|3926731|Brain and Other Nervous System|2012
<1|~|~|~|~|Mortality|1918905|Cervix|2012
<1|~|~|~|~|Incidence|1918905|Cervix|2012
<1|~|~|~|~|Mortality|3926731|Colon and Rectum|2012
<1|~|~|~|~|Incidence|3926731|Colon and Rectum|2012
<1|~|~|~|~|Mortality|1918905|Corpus and Uterus, NOS|2012
<1|~|~|~|~|Incidence|1918905|Corpus and Uterus, NOS|2012
<1|~|~|~|~|Mortality|3926731|Esophagus|2012
<1|~|~|~|~|Incidence|3926731|Esophagus|2012
<1|~|~|~|~|Mortality|1918905|Female Breast|2012
<1|~|~|~|~|Incidence|1918905|Female Breast|2012
<1|~|~|~|~|Incidence|1918905|Female Breast, <i>in situ</i>|2012
<1|~|~|~|~|Mortality|3926731|Hodgkin Lymphoma|2012
<1|~|~|~|~|Incidence|3926731|Hodgkin Lymphoma|2012
<1|.|.|.|.|Mortality|3926731|Kaposi Sarcoma|2012
<1|~|~|~|~|Incidence|3926731|Kaposi Sarcoma|2012
<1|~|~|~|~|Mortality|3926731|Kidney and Renal Pelvis|2012
<1|1.4|2.3|1.8|71|Incidence|3926731|Kidney and Renal Pelvis|2012
<1|~|~|~|~|Mortality|3926731|Larynx|2012
<1|~|~|~|~|Incidence|3926731|Larynx|2012
<1|0.3|0.8|0.5|19|Mortality|3926731|Leukemias|2012
<1|3.5|4.8|4.1|162|Incidence|3926731|Leukemias|2012
<1|~|~|~|~|Mortality|3926731|Liver and Intrahepatic Bile Duct|2012
<1|1.2|2.0|1.5|60|Incidence|3926731|Liver and Intrahepatic Bile Duct|2012
<1|~|~|~|~|Mortality|3926731|Lung and Bronchus|2012
<1|~|~|~|~|Incidence|3926731|Lung and Bronchus|2012
<1|~|~|~|~|Mortality|1918905|Male and Female Breast|2012
<1|~|~|~|~|Incidence|1918905|Male and Female Breast|2012
<1|~|~|~|~|Incidence|1918905|Male and Female Breast, <i>in situ</i>|2012
<1|~|~|~|~|Mortality|3926731|Melanomas of the Skin|2012
<1|~|~|~|~|Incidence|3926731|Melanomas of the Skin|2012
<1|~|~|~|~|Mortality|3926731|Mesothelioma|2012
<1|~|~|~|~|Incidence|3926731|Mesothelioma|2012
<1|~|~|~|~|Mortality|3926731|Myeloma|2012
<1|~|~|~|~|Incidence|3926731|Myeloma|2012
<1|~|~|~|~|Mortality|3926731|Non-Hodgkin Lymphoma|2012
<1|~|~|~|~|Incidence|3926731|Non-Hodgkin Lymphoma|2012
<1|~|~|~|~|Mortality|3926731|Oral Cavity and Pharynx|2012
<1|~|~|~|~|Incidence|3926731|Oral Cavity and Pharynx|2012
<1|~|~|~|~|Mortality|1918905|Ovary|2012
<1|~|~|~|~|Incidence|1918905|Ovary|2012
<1|~|~|~|~|Mortality|3926731|Pancreas|2012
<1|~|~|~|~|Incidence|3926731|Pancreas|2012
<1|~|~|~|~|Mortality|2007826|Prostate|2012
<1|~|~|~|~|Incidence|2007826|Prostate|2012
<1|~|~|~|~|Mortality|3926731|Stomach|2012
<1|~|~|~|~|Incidence|3926731|Stomach|2012
<1|~|~|~|~|Mortality|2007826|Testis|2012
<1|~|~|~|~|Incidence|2007826|Testis|2012
<1|~|~|~|~|Mortality|3926731|Thyroid|2012
<1|~|~|~|~|Incidence|3926731|Thyroid|2012
<1|~|~|~|~|Mortality|3926731|Urinary Bladder|2012
<1|~|~|~|~|Incidence|3926731|Urinary Bladder|2012
1-4|1.8|2.3|2.1|328|Mortality|15923773|All Cancer Sites Combined|2013
1-4|22.3|23.8|23.0|3662|Incidence|15923773|All Cancer Sites Combined|2013
1-4|0.5|0.7|0.6|92|Mortality|15923773|Brain and Other Nervous System|2013
1-4|4.4|5.1|4.7|756|Incidence|15923773|Brain and Other Nervous System|2013
1-4|~|~|~|~|Mortality|7788902|Cervix|2013
1-4|~|~|~|~|Incidence|7788902|Cervix|2013
1-4|~|~|~|~|Mortality|15923773|Colon and Rectum|2013
1-4|~|~|~|~|Incidence|15923773|Colon and Rectum|2013
1-4|~|~|~|~|Mortality|7788902|Corpus and Uterus, NOS|2013
1-4|~|~|~|~|Incidence|7788902|Corpus and Uterus, NOS|2013
1-4|~|~|~|~|Mortality|15923773|Esophagus|2013
1-4|~|~|~|~|Incidence|15923773|Esophagus|2013
1-4|~|~|~|~|Mortality|7788902|Female Breast|2013
1-4|~|~|~|~|Incidence|7788902|Female Breast|2013
1-4|~|~|~|~|Incidence|7788902|Female Breast, <i>in situ</i>|2013
1-4|~|~|~|~|Mortality|15923773|Hodgkin Lymphoma|2013
1-4|0.1|0.2|0.1|16|Incidence|15923773|Hodgkin Lymphoma|2013
1-4|.|.|.|.|Mortality|15923773|Kaposi Sarcoma|2013
1-4|~|~|~|~|Incidence|15923773|Kaposi Sarcoma|2013
1-4|0.1|0.2|0.1|17|Mortality|15923773|Kidney and Renal Pelvis|2013
1-4|1.9|2.3|2.1|333|Incidence|15923773|Kidney and Renal Pelvis|2013
1-4|~|~|~|~|Mortality|15923773|Larynx|2013
1-4|~|~|~|~|Incidence|15923773|Larynx|2013
1-4|0.5|0.7|0.6|96|Mortality|15923773|Leukemias|2013
1-4|8.0|8.9|8.4|1344|Incidence|15923773|Leukemias|2013
1-4|0.1|0.2|0.1|19|Mortality|15923773|Liver and Intrahepatic Bile Duct|2013
1-4|0.5|0.7|0.6|92|Incidence|15923773|Liver and Intrahepatic Bile Duct|2013
1-4|~|~|~|~|Mortality|15923773|Lung and Bronchus|2013
1-4|~|~|~|~|Incidence|15923773|Lung and Bronchus|2013
1-4|~|~|~|~|Mortality|7788902|Male and Female Breast|2013
1-4|~|~|~|~|Incidence|7788902|Male and Female Breast|2013
1-4|~|~|~|~|Incidence|7788902|Male and Female Breast, <i>in situ</i>|2013
1-4|~|~|~|~|Mortality|15923773|Melanomas of the Skin|2013
1-4|~|~|~|~|Incidence|15923773|Melanomas of the Skin|2013
1-4|~|~|~|~|Mortality|15923773|Mesothelioma|2013
1-4|~|~|~|~|Incidence|15923773|Mesothelioma|2013
1-4|~|~|~|~|Mortality|15923773|Myeloma|2013
1-4|~|~|~|~|Incidence|15923773|Myeloma|2013
1-4|~|~|~|~|Mortality|15923773|Non-Hodgkin Lymphoma|2013
1-4|0.7|1.0|0.8|131|Incidence|15923773|Non-Hodgkin Lymphoma|2013
1-4|~|~|~|~|Mortality|15923773|Oral Cavity and Pharynx|2013
1-4|~|~|~|~|Incidence|15923773|Oral Cavity and Pharynx|2013
1-4|~|~|~|~|Mortality|7788902|Ovary|2013
1-4|~|~|~|~|Incidence|7788902|Ovary|2013
1-4|~|~|~|~|Mortality|15923773|Pancreas|2013
1-4|~|~|~|~|Incidence|15923773|Pancreas|2013
1-4|~|~|~|~|Mortality|8134871|Prostate|2013
1-4|~|~|~|~|Incidence|8134871|Prostate|2013
1-4|~|~|~|~|Mortality|15923773|Stomach|2013
1-4|~|~|~|~|Incidence|15923773|Stomach|2013
1-4|~|~|~|~|Mortality|8134871|Testis|2013
1-4|0.2|0.4|0.3|24|Incidence|8134871|Testis|2013
1-4|~|~|~|~|Mortality|15923773|Thyroid|2013
1-4|~|~|~|~|Incidence|15923773|Thyroid|2013
1-4|~|~|~|~|Mortality|15923773|Urinary Bladder|2013
1-4|~|~|~|~|Incidence|15923773|Urinary Bladder|2013
10-14|2.0|2.4|2.2|448|Mortality|20656987|All Cancer Sites Combined|2013
10-14|14.3|15.3|14.8|3051|Incidence|20656987|All Cancer Sites Combined|2013
10-14|0.5|0.7|0.6|129|Mortality|20656987|Brain and Other Nervous System|2013
10-14|3.0|3.5|3.2|662|Incidence|20656987|Brain and Other Nervous System|2013
10-14|~|~|~|~|Mortality|10109744|Cervix|2013
10-14|~|~|~|~|Incidence|10109744|Cervix|2013
10-14|~|~|~|~|Mortality|20656987|Colon and Rectum|2013
10-14|0.1|0.3|0.2|38|Incidence|20656987|Colon and Rectum|2013
10-14|~|~|~|~|Mortality|10109744|Corpus and Uterus, NOS|2013
10-14|~|~|~|~|Incidence|10109744|Corpus and Uterus, NOS|2013
10-14|~|~|~|~|Mortality|20656987|Esophagus|2013
10-14|~|~|~|~|Incidence|20656987|Esophagus|2013
10-14|~|~|~|~|Mortality|10109744|Female Breast|2013
10-14|~|~|~|~|Incidence|10109744|Female Breast|2013
10-14|~|~|~|~|Incidence|10109744|Female Breast, <i>in situ</i>|2013
10-14|~|~|~|~|Mortality|20656987|Hodgkin Lymphoma|2013
10-14|0.9|1.2|1.1|223|Incidence|20656987|Hodgkin Lymphoma|2013
10-14|.|.|.|.|Mortality|20656987|Kaposi Sarcoma|2013
10-14|~|~|~|~|Incidence|20656987|Kaposi Sarcoma|2013
10-14|~|~|~|~|Mortality|20656987|Kidney and Renal Pelvis|2013
10-14|0.1|0.2|0.2|34|Incidence|20656987|Kidney and Renal Pelvis|2013
10-14|~|~|~|~|Mortality|20656987|Larynx|2013
10-14|~|~|~|~|Incidence|20656987|Larynx|2013
10-14|0.6|0.8|0.7|139|Mortality|20656987|Leukemias|2013
10-14|2.8|3.3|3.0|629|Incidence|20656987|Leukemias|2013
10-14|~|~|~|~|Mortality|20656987|Liver and Intrahepatic Bile Duct|2013
10-14|0.1|0.2|0.1|21|Incidence|20656987|Liver and Intrahepatic Bile Duct|2013
10-14|~|~|~|~|Mortality|20656987|Lung and Bronchus|2013
10-14|~|~|~|~|Incidence|20656987|Lung and Bronchus|2013
10-14|~|~|~|~|Mortality|10109744|Male and Female Breast|2013
10-14|~|~|~|~|Incidence|10109744|Male and Female Breast|2013
10-14|~|~|~|~|Incidence|10109744|Male and Female Breast, <i>in situ</i>|2013
10-14|~|~|~|~|Mortality|20656987|Melanomas of the Skin|2013
10-14|0.2|0.4|0.3|58|Incidence|20656987|Melanomas of the Skin|2013
10-14|~|~|~|~|Mortality|20656987|Mesothelioma|2013
10-14|~|~|~|~|Incidence|20656987|Mesothelioma|2013
10-14|~|~|~|~|Mortality|20656987|Myeloma|2013
10-14|~|~|~|~|Incidence|20656987|Myeloma|2013
10-14|0.0|0.1|0.1|17|Mortality|20656987|Non-Hodgkin Lymphoma|2013
10-14|1.1|1.5|1.3|268|Incidence|20656987|Non-Hodgkin Lymphoma|2013
10-14|~|~|~|~|Mortality|20656987|Oral Cavity and Pharynx|2013
10-14|0.3|0.4|0.3|72|Incidence|20656987|Oral Cavity and Pharynx|2013
10-14|~|~|~|~|Mortality|10109744|Ovary|2013
10-14|0.7|1.1|0.9|86|Incidence|10109744|Ovary|2013
10-14|~|~|~|~|Mortality|20656987|Pancreas|2013
10-14|~|~|~|~|Incidence|20656987|Pancreas|2013
10-14|~|~|~|~|Mortality|10547243|Prostate|2013
10-14|~|~|~|~|Incidence|10547243|Prostate|2013
10-14|~|~|~|~|Mortality|20656987|Stomach|2013
10-14|~|~|~|~|Incidence|20656987|Stomach|2013
10-14|~|~|~|~|Mortality|10547243|Testis|2013
10-14|0.1|0.3|0.2|19|Incidence|10547243|Testis|2013
10-14|~|~|~|~|Mortality|20656987|Thyroid|2013
10-14|0.7|1.0|0.9|180|Incidence|20656987|Thyroid|2013
10-14|~|~|~|~|Mortality|20656987|Urinary Bladder|2013
10-14|~|~|~|~|Incidence|20656987|Urinary Bladder|2013
15-19|2.7|3.2|3.0|627|Mortality|21183476|All Cancer Sites Combined|2013
15-19|21.7|22.9|22.3|4723|Incidence|21183476|All Cancer Sites Combined|2013
15-19|0.5|0.7|0.6|119|Mortality|21183476|Brain and Other Nervous System|2013
15-19|2.2|2.6|2.4|504|Incidence|21183476|Brain and Other Nervous System|2013
15-19|~|~|~|~|Mortality|10332561|Cervix|2013
15-19|~|~|~|~|Incidence|10332561|Cervix|2013
15-19|~|~|~|~|Mortality|21183476|Colon and Rectum|2013
15-19|0.5|0.7|0.6|120|Incidence|21183476|Colon and Rectum|2013
15-19|~|~|~|~|Mortality|10332561|Corpus and Uterus, NOS|2013
15-19|~|~|~|~|Incidence|10332561|Corpus and Uterus, NOS|2013
15-19|~|~|~|~|Mortality|21183476|Esophagus|2013
15-19|~|~|~|~|Incidence|21183476|Esophagus|2013
15-19|~|~|~|~|Mortality|10332561|Female Breast|2013
15-19|~|~|~|~|Incidence|10332561|Female Breast|2013
15-19|~|~|~|~|Incidence|10332561|Female Breast, <i>in situ</i>|2013
15-19|~|~|~|~|Mortality|21183476|Hodgkin Lymphoma|2013
15-19|2.7|3.2|3.0|626|Incidence|21183476|Hodgkin Lymphoma|2013
15-19|.|.|.|.|Mortality|21183476|Kaposi Sarcoma|2013
15-19|~|~|~|~|Incidence|21183476|Kaposi Sarcoma|2013
15-19|~|~|~|~|Mortality|21183476|Kidney and Renal Pelvis|2013
15-19|0.2|0.3|0.3|57|Incidence|21183476|Kidney and Renal Pelvis|2013
15-19|~|~|~|~|Mortality|21183476|Larynx|2013
15-19|~|~|~|~|Incidence|21183476|Larynx|2013
15-19|0.6|0.9|0.8|159|Mortality|21183476|Leukemias|2013
15-19|2.8|3.3|3.0|645|Incidence|21183476|Leukemias|2013
15-19|~|~|~|~|Mortality|21183476|Liver and Intrahepatic Bile Duct|2013
15-19|0.1|0.2|0.1|28|Incidence|21183476|Liver and Intrahepatic Bile Duct|2013
15-19|~|~|~|~|Mortality|21183476|Lung and Bronchus|2013
15-19|0.1|0.2|0.2|38|Incidence|21183476|Lung and Bronchus|2013
15-19|~|~|~|~|Mortality|10332561|Male and Female Breast|2013
15-19|~|~|~|~|Incidence|10332561|Male and Female Breast|2013
15-19|~|~|~|~|Incidence|10332561|Male and Female Breast, <i>in situ</i>|2013
15-19|~|~|~|~|Mortality|21183476|Melanomas of the Skin|2013
15-19|0.9|1.2|1.0|216|Incidence|21183476|Melanomas of the Skin|2013
15-19|~|~|~|~|Mortality|21183476|Mesothelioma|2013
15-19|~|~|~|~|Incidence|21183476|Mesothelioma|2013
15-19|~|~|~|~|Mortality|21183476|Myeloma|2013
15-19|~|~|~|~|Incidence|21183476|Myeloma|2013
15-19|0.1|0.2|0.1|31|Mortality|21183476|Non-Hodgkin Lymphoma|2013
15-19|1.6|1.9|1.7|366|Incidence|21183476|Non-Hodgkin Lymphoma|2013
15-19|~|~|~|~|Mortality|21183476|Oral Cavity and Pharynx|2013
15-19|0.3|0.5|0.4|87|Incidence|21183476|Oral Cavity and Pharynx|2013
15-19|~|~|~|~|Mortality|10332561|Ovary|2013
15-19|1.2|1.7|1.4|149|Incidence|10332561|Ovary|2013
15-19|~|~|~|~|Mortality|21183476|Pancreas|2013
15-19|~|~|~|~|Incidence|21183476|Pancreas|2013
15-19|~|~|~|~|Mortality|10850915|Prostate|2013
15-19|~|~|~|~|Incidence|10850915|Prostate|2013
15-19|~|~|~|~|Mortality|21183476|Stomach|2013
15-19|~|~|~|~|Incidence|21183476|Stomach|2013
15-19|~|~|~|~|Mortality|10850915|Testis|2013
15-19|3.4|4.2|3.8|409|Incidence|10850915|Testis|2013
15-19|~|~|~|~|Mortality|21183476|Thyroid|2013
15-19|2.5|2.9|2.7|566|Incidence|21183476|Thyroid|2013
15-19|~|~|~|~|Mortality|21183476|Urinary Bladder|2013
15-19|0.1|0.1|0.1|18|Incidence|21183476|Urinary Bladder|2013
5-9|2.0|2.4|2.2|447|Mortality|20575591|All Cancer Sites Combined|2013
5-9|12.7|13.7|13.2|2721|Incidence|20575591|All Cancer Sites Combined|2013
5-9|0.8|1.1|0.9|193|Mortality|20575591|Brain and Other Nervous System|2013
5-9|3.4|3.9|3.6|748|Incidence|20575591|Brain and Other Nervous System|2013
5-9|~|~|~|~|Mortality|10068928|Cervix|2013
5-9|~|~|~|~|Incidence|10068928|Cervix|2013
5-9|~|~|~|~|Mortality|20575591|Colon and Rectum|2013
5-9|~|~|~|~|Incidence|20575591|Colon and Rectum|2013
5-9|~|~|~|~|Mortality|10068928|Corpus and Uterus, NOS|2013
5-9|~|~|~|~|Incidence|10068928|Corpus and Uterus, NOS|2013
5-9|~|~|~|~|Mortality|20575591|Esophagus|2013
5-9|~|~|~|~|Incidence|20575591|Esophagus|2013
5-9|~|~|~|~|Mortality|10068928|Female Breast|2013
5-9|~|~|~|~|Incidence|10068928|Female Breast|2013
5-9|~|~|~|~|Incidence|10068928|Female Breast, <i>in situ</i>|2013
5-9|~|~|~|~|Mortality|20575591|Hodgkin Lymphoma|2013
5-9|0.4|0.6|0.5|97|Incidence|20575591|Hodgkin Lymphoma|2013
5-9|.|.|.|.|Mortality|20575591|Kaposi Sarcoma|2013
5-9|~|~|~|~|Incidence|20575591|Kaposi Sarcoma|2013
5-9|0.0|0.1|0.1|17|Mortality|20575591|Kidney and Renal Pelvis|2013
5-9|0.5|0.7|0.6|129|Incidence|20575591|Kidney and Renal Pelvis|2013
5-9|~|~|~|~|Mortality|20575591|Larynx|2013
5-9|~|~|~|~|Incidence|20575591|Larynx|2013
5-9|0.4|0.6|0.5|94|Mortality|20575591|Leukemias|2013
5-9|3.9|4.4|4.1|849|Incidence|20575591|Leukemias|2013
5-9|~|~|~|~|Mortality|20575591|Liver and Intrahepatic Bile Duct|2013
5-9|0.1|0.2|0.1|28|Incidence|20575591|Liver and Intrahepatic Bile Duct|2013
5-9|~|~|~|~|Mortality|20575591|Lung and Bronchus|2013
5-9|~|~|~|~|Incidence|20575591|Lung and Bronchus|2013
5-9|~|~|~|~|Mortality|10068928|Male and Female Breast|2013
5-9|~|~|~|~|Incidence|10068928|Male and Female Breast|2013
5-9|~|~|~|~|Incidence|10068928|Male and Female Breast, <i>in situ</i>|2013
5-9|~|~|~|~|Mortality|20575591|Melanomas of the Skin|2013
5-9|0.1|0.3|0.2|40|Incidence|20575591|Melanomas of the Skin|2013
5-9|~|~|~|~|Mortality|20575591|Mesothelioma|2013
5-9|~|~|~|~|Incidence|20575591|Mesothelioma|2013
5-9|~|~|~|~|Mortality|20575591|Myeloma|2013
5-9|~|~|~|~|Incidence|20575591|Myeloma|2013
5-9|~|~|~|~|Mortality|20575591|Non-Hodgkin Lymphoma|2013
5-9|0.8|1.1|0.9|193|Incidence|20575591|Non-Hodgkin Lymphoma|2013
5-9|~|~|~|~|Mortality|20575591|Oral Cavity and Pharynx|2013
5-9|0.1|0.2|0.1|21|Incidence|20575591|Oral Cavity and Pharynx|2013
5-9|~|~|~|~|Mortality|10068928|Ovary|2013
5-9|0.2|0.4|0.2|24|Incidence|10068928|Ovary|2013
5-9|~|~|~|~|Mortality|20575591|Pancreas|2013
5-9|~|~|~|~|Incidence|20575591|Pancreas|2013
5-9|~|~|~|~|Mortality|10506663|Prostate|2013
5-9|~|~|~|~|Incidence|10506663|Prostate|2013
5-9|~|~|~|~|Mortality|20575591|Stomach|2013
5-9|~|~|~|~|Incidence|20575591|Stomach|2013
5-9|~|~|~|~|Mortality|10506663|Testis|2013
5-9|~|~|~|~|Incidence|10506663|Testis|2013
5-9|~|~|~|~|Mortality|20575591|Thyroid|2013
5-9|0.1|0.2|0.2|34|Incidence|20575591|Thyroid|2013
5-9|~|~|~|~|Mortality|20575591|Urinary Bladder|2013
5-9|~|~|~|~|Incidence|20575591|Urinary Bladder|2013
<1|1.3|2.1|1.6|64|Mortality|3931411|All Cancer Sites Combined|2013
<1|27.2|30.6|28.9|1135|Incidence|3931411|All Cancer Sites Combined|2013
<1|0.4|0.9|0.6|23|Mortality|3931411|Brain and Other Nervous System|2013
<1|3.6|4.9|4.2|164|Incidence|3931411|Brain and Other Nervous System|2013
<1|~|~|~|~|Mortality|1921621|Cervix|2013
<1|~|~|~|~|Incidence|1921621|Cervix|2013
<1|~|~|~|~|Mortality|3931411|Colon and Rectum|2013
<1|~|~|~|~|Incidence|3931411|Colon and Rectum|2013
<1|~|~|~|~|Mortality|1921621|Corpus and Uterus, NOS|2013
<1|~|~|~|~|Incidence|1921621|Corpus and Uterus, NOS|2013
<1|~|~|~|~|Mortality|3931411|Esophagus|2013
<1|~|~|~|~|Incidence|3931411|Esophagus|2013
<1|~|~|~|~|Mortality|1921621|Female Breast|2013
<1|~|~|~|~|Incidence|1921621|Female Breast|2013
<1|~|~|~|~|Incidence|1921621|Female Breast, <i>in situ</i>|2013
<1|~|~|~|~|Mortality|3931411|Hodgkin Lymphoma|2013
<1|~|~|~|~|Incidence|3931411|Hodgkin Lymphoma|2013
<1|.|.|.|.|Mortality|3931411|Kaposi Sarcoma|2013
<1|~|~|~|~|Incidence|3931411|Kaposi Sarcoma|2013
<1|~|~|~|~|Mortality|3931411|Kidney and Renal Pelvis|2013
<1|1.3|2.1|1.6|64|Incidence|3931411|Kidney and Renal Pelvis|2013
<1|~|~|~|~|Mortality|3931411|Larynx|2013
<1|~|~|~|~|Incidence|3931411|Larynx|2013
<1|0.3|0.8|0.5|21|Mortality|3931411|Leukemias|2013
<1|3.7|5.1|4.3|171|Incidence|3931411|Leukemias|2013
<1|~|~|~|~|Mortality|3931411|Liver and Intrahepatic Bile Duct|2013
<1|1.0|1.7|1.3|51|Incidence|3931411|Liver and Intrahepatic Bile Duct|2013
<1|~|~|~|~|Mortality|3931411|Lung and Bronchus|2013
<1|~|~|~|~|Incidence|3931411|Lung and Bronchus|2013
<1|~|~|~|~|Mortality|1921621|Male and Female Breast|2013
<1|~|~|~|~|Incidence|1921621|Male and Female Breast|2013
<1|~|~|~|~|Incidence|1921621|Male and Female Breast, <i>in situ</i>|2013
<1|~|~|~|~|Mortality|3931411|Melanomas of the Skin|2013
<1|~|~|~|~|Incidence|3931411|Melanomas of the Skin|2013
<1|~|~|~|~|Mortality|3931411|Mesothelioma|2013
<1|~|~|~|~|Incidence|3931411|Mesothelioma|2013
<1|~|~|~|~|Mortality|3931411|Myeloma|2013
<1|~|~|~|~|Incidence|3931411|Myeloma|2013
<1|~|~|~|~|Mortality|3931411|Non-Hodgkin Lymphoma|2013
<1|~|~|~|~|Incidence|3931411|Non-Hodgkin Lymphoma|2013
<1|~|~|~|~|Mortality|3931411|Oral Cavity and Pharynx|2013
<1|~|~|~|~|Incidence|3931411|Oral Cavity and Pharynx|2013
<1|~|~|~|~|Mortality|1921621|Ovary|2013
<1|~|~|~|~|Incidence|1921621|Ovary|2013
<1|~|~|~|~|Mortality|3931411|Pancreas|2013
<1|~|~|~|~|Incidence|3931411|Pancreas|2013
<1|~|~|~|~|Mortality|2009790|Prostate|2013
<1|~|~|~|~|Incidence|2009790|Prostate|2013
<1|~|~|~|~|Mortality|3931411|Stomach|2013
<1|~|~|~|~|Incidence|3931411|Stomach|2013
<1|~|~|~|~|Mortality|2009790|Testis|2013
<1|0.6|1.5|1.0|20|Incidence|2009790|Testis|2013
<1|~|~|~|~|Mortality|3931411|Thyroid|2013
<1|~|~|~|~|Incidence|3931411|Thyroid|2013
<1|~|~|~|~|Mortality|3931411|Urinary Bladder|2013
<1|~|~|~|~|Incidence|3931411|Urinary Bladder|2013
1-4|1.8|2.2|2.0|321|Mortality|15923833|All Cancer Sites Combined|2014
1-4|22.2|23.7|22.9|3647|Incidence|15923833|All Cancer Sites Combined|2014
1-4|0.4|0.7|0.5|87|Mortality|15923833|Brain and Other Nervous System|2014
1-4|4.3|5.0|4.6|738|Incidence|15923833|Brain and Other Nervous System|2014
1-4|~|~|~|~|Mortality|7785575|Cervix|2014
1-4|~|~|~|~|Incidence|7785575|Cervix|2014
1-4|~|~|~|~|Mortality|15923833|Colon and Rectum|2014
1-4|~|~|~|~|Incidence|15923833|Colon and Rectum|2014
1-4|~|~|~|~|Mortality|7785575|Corpus and Uterus, NOS|2014
1-4|~|~|~|~|Incidence|7785575|Corpus and Uterus, NOS|2014
1-4|~|~|~|~|Mortality|15923833|Esophagus|2014
1-4|~|~|~|~|Incidence|15923833|Esophagus|2014
1-4|~|~|~|~|Mortality|7785575|Female Breast|2014
1-4|~|~|~|~|Incidence|7785575|Female Breast|2014
1-4|~|~|~|~|Incidence|7785575|Female Breast, <i>in situ</i>|2014
1-4|~|~|~|~|Mortality|15923833|Hodgkin Lymphoma|2014
1-4|~|~|~|~|Incidence|15923833|Hodgkin Lymphoma|2014
1-4|.|.|.|.|Mortality|15923833|Kaposi Sarcoma|2014
1-4|~|~|~|~|Incidence|15923833|Kaposi Sarcoma|2014
1-4|~|~|~|~|Mortality|15923833|Kidney and Renal Pelvis|2014
1-4|1.9|2.3|2.1|330|Incidence|15923833|Kidney and Renal Pelvis|2014
1-4|~|~|~|~|Mortality|15923833|Larynx|2014
1-4|~|~|~|~|Incidence|15923833|Larynx|2014
1-4|0.5|0.8|0.6|101|Mortality|15923833|Leukemias|2014
1-4|8.3|9.3|8.8|1399|Incidence|15923833|Leukemias|2014
1-4|~|~|~|~|Mortality|15923833|Liver and Intrahepatic Bile Duct|2014
1-4|0.5|0.8|0.6|101|Incidence|15923833|Liver and Intrahepatic Bile Duct|2014
1-4|~|~|~|~|Mortality|15923833|Lung and Bronchus|2014
1-4|~|~|~|~|Incidence|15923833|Lung and Bronchus|2014
1-4|~|~|~|~|Mortality|7785575|Male and Female Breast|2014
1-4|~|~|~|~|Incidence|7785575|Male and Female Breast|2014
1-4|~|~|~|~|Incidence|7785575|Male and Female Breast, <i>in situ</i>|2014
1-4|~|~|~|~|Mortality|15923833|Melanomas of the Skin|2014
1-4|0.1|0.2|0.2|27|Incidence|15923833|Melanomas of the Skin|2014
1-4|~|~|~|~|Mortality|15923833|Mesothelioma|2014
1-4|~|~|~|~|Incidence|15923833|Mesothelioma|2014
1-4|~|~|~|~|Mortality|15923833|Myeloma|2014
1-4|~|~|~|~|Incidence|15923833|Myeloma|2014
1-4|~|~|~|~|Mortality|15923833|Non-Hodgkin Lymphoma|2014
1-4|0.7|1.0|0.8|129|Incidence|15923833|Non-Hodgkin Lymphoma|2014
1-4|~|~|~|~|Mortality|15923833|Oral Cavity and Pharynx|2014
1-4|~|~|~|~|Incidence|15923833|Oral Cavity and Pharynx|2014
1-4|~|~|~|~|Mortality|7785575|Ovary|2014
1-4|~|~|~|~|Incidence|7785575|Ovary|2014
1-4|~|~|~|~|Mortality|15923833|Pancreas|2014
1-4|~|~|~|~|Incidence|15923833|Pancreas|2014
1-4|~|~|~|~|Mortality|8138258|Prostate|2014
1-4|~|~|~|~|Incidence|8138258|Prostate|2014
1-4|~|~|~|~|Mortality|15923833|Stomach|2014
1-4|~|~|~|~|Incidence|15923833|Stomach|2014
1-4|~|~|~|~|Mortality|8138258|Testis|2014
1-4|0.2|0.4|0.3|22|Incidence|8138258|Testis|2014
1-4|~|~|~|~|Mortality|15923833|Thyroid|2014
1-4|~|~|~|~|Incidence|15923833|Thyroid|2014
1-4|~|~|~|~|Mortality|15923833|Urinary Bladder|2014
1-4|~|~|~|~|Incidence|15923833|Urinary Bladder|2014
10-14|1.8|2.2|2.0|416|Mortality|20673760|All Cancer Sites Combined|2014
10-14|14.9|16.0|15.4|3189|Incidence|20673760|All Cancer Sites Combined|2014
10-14|0.5|0.8|0.6|133|Mortality|20673760|Brain and Other Nervous System|2014
10-14|2.9|3.4|3.1|650|Incidence|20673760|Brain and Other Nervous System|2014
10-14|~|~|~|~|Mortality|10122728|Cervix|2014
10-14|~|~|~|~|Incidence|10122728|Cervix|2014
10-14|~|~|~|~|Mortality|20673760|Colon and Rectum|2014
10-14|0.2|0.4|0.3|62|Incidence|20673760|Colon and Rectum|2014
10-14|~|~|~|~|Mortality|10122728|Corpus and Uterus, NOS|2014
10-14|~|~|~|~|Incidence|10122728|Corpus and Uterus, NOS|2014
10-14|~|~|~|~|Mortality|20673760|Esophagus|2014
10-14|~|~|~|~|Incidence|20673760|Esophagus|2014
10-14|~|~|~|~|Mortality|10122728|Female Breast|2014
10-14|~|~|~|~|Incidence|10122728|Female Breast|2014
10-14|~|~|~|~|Incidence|10122728|Female Breast, <i>in situ</i>|2014
10-14|~|~|~|~|Mortality|20673760|Hodgkin Lymphoma|2014
10-14|1.1|1.4|1.2|253|Incidence|20673760|Hodgkin Lymphoma|2014
10-14|.|.|.|.|Mortality|20673760|Kaposi Sarcoma|2014
10-14|~|~|~|~|Incidence|20673760|Kaposi Sarcoma|2014
10-14|~|~|~|~|Mortality|20673760|Kidney and Renal Pelvis|2014
10-14|0.1|0.2|0.2|34|Incidence|20673760|Kidney and Renal Pelvis|2014
10-14|~|~|~|~|Mortality|20673760|Larynx|2014
10-14|~|~|~|~|Incidence|20673760|Larynx|2014
10-14|0.4|0.6|0.5|97|Mortality|20673760|Leukemias|2014
10-14|2.8|3.3|3.1|633|Incidence|20673760|Leukemias|2014
10-14|~|~|~|~|Mortality|20673760|Liver and Intrahepatic Bile Duct|2014
10-14|0.1|0.2|0.1|23|Incidence|20673760|Liver and Intrahepatic Bile Duct|2014
10-14|~|~|~|~|Mortality|20673760|Lung and Bronchus|2014
10-14|~|~|~|~|Incidence|20673760|Lung and Bronchus|2014
10-14|~|~|~|~|Mortality|10122728|Male and Female Breast|2014
10-14|~|~|~|~|Incidence|10122728|Male and Female Breast|2014
10-14|~|~|~|~|Incidence|10122728|Male and Female Breast, <i>in situ</i>|2014
10-14|~|~|~|~|Mortality|20673760|Melanomas of the Skin|2014
10-14|0.2|0.3|0.3|53|Incidence|20673760|Melanomas of the Skin|2014
10-14|~|~|~|~|Mortality|20673760|Mesothelioma|2014
10-14|~|~|~|~|Incidence|20673760|Mesothelioma|2014
10-14|~|~|~|~|Mortality|20673760|Myeloma|2014
10-14|~|~|~|~|Incidence|20673760|Myeloma|2014
10-14|0.1|0.1|0.1|19|Mortality|20673760|Non-Hodgkin Lymphoma|2014
10-14|1.3|1.7|1.5|312|Incidence|20673760|Non-Hodgkin Lymphoma|2014
10-14|~|~|~|~|Mortality|20673760|Oral Cavity and Pharynx|2014
10-14|0.2|0.3|0.2|44|Incidence|20673760|Oral Cavity and Pharynx|2014
10-14|~|~|~|~|Mortality|10122728|Ovary|2014
10-14|0.7|1.0|0.8|84|Incidence|10122728|Ovary|2014
10-14|~|~|~|~|Mortality|20673760|Pancreas|2014
10-14|0.0|0.1|0.1|17|Incidence|20673760|Pancreas|2014
10-14|~|~|~|~|Mortality|10551032|Prostate|2014
10-14|~|~|~|~|Incidence|10551032|Prostate|2014
10-14|~|~|~|~|Mortality|20673760|Stomach|2014
10-14|~|~|~|~|Incidence|20673760|Stomach|2014
10-14|~|~|~|~|Mortality|10551032|Testis|2014
10-14|0.1|0.2|0.2|16|Incidence|10551032|Testis|2014
10-14|~|~|~|~|Mortality|20673760|Thyroid|2014
10-14|0.8|1.1|0.9|196|Incidence|20673760|Thyroid|2014
10-14|~|~|~|~|Mortality|20673760|Urinary Bladder|2014
10-14|~|~|~|~|Incidence|20673760|Urinary Bladder|2014
15-19|2.7|3.1|2.9|612|Mortality|21060362|All Cancer Sites Combined|2014
15-19|22.9|24.2|23.6|4960|Incidence|21060362|All Cancer Sites Combined|2014
15-19|0.6|0.8|0.7|139|Mortality|21060362|Brain and Other Nervous System|2014
15-19|2.2|2.7|2.4|514|Incidence|21060362|Brain and Other Nervous System|2014
15-19|~|~|~|~|Mortality|10282180|Cervix|2014
15-19|~|~|~|~|Incidence|10282180|Cervix|2014
15-19|~|~|~|~|Mortality|21060362|Colon and Rectum|2014
15-19|0.6|0.8|0.7|146|Incidence|21060362|Colon and Rectum|2014
15-19|~|~|~|~|Mortality|10282180|Corpus and Uterus, NOS|2014
15-19|~|~|~|~|Incidence|10282180|Corpus and Uterus, NOS|2014
15-19|~|~|~|~|Mortality|21060362|Esophagus|2014
15-19|~|~|~|~|Incidence|21060362|Esophagus|2014
15-19|~|~|~|~|Mortality|10282180|Female Breast|2014
15-19|0.1|0.3|0.2|16|Incidence|10282180|Female Breast|2014
15-19|~|~|~|~|Incidence|10282180|Female Breast, <i>in situ</i>|2014
15-19|~|~|~|~|Mortality|21060362|Hodgkin Lymphoma|2014
15-19|2.9|3.3|3.1|651|Incidence|21060362|Hodgkin Lymphoma|2014
15-19|.|.|.|.|Mortality|21060362|Kaposi Sarcoma|2014
15-19|~|~|~|~|Incidence|21060362|Kaposi Sarcoma|2014
15-19|~|~|~|~|Mortality|21060362|Kidney and Renal Pelvis|2014
15-19|0.2|0.3|0.2|50|Incidence|21060362|Kidney and Renal Pelvis|2014
15-19|~|~|~|~|Mortality|21060362|Larynx|2014
15-19|~|~|~|~|Incidence|21060362|Larynx|2014
15-19|0.6|0.9|0.8|160|Mortality|21060362|Leukemias|2014
15-19|3.0|3.5|3.2|679|Incidence|21060362|Leukemias|2014
15-19|~|~|~|~|Mortality|21060362|Liver and Intrahepatic Bile Duct|2014
15-19|0.1|0.2|0.1|23|Incidence|21060362|Liver and Intrahepatic Bile Duct|2014
15-19|~|~|~|~|Mortality|21060362|Lung and Bronchus|2014
15-19|0.1|0.1|0.1|19|Incidence|21060362|Lung and Bronchus|2014
15-19|~|~|~|~|Mortality|10282180|Male and Female Breast|2014
15-19|0.1|0.3|0.2|16|Incidence|10282180|Male and Female Breast|2014
15-19|~|~|~|~|Incidence|10282180|Male and Female Breast, <i>in situ</i>|2014
15-19|~|~|~|~|Mortality|21060362|Melanomas of the Skin|2014
15-19|0.8|1.1|0.9|192|Incidence|21060362|Melanomas of the Skin|2014
15-19|~|~|~|~|Mortality|21060362|Mesothelioma|2014
15-19|~|~|~|~|Incidence|21060362|Mesothelioma|2014
15-19|~|~|~|~|Mortality|21060362|Myeloma|2014
15-19|~|~|~|~|Incidence|21060362|Myeloma|2014
15-19|0.1|0.2|0.1|30|Mortality|21060362|Non-Hodgkin Lymphoma|2014
15-19|1.9|2.3|2.1|444|Incidence|21060362|Non-Hodgkin Lymphoma|2014
15-19|~|~|~|~|Mortality|21060362|Oral Cavity and Pharynx|2014
15-19|0.3|0.5|0.4|87|Incidence|21060362|Oral Cavity and Pharynx|2014
15-19|~|~|~|~|Mortality|10282180|Ovary|2014
15-19|1.0|1.4|1.2|123|Incidence|10282180|Ovary|2014
15-19|~|~|~|~|Mortality|21060362|Pancreas|2014
15-19|0.1|0.2|0.2|32|Incidence|21060362|Pancreas|2014
15-19|~|~|~|~|Mortality|10778182|Prostate|2014
15-19|~|~|~|~|Incidence|10778182|Prostate|2014
15-19|~|~|~|~|Mortality|21060362|Stomach|2014
15-19|~|~|~|~|Incidence|21060362|Stomach|2014
15-19|~|~|~|~|Mortality|10778182|Testis|2014
15-19|3.2|3.9|3.6|385|Incidence|10778182|Testis|2014
15-19|~|~|~|~|Mortality|21060362|Thyroid|2014
15-19|2.9|3.4|3.1|657|Incidence|21060362|Thyroid|2014
15-19|~|~|~|~|Mortality|21060362|Urinary Bladder|2014
15-19|0.1|0.1|0.1|18|Incidence|21060362|Urinary Bladder|2014
5-9|1.9|2.3|2.1|436|Mortality|20526270|All Cancer Sites Combined|2014
5-9|13.3|14.3|13.8|2828|Incidence|20526270|All Cancer Sites Combined|2014
5-9|0.8|1.1|0.9|188|Mortality|20526270|Brain and Other Nervous System|2014
5-9|3.4|3.9|3.7|754|Incidence|20526270|Brain and Other Nervous System|2014
5-9|~|~|~|~|Mortality|10046117|Cervix|2014
5-9|~|~|~|~|Incidence|10046117|Cervix|2014
5-9|~|~|~|~|Mortality|20526270|Colon and Rectum|2014
5-9|~|~|~|~|Incidence|20526270|Colon and Rectum|2014
5-9|~|~|~|~|Mortality|10046117|Corpus and Uterus, NOS|2014
5-9|~|~|~|~|Incidence|10046117|Corpus and Uterus, NOS|2014
5-9|~|~|~|~|Mortality|20526270|Esophagus|2014
5-9|~|~|~|~|Incidence|20526270|Esophagus|2014
5-9|~|~|~|~|Mortality|10046117|Female Breast|2014
5-9|~|~|~|~|Incidence|10046117|Female Breast|2014
5-9|~|~|~|~|Incidence|10046117|Female Breast, <i>in situ</i>|2014
5-9|~|~|~|~|Mortality|20526270|Hodgkin Lymphoma|2014
5-9|0.3|0.5|0.4|80|Incidence|20526270|Hodgkin Lymphoma|2014
5-9|.|.|.|.|Mortality|20526270|Kaposi Sarcoma|2014
5-9|~|~|~|~|Incidence|20526270|Kaposi Sarcoma|2014
5-9|~|~|~|~|Mortality|20526270|Kidney and Renal Pelvis|2014
5-9|0.6|0.8|0.7|137|Incidence|20526270|Kidney and Renal Pelvis|2014
5-9|~|~|~|~|Mortality|20526270|Larynx|2014
5-9|~|~|~|~|Incidence|20526270|Larynx|2014
5-9|0.3|0.5|0.4|87|Mortality|20526270|Leukemias|2014
5-9|3.9|4.5|4.2|858|Incidence|20526270|Leukemias|2014
5-9|~|~|~|~|Mortality|20526270|Liver and Intrahepatic Bile Duct|2014
5-9|0.1|0.2|0.1|22|Incidence|20526270|Liver and Intrahepatic Bile Duct|2014
5-9|~|~|~|~|Mortality|20526270|Lung and Bronchus|2014
5-9|~|~|~|~|Incidence|20526270|Lung and Bronchus|2014
5-9|~|~|~|~|Mortality|10046117|Male and Female Breast|2014
5-9|~|~|~|~|Incidence|10046117|Male and Female Breast|2014
5-9|~|~|~|~|Incidence|10046117|Male and Female Breast, <i>in situ</i>|2014
5-9|~|~|~|~|Mortality|20526270|Melanomas of the Skin|2014
5-9|0.1|0.2|0.2|37|Incidence|20526270|Melanomas of the Skin|2014
5-9|~|~|~|~|Mortality|20526270|Mesothelioma|2014
5-9|~|~|~|~|Incidence|20526270|Mesothelioma|2014
5-9|~|~|~|~|Mortality|20526270|Myeloma|2014
5-9|~|~|~|~|Incidence|20526270|Myeloma|2014
5-9|~|~|~|~|Mortality|20526270|Non-Hodgkin Lymphoma|2014
5-9|1.0|1.3|1.2|241|Incidence|20526270|Non-Hodgkin Lymphoma|2014
5-9|~|~|~|~|Mortality|20526270|Oral Cavity and Pharynx|2014
5-9|0.1|0.1|0.1|18|Incidence|20526270|Oral Cavity and Pharynx|2014
5-9|~|~|~|~|Mortality|10046117|Ovary|2014
5-9|0.2|0.4|0.2|24|Incidence|10046117|Ovary|2014
5-9|~|~|~|~|Mortality|20526270|Pancreas|2014
5-9|~|~|~|~|Incidence|20526270|Pancreas|2014
5-9|~|~|~|~|Mortality|10480153|Prostate|2014
5-9|~|~|~|~|Incidence|10480153|Prostate|2014
5-9|~|~|~|~|Mortality|20526270|Stomach|2014
5-9|~|~|~|~|Incidence|20526270|Stomach|2014
5-9|~|~|~|~|Mortality|10480153|Testis|2014
5-9|~|~|~|~|Incidence|10480153|Testis|2014
5-9|~|~|~|~|Mortality|20526270|Thyroid|2014
5-9|0.1|0.3|0.2|40|Incidence|20526270|Thyroid|2014
5-9|~|~|~|~|Mortality|20526270|Urinary Bladder|2014
5-9|~|~|~|~|Incidence|20526270|Urinary Bladder|2014
<1|1.0|1.7|1.3|52|Mortality|3954973|All Cancer Sites Combined|2014
<1|26.8|30.2|28.4|1125|Incidence|3954973|All Cancer Sites Combined|2014
<1|~|~|~|~|Mortality|3954973|Brain and Other Nervous System|2014
<1|3.6|4.9|4.2|166|Incidence|3954973|Brain and Other Nervous System|2014
<1|~|~|~|~|Mortality|1930369|Cervix|2014
<1|~|~|~|~|Incidence|1930369|Cervix|2014
<1|~|~|~|~|Mortality|3954973|Colon and Rectum|2014
<1|~|~|~|~|Incidence|3954973|Colon and Rectum|2014
<1|~|~|~|~|Mortality|1930369|Corpus and Uterus, NOS|2014
<1|~|~|~|~|Incidence|1930369|Corpus and Uterus, NOS|2014
<1|~|~|~|~|Mortality|3954973|Esophagus|2014
<1|~|~|~|~|Incidence|3954973|Esophagus|2014
<1|~|~|~|~|Mortality|1930369|Female Breast|2014
<1|~|~|~|~|Incidence|1930369|Female Breast|2014
<1|~|~|~|~|Incidence|1930369|Female Breast, <i>in situ</i>|2014
<1|~|~|~|~|Mortality|3954973|Hodgkin Lymphoma|2014
<1|~|~|~|~|Incidence|3954973|Hodgkin Lymphoma|2014
<1|.|.|.|.|Mortality|3954973|Kaposi Sarcoma|2014
<1|~|~|~|~|Incidence|3954973|Kaposi Sarcoma|2014
<1|~|~|~|~|Mortality|3954973|Kidney and Renal Pelvis|2014
<1|1.5|2.3|1.9|74|Incidence|3954973|Kidney and Renal Pelvis|2014
<1|~|~|~|~|Mortality|3954973|Larynx|2014
<1|~|~|~|~|Incidence|3954973|Larynx|2014
<1|~|~|~|~|Mortality|3954973|Leukemias|2014
<1|3.3|4.6|3.9|155|Incidence|3954973|Leukemias|2014
<1|~|~|~|~|Mortality|3954973|Liver and Intrahepatic Bile Duct|2014
<1|1.2|2.0|1.6|63|Incidence|3954973|Liver and Intrahepatic Bile Duct|2014
<1|~|~|~|~|Mortality|3954973|Lung and Bronchus|2014
<1|~|~|~|~|Incidence|3954973|Lung and Bronchus|2014
<1|~|~|~|~|Mortality|1930369|Male and Female Breast|2014
<1|~|~|~|~|Incidence|1930369|Male and Female Breast|2014
<1|~|~|~|~|Incidence|1930369|Male and Female Breast, <i>in situ</i>|2014
<1|~|~|~|~|Mortality|3954973|Melanomas of the Skin|2014
<1|~|~|~|~|Incidence|3954973|Melanomas of the Skin|2014
<1|~|~|~|~|Mortality|3954973|Mesothelioma|2014
<1|~|~|~|~|Incidence|3954973|Mesothelioma|2014
<1|~|~|~|~|Mortality|3954973|Myeloma|2014
<1|~|~|~|~|Incidence|3954973|Myeloma|2014
<1|~|~|~|~|Mortality|3954973|Non-Hodgkin Lymphoma|2014
<1|~|~|~|~|Incidence|3954973|Non-Hodgkin Lymphoma|2014
<1|~|~|~|~|Mortality|3954973|Oral Cavity and Pharynx|2014
<1|~|~|~|~|Incidence|3954973|Oral Cavity and Pharynx|2014
<1|~|~|~|~|Mortality|1930369|Ovary|2014
<1|~|~|~|~|Incidence|1930369|Ovary|2014
<1|~|~|~|~|Mortality|3954973|Pancreas|2014
<1|~|~|~|~|Incidence|3954973|Pancreas|2014
<1|~|~|~|~|Mortality|2024604|Prostate|2014
<1|~|~|~|~|Incidence|2024604|Prostate|2014
<1|~|~|~|~|Mortality|3954973|Stomach|2014
<1|~|~|~|~|Incidence|3954973|Stomach|2014
<1|~|~|~|~|Mortality|2024604|Testis|2014
<1|~|~|~|~|Incidence|2024604|Testis|2014
<1|~|~|~|~|Mortality|3954973|Thyroid|2014
<1|~|~|~|~|Incidence|3954973|Thyroid|2014
<1|~|~|~|~|Mortality|3954973|Urinary Bladder|2014
<1|~|~|~|~|Incidence|3954973|Urinary Bladder|2014
1-4|2.0|2.5|2.2|354|Mortality|15940562|All Cancer Sites Combined|2015
1-4|22.9|24.4|23.7|3771|Incidence|15940562|All Cancer Sites Combined|2015
1-4|0.5|0.7|0.6|94|Mortality|15940562|Brain and Other Nervous System|2015
1-4|4.1|4.8|4.5|712|Incidence|15940562|Brain and Other Nervous System|2015
1-4|~|~|~|~|Mortality|7788156|Cervix|2015
1-4|~|~|~|~|Incidence|7788156|Cervix|2015
1-4|~|~|~|~|Mortality|15940562|Colon and Rectum|2015
1-4|~|~|~|~|Incidence|15940562|Colon and Rectum|2015
1-4|~|~|~|~|Mortality|7788156|Corpus and Uterus, NOS|2015
1-4|~|~|~|~|Incidence|7788156|Corpus and Uterus, NOS|2015
1-4|~|~|~|~|Mortality|15940562|Esophagus|2015
1-4|~|~|~|~|Incidence|15940562|Esophagus|2015
1-4|~|~|~|~|Mortality|7788156|Female Breast|2015
1-4|~|~|~|~|Incidence|7788156|Female Breast|2015
1-4|~|~|~|~|Incidence|7788156|Female Breast, <i>in situ</i>|2015
1-4|~|~|~|~|Mortality|15940562|Hodgkin Lymphoma|2015
1-4|~|~|~|~|Incidence|15940562|Hodgkin Lymphoma|2015
1-4|.|.|.|.|Mortality|15940562|Kaposi Sarcoma|2015
1-4|~|~|~|~|Incidence|15940562|Kaposi Sarcoma|2015
1-4|~|~|~|~|Mortality|15940562|Kidney and Renal Pelvis|2015
1-4|1.9|2.4|2.2|344|Incidence|15940562|Kidney and Renal Pelvis|2015
1-4|~|~|~|~|Mortality|15940562|Larynx|2015
1-4|~|~|~|~|Incidence|15940562|Larynx|2015
1-4|0.6|0.9|0.7|115|Mortality|15940562|Leukemias|2015
1-4|8.9|9.8|9.4|1491|Incidence|15940562|Leukemias|2015
1-4|~|~|~|~|Mortality|15940562|Liver and Intrahepatic Bile Duct|2015
1-4|0.5|0.8|0.7|104|Incidence|15940562|Liver and Intrahepatic Bile Duct|2015
1-4|~|~|~|~|Mortality|15940562|Lung and Bronchus|2015
1-4|0.1|0.2|0.1|17|Incidence|15940562|Lung and Bronchus|2015
1-4|~|~|~|~|Mortality|7788156|Male and Female Breast|2015
1-4|~|~|~|~|Incidence|7788156|Male and Female Breast|2015
1-4|~|~|~|~|Incidence|7788156|Male and Female Breast, <i>in situ</i>|2015
1-4|~|~|~|~|Mortality|15940562|Melanomas of the Skin|2015
1-4|0.1|0.2|0.1|19|Incidence|15940562|Melanomas of the Skin|2015
1-4|~|~|~|~|Mortality|15940562|Mesothelioma|2015
1-4|~|~|~|~|Incidence|15940562|Mesothelioma|2015
1-4|~|~|~|~|Mortality|15940562|Myeloma|2015
1-4|~|~|~|~|Incidence|15940562|Myeloma|2015
1-4|~|~|~|~|Mortality|15940562|Non-Hodgkin Lymphoma|2015
1-4|0.6|0.9|0.7|113|Incidence|15940562|Non-Hodgkin Lymphoma|2015
1-4|~|~|~|~|Mortality|15940562|Oral Cavity and Pharynx|2015
1-4|~|~|~|~|Incidence|15940562|Oral Cavity and Pharynx|2015
1-4|~|~|~|~|Mortality|7788156|Ovary|2015
1-4|~|~|~|~|Incidence|7788156|Ovary|2015
1-4|~|~|~|~|Mortality|15940562|Pancreas|2015
1-4|~|~|~|~|Incidence|15940562|Pancreas|2015
1-4|~|~|~|~|Mortality|8152406|Prostate|2015
1-4|~|~|~|~|Incidence|8152406|Prostate|2015
1-4|~|~|~|~|Mortality|15940562|Stomach|2015
1-4|~|~|~|~|Incidence|15940562|Stomach|2015
1-4|~|~|~|~|Mortality|8152406|Testis|2015
1-4|0.1|0.3|0.2|16|Incidence|8152406|Testis|2015
1-4|~|~|~|~|Mortality|15940562|Thyroid|2015
1-4|~|~|~|~|Incidence|15940562|Thyroid|2015
1-4|~|~|~|~|Mortality|15940562|Urinary Bladder|2015
1-4|~|~|~|~|Incidence|15940562|Urinary Bladder|2015
10-14|1.9|2.3|2.1|428|Mortality|20614613|All Cancer Sites Combined|2015
10-14|14.9|16.0|15.4|3183|Incidence|20614613|All Cancer Sites Combined|2015
10-14|0.5|0.8|0.7|135|Mortality|20614613|Brain and Other Nervous System|2015
10-14|2.6|3.1|2.8|587|Incidence|20614613|Brain and Other Nervous System|2015
10-14|~|~|~|~|Mortality|10097361|Cervix|2015
10-14|~|~|~|~|Incidence|10097361|Cervix|2015
10-14|~|~|~|~|Mortality|20614613|Colon and Rectum|2015
10-14|0.5|0.7|0.5|113|Incidence|20614613|Colon and Rectum|2015
10-14|~|~|~|~|Mortality|10097361|Corpus and Uterus, NOS|2015
10-14|~|~|~|~|Incidence|10097361|Corpus and Uterus, NOS|2015
10-14|~|~|~|~|Mortality|20614613|Esophagus|2015
10-14|~|~|~|~|Incidence|20614613|Esophagus|2015
10-14|~|~|~|~|Mortality|10097361|Female Breast|2015
10-14|~|~|~|~|Incidence|10097361|Female Breast|2015
10-14|~|~|~|~|Incidence|10097361|Female Breast, <i>in situ</i>|2015
10-14|~|~|~|~|Mortality|20614613|Hodgkin Lymphoma|2015
10-14|1.1|1.4|1.3|263|Incidence|20614613|Hodgkin Lymphoma|2015
10-14|.|.|.|.|Mortality|20614613|Kaposi Sarcoma|2015
10-14|~|~|~|~|Incidence|20614613|Kaposi Sarcoma|2015
10-14|~|~|~|~|Mortality|20614613|Kidney and Renal Pelvis|2015
10-14|0.1|0.3|0.2|39|Incidence|20614613|Kidney and Renal Pelvis|2015
10-14|~|~|~|~|Mortality|20614613|Larynx|2015
10-14|~|~|~|~|Incidence|20614613|Larynx|2015
10-14|0.5|0.7|0.6|115|Mortality|20614613|Leukemias|2015
10-14|2.9|3.4|3.1|646|Incidence|20614613|Leukemias|2015
10-14|~|~|~|~|Mortality|20614613|Liver and Intrahepatic Bile Duct|2015
10-14|0.1|0.2|0.1|29|Incidence|20614613|Liver and Intrahepatic Bile Duct|2015
10-14|~|~|~|~|Mortality|20614613|Lung and Bronchus|2015
10-14|~|~|~|~|Incidence|20614613|Lung and Bronchus|2015
10-14|~|~|~|~|Mortality|10097361|Male and Female Breast|2015
10-14|~|~|~|~|Incidence|10097361|Male and Female Breast|2015
10-14|~|~|~|~|Incidence|10097361|Male and Female Breast, <i>in situ</i>|2015
10-14|~|~|~|~|Mortality|20614613|Melanomas of the Skin|2015
10-14|0.2|0.4|0.3|63|Incidence|20614613|Melanomas of the Skin|2015
10-14|~|~|~|~|Mortality|20614613|Mesothelioma|2015
10-14|~|~|~|~|Incidence|20614613|Mesothelioma|2015
10-14|~|~|~|~|Mortality|20614613|Myeloma|2015
10-14|~|~|~|~|Incidence|20614613|Myeloma|2015
10-14|0.1|0.1|0.1|18|Mortality|20614613|Non-Hodgkin Lymphoma|2015
10-14|1.2|1.5|1.3|274|Incidence|20614613|Non-Hodgkin Lymphoma|2015
10-14|~|~|~|~|Mortality|20614613|Oral Cavity and Pharynx|2015
10-14|0.2|0.4|0.3|56|Incidence|20614613|Oral Cavity and Pharynx|2015
10-14|~|~|~|~|Mortality|10097361|Ovary|2015
10-14|0.7|1.1|0.9|92|Incidence|10097361|Ovary|2015
10-14|~|~|~|~|Mortality|20614613|Pancreas|2015
10-14|~|~|~|~|Incidence|20614613|Pancreas|2015
10-14|~|~|~|~|Mortality|10517252|Prostate|2015
10-14|~|~|~|~|Incidence|10517252|Prostate|2015
10-14|~|~|~|~|Mortality|20614613|Stomach|2015
10-14|~|~|~|~|Incidence|20614613|Stomach|2015
10-14|~|~|~|~|Mortality|10517252|Testis|2015
10-14|0.1|0.3|0.2|21|Incidence|10517252|Testis|2015
10-14|~|~|~|~|Mortality|20614613|Thyroid|2015
10-14|0.8|1.0|0.9|183|Incidence|20614613|Thyroid|2015
10-14|~|~|~|~|Mortality|20614613|Urinary Bladder|2015
10-14|~|~|~|~|Incidence|20614613|Urinary Bladder|2015
15-19|2.5|3.0|2.8|583|Mortality|21090272|All Cancer Sites Combined|2015
15-19|24.2|25.6|24.9|5248|Incidence|21090272|All Cancer Sites Combined|2015
15-19|0.4|0.6|0.5|101|Mortality|21090272|Brain and Other Nervous System|2015
15-19|2.2|2.6|2.4|511|Incidence|21090272|Brain and Other Nervous System|2015
15-19|~|~|~|~|Mortality|10303239|Cervix|2015
15-19|~|~|~|~|Incidence|10303239|Cervix|2015
15-19|~|~|~|~|Mortality|21090272|Colon and Rectum|2015
15-19|1.2|1.5|1.3|276|Incidence|21090272|Colon and Rectum|2015
15-19|~|~|~|~|Mortality|10303239|Corpus and Uterus, NOS|2015
15-19|~|~|~|~|Incidence|10303239|Corpus and Uterus, NOS|2015
15-19|~|~|~|~|Mortality|21090272|Esophagus|2015
15-19|~|~|~|~|Incidence|21090272|Esophagus|2015
15-19|~|~|~|~|Mortality|10303239|Female Breast|2015
15-19|~|~|~|~|Incidence|10303239|Female Breast|2015
15-19|~|~|~|~|Incidence|10303239|Female Breast, <i>in situ</i>|2015
15-19|~|~|~|~|Mortality|21090272|Hodgkin Lymphoma|2015
15-19|2.9|3.4|3.2|670|Incidence|21090272|Hodgkin Lymphoma|2015
15-19|.|.|.|.|Mortality|21090272|Kaposi Sarcoma|2015
15-19|~|~|~|~|Incidence|21090272|Kaposi Sarcoma|2015
15-19|~|~|~|~|Mortality|21090272|Kidney and Renal Pelvis|2015
15-19|0.2|0.3|0.3|53|Incidence|21090272|Kidney and Renal Pelvis|2015
15-19|~|~|~|~|Mortality|21090272|Larynx|2015
15-19|~|~|~|~|Incidence|21090272|Larynx|2015
15-19|0.6|0.8|0.7|147|Mortality|21090272|Leukemias|2015
15-19|3.1|3.6|3.3|700|Incidence|21090272|Leukemias|2015
15-19|~|~|~|~|Mortality|21090272|Liver and Intrahepatic Bile Duct|2015
15-19|0.1|0.2|0.2|36|Incidence|21090272|Liver and Intrahepatic Bile Duct|2015
15-19|~|~|~|~|Mortality|21090272|Lung and Bronchus|2015
15-19|0.1|0.1|0.1|19|Incidence|21090272|Lung and Bronchus|2015
15-19|~|~|~|~|Mortality|10303239|Male and Female Breast|2015
15-19|~|~|~|~|Incidence|10303239|Male and Female Breast|2015
15-19|~|~|~|~|Incidence|10303239|Male and Female Breast, <i>in situ</i>|2015
15-19|~|~|~|~|Mortality|21090272|Melanomas of the Skin|2015
15-19|0.8|1.0|0.9|189|Incidence|21090272|Melanomas of the Skin|2015
15-19|~|~|~|~|Mortality|21090272|Mesothelioma|2015
15-19|~|~|~|~|Incidence|21090272|Mesothelioma|2015
15-19|~|~|~|~|Mortality|21090272|Myeloma|2015
15-19|~|~|~|~|Incidence|21090272|Myeloma|2015
15-19|0.1|0.2|0.2|38|Mortality|21090272|Non-Hodgkin Lymphoma|2015
15-19|1.8|2.2|2.0|425|Incidence|21090272|Non-Hodgkin Lymphoma|2015
15-19|~|~|~|~|Mortality|21090272|Oral Cavity and Pharynx|2015
15-19|0.4|0.6|0.5|103|Incidence|21090272|Oral Cavity and Pharynx|2015
15-19|~|~|~|~|Mortality|10303239|Ovary|2015
15-19|1.2|1.6|1.4|142|Incidence|10303239|Ovary|2015
15-19|~|~|~|~|Mortality|21090272|Pancreas|2015
15-19|0.1|0.2|0.1|28|Incidence|21090272|Pancreas|2015
15-19|~|~|~|~|Mortality|10787033|Prostate|2015
15-19|~|~|~|~|Incidence|10787033|Prostate|2015
15-19|~|~|~|~|Mortality|21090272|Stomach|2015
15-19|0.1|0.2|0.1|21|Incidence|21090272|Stomach|2015
15-19|~|~|~|~|Mortality|10787033|Testis|2015
15-19|3.5|4.2|3.9|416|Incidence|10787033|Testis|2015
15-19|~|~|~|~|Mortality|21090272|Thyroid|2015
15-19|3.1|3.5|3.3|695|Incidence|21090272|Thyroid|2015
15-19|~|~|~|~|Mortality|21090272|Urinary Bladder|2015
15-19|0.1|0.1|0.1|18|Incidence|21090272|Urinary Bladder|2015
5-9|1.9|2.3|2.1|437|Mortality|20490819|All Cancer Sites Combined|2015
5-9|13.3|14.4|13.8|2836|Incidence|20490819|All Cancer Sites Combined|2015
5-9|0.8|1.1|0.9|192|Mortality|20490819|Brain and Other Nervous System|2015
5-9|3.6|4.1|3.8|783|Incidence|20490819|Brain and Other Nervous System|2015
5-9|~|~|~|~|Mortality|10029953|Cervix|2015
5-9|~|~|~|~|Incidence|10029953|Cervix|2015
5-9|~|~|~|~|Mortality|20490819|Colon and Rectum|2015
5-9|0.1|0.2|0.1|24|Incidence|20490819|Colon and Rectum|2015
5-9|~|~|~|~|Mortality|10029953|Corpus and Uterus, NOS|2015
5-9|~|~|~|~|Incidence|10029953|Corpus and Uterus, NOS|2015
5-9|~|~|~|~|Mortality|20490819|Esophagus|2015
5-9|~|~|~|~|Incidence|20490819|Esophagus|2015
5-9|~|~|~|~|Mortality|10029953|Female Breast|2015
5-9|~|~|~|~|Incidence|10029953|Female Breast|2015
5-9|~|~|~|~|Incidence|10029953|Female Breast, <i>in situ</i>|2015
5-9|~|~|~|~|Mortality|20490819|Hodgkin Lymphoma|2015
5-9|0.3|0.5|0.4|83|Incidence|20490819|Hodgkin Lymphoma|2015
5-9|.|.|.|.|Mortality|20490819|Kaposi Sarcoma|2015
5-9|~|~|~|~|Incidence|20490819|Kaposi Sarcoma|2015
5-9|~|~|~|~|Mortality|20490819|Kidney and Renal Pelvis|2015
5-9|0.6|0.8|0.7|143|Incidence|20490819|Kidney and Renal Pelvis|2015
5-9|~|~|~|~|Mortality|20490819|Larynx|2015
5-9|~|~|~|~|Incidence|20490819|Larynx|2015
5-9|0.4|0.5|0.4|91|Mortality|20490819|Leukemias|2015
5-9|4.0|4.5|4.2|867|Incidence|20490819|Leukemias|2015
5-9|~|~|~|~|Mortality|20490819|Liver and Intrahepatic Bile Duct|2015
5-9|0.1|0.2|0.1|28|Incidence|20490819|Liver and Intrahepatic Bile Duct|2015
5-9|~|~|~|~|Mortality|20490819|Lung and Bronchus|2015
5-9|~|~|~|~|Incidence|20490819|Lung and Bronchus|2015
5-9|~|~|~|~|Mortality|10029953|Male and Female Breast|2015
5-9|~|~|~|~|Incidence|10029953|Male and Female Breast|2015
5-9|~|~|~|~|Incidence|10029953|Male and Female Breast, <i>in situ</i>|2015
5-9|~|~|~|~|Mortality|20490819|Melanomas of the Skin|2015
5-9|0.1|0.2|0.2|36|Incidence|20490819|Melanomas of the Skin|2015
5-9|~|~|~|~|Mortality|20490819|Mesothelioma|2015
5-9|~|~|~|~|Incidence|20490819|Mesothelioma|2015
5-9|~|~|~|~|Mortality|20490819|Myeloma|2015
5-9|~|~|~|~|Incidence|20490819|Myeloma|2015
5-9|~|~|~|~|Mortality|20490819|Non-Hodgkin Lymphoma|2015
5-9|1.0|1.3|1.1|234|Incidence|20490819|Non-Hodgkin Lymphoma|2015
5-9|~|~|~|~|Mortality|20490819|Oral Cavity and Pharynx|2015
5-9|0.1|0.2|0.1|23|Incidence|20490819|Oral Cavity and Pharynx|2015
5-9|~|~|~|~|Mortality|10029953|Ovary|2015
5-9|0.1|0.3|0.2|18|Incidence|10029953|Ovary|2015
5-9|~|~|~|~|Mortality|20490819|Pancreas|2015
5-9|~|~|~|~|Incidence|20490819|Pancreas|2015
5-9|~|~|~|~|Mortality|10460866|Prostate|2015
5-9|~|~|~|~|Incidence|10460866|Prostate|2015
5-9|~|~|~|~|Mortality|20490819|Stomach|2015
5-9|~|~|~|~|Incidence|20490819|Stomach|2015
5-9|~|~|~|~|Mortality|10460866|Testis|2015
5-9|~|~|~|~|Incidence|10460866|Testis|2015
5-9|~|~|~|~|Mortality|20490819|Thyroid|2015
5-9|0.1|0.2|0.1|25|Incidence|20490819|Thyroid|2015
5-9|~|~|~|~|Mortality|20490819|Urinary Bladder|2015
5-9|~|~|~|~|Incidence|20490819|Urinary Bladder|2015
<1|1.0|1.7|1.3|53|Mortality|3984144|All Cancer Sites Combined|2015
<1|27.8|31.2|29.5|1175|Incidence|3984144|All Cancer Sites Combined|2015
<1|~|~|~|~|Mortality|3984144|Brain and Other Nervous System|2015
<1|3.4|4.7|4.0|159|Incidence|3984144|Brain and Other Nervous System|2015
<1|~|~|~|~|Mortality|1946416|Cervix|2015
<1|~|~|~|~|Incidence|1946416|Cervix|2015
<1|~|~|~|~|Mortality|3984144|Colon and Rectum|2015
<1|~|~|~|~|Incidence|3984144|Colon and Rectum|2015
<1|~|~|~|~|Mortality|1946416|Corpus and Uterus, NOS|2015
<1|~|~|~|~|Incidence|1946416|Corpus and Uterus, NOS|2015
<1|~|~|~|~|Mortality|3984144|Esophagus|2015
<1|~|~|~|~|Incidence|3984144|Esophagus|2015
<1|~|~|~|~|Mortality|1946416|Female Breast|2015
<1|~|~|~|~|Incidence|1946416|Female Breast|2015
<1|~|~|~|~|Incidence|1946416|Female Breast, <i>in situ</i>|2015
<1|~|~|~|~|Mortality|3984144|Hodgkin Lymphoma|2015
<1|~|~|~|~|Incidence|3984144|Hodgkin Lymphoma|2015
<1|.|.|.|.|Mortality|3984144|Kaposi Sarcoma|2015
<1|~|~|~|~|Incidence|3984144|Kaposi Sarcoma|2015
<1|~|~|~|~|Mortality|3984144|Kidney and Renal Pelvis|2015
<1|1.7|2.6|2.1|83|Incidence|3984144|Kidney and Renal Pelvis|2015
<1|~|~|~|~|Mortality|3984144|Larynx|2015
<1|~|~|~|~|Incidence|3984144|Larynx|2015
<1|0.3|0.8|0.6|22|Mortality|3984144|Leukemias|2015
<1|3.8|5.1|4.4|177|Incidence|3984144|Leukemias|2015
<1|~|~|~|~|Mortality|3984144|Liver and Intrahepatic Bile Duct|2015
<1|1.3|2.1|1.6|65|Incidence|3984144|Liver and Intrahepatic Bile Duct|2015
<1|~|~|~|~|Mortality|3984144|Lung and Bronchus|2015
<1|~|~|~|~|Incidence|3984144|Lung and Bronchus|2015
<1|~|~|~|~|Mortality|1946416|Male and Female Breast|2015
<1|~|~|~|~|Incidence|1946416|Male and Female Breast|2015
<1|~|~|~|~|Incidence|1946416|Male and Female Breast, <i>in situ</i>|2015
<1|~|~|~|~|Mortality|3984144|Melanomas of the Skin|2015
<1|~|~|~|~|Incidence|3984144|Melanomas of the Skin|2015
<1|~|~|~|~|Mortality|3984144|Mesothelioma|2015
<1|~|~|~|~|Incidence|3984144|Mesothelioma|2015
<1|~|~|~|~|Mortality|3984144|Myeloma|2015
<1|~|~|~|~|Incidence|3984144|Myeloma|2015
<1|~|~|~|~|Mortality|3984144|Non-Hodgkin Lymphoma|2015
<1|~|~|~|~|Incidence|3984144|Non-Hodgkin Lymphoma|2015
<1|~|~|~|~|Mortality|3984144|Oral Cavity and Pharynx|2015
<1|~|~|~|~|Incidence|3984144|Oral Cavity and Pharynx|2015
<1|~|~|~|~|Mortality|1946416|Ovary|2015
<1|~|~|~|~|Incidence|1946416|Ovary|2015
<1|~|~|~|~|Mortality|3984144|Pancreas|2015
<1|~|~|~|~|Incidence|3984144|Pancreas|2015
<1|~|~|~|~|Mortality|2037728|Prostate|2015
<1|~|~|~|~|Incidence|2037728|Prostate|2015
<1|~|~|~|~|Mortality|3984144|Stomach|2015
<1|~|~|~|~|Incidence|3984144|Stomach|2015
<1|~|~|~|~|Mortality|2037728|Testis|2015
<1|~|~|~|~|Incidence|2037728|Testis|2015
<1|~|~|~|~|Mortality|3984144|Thyroid|2015
<1|~|~|~|~|Incidence|3984144|Thyroid|2015
<1|~|~|~|~|Mortality|3984144|Urinary Bladder|2015
<1|~|~|~|~|Incidence|3984144|Urinary Bladder|2015
1-4|2.1|2.6|2.4|377|Mortality|15973469|All Cancer Sites Combined|2016
1-4|22.1|23.6|22.8|3644|Incidence|15973469|All Cancer Sites Combined|2016
1-4|0.5|0.8|0.7|104|Mortality|15973469|Brain and Other Nervous System|2016
1-4|4.4|5.1|4.8|761|Incidence|15973469|Brain and Other Nervous System|2016
1-4|~|~|~|~|Mortality|7805332|Cervix|2016
1-4|~|~|~|~|Incidence|7805332|Cervix|2016
1-4|~|~|~|~|Mortality|15973469|Colon and Rectum|2016
1-4|~|~|~|~|Incidence|15973469|Colon and Rectum|2016
1-4|~|~|~|~|Mortality|7805332|Corpus and Uterus, NOS|2016
1-4|~|~|~|~|Incidence|7805332|Corpus and Uterus, NOS|2016
1-4|~|~|~|~|Mortality|15973469|Esophagus|2016
1-4|~|~|~|~|Incidence|15973469|Esophagus|2016
1-4|~|~|~|~|Mortality|7805332|Female Breast|2016
1-4|~|~|~|~|Incidence|7805332|Female Breast|2016
1-4|~|~|~|~|Incidence|7805332|Female Breast, <i>in situ</i>|2016
1-4|~|~|~|~|Mortality|15973469|Hodgkin Lymphoma|2016
1-4|~|~|~|~|Incidence|15973469|Hodgkin Lymphoma|2016
1-4|.|.|.|.|Mortality|15973469|Kaposi Sarcoma|2016
1-4|~|~|~|~|Incidence|15973469|Kaposi Sarcoma|2016
1-4|~|~|~|~|Mortality|15973469|Kidney and Renal Pelvis|2016
1-4|1.6|2.1|1.8|294|Incidence|15973469|Kidney and Renal Pelvis|2016
1-4|~|~|~|~|Mortality|15973469|Larynx|2016
1-4|~|~|~|~|Incidence|15973469|Larynx|2016
1-4|0.6|0.8|0.7|108|Mortality|15973469|Leukemias|2016
1-4|8.4|9.4|8.9|1422|Incidence|15973469|Leukemias|2016
1-4|0.1|0.2|0.2|25|Mortality|15973469|Liver and Intrahepatic Bile Duct|2016
1-4|0.5|0.7|0.6|98|Incidence|15973469|Liver and Intrahepatic Bile Duct|2016
1-4|~|~|~|~|Mortality|15973469|Lung and Bronchus|2016
1-4|0.1|0.2|0.1|17|Incidence|15973469|Lung and Bronchus|2016
1-4|~|~|~|~|Mortality|7805332|Male and Female Breast|2016
1-4|~|~|~|~|Incidence|7805332|Male and Female Breast|2016
1-4|~|~|~|~|Incidence|7805332|Male and Female Breast, <i>in situ</i>|2016
1-4|~|~|~|~|Mortality|15973469|Melanomas of the Skin|2016
1-4|0.1|0.2|0.1|16|Incidence|15973469|Melanomas of the Skin|2016
1-4|~|~|~|~|Mortality|15973469|Mesothelioma|2016
1-4|~|~|~|~|Incidence|15973469|Mesothelioma|2016
1-4|~|~|~|~|Mortality|15973469|Myeloma|2016
1-4|~|~|~|~|Incidence|15973469|Myeloma|2016
1-4|~|~|~|~|Mortality|15973469|Non-Hodgkin Lymphoma|2016
1-4|0.6|0.9|0.7|117|Incidence|15973469|Non-Hodgkin Lymphoma|2016
1-4|~|~|~|~|Mortality|15973469|Oral Cavity and Pharynx|2016
1-4|~|~|~|~|Incidence|15973469|Oral Cavity and Pharynx|2016
1-4|~|~|~|~|Mortality|7805332|Ovary|2016
1-4|~|~|~|~|Incidence|7805332|Ovary|2016
1-4|~|~|~|~|Mortality|15973469|Pancreas|2016
1-4|~|~|~|~|Incidence|15973469|Pancreas|2016
1-4|~|~|~|~|Mortality|8168137|Prostate|2016
1-4|~|~|~|~|Incidence|8168137|Prostate|2016
1-4|~|~|~|~|Mortality|15973469|Stomach|2016
1-4|~|~|~|~|Incidence|15973469|Stomach|2016
1-4|~|~|~|~|Mortality|8168137|Testis|2016
1-4|0.3|0.6|0.5|38|Incidence|8168137|Testis|2016
1-4|~|~|~|~|Mortality|15973469|Thyroid|2016
1-4|~|~|~|~|Incidence|15973469|Thyroid|2016
1-4|~|~|~|~|Mortality|15973469|Urinary Bladder|2016
1-4|~|~|~|~|Incidence|15973469|Urinary Bladder|2016
10-14|1.9|2.3|2.1|431|Mortality|20634000|All Cancer Sites Combined|2016
10-14|15.5|16.6|16.1|3312|Incidence|20634000|All Cancer Sites Combined|2016
10-14|0.6|0.8|0.7|141|Mortality|20634000|Brain and Other Nervous System|2016
10-14|2.7|3.2|3.0|609|Incidence|20634000|Brain and Other Nervous System|2016
10-14|~|~|~|~|Mortality|10104766|Cervix|2016
10-14|~|~|~|~|Incidence|10104766|Cervix|2016
10-14|~|~|~|~|Mortality|20634000|Colon and Rectum|2016
10-14|0.5|0.7|0.6|123|Incidence|20634000|Colon and Rectum|2016
10-14|~|~|~|~|Mortality|10104766|Corpus and Uterus, NOS|2016
10-14|~|~|~|~|Incidence|10104766|Corpus and Uterus, NOS|2016
10-14|~|~|~|~|Mortality|20634000|Esophagus|2016
10-14|~|~|~|~|Incidence|20634000|Esophagus|2016
10-14|~|~|~|~|Mortality|10104766|Female Breast|2016
10-14|~|~|~|~|Incidence|10104766|Female Breast|2016
10-14|~|~|~|~|Incidence|10104766|Female Breast, <i>in situ</i>|2016
10-14|~|~|~|~|Mortality|20634000|Hodgkin Lymphoma|2016
10-14|1.2|1.5|1.3|272|Incidence|20634000|Hodgkin Lymphoma|2016
10-14|.|.|.|.|Mortality|20634000|Kaposi Sarcoma|2016
10-14|~|~|~|~|Incidence|20634000|Kaposi Sarcoma|2016
10-14|~|~|~|~|Mortality|20634000|Kidney and Renal Pelvis|2016
10-14|0.1|0.3|0.2|42|Incidence|20634000|Kidney and Renal Pelvis|2016
10-14|~|~|~|~|Mortality|20634000|Larynx|2016
10-14|~|~|~|~|Incidence|20634000|Larynx|2016
10-14|0.4|0.6|0.5|108|Mortality|20634000|Leukemias|2016
10-14|3.4|3.9|3.6|747|Incidence|20634000|Leukemias|2016
10-14|~|~|~|~|Mortality|20634000|Liver and Intrahepatic Bile Duct|2016
10-14|0.1|0.2|0.1|21|Incidence|20634000|Liver and Intrahepatic Bile Duct|2016
10-14|~|~|~|~|Mortality|20634000|Lung and Bronchus|2016
10-14|~|~|~|~|Incidence|20634000|Lung and Bronchus|2016
10-14|~|~|~|~|Mortality|10104766|Male and Female Breast|2016
10-14|~|~|~|~|Incidence|10104766|Male and Female Breast|2016
10-14|~|~|~|~|Incidence|10104766|Male and Female Breast, <i>in situ</i>|2016
10-14|~|~|~|~|Mortality|20634000|Melanomas of the Skin|2016
10-14|0.2|0.3|0.3|54|Incidence|20634000|Melanomas of the Skin|2016
10-14|~|~|~|~|Mortality|20634000|Mesothelioma|2016
10-14|~|~|~|~|Incidence|20634000|Mesothelioma|2016
10-14|~|~|~|~|Mortality|20634000|Myeloma|2016
10-14|~|~|~|~|Incidence|20634000|Myeloma|2016
10-14|~|~|~|~|Mortality|20634000|Non-Hodgkin Lymphoma|2016
10-14|1.3|1.7|1.5|305|Incidence|20634000|Non-Hodgkin Lymphoma|2016
10-14|~|~|~|~|Mortality|20634000|Oral Cavity and Pharynx|2016
10-14|0.2|0.4|0.3|56|Incidence|20634000|Oral Cavity and Pharynx|2016
10-14|~|~|~|~|Mortality|10104766|Ovary|2016
10-14|0.6|0.9|0.7|72|Incidence|10104766|Ovary|2016
10-14|~|~|~|~|Mortality|20634000|Pancreas|2016
10-14|0.1|0.2|0.1|24|Incidence|20634000|Pancreas|2016
10-14|~|~|~|~|Mortality|10529234|Prostate|2016
10-14|~|~|~|~|Incidence|10529234|Prostate|2016
10-14|~|~|~|~|Mortality|20634000|Stomach|2016
10-14|~|~|~|~|Incidence|20634000|Stomach|2016
10-14|~|~|~|~|Mortality|10529234|Testis|2016
10-14|0.2|0.4|0.2|25|Incidence|10529234|Testis|2016
10-14|~|~|~|~|Mortality|20634000|Thyroid|2016
10-14|0.7|1.0|0.8|174|Incidence|20634000|Thyroid|2016
10-14|~|~|~|~|Mortality|20634000|Urinary Bladder|2016
10-14|~|~|~|~|Incidence|20634000|Urinary Bladder|2016
15-19|2.6|3.1|2.8|596|Mortality|21140143|All Cancer Sites Combined|2016
15-19|24.0|25.3|24.6|5208|Incidence|21140143|All Cancer Sites Combined|2016
15-19|0.4|0.6|0.5|108|Mortality|21140143|Brain and Other Nervous System|2016
15-19|1.9|2.3|2.1|443|Incidence|21140143|Brain and Other Nervous System|2016
15-19|~|~|~|~|Mortality|10335334|Cervix|2016
15-19|~|~|~|~|Incidence|10335334|Cervix|2016
15-19|~|~|~|~|Mortality|21140143|Colon and Rectum|2016
15-19|1.3|1.6|1.4|303|Incidence|21140143|Colon and Rectum|2016
15-19|~|~|~|~|Mortality|10335334|Corpus and Uterus, NOS|2016
15-19|~|~|~|~|Incidence|10335334|Corpus and Uterus, NOS|2016
15-19|~|~|~|~|Mortality|21140143|Esophagus|2016
15-19|~|~|~|~|Incidence|21140143|Esophagus|2016
15-19|~|~|~|~|Mortality|10335334|Female Breast|2016
15-19|0.1|0.3|0.2|20|Incidence|10335334|Female Breast|2016
15-19|~|~|~|~|Incidence|10335334|Female Breast, <i>in situ</i>|2016
15-19|~|~|~|~|Mortality|21140143|Hodgkin Lymphoma|2016
15-19|3.0|3.5|3.3|688|Incidence|21140143|Hodgkin Lymphoma|2016
15-19|.|.|.|.|Mortality|21140143|Kaposi Sarcoma|2016
15-19|~|~|~|~|Incidence|21140143|Kaposi Sarcoma|2016
15-19|~|~|~|~|Mortality|21140143|Kidney and Renal Pelvis|2016
15-19|0.2|0.3|0.2|45|Incidence|21140143|Kidney and Renal Pelvis|2016
15-19|~|~|~|~|Mortality|21140143|Larynx|2016
15-19|~|~|~|~|Incidence|21140143|Larynx|2016
15-19|0.6|0.8|0.7|148|Mortality|21140143|Leukemias|2016
15-19|3.0|3.5|3.2|681|Incidence|21140143|Leukemias|2016
15-19|~|~|~|~|Mortality|21140143|Liver and Intrahepatic Bile Duct|2016
15-19|0.1|0.2|0.1|26|Incidence|21140143|Liver and Intrahepatic Bile Duct|2016
15-19|~|~|~|~|Mortality|21140143|Lung and Bronchus|2016
15-19|0.1|0.2|0.1|30|Incidence|21140143|Lung and Bronchus|2016
15-19|~|~|~|~|Mortality|10335334|Male and Female Breast|2016
15-19|0.1|0.3|0.2|20|Incidence|10335334|Male and Female Breast|2016
15-19|~|~|~|~|Incidence|10335334|Male and Female Breast, <i>in situ</i>|2016
15-19|~|~|~|~|Mortality|21140143|Melanomas of the Skin|2016
15-19|0.8|1.1|0.9|197|Incidence|21140143|Melanomas of the Skin|2016
15-19|~|~|~|~|Mortality|21140143|Mesothelioma|2016
15-19|~|~|~|~|Incidence|21140143|Mesothelioma|2016
15-19|~|~|~|~|Mortality|21140143|Myeloma|2016
15-19|~|~|~|~|Incidence|21140143|Myeloma|2016
15-19|0.1|0.2|0.1|29|Mortality|21140143|Non-Hodgkin Lymphoma|2016
15-19|1.8|2.2|2.0|420|Incidence|21140143|Non-Hodgkin Lymphoma|2016
15-19|~|~|~|~|Mortality|21140143|Oral Cavity and Pharynx|2016
15-19|0.4|0.6|0.5|106|Incidence|21140143|Oral Cavity and Pharynx|2016
15-19|~|~|~|~|Mortality|10335334|Ovary|2016
15-19|1.1|1.5|1.3|131|Incidence|10335334|Ovary|2016
15-19|~|~|~|~|Mortality|21140143|Pancreas|2016
15-19|0.1|0.2|0.2|33|Incidence|21140143|Pancreas|2016
15-19|~|~|~|~|Mortality|10804809|Prostate|2016
15-19|~|~|~|~|Incidence|10804809|Prostate|2016
15-19|~|~|~|~|Mortality|21140143|Stomach|2016
15-19|0.1|0.1|0.1|18|Incidence|21140143|Stomach|2016
15-19|~|~|~|~|Mortality|10804809|Testis|2016
15-19|3.2|3.9|3.5|381|Incidence|10804809|Testis|2016
15-19|~|~|~|~|Mortality|21140143|Thyroid|2016
15-19|3.2|3.7|3.4|729|Incidence|21140143|Thyroid|2016
15-19|~|~|~|~|Mortality|21140143|Urinary Bladder|2016
15-19|~|~|~|~|Incidence|21140143|Urinary Bladder|2016
5-9|2.0|2.4|2.2|449|Mortality|20450557|All Cancer Sites Combined|2016
5-9|13.2|14.2|13.7|2800|Incidence|20450557|All Cancer Sites Combined|2016
5-9|0.8|1.1|0.9|186|Mortality|20450557|Brain and Other Nervous System|2016
5-9|3.3|3.8|3.5|723|Incidence|20450557|Brain and Other Nervous System|2016
5-9|~|~|~|~|Mortality|10008005|Cervix|2016
5-9|~|~|~|~|Incidence|10008005|Cervix|2016
5-9|~|~|~|~|Mortality|20450557|Colon and Rectum|2016
5-9|0.0|0.1|0.1|16|Incidence|20450557|Colon and Rectum|2016
5-9|~|~|~|~|Mortality|10008005|Corpus and Uterus, NOS|2016
5-9|~|~|~|~|Incidence|10008005|Corpus and Uterus, NOS|2016
5-9|~|~|~|~|Mortality|20450557|Esophagus|2016
5-9|~|~|~|~|Incidence|20450557|Esophagus|2016
5-9|~|~|~|~|Mortality|10008005|Female Breast|2016
5-9|~|~|~|~|Incidence|10008005|Female Breast|2016
5-9|~|~|~|~|Incidence|10008005|Female Breast, <i>in situ</i>|2016
5-9|~|~|~|~|Mortality|20450557|Hodgkin Lymphoma|2016
5-9|0.3|0.4|0.3|68|Incidence|20450557|Hodgkin Lymphoma|2016
5-9|.|.|.|.|Mortality|20450557|Kaposi Sarcoma|2016
5-9|~|~|~|~|Incidence|20450557|Kaposi Sarcoma|2016
5-9|~|~|~|~|Mortality|20450557|Kidney and Renal Pelvis|2016
5-9|0.6|0.8|0.7|143|Incidence|20450557|Kidney and Renal Pelvis|2016
5-9|~|~|~|~|Mortality|20450557|Larynx|2016
5-9|~|~|~|~|Incidence|20450557|Larynx|2016
5-9|0.4|0.6|0.5|106|Mortality|20450557|Leukemias|2016
5-9|4.0|4.6|4.3|882|Incidence|20450557|Leukemias|2016
5-9|~|~|~|~|Mortality|20450557|Liver and Intrahepatic Bile Duct|2016
5-9|0.1|0.2|0.1|28|Incidence|20450557|Liver and Intrahepatic Bile Duct|2016
5-9|~|~|~|~|Mortality|20450557|Lung and Bronchus|2016
5-9|~|~|~|~|Incidence|20450557|Lung and Bronchus|2016
5-9|~|~|~|~|Mortality|10008005|Male and Female Breast|2016
5-9|~|~|~|~|Incidence|10008005|Male and Female Breast|2016
5-9|~|~|~|~|Incidence|10008005|Male and Female Breast, <i>in situ</i>|2016
5-9|~|~|~|~|Mortality|20450557|Melanomas of the Skin|2016
5-9|0.1|0.2|0.1|29|Incidence|20450557|Melanomas of the Skin|2016
5-9|~|~|~|~|Mortality|20450557|Mesothelioma|2016
5-9|~|~|~|~|Incidence|20450557|Mesothelioma|2016
5-9|~|~|~|~|Mortality|20450557|Myeloma|2016
5-9|~|~|~|~|Incidence|20450557|Myeloma|2016
5-9|~|~|~|~|Mortality|20450557|Non-Hodgkin Lymphoma|2016
5-9|1.0|1.3|1.1|235|Incidence|20450557|Non-Hodgkin Lymphoma|2016
5-9|~|~|~|~|Mortality|20450557|Oral Cavity and Pharynx|2016
5-9|0.1|0.2|0.1|21|Incidence|20450557|Oral Cavity and Pharynx|2016
5-9|~|~|~|~|Mortality|10008005|Ovary|2016
5-9|0.2|0.5|0.3|32|Incidence|10008005|Ovary|2016
5-9|~|~|~|~|Mortality|20450557|Pancreas|2016
5-9|~|~|~|~|Incidence|20450557|Pancreas|2016
5-9|~|~|~|~|Mortality|10442552|Prostate|2016
5-9|~|~|~|~|Incidence|10442552|Prostate|2016
5-9|~|~|~|~|Mortality|20450557|Stomach|2016
5-9|~|~|~|~|Incidence|20450557|Stomach|2016
5-9|~|~|~|~|Mortality|10442552|Testis|2016
5-9|~|~|~|~|Incidence|10442552|Testis|2016
5-9|~|~|~|~|Mortality|20450557|Thyroid|2016
5-9|0.1|0.2|0.2|32|Incidence|20450557|Thyroid|2016
5-9|~|~|~|~|Mortality|20450557|Urinary Bladder|2016
5-9|~|~|~|~|Incidence|20450557|Urinary Bladder|2016
<1|1.3|2.1|1.7|67|Mortality|3963268|All Cancer Sites Combined|2016
<1|26.2|29.5|27.8|1103|Incidence|3963268|All Cancer Sites Combined|2016
<1|~|~|~|~|Mortality|3963268|Brain and Other Nervous System|2016
<1|3.6|5.0|4.3|169|Incidence|3963268|Brain and Other Nervous System|2016
<1|~|~|~|~|Mortality|1937196|Cervix|2016
<1|~|~|~|~|Incidence|1937196|Cervix|2016
<1|~|~|~|~|Mortality|3963268|Colon and Rectum|2016
<1|~|~|~|~|Incidence|3963268|Colon and Rectum|2016
<1|~|~|~|~|Mortality|1937196|Corpus and Uterus, NOS|2016
<1|~|~|~|~|Incidence|1937196|Corpus and Uterus, NOS|2016
<1|~|~|~|~|Mortality|3963268|Esophagus|2016
<1|~|~|~|~|Incidence|3963268|Esophagus|2016
<1|~|~|~|~|Mortality|1937196|Female Breast|2016
<1|~|~|~|~|Incidence|1937196|Female Breast|2016
<1|~|~|~|~|Incidence|1937196|Female Breast, <i>in situ</i>|2016
<1|~|~|~|~|Mortality|3963268|Hodgkin Lymphoma|2016
<1|~|~|~|~|Incidence|3963268|Hodgkin Lymphoma|2016
<1|.|.|.|.|Mortality|3963268|Kaposi Sarcoma|2016
<1|~|~|~|~|Incidence|3963268|Kaposi Sarcoma|2016
<1|~|~|~|~|Mortality|3963268|Kidney and Renal Pelvis|2016
<1|1.2|2.0|1.6|63|Incidence|3963268|Kidney and Renal Pelvis|2016
<1|~|~|~|~|Mortality|3963268|Larynx|2016
<1|~|~|~|~|Incidence|3963268|Larynx|2016
<1|0.5|1.1|0.7|29|Mortality|3963268|Leukemias|2016
<1|3.7|5.0|4.3|170|Incidence|3963268|Leukemias|2016
<1|~|~|~|~|Mortality|3963268|Liver and Intrahepatic Bile Duct|2016
<1|1.5|2.4|1.9|75|Incidence|3963268|Liver and Intrahepatic Bile Duct|2016
<1|~|~|~|~|Mortality|3963268|Lung and Bronchus|2016
<1|~|~|~|~|Incidence|3963268|Lung and Bronchus|2016
<1|~|~|~|~|Mortality|1937196|Male and Female Breast|2016
<1|~|~|~|~|Incidence|1937196|Male and Female Breast|2016
<1|~|~|~|~|Incidence|1937196|Male and Female Breast, <i>in situ</i>|2016
<1|~|~|~|~|Mortality|3963268|Melanomas of the Skin|2016
<1|~|~|~|~|Incidence|3963268|Melanomas of the Skin|2016
<1|~|~|~|~|Mortality|3963268|Mesothelioma|2016
<1|~|~|~|~|Incidence|3963268|Mesothelioma|2016
<1|~|~|~|~|Mortality|3963268|Myeloma|2016
<1|~|~|~|~|Incidence|3963268|Myeloma|2016
<1|~|~|~|~|Mortality|3963268|Non-Hodgkin Lymphoma|2016
<1|~|~|~|~|Incidence|3963268|Non-Hodgkin Lymphoma|2016
<1|~|~|~|~|Mortality|3963268|Oral Cavity and Pharynx|2016
<1|~|~|~|~|Incidence|3963268|Oral Cavity and Pharynx|2016
<1|~|~|~|~|Mortality|1937196|Ovary|2016
<1|~|~|~|~|Incidence|1937196|Ovary|2016
<1|~|~|~|~|Mortality|3963268|Pancreas|2016
<1|~|~|~|~|Incidence|3963268|Pancreas|2016
<1|~|~|~|~|Mortality|2026072|Prostate|2016
<1|~|~|~|~|Incidence|2026072|Prostate|2016
<1|~|~|~|~|Mortality|3963268|Stomach|2016
<1|~|~|~|~|Incidence|3963268|Stomach|2016
<1|~|~|~|~|Mortality|2026072|Testis|2016
<1|~|~|~|~|Incidence|2026072|Testis|2016
<1|~|~|~|~|Mortality|3963268|Thyroid|2016
<1|~|~|~|~|Incidence|3963268|Thyroid|2016
<1|~|~|~|~|Mortality|3963268|Urinary Bladder|2016
<1|~|~|~|~|Incidence|3963268|Urinary Bladder|2016
1-4|1.9|2.1|2.0|1620|Mortality|79313061|All Cancer Sites Combined|2016-2020
1-4|21.7|22.3|22.0|16922|Incidence|76880096|All Cancer Sites Combined|2016-2020
1-4|0.4|0.5|0.5|389|Mortality|79313061|Brain and Other Nervous System|2016-2020
1-4|4.1|4.4|4.2|3258|Incidence|76880096|Brain and Other Nervous System|2016-2020
1-4|~|~|~|~|Mortality|38767329|Cervix|2016-2020
1-4|~|~|~|~|Incidence|37582299|Cervix|2016-2020
1-4|~|~|~|~|Mortality|79313061|Colon and Rectum|2016-2020
1-4|~|~|~|~|Incidence|76880096|Colon and Rectum|2016-2020
1-4|~|~|~|~|Mortality|38767329|Corpus and Uterus, NOS|2016-2020
1-4|~|~|~|~|Incidence|37582299|Corpus and Uterus, NOS|2016-2020
1-4|~|~|~|~|Mortality|79313061|Esophagus|2016-2020
1-4|~|~|~|~|Incidence|76880096|Esophagus|2016-2020
1-4|~|~|~|~|Mortality|38767329|Female Breast|2016-2020
1-4|~|~|~|~|Incidence|37582299|Female Breast|2016-2020
1-4|~|~|~|~|Incidence|37582299|Female Breast, <i>in situ</i>|2016-2020
1-4|~|~|~|~|Mortality|79313061|Hodgkin Lymphoma|2016-2020
1-4|0.1|0.1|0.1|64|Incidence|76880096|Hodgkin Lymphoma|2016-2020
1-4|.|.|.|.|Mortality|79313061|Kaposi Sarcoma|2016-2020
1-4|~|~|~|~|Incidence|76880096|Kaposi Sarcoma|2016-2020
1-4|0.1|0.1|0.1|66|Mortality|79313061|Kidney and Renal Pelvis|2016-2020
1-4|1.8|2.0|1.9|1467|Incidence|76880096|Kidney and Renal Pelvis|2016-2020
1-4|~|~|~|~|Mortality|79313061|Larynx|2016-2020
1-4|~|~|~|~|Incidence|76880096|Larynx|2016-2020
1-4|0.6|0.7|0.6|499|Mortality|79313061|Leukemias|2016-2020
1-4|8.5|8.9|8.7|6668|Incidence|76880096|Leukemias|2016-2020
1-4|0.1|0.1|0.1|81|Mortality|79313061|Liver and Intrahepatic Bile Duct|2016-2020
1-4|0.6|0.7|0.6|499|Incidence|76880096|Liver and Intrahepatic Bile Duct|2016-2020
1-4|~|~|~|~|Mortality|79313061|Lung and Bronchus|2016-2020
1-4|0.1|0.1|0.1|63|Incidence|76880096|Lung and Bronchus|2016-2020
1-4|~|~|~|~|Mortality|38767329|Male and Female Breast|2016-2020
1-4|~|~|~|~|Incidence|37582299|Male and Female Breast|2016-2020
1-4|~|~|~|~|Incidence|37582299|Male and Female Breast, <i>in situ</i>|2016-2020
1-4|~|~|~|~|Mortality|79313061|Melanomas of the Skin|2016-2020
1-4|0.1|0.1|0.1|72|Incidence|76880096|Melanomas of the Skin|2016-2020
1-4|~|~|~|~|Mortality|79313061|Mesothelioma|2016-2020
1-4|~|~|~|~|Incidence|76880096|Mesothelioma|2016-2020
1-4|~|~|~|~|Mortality|79313061|Myeloma|2016-2020
1-4|~|~|~|~|Incidence|76880096|Myeloma|2016-2020
1-4|0.0|0.0|0.0|24|Mortality|79313061|Non-Hodgkin Lymphoma|2016-2020
1-4|0.6|0.8|0.7|537|Incidence|76880096|Non-Hodgkin Lymphoma|2016-2020
1-4|~|~|~|~|Mortality|79313061|Oral Cavity and Pharynx|2016-2020
1-4|0.0|0.1|0.0|33|Incidence|76880096|Oral Cavity and Pharynx|2016-2020
1-4|~|~|~|~|Mortality|38767329|Ovary|2016-2020
1-4|0.1|0.1|0.1|29|Incidence|37582299|Ovary|2016-2020
1-4|~|~|~|~|Mortality|79313061|Pancreas|2016-2020
1-4|~|~|~|~|Incidence|76880096|Pancreas|2016-2020
1-4|~|~|~|~|Mortality|40545732|Prostate|2016-2020
1-4|~|~|~|~|Incidence|39297797|Prostate|2016-2020
1-4|~|~|~|~|Mortality|79313061|Stomach|2016-2020
1-4|~|~|~|~|Incidence|76880096|Stomach|2016-2020
1-4|~|~|~|~|Mortality|40545732|Testis|2016-2020
1-4|0.3|0.4|0.3|123|Incidence|39297797|Testis|2016-2020
1-4|~|~|~|~|Mortality|79313061|Thyroid|2016-2020
1-4|0.0|0.0|0.0|20|Incidence|76880096|Thyroid|2016-2020
1-4|~|~|~|~|Mortality|79313061|Urinary Bladder|2016-2020
1-4|0.1|0.1|0.1|53|Incidence|76880096|Urinary Bladder|2016-2020
10-14|2.0|2.1|2.1|2132|Mortality|103879774|All Cancer Sites Combined|2016-2020
10-14|15.2|15.7|15.5|15585|Incidence|100666137|All Cancer Sites Combined|2016-2020
10-14|0.6|0.7|0.7|683|Mortality|103879774|Brain and Other Nervous System|2016-2020
10-14|2.8|3.0|2.9|2900|Incidence|100666137|Brain and Other Nervous System|2016-2020
10-14|~|~|~|~|Mortality|50853310|Cervix|2016-2020
10-14|~|~|~|~|Incidence|49281324|Cervix|2016-2020
10-14|~|~|~|~|Mortality|103879774|Colon and Rectum|2016-2020
10-14|0.6|0.7|0.6|641|Incidence|100666137|Colon and Rectum|2016-2020
10-14|~|~|~|~|Mortality|50853310|Corpus and Uterus, NOS|2016-2020
10-14|~|~|~|~|Incidence|49281324|Corpus and Uterus, NOS|2016-2020
10-14|~|~|~|~|Mortality|103879774|Esophagus|2016-2020
10-14|~|~|~|~|Incidence|100666137|Esophagus|2016-2020
10-14|~|~|~|~|Mortality|50853310|Female Breast|2016-2020
10-14|~|~|~|~|Incidence|49281324|Female Breast|2016-2020
10-14|~|~|~|~|Incidence|49281324|Female Breast, <i>in situ</i>|2016-2020
10-14|~|~|~|~|Mortality|103879774|Hodgkin Lymphoma|2016-2020
10-14|1.2|1.3|1.3|1262|Incidence|100666137|Hodgkin Lymphoma|2016-2020
10-14|.|.|.|.|Mortality|103879774|Kaposi Sarcoma|2016-2020
10-14|~|~|~|~|Incidence|100666137|Kaposi Sarcoma|2016-2020
10-14|0.0|0.1|0.0|45|Mortality|103879774|Kidney and Renal Pelvis|2016-2020
10-14|0.2|0.2|0.2|189|Incidence|100666137|Kidney and Renal Pelvis|2016-2020
10-14|~|~|~|~|Mortality|103879774|Larynx|2016-2020
10-14|~|~|~|~|Incidence|100666137|Larynx|2016-2020
10-14|0.5|0.6|0.5|534|Mortality|103879774|Leukemias|2016-2020
10-14|3.3|3.5|3.4|3400|Incidence|100666137|Leukemias|2016-2020
10-14|0.0|0.0|0.0|33|Mortality|103879774|Liver and Intrahepatic Bile Duct|2016-2020
10-14|0.1|0.1|0.1|102|Incidence|100666137|Liver and Intrahepatic Bile Duct|2016-2020
10-14|0.0|0.0|0.0|16|Mortality|103879774|Lung and Bronchus|2016-2020
10-14|0.0|0.1|0.1|54|Incidence|100666137|Lung and Bronchus|2016-2020
10-14|~|~|~|~|Mortality|50853310|Male and Female Breast|2016-2020
10-14|~|~|~|~|Incidence|49281324|Male and Female Breast|2016-2020
10-14|~|~|~|~|Incidence|49281324|Male and Female Breast, <i>in situ</i>|2016-2020
10-14|~|~|~|~|Mortality|103879774|Melanomas of the Skin|2016-2020
10-14|0.2|0.3|0.2|223|Incidence|100666137|Melanomas of the Skin|2016-2020
10-14|~|~|~|~|Mortality|103879774|Mesothelioma|2016-2020
10-14|~|~|~|~|Incidence|100666137|Mesothelioma|2016-2020
10-14|~|~|~|~|Mortality|103879774|Myeloma|2016-2020
10-14|~|~|~|~|Incidence|100666137|Myeloma|2016-2020
10-14|0.1|0.1|0.1|70|Mortality|103879774|Non-Hodgkin Lymphoma|2016-2020
10-14|1.3|1.5|1.4|1391|Incidence|100666137|Non-Hodgkin Lymphoma|2016-2020
10-14|~|~|~|~|Mortality|103879774|Oral Cavity and Pharynx|2016-2020
10-14|0.2|0.3|0.3|256|Incidence|100666137|Oral Cavity and Pharynx|2016-2020
10-14|~|~|~|~|Mortality|50853310|Ovary|2016-2020
10-14|0.8|0.9|0.8|412|Incidence|49281324|Ovary|2016-2020
10-14|~|~|~|~|Mortality|103879774|Pancreas|2016-2020
10-14|0.1|0.1|0.1|89|Incidence|100666137|Pancreas|2016-2020
10-14|~|~|~|~|Mortality|53026464|Prostate|2016-2020
10-14|~|~|~|~|Incidence|51384813|Prostate|2016-2020
10-14|~|~|~|~|Mortality|103879774|Stomach|2016-2020
10-14|0.0|0.0|0.0|19|Incidence|100666137|Stomach|2016-2020
10-14|~|~|~|~|Mortality|53026464|Testis|2016-2020
10-14|0.2|0.3|0.2|127|Incidence|51384813|Testis|2016-2020
10-14|~|~|~|~|Mortality|103879774|Thyroid|2016-2020
10-14|0.8|0.9|0.9|894|Incidence|100666137|Thyroid|2016-2020
10-14|~|~|~|~|Mortality|103879774|Urinary Bladder|2016-2020
10-14|~|~|~|~|Incidence|100666137|Urinary Bladder|2016-2020
15-19|2.7|2.9|2.8|2915|Mortality|105350147|All Cancer Sites Combined|2016-2020
15-19|23.7|24.3|24.0|24536|Incidence|102161808|All Cancer Sites Combined|2016-2020
15-19|0.5|0.6|0.6|589|Mortality|105350147|Brain and Other Nervous System|2016-2020
15-19|2.2|2.4|2.3|2316|Incidence|102161808|Brain and Other Nervous System|2016-2020
15-19|~|~|~|~|Mortality|51551770|Cervix|2016-2020
15-19|0.0|0.1|0.1|35|Incidence|49999406|Cervix|2016-2020
15-19|0.0|0.1|0.0|40|Mortality|105350147|Colon and Rectum|2016-2020
15-19|1.3|1.4|1.4|1390|Incidence|102161808|Colon and Rectum|2016-2020
15-19|~|~|~|~|Mortality|51551770|Corpus and Uterus, NOS|2016-2020
15-19|0.0|0.1|0.1|29|Incidence|49999406|Corpus and Uterus, NOS|2016-2020
15-19|~|~|~|~|Mortality|105350147|Esophagus|2016-2020
15-19|~|~|~|~|Incidence|102161808|Esophagus|2016-2020
15-19|~|~|~|~|Mortality|51551770|Female Breast|2016-2020
15-19|0.2|0.2|0.2|99|Incidence|49999406|Female Breast|2016-2020
15-19|0.0|0.1|0.0|19|Incidence|49999406|Female Breast, <i>in situ</i>|2016-2020
15-19|0.0|0.0|0.0|33|Mortality|105350147|Hodgkin Lymphoma|2016-2020
15-19|3.1|3.3|3.2|3241|Incidence|102161808|Hodgkin Lymphoma|2016-2020
15-19|.|.|.|.|Mortality|105350147|Kaposi Sarcoma|2016-2020
15-19|~|~|~|~|Incidence|102161808|Kaposi Sarcoma|2016-2020
15-19|0.0|0.1|0.1|53|Mortality|105350147|Kidney and Renal Pelvis|2016-2020
15-19|0.2|0.2|0.2|222|Incidence|102161808|Kidney and Renal Pelvis|2016-2020
15-19|~|~|~|~|Mortality|105350147|Larynx|2016-2020
15-19|~|~|~|~|Incidence|102161808|Larynx|2016-2020
15-19|0.6|0.7|0.6|684|Mortality|105350147|Leukemias|2016-2020
15-19|3.0|3.2|3.1|3198|Incidence|102161808|Leukemias|2016-2020
15-19|0.0|0.1|0.1|65|Mortality|105350147|Liver and Intrahepatic Bile Duct|2016-2020
15-19|0.1|0.2|0.1|153|Incidence|102161808|Liver and Intrahepatic Bile Duct|2016-2020
15-19|0.0|0.0|0.0|28|Mortality|105350147|Lung and Bronchus|2016-2020
15-19|0.1|0.2|0.1|145|Incidence|102161808|Lung and Bronchus|2016-2020
15-19|~|~|~|~|Mortality|51551770|Male and Female Breast|2016-2020
15-19|0.2|0.2|0.2|99|Incidence|49999406|Male and Female Breast|2016-2020
15-19|0.0|0.1|0.0|19|Incidence|49999406|Male and Female Breast, <i>in situ</i>|2016-2020
15-19|0.0|0.0|0.0|19|Mortality|105350147|Melanomas of the Skin|2016-2020
15-19|0.7|0.8|0.8|789|Incidence|102161808|Melanomas of the Skin|2016-2020
15-19|~|~|~|~|Mortality|105350147|Mesothelioma|2016-2020
15-19|~|~|~|~|Incidence|102161808|Mesothelioma|2016-2020
15-19|~|~|~|~|Mortality|105350147|Myeloma|2016-2020
15-19|~|~|~|~|Incidence|102161808|Myeloma|2016-2020
15-19|0.1|0.2|0.1|137|Mortality|105350147|Non-Hodgkin Lymphoma|2016-2020
15-19|1.8|2.0|1.9|1930|Incidence|102161808|Non-Hodgkin Lymphoma|2016-2020
15-19|0.0|0.0|0.0|22|Mortality|105350147|Oral Cavity and Pharynx|2016-2020
15-19|0.4|0.5|0.4|458|Incidence|102161808|Oral Cavity and Pharynx|2016-2020
15-19|0.0|0.1|0.0|24|Mortality|51551770|Ovary|2016-2020
15-19|1.1|1.3|1.2|620|Incidence|49999406|Ovary|2016-2020
15-19|~|~|~|~|Mortality|105350147|Pancreas|2016-2020
15-19|0.2|0.2|0.2|197|Incidence|102161808|Pancreas|2016-2020
15-19|~|~|~|~|Mortality|53798377|Prostate|2016-2020
15-19|~|~|~|~|Incidence|52162402|Prostate|2016-2020
15-19|0.0|0.0|0.0|18|Mortality|105350147|Stomach|2016-2020
15-19|0.1|0.1|0.1|88|Incidence|102161808|Stomach|2016-2020
15-19|0.0|0.1|0.1|38|Mortality|53798377|Testis|2016-2020
15-19|3.2|3.5|3.4|1755|Incidence|52162402|Testis|2016-2020
15-19|~|~|~|~|Mortality|105350147|Thyroid|2016-2020
15-19|3.2|3.5|3.3|3421|Incidence|102161808|Thyroid|2016-2020
15-19|~|~|~|~|Mortality|105350147|Urinary Bladder|2016-2020
15-19|0.1|0.1|0.1|88|Incidence|102161808|Urinary Bladder|2016-2020
5-9|1.9|2.1|2.0|2013|Mortality|101453285|All Cancer Sites Combined|2016-2020
5-9|12.7|13.2|13.0|12748|Incidence|98323876|All Cancer Sites Combined|2016-2020
5-9|0.8|1.0|0.9|910|Mortality|101453285|Brain and Other Nervous System|2016-2020
5-9|3.3|3.5|3.4|3366|Incidence|98323876|Brain and Other Nervous System|2016-2020
5-9|~|~|~|~|Mortality|49621733|Cervix|2016-2020
5-9|~|~|~|~|Incidence|48092704|Cervix|2016-2020
5-9|~|~|~|~|Mortality|101453285|Colon and Rectum|2016-2020
5-9|0.1|0.1|0.1|98|Incidence|98323876|Colon and Rectum|2016-2020
5-9|~|~|~|~|Mortality|49621733|Corpus and Uterus, NOS|2016-2020
5-9|~|~|~|~|Incidence|48092704|Corpus and Uterus, NOS|2016-2020
5-9|~|~|~|~|Mortality|101453285|Esophagus|2016-2020
5-9|~|~|~|~|Incidence|98323876|Esophagus|2016-2020
5-9|~|~|~|~|Mortality|49621733|Female Breast|2016-2020
5-9|~|~|~|~|Incidence|48092704|Female Breast|2016-2020
5-9|~|~|~|~|Incidence|48092704|Female Breast, <i>in situ</i>|2016-2020
5-9|~|~|~|~|Mortality|101453285|Hodgkin Lymphoma|2016-2020
5-9|0.3|0.4|0.4|362|Incidence|98323876|Hodgkin Lymphoma|2016-2020
5-9|.|.|.|.|Mortality|101453285|Kaposi Sarcoma|2016-2020
5-9|~|~|~|~|Incidence|98323876|Kaposi Sarcoma|2016-2020
5-9|0.1|0.1|0.1|72|Mortality|101453285|Kidney and Renal Pelvis|2016-2020
5-9|0.6|0.7|0.6|624|Incidence|98323876|Kidney and Renal Pelvis|2016-2020
5-9|~|~|~|~|Mortality|101453285|Larynx|2016-2020
5-9|~|~|~|~|Incidence|98323876|Larynx|2016-2020
5-9|0.4|0.4|0.4|402|Mortality|101453285|Leukemias|2016-2020
5-9|4.0|4.3|4.2|4084|Incidence|98323876|Leukemias|2016-2020
5-9|0.0|0.1|0.0|40|Mortality|101453285|Liver and Intrahepatic Bile Duct|2016-2020
5-9|0.1|0.2|0.1|127|Incidence|98323876|Liver and Intrahepatic Bile Duct|2016-2020
5-9|~|~|~|~|Mortality|101453285|Lung and Bronchus|2016-2020
5-9|0.0|0.0|0.0|24|Incidence|98323876|Lung and Bronchus|2016-2020
5-9|~|~|~|~|Mortality|49621733|Male and Female Breast|2016-2020
5-9|~|~|~|~|Incidence|48092704|Male and Female Breast|2016-2020
5-9|~|~|~|~|Incidence|48092704|Male and Female Breast, <i>in situ</i>|2016-2020
5-9|~|~|~|~|Mortality|101453285|Melanomas of the Skin|2016-2020
5-9|0.1|0.1|0.1|95|Incidence|98323876|Melanomas of the Skin|2016-2020
5-9|~|~|~|~|Mortality|101453285|Mesothelioma|2016-2020
5-9|~|~|~|~|Incidence|98323876|Mesothelioma|2016-2020
5-9|~|~|~|~|Mortality|101453285|Myeloma|2016-2020
5-9|~|~|~|~|Incidence|98323876|Myeloma|2016-2020
5-9|0.0|0.1|0.0|38|Mortality|101453285|Non-Hodgkin Lymphoma|2016-2020
5-9|1.0|1.1|1.1|1033|Incidence|98323876|Non-Hodgkin Lymphoma|2016-2020
5-9|~|~|~|~|Mortality|101453285|Oral Cavity and Pharynx|2016-2020
5-9|0.1|0.1|0.1|96|Incidence|98323876|Oral Cavity and Pharynx|2016-2020
5-9|~|~|~|~|Mortality|49621733|Ovary|2016-2020
5-9|0.2|0.3|0.2|118|Incidence|48092704|Ovary|2016-2020
5-9|~|~|~|~|Mortality|101453285|Pancreas|2016-2020
5-9|0.0|0.0|0.0|22|Incidence|98323876|Pancreas|2016-2020
5-9|~|~|~|~|Mortality|51831552|Prostate|2016-2020
5-9|~|~|~|~|Incidence|50231172|Prostate|2016-2020
5-9|~|~|~|~|Mortality|101453285|Stomach|2016-2020
5-9|~|~|~|~|Incidence|98323876|Stomach|2016-2020
5-9|~|~|~|~|Mortality|51831552|Testis|2016-2020
5-9|0.1|0.1|0.1|44|Incidence|50231172|Testis|2016-2020
5-9|~|~|~|~|Mortality|101453285|Thyroid|2016-2020
5-9|0.1|0.2|0.1|138|Incidence|98323876|Thyroid|2016-2020
5-9|~|~|~|~|Mortality|101453285|Urinary Bladder|2016-2020
5-9|0.0|0.0|0.0|18|Incidence|98323876|Urinary Bladder|2016-2020
<1|1.3|1.7|1.5|284|Mortality|19169850|All Cancer Sites Combined|2016-2020
<1|25.7|27.2|26.4|4907|Incidence|18583091|All Cancer Sites Combined|2016-2020
<1|0.3|0.4|0.3|67|Mortality|19169850|Brain and Other Nervous System|2016-2020
<1|3.3|3.8|3.5|657|Incidence|18583091|Brain and Other Nervous System|2016-2020
<1|~|~|~|~|Mortality|9373225|Cervix|2016-2020
<1|~|~|~|~|Incidence|9086752|Cervix|2016-2020
<1|~|~|~|~|Mortality|19169850|Colon and Rectum|2016-2020
<1|~|~|~|~|Incidence|18583091|Colon and Rectum|2016-2020
<1|~|~|~|~|Mortality|9373225|Corpus and Uterus, NOS|2016-2020
<1|~|~|~|~|Incidence|9086752|Corpus and Uterus, NOS|2016-2020
<1|~|~|~|~|Mortality|19169850|Esophagus|2016-2020
<1|~|~|~|~|Incidence|18583091|Esophagus|2016-2020
<1|~|~|~|~|Mortality|9373225|Female Breast|2016-2020
<1|~|~|~|~|Incidence|9086752|Female Breast|2016-2020
<1|~|~|~|~|Incidence|9086752|Female Breast, <i>in situ</i>|2016-2020
<1|~|~|~|~|Mortality|19169850|Hodgkin Lymphoma|2016-2020
<1|~|~|~|~|Incidence|18583091|Hodgkin Lymphoma|2016-2020
<1|.|.|.|.|Mortality|19169850|Kaposi Sarcoma|2016-2020
<1|~|~|~|~|Incidence|18583091|Kaposi Sarcoma|2016-2020
<1|~|~|~|~|Mortality|19169850|Kidney and Renal Pelvis|2016-2020
<1|1.4|1.7|1.5|284|Incidence|18583091|Kidney and Renal Pelvis|2016-2020
<1|~|~|~|~|Mortality|19169850|Larynx|2016-2020
<1|~|~|~|~|Incidence|18583091|Larynx|2016-2020
<1|0.4|0.6|0.5|96|Mortality|19169850|Leukemias|2016-2020
<1|3.8|4.4|4.1|760|Incidence|18583091|Leukemias|2016-2020
<1|0.1|0.1|0.1|17|Mortality|19169850|Liver and Intrahepatic Bile Duct|2016-2020
<1|1.4|1.8|1.6|293|Incidence|18583091|Liver and Intrahepatic Bile Duct|2016-2020
<1|~|~|~|~|Mortality|19169850|Lung and Bronchus|2016-2020
<1|0.1|0.3|0.2|35|Incidence|18583091|Lung and Bronchus|2016-2020
<1|~|~|~|~|Mortality|9373225|Male and Female Breast|2016-2020
<1|~|~|~|~|Incidence|9086752|Male and Female Breast|2016-2020
<1|~|~|~|~|Incidence|9086752|Male and Female Breast, <i>in situ</i>|2016-2020
<1|~|~|~|~|Mortality|19169850|Melanomas of the Skin|2016-2020
<1|0.2|0.3|0.2|43|Incidence|18583091|Melanomas of the Skin|2016-2020
<1|~|~|~|~|Mortality|19169850|Mesothelioma|2016-2020
<1|~|~|~|~|Incidence|18583091|Mesothelioma|2016-2020
<1|~|~|~|~|Mortality|19169850|Myeloma|2016-2020
<1|~|~|~|~|Incidence|18583091|Myeloma|2016-2020
<1|~|~|~|~|Mortality|19169850|Non-Hodgkin Lymphoma|2016-2020
<1|0.2|0.4|0.3|54|Incidence|18583091|Non-Hodgkin Lymphoma|2016-2020
<1|~|~|~|~|Mortality|19169850|Oral Cavity and Pharynx|2016-2020
<1|0.1|0.2|0.1|21|Incidence|18583091|Oral Cavity and Pharynx|2016-2020
<1|~|~|~|~|Mortality|9373225|Ovary|2016-2020
<1|~|~|~|~|Incidence|9086752|Ovary|2016-2020
<1|~|~|~|~|Mortality|19169850|Pancreas|2016-2020
<1|~|~|~|~|Incidence|18583091|Pancreas|2016-2020
<1|~|~|~|~|Mortality|9796625|Prostate|2016-2020
<1|~|~|~|~|Incidence|9496339|Prostate|2016-2020
<1|~|~|~|~|Mortality|19169850|Stomach|2016-2020
<1|~|~|~|~|Incidence|18583091|Stomach|2016-2020
<1|~|~|~|~|Mortality|9796625|Testis|2016-2020
<1|0.4|0.8|0.6|56|Incidence|9496339|Testis|2016-2020
<1|~|~|~|~|Mortality|19169850|Thyroid|2016-2020
<1|~|~|~|~|Incidence|18583091|Thyroid|2016-2020
<1|~|~|~|~|Mortality|19169850|Urinary Bladder|2016-2020
<1|0.1|0.1|0.1|17|Incidence|18583091|Urinary Bladder|2016-2020
1-4|1.8|2.3|2.0|325|Mortality|16012579|All Cancer Sites Combined|2017
1-4|22.1|23.6|22.8|3657|Incidence|16012579|All Cancer Sites Combined|2017
1-4|0.4|0.6|0.5|73|Mortality|16012579|Brain and Other Nervous System|2017
1-4|4.4|5.1|4.8|762|Incidence|16012579|Brain and Other Nervous System|2017
1-4|~|~|~|~|Mortality|7825088|Cervix|2017
1-4|~|~|~|~|Incidence|7825088|Cervix|2017
1-4|~|~|~|~|Mortality|16012579|Colon and Rectum|2017
1-4|~|~|~|~|Incidence|16012579|Colon and Rectum|2017
1-4|~|~|~|~|Mortality|7825088|Corpus and Uterus, NOS|2017
1-4|~|~|~|~|Incidence|7825088|Corpus and Uterus, NOS|2017
1-4|~|~|~|~|Mortality|16012579|Esophagus|2017
1-4|~|~|~|~|Incidence|16012579|Esophagus|2017
1-4|~|~|~|~|Mortality|7825088|Female Breast|2017
1-4|~|~|~|~|Incidence|7825088|Female Breast|2017
1-4|~|~|~|~|Incidence|7825088|Female Breast, <i>in situ</i>|2017
1-4|~|~|~|~|Mortality|16012579|Hodgkin Lymphoma|2017
1-4|~|~|~|~|Incidence|16012579|Hodgkin Lymphoma|2017
1-4|.|.|.|.|Mortality|16012579|Kaposi Sarcoma|2017
1-4|~|~|~|~|Incidence|16012579|Kaposi Sarcoma|2017
1-4|0.1|0.2|0.1|16|Mortality|16012579|Kidney and Renal Pelvis|2017
1-4|1.7|2.1|1.9|305|Incidence|16012579|Kidney and Renal Pelvis|2017
1-4|~|~|~|~|Mortality|16012579|Larynx|2017
1-4|~|~|~|~|Incidence|16012579|Larynx|2017
1-4|0.6|0.8|0.7|110|Mortality|16012579|Leukemias|2017
1-4|8.3|9.2|8.7|1400|Incidence|16012579|Leukemias|2017
1-4|~|~|~|~|Mortality|16012579|Liver and Intrahepatic Bile Duct|2017
1-4|0.5|0.8|0.7|107|Incidence|16012579|Liver and Intrahepatic Bile Duct|2017
1-4|~|~|~|~|Mortality|16012579|Lung and Bronchus|2017
1-4|0.1|0.2|0.1|16|Incidence|16012579|Lung and Bronchus|2017
1-4|~|~|~|~|Mortality|7825088|Male and Female Breast|2017
1-4|~|~|~|~|Incidence|7825088|Male and Female Breast|2017
1-4|~|~|~|~|Incidence|7825088|Male and Female Breast, <i>in situ</i>|2017
1-4|~|~|~|~|Mortality|16012579|Melanomas of the Skin|2017
1-4|~|~|~|~|Incidence|16012579|Melanomas of the Skin|2017
1-4|~|~|~|~|Mortality|16012579|Mesothelioma|2017
1-4|~|~|~|~|Incidence|16012579|Mesothelioma|2017
1-4|~|~|~|~|Mortality|16012579|Myeloma|2017
1-4|~|~|~|~|Incidence|16012579|Myeloma|2017
1-4|~|~|~|~|Mortality|16012579|Non-Hodgkin Lymphoma|2017
1-4|0.6|0.8|0.7|108|Incidence|16012579|Non-Hodgkin Lymphoma|2017
1-4|~|~|~|~|Mortality|16012579|Oral Cavity and Pharynx|2017
1-4|~|~|~|~|Incidence|16012579|Oral Cavity and Pharynx|2017
1-4|~|~|~|~|Mortality|7825088|Ovary|2017
1-4|~|~|~|~|Incidence|7825088|Ovary|2017
1-4|~|~|~|~|Mortality|16012579|Pancreas|2017
1-4|~|~|~|~|Incidence|16012579|Pancreas|2017
1-4|~|~|~|~|Mortality|8187491|Prostate|2017
1-4|~|~|~|~|Incidence|8187491|Prostate|2017
1-4|~|~|~|~|Mortality|16012579|Stomach|2017
1-4|~|~|~|~|Incidence|16012579|Stomach|2017
1-4|~|~|~|~|Mortality|8187491|Testis|2017
1-4|0.2|0.4|0.3|21|Incidence|8187491|Testis|2017
1-4|~|~|~|~|Mortality|16012579|Thyroid|2017
1-4|~|~|~|~|Incidence|16012579|Thyroid|2017
1-4|~|~|~|~|Mortality|16012579|Urinary Bladder|2017
1-4|~|~|~|~|Incidence|16012579|Urinary Bladder|2017
10-14|1.9|2.3|2.1|437|Mortality|20783456|All Cancer Sites Combined|2017
10-14|15.1|16.1|15.6|3241|Incidence|20783456|All Cancer Sites Combined|2017
10-14|0.6|0.8|0.7|137|Mortality|20783456|Brain and Other Nervous System|2017
10-14|3.0|3.5|3.3|677|Incidence|20783456|Brain and Other Nervous System|2017
10-14|~|~|~|~|Mortality|10174304|Cervix|2017
10-14|~|~|~|~|Incidence|10174304|Cervix|2017
10-14|~|~|~|~|Mortality|20783456|Colon and Rectum|2017
10-14|0.5|0.7|0.6|122|Incidence|20783456|Colon and Rectum|2017
10-14|~|~|~|~|Mortality|10174304|Corpus and Uterus, NOS|2017
10-14|~|~|~|~|Incidence|10174304|Corpus and Uterus, NOS|2017
10-14|~|~|~|~|Mortality|20783456|Esophagus|2017
10-14|~|~|~|~|Incidence|20783456|Esophagus|2017
10-14|~|~|~|~|Mortality|10174304|Female Breast|2017
10-14|~|~|~|~|Incidence|10174304|Female Breast|2017
10-14|~|~|~|~|Incidence|10174304|Female Breast, <i>in situ</i>|2017
10-14|~|~|~|~|Mortality|20783456|Hodgkin Lymphoma|2017
10-14|1.1|1.4|1.2|259|Incidence|20783456|Hodgkin Lymphoma|2017
10-14|.|.|.|.|Mortality|20783456|Kaposi Sarcoma|2017
10-14|~|~|~|~|Incidence|20783456|Kaposi Sarcoma|2017
10-14|~|~|~|~|Mortality|20783456|Kidney and Renal Pelvis|2017
10-14|0.1|0.3|0.2|43|Incidence|20783456|Kidney and Renal Pelvis|2017
10-14|~|~|~|~|Mortality|20783456|Larynx|2017
10-14|~|~|~|~|Incidence|20783456|Larynx|2017
10-14|0.4|0.6|0.5|109|Mortality|20783456|Leukemias|2017
10-14|3.1|3.6|3.3|687|Incidence|20783456|Leukemias|2017
10-14|~|~|~|~|Mortality|20783456|Liver and Intrahepatic Bile Duct|2017
10-14|0.0|0.1|0.1|17|Incidence|20783456|Liver and Intrahepatic Bile Duct|2017
10-14|~|~|~|~|Mortality|20783456|Lung and Bronchus|2017
10-14|~|~|~|~|Incidence|20783456|Lung and Bronchus|2017
10-14|~|~|~|~|Mortality|10174304|Male and Female Breast|2017
10-14|~|~|~|~|Incidence|10174304|Male and Female Breast|2017
10-14|~|~|~|~|Incidence|10174304|Male and Female Breast, <i>in situ</i>|2017
10-14|~|~|~|~|Mortality|20783456|Melanomas of the Skin|2017
10-14|0.1|0.2|0.2|36|Incidence|20783456|Melanomas of the Skin|2017
10-14|~|~|~|~|Mortality|20783456|Mesothelioma|2017
10-14|~|~|~|~|Incidence|20783456|Mesothelioma|2017
10-14|~|~|~|~|Mortality|20783456|Myeloma|2017
10-14|~|~|~|~|Incidence|20783456|Myeloma|2017
10-14|0.1|0.2|0.1|22|Mortality|20783456|Non-Hodgkin Lymphoma|2017
10-14|1.2|1.5|1.3|271|Incidence|20783456|Non-Hodgkin Lymphoma|2017
10-14|~|~|~|~|Mortality|20783456|Oral Cavity and Pharynx|2017
10-14|0.2|0.4|0.3|63|Incidence|20783456|Oral Cavity and Pharynx|2017
10-14|~|~|~|~|Mortality|10174304|Ovary|2017
10-14|0.7|1.1|0.9|88|Incidence|10174304|Ovary|2017
10-14|~|~|~|~|Mortality|20783456|Pancreas|2017
10-14|0.1|0.1|0.1|18|Incidence|20783456|Pancreas|2017
10-14|~|~|~|~|Mortality|10609152|Prostate|2017
10-14|~|~|~|~|Incidence|10609152|Prostate|2017
10-14|~|~|~|~|Mortality|20783456|Stomach|2017
10-14|~|~|~|~|Incidence|20783456|Stomach|2017
10-14|~|~|~|~|Mortality|10609152|Testis|2017
10-14|0.2|0.3|0.2|25|Incidence|10609152|Testis|2017
10-14|~|~|~|~|Mortality|20783456|Thyroid|2017
10-14|0.7|0.9|0.8|162|Incidence|20783456|Thyroid|2017
10-14|~|~|~|~|Mortality|20783456|Urinary Bladder|2017
10-14|~|~|~|~|Incidence|20783456|Urinary Bladder|2017
15-19|2.4|2.9|2.7|560|Mortality|21105586|All Cancer Sites Combined|2017
15-19|23.1|24.4|23.7|5011|Incidence|21105586|All Cancer Sites Combined|2017
15-19|0.4|0.6|0.5|97|Mortality|21105586|Brain and Other Nervous System|2017
15-19|2.3|2.7|2.5|531|Incidence|21105586|Brain and Other Nervous System|2017
15-19|~|~|~|~|Mortality|10322453|Cervix|2017
15-19|~|~|~|~|Incidence|10322453|Cervix|2017
15-19|~|~|~|~|Mortality|21105586|Colon and Rectum|2017
15-19|1.1|1.4|1.2|262|Incidence|21105586|Colon and Rectum|2017
15-19|~|~|~|~|Mortality|10322453|Corpus and Uterus, NOS|2017
15-19|~|~|~|~|Incidence|10322453|Corpus and Uterus, NOS|2017
15-19|~|~|~|~|Mortality|21105586|Esophagus|2017
15-19|~|~|~|~|Incidence|21105586|Esophagus|2017
15-19|~|~|~|~|Mortality|10322453|Female Breast|2017
15-19|0.1|0.3|0.2|21|Incidence|10322453|Female Breast|2017
15-19|~|~|~|~|Incidence|10322453|Female Breast, <i>in situ</i>|2017
15-19|~|~|~|~|Mortality|21105586|Hodgkin Lymphoma|2017
15-19|2.9|3.4|3.1|660|Incidence|21105586|Hodgkin Lymphoma|2017
15-19|.|.|.|.|Mortality|21105586|Kaposi Sarcoma|2017
15-19|~|~|~|~|Incidence|21105586|Kaposi Sarcoma|2017
15-19|~|~|~|~|Mortality|21105586|Kidney and Renal Pelvis|2017
15-19|0.2|0.3|0.2|44|Incidence|21105586|Kidney and Renal Pelvis|2017
15-19|~|~|~|~|Mortality|21105586|Larynx|2017
15-19|~|~|~|~|Incidence|21105586|Larynx|2017
15-19|0.6|0.8|0.7|145|Mortality|21105586|Leukemias|2017
15-19|2.8|3.3|3.0|635|Incidence|21105586|Leukemias|2017
15-19|~|~|~|~|Mortality|21105586|Liver and Intrahepatic Bile Duct|2017
15-19|0.1|0.2|0.2|33|Incidence|21105586|Liver and Intrahepatic Bile Duct|2017
15-19|~|~|~|~|Mortality|21105586|Lung and Bronchus|2017
15-19|0.1|0.2|0.1|22|Incidence|21105586|Lung and Bronchus|2017
15-19|~|~|~|~|Mortality|10322453|Male and Female Breast|2017
15-19|0.1|0.3|0.2|21|Incidence|10322453|Male and Female Breast|2017
15-19|~|~|~|~|Incidence|10322453|Male and Female Breast, <i>in situ</i>|2017
15-19|~|~|~|~|Mortality|21105586|Melanomas of the Skin|2017
15-19|0.6|0.9|0.7|158|Incidence|21105586|Melanomas of the Skin|2017
15-19|~|~|~|~|Mortality|21105586|Mesothelioma|2017
15-19|~|~|~|~|Incidence|21105586|Mesothelioma|2017
15-19|~|~|~|~|Mortality|21105586|Myeloma|2017
15-19|~|~|~|~|Incidence|21105586|Myeloma|2017
15-19|0.1|0.2|0.1|24|Mortality|21105586|Non-Hodgkin Lymphoma|2017
15-19|1.8|2.1|1.9|408|Incidence|21105586|Non-Hodgkin Lymphoma|2017
15-19|~|~|~|~|Mortality|21105586|Oral Cavity and Pharynx|2017
15-19|0.4|0.5|0.4|93|Incidence|21105586|Oral Cavity and Pharynx|2017
15-19|~|~|~|~|Mortality|10322453|Ovary|2017
15-19|1.0|1.4|1.2|123|Incidence|10322453|Ovary|2017
15-19|~|~|~|~|Mortality|21105586|Pancreas|2017
15-19|0.1|0.2|0.1|30|Incidence|21105586|Pancreas|2017
15-19|~|~|~|~|Mortality|10783133|Prostate|2017
15-19|~|~|~|~|Incidence|10783133|Prostate|2017
15-19|~|~|~|~|Mortality|21105586|Stomach|2017
15-19|0.0|0.1|0.1|17|Incidence|21105586|Stomach|2017
15-19|~|~|~|~|Mortality|10783133|Testis|2017
15-19|3.0|3.8|3.4|365|Incidence|10783133|Testis|2017
15-19|~|~|~|~|Mortality|21105586|Thyroid|2017
15-19|2.9|3.3|3.1|654|Incidence|21105586|Thyroid|2017
15-19|~|~|~|~|Mortality|21105586|Urinary Bladder|2017
15-19|0.1|0.1|0.1|20|Incidence|21105586|Urinary Bladder|2017
5-9|1.9|2.3|2.1|418|Mortality|20330306|All Cancer Sites Combined|2017
5-9|12.6|13.6|13.1|2670|Incidence|20330306|All Cancer Sites Combined|2017
5-9|0.8|1.1|1.0|199|Mortality|20330306|Brain and Other Nervous System|2017
5-9|3.5|4.1|3.8|770|Incidence|20330306|Brain and Other Nervous System|2017
5-9|~|~|~|~|Mortality|9948106|Cervix|2017
5-9|~|~|~|~|Incidence|9948106|Cervix|2017
5-9|~|~|~|~|Mortality|20330306|Colon and Rectum|2017
5-9|0.1|0.2|0.1|20|Incidence|20330306|Colon and Rectum|2017
5-9|~|~|~|~|Mortality|9948106|Corpus and Uterus, NOS|2017
5-9|~|~|~|~|Incidence|9948106|Corpus and Uterus, NOS|2017
5-9|~|~|~|~|Mortality|20330306|Esophagus|2017
5-9|~|~|~|~|Incidence|20330306|Esophagus|2017
5-9|~|~|~|~|Mortality|9948106|Female Breast|2017
5-9|~|~|~|~|Incidence|9948106|Female Breast|2017
5-9|~|~|~|~|Incidence|9948106|Female Breast, <i>in situ</i>|2017
5-9|~|~|~|~|Mortality|20330306|Hodgkin Lymphoma|2017
5-9|0.3|0.5|0.4|79|Incidence|20330306|Hodgkin Lymphoma|2017
5-9|.|.|.|.|Mortality|20330306|Kaposi Sarcoma|2017
5-9|~|~|~|~|Incidence|20330306|Kaposi Sarcoma|2017
5-9|~|~|~|~|Mortality|20330306|Kidney and Renal Pelvis|2017
5-9|0.5|0.8|0.6|130|Incidence|20330306|Kidney and Renal Pelvis|2017
5-9|~|~|~|~|Mortality|20330306|Larynx|2017
5-9|~|~|~|~|Incidence|20330306|Larynx|2017
5-9|0.3|0.5|0.4|77|Mortality|20330306|Leukemias|2017
5-9|3.6|4.2|3.9|787|Incidence|20330306|Leukemias|2017
5-9|~|~|~|~|Mortality|20330306|Liver and Intrahepatic Bile Duct|2017
5-9|0.1|0.2|0.1|25|Incidence|20330306|Liver and Intrahepatic Bile Duct|2017
5-9|~|~|~|~|Mortality|20330306|Lung and Bronchus|2017
5-9|~|~|~|~|Incidence|20330306|Lung and Bronchus|2017
5-9|~|~|~|~|Mortality|9948106|Male and Female Breast|2017
5-9|~|~|~|~|Incidence|9948106|Male and Female Breast|2017
5-9|~|~|~|~|Incidence|9948106|Male and Female Breast, <i>in situ</i>|2017
5-9|~|~|~|~|Mortality|20330306|Melanomas of the Skin|2017
5-9|0.1|0.2|0.1|22|Incidence|20330306|Melanomas of the Skin|2017
5-9|~|~|~|~|Mortality|20330306|Mesothelioma|2017
5-9|~|~|~|~|Incidence|20330306|Mesothelioma|2017
5-9|~|~|~|~|Mortality|20330306|Myeloma|2017
5-9|~|~|~|~|Incidence|20330306|Myeloma|2017
5-9|~|~|~|~|Mortality|20330306|Non-Hodgkin Lymphoma|2017
5-9|1.0|1.2|1.1|222|Incidence|20330306|Non-Hodgkin Lymphoma|2017
5-9|~|~|~|~|Mortality|20330306|Oral Cavity and Pharynx|2017
5-9|0.1|0.1|0.1|18|Incidence|20330306|Oral Cavity and Pharynx|2017
5-9|~|~|~|~|Mortality|9948106|Ovary|2017
5-9|0.2|0.4|0.3|25|Incidence|9948106|Ovary|2017
5-9|~|~|~|~|Mortality|20330306|Pancreas|2017
5-9|~|~|~|~|Incidence|20330306|Pancreas|2017
5-9|~|~|~|~|Mortality|10382200|Prostate|2017
5-9|~|~|~|~|Incidence|10382200|Prostate|2017
5-9|~|~|~|~|Mortality|20330306|Stomach|2017
5-9|~|~|~|~|Incidence|20330306|Stomach|2017
5-9|~|~|~|~|Mortality|10382200|Testis|2017
5-9|~|~|~|~|Incidence|10382200|Testis|2017
5-9|~|~|~|~|Mortality|20330306|Thyroid|2017
5-9|0.1|0.2|0.1|29|Incidence|20330306|Thyroid|2017
5-9|~|~|~|~|Mortality|20330306|Urinary Bladder|2017
5-9|~|~|~|~|Incidence|20330306|Urinary Bladder|2017
<1|1.1|1.9|1.5|57|Mortality|3882437|All Cancer Sites Combined|2017
<1|24.9|28.2|26.5|1029|Incidence|3882437|All Cancer Sites Combined|2017
<1|~|~|~|~|Mortality|3882437|Brain and Other Nervous System|2017
<1|3.2|4.4|3.8|146|Incidence|3882437|Brain and Other Nervous System|2017
<1|~|~|~|~|Mortality|1896804|Cervix|2017
<1|~|~|~|~|Incidence|1896804|Cervix|2017
<1|~|~|~|~|Mortality|3882437|Colon and Rectum|2017
<1|~|~|~|~|Incidence|3882437|Colon and Rectum|2017
<1|~|~|~|~|Mortality|1896804|Corpus and Uterus, NOS|2017
<1|~|~|~|~|Incidence|1896804|Corpus and Uterus, NOS|2017
<1|~|~|~|~|Mortality|3882437|Esophagus|2017
<1|~|~|~|~|Incidence|3882437|Esophagus|2017
<1|~|~|~|~|Mortality|1896804|Female Breast|2017
<1|~|~|~|~|Incidence|1896804|Female Breast|2017
<1|~|~|~|~|Incidence|1896804|Female Breast, <i>in situ</i>|2017
<1|~|~|~|~|Mortality|3882437|Hodgkin Lymphoma|2017
<1|~|~|~|~|Incidence|3882437|Hodgkin Lymphoma|2017
<1|.|.|.|.|Mortality|3882437|Kaposi Sarcoma|2017
<1|~|~|~|~|Incidence|3882437|Kaposi Sarcoma|2017
<1|~|~|~|~|Mortality|3882437|Kidney and Renal Pelvis|2017
<1|1.2|2.0|1.6|62|Incidence|3882437|Kidney and Renal Pelvis|2017
<1|~|~|~|~|Mortality|3882437|Larynx|2017
<1|~|~|~|~|Incidence|3882437|Larynx|2017
<1|0.3|0.8|0.5|19|Mortality|3882437|Leukemias|2017
<1|3.6|4.9|4.2|162|Incidence|3882437|Leukemias|2017
<1|~|~|~|~|Mortality|3882437|Liver and Intrahepatic Bile Duct|2017
<1|1.0|1.7|1.3|50|Incidence|3882437|Liver and Intrahepatic Bile Duct|2017
<1|~|~|~|~|Mortality|3882437|Lung and Bronchus|2017
<1|~|~|~|~|Incidence|3882437|Lung and Bronchus|2017
<1|~|~|~|~|Mortality|1896804|Male and Female Breast|2017
<1|~|~|~|~|Incidence|1896804|Male and Female Breast|2017
<1|~|~|~|~|Incidence|1896804|Male and Female Breast, <i>in situ</i>|2017
<1|~|~|~|~|Mortality|3882437|Melanomas of the Skin|2017
<1|~|~|~|~|Incidence|3882437|Melanomas of the Skin|2017
<1|~|~|~|~|Mortality|3882437|Mesothelioma|2017
<1|~|~|~|~|Incidence|3882437|Mesothelioma|2017
<1|~|~|~|~|Mortality|3882437|Myeloma|2017
<1|~|~|~|~|Incidence|3882437|Myeloma|2017
<1|~|~|~|~|Mortality|3882437|Non-Hodgkin Lymphoma|2017
<1|~|~|~|~|Incidence|3882437|Non-Hodgkin Lymphoma|2017
<1|~|~|~|~|Mortality|3882437|Oral Cavity and Pharynx|2017
<1|~|~|~|~|Incidence|3882437|Oral Cavity and Pharynx|2017
<1|~|~|~|~|Mortality|1896804|Ovary|2017
<1|~|~|~|~|Incidence|1896804|Ovary|2017
<1|~|~|~|~|Mortality|3882437|Pancreas|2017
<1|~|~|~|~|Incidence|3882437|Pancreas|2017
<1|~|~|~|~|Mortality|1985633|Prostate|2017
<1|~|~|~|~|Incidence|1985633|Prostate|2017
<1|~|~|~|~|Mortality|3882437|Stomach|2017
<1|~|~|~|~|Incidence|3882437|Stomach|2017
<1|~|~|~|~|Mortality|1985633|Testis|2017
<1|~|~|~|~|Incidence|1985633|Testis|2017
<1|~|~|~|~|Mortality|3882437|Thyroid|2017
<1|~|~|~|~|Incidence|3882437|Thyroid|2017
<1|~|~|~|~|Mortality|3882437|Urinary Bladder|2017
<1|~|~|~|~|Incidence|3882437|Urinary Bladder|2017
1-4|1.8|2.3|2.0|326|Mortality|15951619|All Cancer Sites Combined|2018
1-4|21.3|22.7|22.0|3510|Incidence|15951619|All Cancer Sites Combined|2018
1-4|0.3|0.5|0.4|69|Mortality|15951619|Brain and Other Nervous System|2018
1-4|3.9|4.5|4.2|668|Incidence|15951619|Brain and Other Nervous System|2018
1-4|~|~|~|~|Mortality|7794796|Cervix|2018
1-4|~|~|~|~|Incidence|7794796|Cervix|2018
1-4|~|~|~|~|Mortality|15951619|Colon and Rectum|2018
1-4|~|~|~|~|Incidence|15951619|Colon and Rectum|2018
1-4|~|~|~|~|Mortality|7794796|Corpus and Uterus, NOS|2018
1-4|~|~|~|~|Incidence|7794796|Corpus and Uterus, NOS|2018
1-4|~|~|~|~|Mortality|15951619|Esophagus|2018
1-4|~|~|~|~|Incidence|15951619|Esophagus|2018
1-4|~|~|~|~|Mortality|7794796|Female Breast|2018
1-4|~|~|~|~|Incidence|7794796|Female Breast|2018
1-4|~|~|~|~|Incidence|7794796|Female Breast, <i>in situ</i>|2018
1-4|~|~|~|~|Mortality|15951619|Hodgkin Lymphoma|2018
1-4|0.1|0.2|0.1|21|Incidence|15951619|Hodgkin Lymphoma|2018
1-4|.|.|.|.|Mortality|15951619|Kaposi Sarcoma|2018
1-4|~|~|~|~|Incidence|15951619|Kaposi Sarcoma|2018
1-4|~|~|~|~|Mortality|15951619|Kidney and Renal Pelvis|2018
1-4|1.6|2.0|1.8|290|Incidence|15951619|Kidney and Renal Pelvis|2018
1-4|~|~|~|~|Mortality|15951619|Larynx|2018
1-4|~|~|~|~|Incidence|15951619|Larynx|2018
1-4|0.5|0.8|0.7|106|Mortality|15951619|Leukemias|2018
1-4|8.7|9.7|9.2|1467|Incidence|15951619|Leukemias|2018
1-4|~|~|~|~|Mortality|15951619|Liver and Intrahepatic Bile Duct|2018
1-4|0.5|0.8|0.6|99|Incidence|15951619|Liver and Intrahepatic Bile Duct|2018
1-4|~|~|~|~|Mortality|15951619|Lung and Bronchus|2018
1-4|~|~|~|~|Incidence|15951619|Lung and Bronchus|2018
1-4|~|~|~|~|Mortality|7794796|Male and Female Breast|2018
1-4|~|~|~|~|Incidence|7794796|Male and Female Breast|2018
1-4|~|~|~|~|Incidence|7794796|Male and Female Breast, <i>in situ</i>|2018
1-4|~|~|~|~|Mortality|15951619|Melanomas of the Skin|2018
1-4|0.1|0.2|0.1|17|Incidence|15951619|Melanomas of the Skin|2018
1-4|~|~|~|~|Mortality|15951619|Mesothelioma|2018
1-4|~|~|~|~|Incidence|15951619|Mesothelioma|2018
1-4|~|~|~|~|Mortality|15951619|Myeloma|2018
1-4|~|~|~|~|Incidence|15951619|Myeloma|2018
1-4|~|~|~|~|Mortality|15951619|Non-Hodgkin Lymphoma|2018
1-4|0.5|0.7|0.6|97|Incidence|15951619|Non-Hodgkin Lymphoma|2018
1-4|~|~|~|~|Mortality|15951619|Oral Cavity and Pharynx|2018
1-4|~|~|~|~|Incidence|15951619|Oral Cavity and Pharynx|2018
1-4|~|~|~|~|Mortality|7794796|Ovary|2018
1-4|~|~|~|~|Incidence|7794796|Ovary|2018
1-4|~|~|~|~|Mortality|15951619|Pancreas|2018
1-4|~|~|~|~|Incidence|15951619|Pancreas|2018
1-4|~|~|~|~|Mortality|8156823|Prostate|2018
1-4|~|~|~|~|Incidence|8156823|Prostate|2018
1-4|~|~|~|~|Mortality|15951619|Stomach|2018
1-4|~|~|~|~|Incidence|15951619|Stomach|2018
1-4|~|~|~|~|Mortality|8156823|Testis|2018
1-4|0.1|0.4|0.2|19|Incidence|8156823|Testis|2018
1-4|~|~|~|~|Mortality|15951619|Thyroid|2018
1-4|~|~|~|~|Incidence|15951619|Thyroid|2018
1-4|~|~|~|~|Mortality|15951619|Urinary Bladder|2018
1-4|~|~|~|~|Incidence|15951619|Urinary Bladder|2018
10-14|2.0|2.4|2.2|450|Mortality|20887842|All Cancer Sites Combined|2018
10-14|15.6|16.7|16.1|3364|Incidence|20887842|All Cancer Sites Combined|2018
10-14|0.6|0.8|0.7|143|Mortality|20887842|Brain and Other Nervous System|2018
10-14|2.7|3.2|3.0|619|Incidence|20887842|Brain and Other Nervous System|2018
10-14|~|~|~|~|Mortality|10223894|Cervix|2018
10-14|~|~|~|~|Incidence|10223894|Cervix|2018
10-14|~|~|~|~|Mortality|20887842|Colon and Rectum|2018
10-14|0.6|0.8|0.7|141|Incidence|20887842|Colon and Rectum|2018
10-14|~|~|~|~|Mortality|10223894|Corpus and Uterus, NOS|2018
10-14|~|~|~|~|Incidence|10223894|Corpus and Uterus, NOS|2018
10-14|~|~|~|~|Mortality|20887842|Esophagus|2018
10-14|~|~|~|~|Incidence|20887842|Esophagus|2018
10-14|~|~|~|~|Mortality|10223894|Female Breast|2018
10-14|~|~|~|~|Incidence|10223894|Female Breast|2018
10-14|~|~|~|~|Incidence|10223894|Female Breast, <i>in situ</i>|2018
10-14|~|~|~|~|Mortality|20887842|Hodgkin Lymphoma|2018
10-14|1.1|1.4|1.3|266|Incidence|20887842|Hodgkin Lymphoma|2018
10-14|.|.|.|.|Mortality|20887842|Kaposi Sarcoma|2018
10-14|~|~|~|~|Incidence|20887842|Kaposi Sarcoma|2018
10-14|~|~|~|~|Mortality|20887842|Kidney and Renal Pelvis|2018
10-14|0.2|0.3|0.2|46|Incidence|20887842|Kidney and Renal Pelvis|2018
10-14|~|~|~|~|Mortality|20887842|Larynx|2018
10-14|~|~|~|~|Incidence|20887842|Larynx|2018
10-14|0.4|0.6|0.5|110|Mortality|20887842|Leukemias|2018
10-14|3.0|3.5|3.3|683|Incidence|20887842|Leukemias|2018
10-14|~|~|~|~|Mortality|20887842|Liver and Intrahepatic Bile Duct|2018
10-14|0.1|0.1|0.1|19|Incidence|20887842|Liver and Intrahepatic Bile Duct|2018
10-14|~|~|~|~|Mortality|20887842|Lung and Bronchus|2018
10-14|~|~|~|~|Incidence|20887842|Lung and Bronchus|2018
10-14|~|~|~|~|Mortality|10223894|Male and Female Breast|2018
10-14|~|~|~|~|Incidence|10223894|Male and Female Breast|2018
10-14|~|~|~|~|Incidence|10223894|Male and Female Breast, <i>in situ</i>|2018
10-14|~|~|~|~|Mortality|20887842|Melanomas of the Skin|2018
10-14|0.2|0.3|0.3|55|Incidence|20887842|Melanomas of the Skin|2018
10-14|~|~|~|~|Mortality|20887842|Mesothelioma|2018
10-14|~|~|~|~|Incidence|20887842|Mesothelioma|2018
10-14|~|~|~|~|Mortality|20887842|Myeloma|2018
10-14|~|~|~|~|Incidence|20887842|Myeloma|2018
10-14|~|~|~|~|Mortality|20887842|Non-Hodgkin Lymphoma|2018
10-14|1.3|1.7|1.5|312|Incidence|20887842|Non-Hodgkin Lymphoma|2018
10-14|~|~|~|~|Mortality|20887842|Oral Cavity and Pharynx|2018
10-14|0.2|0.3|0.2|46|Incidence|20887842|Oral Cavity and Pharynx|2018
10-14|~|~|~|~|Mortality|10223894|Ovary|2018
10-14|0.8|1.2|0.9|97|Incidence|10223894|Ovary|2018
10-14|~|~|~|~|Mortality|20887842|Pancreas|2018
10-14|~|~|~|~|Incidence|20887842|Pancreas|2018
10-14|~|~|~|~|Mortality|10663948|Prostate|2018
10-14|~|~|~|~|Incidence|10663948|Prostate|2018
10-14|~|~|~|~|Mortality|20887842|Stomach|2018
10-14|~|~|~|~|Incidence|20887842|Stomach|2018
10-14|~|~|~|~|Mortality|10663948|Testis|2018
10-14|0.2|0.4|0.3|30|Incidence|10663948|Testis|2018
10-14|~|~|~|~|Mortality|20887842|Thyroid|2018
10-14|0.9|1.2|1.0|218|Incidence|20887842|Thyroid|2018
10-14|~|~|~|~|Mortality|20887842|Urinary Bladder|2018
10-14|~|~|~|~|Incidence|20887842|Urinary Bladder|2018
15-19|2.7|3.2|2.9|621|Mortality|21077066|All Cancer Sites Combined|2018
15-19|23.6|25.0|24.3|5117|Incidence|21077066|All Cancer Sites Combined|2018
15-19|0.5|0.7|0.6|123|Mortality|21077066|Brain and Other Nervous System|2018
15-19|2.1|2.5|2.3|475|Incidence|21077066|Brain and Other Nervous System|2018
15-19|~|~|~|~|Mortality|10314076|Cervix|2018
15-19|~|~|~|~|Incidence|10314076|Cervix|2018
15-19|~|~|~|~|Mortality|21077066|Colon and Rectum|2018
15-19|1.2|1.6|1.4|296|Incidence|21077066|Colon and Rectum|2018
15-19|~|~|~|~|Mortality|10314076|Corpus and Uterus, NOS|2018
15-19|~|~|~|~|Incidence|10314076|Corpus and Uterus, NOS|2018
15-19|~|~|~|~|Mortality|21077066|Esophagus|2018
15-19|~|~|~|~|Incidence|21077066|Esophagus|2018
15-19|~|~|~|~|Mortality|10314076|Female Breast|2018
15-19|0.1|0.3|0.2|21|Incidence|10314076|Female Breast|2018
15-19|~|~|~|~|Incidence|10314076|Female Breast, <i>in situ</i>|2018
15-19|~|~|~|~|Mortality|21077066|Hodgkin Lymphoma|2018
15-19|2.9|3.4|3.1|663|Incidence|21077066|Hodgkin Lymphoma|2018
15-19|.|.|.|.|Mortality|21077066|Kaposi Sarcoma|2018
15-19|~|~|~|~|Incidence|21077066|Kaposi Sarcoma|2018
15-19|~|~|~|~|Mortality|21077066|Kidney and Renal Pelvis|2018
15-19|0.2|0.3|0.2|45|Incidence|21077066|Kidney and Renal Pelvis|2018
15-19|~|~|~|~|Mortality|21077066|Larynx|2018
15-19|~|~|~|~|Incidence|21077066|Larynx|2018
15-19|0.7|0.9|0.8|162|Mortality|21077066|Leukemias|2018
15-19|3.1|3.6|3.3|705|Incidence|21077066|Leukemias|2018
15-19|~|~|~|~|Mortality|21077066|Liver and Intrahepatic Bile Duct|2018
15-19|0.1|0.2|0.2|34|Incidence|21077066|Liver and Intrahepatic Bile Duct|2018
15-19|~|~|~|~|Mortality|21077066|Lung and Bronchus|2018
15-19|0.1|0.2|0.2|35|Incidence|21077066|Lung and Bronchus|2018
15-19|~|~|~|~|Mortality|10314076|Male and Female Breast|2018
15-19|0.1|0.3|0.2|21|Incidence|10314076|Male and Female Breast|2018
15-19|~|~|~|~|Incidence|10314076|Male and Female Breast, <i>in situ</i>|2018
15-19|~|~|~|~|Mortality|21077066|Melanomas of the Skin|2018
15-19|0.7|0.9|0.8|165|Incidence|21077066|Melanomas of the Skin|2018
15-19|~|~|~|~|Mortality|21077066|Mesothelioma|2018
15-19|~|~|~|~|Incidence|21077066|Mesothelioma|2018
15-19|~|~|~|~|Mortality|21077066|Myeloma|2018
15-19|~|~|~|~|Incidence|21077066|Myeloma|2018
15-19|0.1|0.2|0.1|26|Mortality|21077066|Non-Hodgkin Lymphoma|2018
15-19|1.6|2.0|1.8|374|Incidence|21077066|Non-Hodgkin Lymphoma|2018
15-19|~|~|~|~|Mortality|21077066|Oral Cavity and Pharynx|2018
15-19|0.4|0.5|0.4|92|Incidence|21077066|Oral Cavity and Pharynx|2018
15-19|~|~|~|~|Mortality|10314076|Ovary|2018
15-19|1.0|1.5|1.3|129|Incidence|10314076|Ovary|2018
15-19|~|~|~|~|Mortality|21077066|Pancreas|2018
15-19|0.2|0.3|0.2|48|Incidence|21077066|Pancreas|2018
15-19|~|~|~|~|Mortality|10762990|Prostate|2018
15-19|~|~|~|~|Incidence|10762990|Prostate|2018
15-19|~|~|~|~|Mortality|21077066|Stomach|2018
15-19|0.1|0.1|0.1|19|Incidence|21077066|Stomach|2018
15-19|~|~|~|~|Mortality|10762990|Testis|2018
15-19|2.8|3.5|3.1|334|Incidence|10762990|Testis|2018
15-19|~|~|~|~|Mortality|21077066|Thyroid|2018
15-19|3.4|3.9|3.7|775|Incidence|21077066|Thyroid|2018
15-19|~|~|~|~|Mortality|21077066|Urinary Bladder|2018
15-19|0.1|0.2|0.1|22|Incidence|21077066|Urinary Bladder|2018
5-9|1.8|2.1|1.9|393|Mortality|20212958|All Cancer Sites Combined|2018
5-9|12.6|13.6|13.1|2656|Incidence|20212958|All Cancer Sites Combined|2018
5-9|0.8|1.0|0.9|183|Mortality|20212958|Brain and Other Nervous System|2018
5-9|3.2|3.7|3.4|693|Incidence|20212958|Brain and Other Nervous System|2018
5-9|~|~|~|~|Mortality|9888217|Cervix|2018
5-9|~|~|~|~|Incidence|9888217|Cervix|2018
5-9|~|~|~|~|Mortality|20212958|Colon and Rectum|2018
5-9|0.1|0.2|0.1|24|Incidence|20212958|Colon and Rectum|2018
5-9|~|~|~|~|Mortality|9888217|Corpus and Uterus, NOS|2018
5-9|~|~|~|~|Incidence|9888217|Corpus and Uterus, NOS|2018
5-9|~|~|~|~|Mortality|20212958|Esophagus|2018
5-9|~|~|~|~|Incidence|20212958|Esophagus|2018
5-9|~|~|~|~|Mortality|9888217|Female Breast|2018
5-9|~|~|~|~|Incidence|9888217|Female Breast|2018
5-9|~|~|~|~|Incidence|9888217|Female Breast, <i>in situ</i>|2018
5-9|~|~|~|~|Mortality|20212958|Hodgkin Lymphoma|2018
5-9|0.3|0.5|0.4|80|Incidence|20212958|Hodgkin Lymphoma|2018
5-9|.|.|.|.|Mortality|20212958|Kaposi Sarcoma|2018
5-9|~|~|~|~|Incidence|20212958|Kaposi Sarcoma|2018
5-9|0.1|0.1|0.1|18|Mortality|20212958|Kidney and Renal Pelvis|2018
5-9|0.6|0.8|0.7|141|Incidence|20212958|Kidney and Renal Pelvis|2018
5-9|~|~|~|~|Mortality|20212958|Larynx|2018
5-9|~|~|~|~|Incidence|20212958|Larynx|2018
5-9|0.3|0.4|0.3|66|Mortality|20212958|Leukemias|2018
5-9|3.9|4.5|4.2|847|Incidence|20212958|Leukemias|2018
5-9|~|~|~|~|Mortality|20212958|Liver and Intrahepatic Bile Duct|2018
5-9|0.1|0.2|0.1|24|Incidence|20212958|Liver and Intrahepatic Bile Duct|2018
5-9|~|~|~|~|Mortality|20212958|Lung and Bronchus|2018
5-9|~|~|~|~|Incidence|20212958|Lung and Bronchus|2018
5-9|~|~|~|~|Mortality|9888217|Male and Female Breast|2018
5-9|~|~|~|~|Incidence|9888217|Male and Female Breast|2018
5-9|~|~|~|~|Incidence|9888217|Male and Female Breast, <i>in situ</i>|2018
5-9|~|~|~|~|Mortality|20212958|Melanomas of the Skin|2018
5-9|~|~|~|~|Incidence|20212958|Melanomas of the Skin|2018
5-9|~|~|~|~|Mortality|20212958|Mesothelioma|2018
5-9|~|~|~|~|Incidence|20212958|Mesothelioma|2018
5-9|~|~|~|~|Mortality|20212958|Myeloma|2018
5-9|~|~|~|~|Incidence|20212958|Myeloma|2018
5-9|~|~|~|~|Mortality|20212958|Non-Hodgkin Lymphoma|2018
5-9|0.9|1.2|1.1|216|Incidence|20212958|Non-Hodgkin Lymphoma|2018
5-9|~|~|~|~|Mortality|20212958|Oral Cavity and Pharynx|2018
5-9|0.1|0.1|0.1|18|Incidence|20212958|Oral Cavity and Pharynx|2018
5-9|~|~|~|~|Mortality|9888217|Ovary|2018
5-9|0.1|0.3|0.2|17|Incidence|9888217|Ovary|2018
5-9|~|~|~|~|Mortality|20212958|Pancreas|2018
5-9|~|~|~|~|Incidence|20212958|Pancreas|2018
5-9|~|~|~|~|Mortality|10324741|Prostate|2018
5-9|~|~|~|~|Incidence|10324741|Prostate|2018
5-9|~|~|~|~|Mortality|20212958|Stomach|2018
5-9|~|~|~|~|Incidence|20212958|Stomach|2018
5-9|~|~|~|~|Mortality|10324741|Testis|2018
5-9|~|~|~|~|Incidence|10324741|Testis|2018
5-9|~|~|~|~|Mortality|20212958|Thyroid|2018
5-9|0.1|0.2|0.2|32|Incidence|20212958|Thyroid|2018
5-9|~|~|~|~|Mortality|20212958|Urinary Bladder|2018
5-9|~|~|~|~|Incidence|20212958|Urinary Bladder|2018
<1|1.0|1.8|1.3|51|Mortality|3826908|All Cancer Sites Combined|2018
<1|25.0|28.3|26.6|1017|Incidence|3826908|All Cancer Sites Combined|2018
<1|~|~|~|~|Mortality|3826908|Brain and Other Nervous System|2018
<1|2.4|3.6|3.0|113|Incidence|3826908|Brain and Other Nervous System|2018
<1|~|~|~|~|Mortality|1871130|Cervix|2018
<1|~|~|~|~|Incidence|1871130|Cervix|2018
<1|~|~|~|~|Mortality|3826908|Colon and Rectum|2018
<1|~|~|~|~|Incidence|3826908|Colon and Rectum|2018
<1|~|~|~|~|Mortality|1871130|Corpus and Uterus, NOS|2018
<1|~|~|~|~|Incidence|1871130|Corpus and Uterus, NOS|2018
<1|~|~|~|~|Mortality|3826908|Esophagus|2018
<1|~|~|~|~|Incidence|3826908|Esophagus|2018
<1|~|~|~|~|Mortality|1871130|Female Breast|2018
<1|~|~|~|~|Incidence|1871130|Female Breast|2018
<1|~|~|~|~|Incidence|1871130|Female Breast, <i>in situ</i>|2018
<1|~|~|~|~|Mortality|3826908|Hodgkin Lymphoma|2018
<1|~|~|~|~|Incidence|3826908|Hodgkin Lymphoma|2018
<1|.|.|.|.|Mortality|3826908|Kaposi Sarcoma|2018
<1|~|~|~|~|Incidence|3826908|Kaposi Sarcoma|2018
<1|~|~|~|~|Mortality|3826908|Kidney and Renal Pelvis|2018
<1|1.1|1.9|1.4|55|Incidence|3826908|Kidney and Renal Pelvis|2018
<1|~|~|~|~|Mortality|3826908|Larynx|2018
<1|~|~|~|~|Incidence|3826908|Larynx|2018
<1|~|~|~|~|Mortality|3826908|Leukemias|2018
<1|3.7|5.1|4.3|166|Incidence|3826908|Leukemias|2018
<1|~|~|~|~|Mortality|3826908|Liver and Intrahepatic Bile Duct|2018
<1|1.3|2.2|1.7|65|Incidence|3826908|Liver and Intrahepatic Bile Duct|2018
<1|~|~|~|~|Mortality|3826908|Lung and Bronchus|2018
<1|~|~|~|~|Incidence|3826908|Lung and Bronchus|2018
<1|~|~|~|~|Mortality|1871130|Male and Female Breast|2018
<1|~|~|~|~|Incidence|1871130|Male and Female Breast|2018
<1|~|~|~|~|Incidence|1871130|Male and Female Breast, <i>in situ</i>|2018
<1|~|~|~|~|Mortality|3826908|Melanomas of the Skin|2018
<1|~|~|~|~|Incidence|3826908|Melanomas of the Skin|2018
<1|~|~|~|~|Mortality|3826908|Mesothelioma|2018
<1|~|~|~|~|Incidence|3826908|Mesothelioma|2018
<1|~|~|~|~|Mortality|3826908|Myeloma|2018
<1|~|~|~|~|Incidence|3826908|Myeloma|2018
<1|~|~|~|~|Mortality|3826908|Non-Hodgkin Lymphoma|2018
<1|~|~|~|~|Incidence|3826908|Non-Hodgkin Lymphoma|2018
<1|~|~|~|~|Mortality|3826908|Oral Cavity and Pharynx|2018
<1|~|~|~|~|Incidence|3826908|Oral Cavity and Pharynx|2018
<1|~|~|~|~|Mortality|1871130|Ovary|2018
<1|~|~|~|~|Incidence|1871130|Ovary|2018
<1|~|~|~|~|Mortality|3826908|Pancreas|2018
<1|~|~|~|~|Incidence|3826908|Pancreas|2018
<1|~|~|~|~|Mortality|1955778|Prostate|2018
<1|~|~|~|~|Incidence|1955778|Prostate|2018
<1|~|~|~|~|Mortality|3826908|Stomach|2018
<1|~|~|~|~|Incidence|3826908|Stomach|2018
<1|~|~|~|~|Mortality|1955778|Testis|2018
<1|~|~|~|~|Incidence|1955778|Testis|2018
<1|~|~|~|~|Mortality|3826908|Thyroid|2018
<1|~|~|~|~|Incidence|3826908|Thyroid|2018
<1|~|~|~|~|Mortality|3826908|Urinary Bladder|2018
<1|~|~|~|~|Incidence|3826908|Urinary Bladder|2018
1-4|1.6|2.0|1.8|285|Mortality|15809112|All Cancer Sites Combined|2019
1-4|20.6|22.0|21.3|3369|Incidence|15809112|All Cancer Sites Combined|2019
1-4|0.3|0.6|0.4|70|Mortality|15809112|Brain and Other Nervous System|2019
1-4|3.6|4.2|3.9|615|Incidence|15809112|Brain and Other Nervous System|2019
1-4|~|~|~|~|Mortality|7728847|Cervix|2019
1-4|~|~|~|~|Incidence|7728847|Cervix|2019
1-4|~|~|~|~|Mortality|15809112|Colon and Rectum|2019
1-4|~|~|~|~|Incidence|15809112|Colon and Rectum|2019
1-4|~|~|~|~|Mortality|7728847|Corpus and Uterus, NOS|2019
1-4|~|~|~|~|Incidence|7728847|Corpus and Uterus, NOS|2019
1-4|~|~|~|~|Mortality|15809112|Esophagus|2019
1-4|~|~|~|~|Incidence|15809112|Esophagus|2019
1-4|~|~|~|~|Mortality|7728847|Female Breast|2019
1-4|~|~|~|~|Incidence|7728847|Female Breast|2019
1-4|~|~|~|~|Incidence|7728847|Female Breast, <i>in situ</i>|2019
1-4|~|~|~|~|Mortality|15809112|Hodgkin Lymphoma|2019
1-4|~|~|~|~|Incidence|15809112|Hodgkin Lymphoma|2019
1-4|.|.|.|.|Mortality|15809112|Kaposi Sarcoma|2019
1-4|~|~|~|~|Incidence|15809112|Kaposi Sarcoma|2019
1-4|~|~|~|~|Mortality|15809112|Kidney and Renal Pelvis|2019
1-4|1.7|2.1|1.9|300|Incidence|15809112|Kidney and Renal Pelvis|2019
1-4|~|~|~|~|Mortality|15809112|Larynx|2019
1-4|~|~|~|~|Incidence|15809112|Larynx|2019
1-4|0.5|0.7|0.6|90|Mortality|15809112|Leukemias|2019
1-4|7.7|8.6|8.1|1284|Incidence|15809112|Leukemias|2019
1-4|~|~|~|~|Mortality|15809112|Liver and Intrahepatic Bile Duct|2019
1-4|0.5|0.8|0.7|105|Incidence|15809112|Liver and Intrahepatic Bile Duct|2019
1-4|~|~|~|~|Mortality|15809112|Lung and Bronchus|2019
1-4|0.1|0.2|0.1|16|Incidence|15809112|Lung and Bronchus|2019
1-4|~|~|~|~|Mortality|7728847|Male and Female Breast|2019
1-4|~|~|~|~|Incidence|7728847|Male and Female Breast|2019
1-4|~|~|~|~|Incidence|7728847|Male and Female Breast, <i>in situ</i>|2019
1-4|~|~|~|~|Mortality|15809112|Melanomas of the Skin|2019
1-4|0.1|0.2|0.1|18|Incidence|15809112|Melanomas of the Skin|2019
1-4|~|~|~|~|Mortality|15809112|Mesothelioma|2019
1-4|~|~|~|~|Incidence|15809112|Mesothelioma|2019
1-4|~|~|~|~|Mortality|15809112|Myeloma|2019
1-4|~|~|~|~|Incidence|15809112|Myeloma|2019
1-4|~|~|~|~|Mortality|15809112|Non-Hodgkin Lymphoma|2019
1-4|0.6|0.9|0.7|113|Incidence|15809112|Non-Hodgkin Lymphoma|2019
1-4|~|~|~|~|Mortality|15809112|Oral Cavity and Pharynx|2019
1-4|~|~|~|~|Incidence|15809112|Oral Cavity and Pharynx|2019
1-4|~|~|~|~|Mortality|7728847|Ovary|2019
1-4|~|~|~|~|Incidence|7728847|Ovary|2019
1-4|~|~|~|~|Mortality|15809112|Pancreas|2019
1-4|~|~|~|~|Incidence|15809112|Pancreas|2019
1-4|~|~|~|~|Mortality|8080265|Prostate|2019
1-4|~|~|~|~|Incidence|8080265|Prostate|2019
1-4|~|~|~|~|Mortality|15809112|Stomach|2019
1-4|~|~|~|~|Incidence|15809112|Stomach|2019
1-4|~|~|~|~|Mortality|8080265|Testis|2019
1-4|0.2|0.4|0.3|22|Incidence|8080265|Testis|2019
1-4|~|~|~|~|Mortality|15809112|Thyroid|2019
1-4|~|~|~|~|Incidence|15809112|Thyroid|2019
1-4|~|~|~|~|Mortality|15809112|Urinary Bladder|2019
1-4|~|~|~|~|Incidence|15809112|Urinary Bladder|2019
10-14|1.8|2.1|1.9|404|Mortality|20820053|All Cancer Sites Combined|2019
10-14|14.9|15.9|15.4|3202|Incidence|20820053|All Cancer Sites Combined|2019
10-14|0.6|0.8|0.7|141|Mortality|20820053|Brain and Other Nervous System|2019
10-14|2.5|3.0|2.7|566|Incidence|20820053|Brain and Other Nervous System|2019
10-14|~|~|~|~|Mortality|10190891|Cervix|2019
10-14|~|~|~|~|Incidence|10190891|Cervix|2019
10-14|~|~|~|~|Mortality|20820053|Colon and Rectum|2019
10-14|0.5|0.8|0.6|134|Incidence|20820053|Colon and Rectum|2019
10-14|~|~|~|~|Mortality|10190891|Corpus and Uterus, NOS|2019
10-14|~|~|~|~|Incidence|10190891|Corpus and Uterus, NOS|2019
10-14|~|~|~|~|Mortality|20820053|Esophagus|2019
10-14|~|~|~|~|Incidence|20820053|Esophagus|2019
10-14|~|~|~|~|Mortality|10190891|Female Breast|2019
10-14|~|~|~|~|Incidence|10190891|Female Breast|2019
10-14|~|~|~|~|Incidence|10190891|Female Breast, <i>in situ</i>|2019
10-14|~|~|~|~|Mortality|20820053|Hodgkin Lymphoma|2019
10-14|1.1|1.4|1.2|259|Incidence|20820053|Hodgkin Lymphoma|2019
10-14|.|.|.|.|Mortality|20820053|Kaposi Sarcoma|2019
10-14|~|~|~|~|Incidence|20820053|Kaposi Sarcoma|2019
10-14|~|~|~|~|Mortality|20820053|Kidney and Renal Pelvis|2019
10-14|0.1|0.2|0.1|28|Incidence|20820053|Kidney and Renal Pelvis|2019
10-14|~|~|~|~|Mortality|20820053|Larynx|2019
10-14|~|~|~|~|Incidence|20820053|Larynx|2019
10-14|0.4|0.6|0.5|109|Mortality|20820053|Leukemias|2019
10-14|3.2|3.7|3.4|707|Incidence|20820053|Leukemias|2019
10-14|~|~|~|~|Mortality|20820053|Liver and Intrahepatic Bile Duct|2019
10-14|0.1|0.2|0.1|25|Incidence|20820053|Liver and Intrahepatic Bile Duct|2019
10-14|~|~|~|~|Mortality|20820053|Lung and Bronchus|2019
10-14|0.0|0.1|0.1|16|Incidence|20820053|Lung and Bronchus|2019
10-14|~|~|~|~|Mortality|10190891|Male and Female Breast|2019
10-14|~|~|~|~|Incidence|10190891|Male and Female Breast|2019
10-14|~|~|~|~|Incidence|10190891|Male and Female Breast, <i>in situ</i>|2019
10-14|~|~|~|~|Mortality|20820053|Melanomas of the Skin|2019
10-14|0.2|0.3|0.2|48|Incidence|20820053|Melanomas of the Skin|2019
10-14|~|~|~|~|Mortality|20820053|Mesothelioma|2019
10-14|~|~|~|~|Incidence|20820053|Mesothelioma|2019
10-14|~|~|~|~|Mortality|20820053|Myeloma|2019
10-14|~|~|~|~|Incidence|20820053|Myeloma|2019
10-14|~|~|~|~|Mortality|20820053|Non-Hodgkin Lymphoma|2019
10-14|1.2|1.5|1.3|275|Incidence|20820053|Non-Hodgkin Lymphoma|2019
10-14|~|~|~|~|Mortality|20820053|Oral Cavity and Pharynx|2019
10-14|0.2|0.4|0.3|57|Incidence|20820053|Oral Cavity and Pharynx|2019
10-14|~|~|~|~|Mortality|10190891|Ovary|2019
10-14|0.5|0.9|0.7|69|Incidence|10190891|Ovary|2019
10-14|~|~|~|~|Mortality|20820053|Pancreas|2019
10-14|0.1|0.2|0.1|22|Incidence|20820053|Pancreas|2019
10-14|~|~|~|~|Mortality|10629162|Prostate|2019
10-14|~|~|~|~|Incidence|10629162|Prostate|2019
10-14|~|~|~|~|Mortality|20820053|Stomach|2019
10-14|~|~|~|~|Incidence|20820053|Stomach|2019
10-14|~|~|~|~|Mortality|10629162|Testis|2019
10-14|0.2|0.4|0.3|27|Incidence|10629162|Testis|2019
10-14|~|~|~|~|Mortality|20820053|Thyroid|2019
10-14|0.9|1.1|1.0|205|Incidence|20820053|Thyroid|2019
10-14|~|~|~|~|Mortality|20820053|Urinary Bladder|2019
10-14|~|~|~|~|Incidence|20820053|Urinary Bladder|2019
15-19|2.6|3.0|2.8|589|Mortality|21066423|All Cancer Sites Combined|2019
15-19|23.8|25.2|24.5|5163|Incidence|21066423|All Cancer Sites Combined|2019
15-19|0.5|0.7|0.6|132|Mortality|21066423|Brain and Other Nervous System|2019
15-19|2.0|2.4|2.2|470|Incidence|21066423|Brain and Other Nervous System|2019
15-19|~|~|~|~|Mortality|10313575|Cervix|2019
15-19|~|~|~|~|Incidence|10313575|Cervix|2019
15-19|~|~|~|~|Mortality|21066423|Colon and Rectum|2019
15-19|1.2|1.6|1.4|296|Incidence|21066423|Colon and Rectum|2019
15-19|~|~|~|~|Mortality|10313575|Corpus and Uterus, NOS|2019
15-19|~|~|~|~|Incidence|10313575|Corpus and Uterus, NOS|2019
15-19|~|~|~|~|Mortality|21066423|Esophagus|2019
15-19|~|~|~|~|Incidence|21066423|Esophagus|2019
15-19|~|~|~|~|Mortality|10313575|Female Breast|2019
15-19|0.1|0.3|0.2|24|Incidence|10313575|Female Breast|2019
15-19|~|~|~|~|Incidence|10313575|Female Breast, <i>in situ</i>|2019
15-19|~|~|~|~|Mortality|21066423|Hodgkin Lymphoma|2019
15-19|3.0|3.5|3.3|691|Incidence|21066423|Hodgkin Lymphoma|2019
15-19|.|.|.|.|Mortality|21066423|Kaposi Sarcoma|2019
15-19|~|~|~|~|Incidence|21066423|Kaposi Sarcoma|2019
15-19|~|~|~|~|Mortality|21066423|Kidney and Renal Pelvis|2019
15-19|0.2|0.3|0.3|53|Incidence|21066423|Kidney and Renal Pelvis|2019
15-19|~|~|~|~|Mortality|21066423|Larynx|2019
15-19|~|~|~|~|Incidence|21066423|Larynx|2019
15-19|0.4|0.6|0.5|113|Mortality|21066423|Leukemias|2019
15-19|2.9|3.4|3.1|656|Incidence|21066423|Leukemias|2019
15-19|0.1|0.1|0.1|18|Mortality|21066423|Liver and Intrahepatic Bile Duct|2019
15-19|0.1|0.2|0.1|29|Incidence|21066423|Liver and Intrahepatic Bile Duct|2019
15-19|~|~|~|~|Mortality|21066423|Lung and Bronchus|2019
15-19|0.1|0.2|0.1|31|Incidence|21066423|Lung and Bronchus|2019
15-19|~|~|~|~|Mortality|10313575|Male and Female Breast|2019
15-19|0.1|0.3|0.2|24|Incidence|10313575|Male and Female Breast|2019
15-19|~|~|~|~|Incidence|10313575|Male and Female Breast, <i>in situ</i>|2019
15-19|~|~|~|~|Mortality|21066423|Melanomas of the Skin|2019
15-19|0.6|0.9|0.7|157|Incidence|21066423|Melanomas of the Skin|2019
15-19|~|~|~|~|Mortality|21066423|Mesothelioma|2019
15-19|~|~|~|~|Incidence|21066423|Mesothelioma|2019
15-19|~|~|~|~|Mortality|21066423|Myeloma|2019
15-19|~|~|~|~|Incidence|21066423|Myeloma|2019
15-19|0.1|0.3|0.2|42|Mortality|21066423|Non-Hodgkin Lymphoma|2019
15-19|1.7|2.1|1.9|400|Incidence|21066423|Non-Hodgkin Lymphoma|2019
15-19|~|~|~|~|Mortality|21066423|Oral Cavity and Pharynx|2019
15-19|0.4|0.6|0.5|100|Incidence|21066423|Oral Cavity and Pharynx|2019
15-19|~|~|~|~|Mortality|10313575|Ovary|2019
15-19|1.0|1.4|1.2|124|Incidence|10313575|Ovary|2019
15-19|~|~|~|~|Mortality|21066423|Pancreas|2019
15-19|0.2|0.3|0.3|53|Incidence|21066423|Pancreas|2019
15-19|~|~|~|~|Mortality|10752848|Prostate|2019
15-19|~|~|~|~|Incidence|10752848|Prostate|2019
15-19|~|~|~|~|Mortality|21066423|Stomach|2019
15-19|~|~|~|~|Incidence|21066423|Stomach|2019
15-19|~|~|~|~|Mortality|10752848|Testis|2019
15-19|3.0|3.7|3.3|355|Incidence|10752848|Testis|2019
15-19|~|~|~|~|Mortality|21066423|Thyroid|2019
15-19|3.3|3.9|3.6|758|Incidence|21066423|Thyroid|2019
15-19|~|~|~|~|Mortality|21066423|Urinary Bladder|2019
15-19|0.0|0.1|0.1|16|Incidence|21066423|Urinary Bladder|2019
5-9|1.7|2.0|1.8|371|Mortality|20221753|All Cancer Sites Combined|2019
5-9|12.0|13.0|12.5|2528|Incidence|20221753|All Cancer Sites Combined|2019
5-9|0.6|0.9|0.8|153|Mortality|20221753|Brain and Other Nervous System|2019
5-9|3.0|3.6|3.3|666|Incidence|20221753|Brain and Other Nervous System|2019
5-9|~|~|~|~|Mortality|9886447|Cervix|2019
5-9|~|~|~|~|Incidence|9886447|Cervix|2019
5-9|~|~|~|~|Mortality|20221753|Colon and Rectum|2019
5-9|0.1|0.2|0.1|21|Incidence|20221753|Colon and Rectum|2019
5-9|~|~|~|~|Mortality|9886447|Corpus and Uterus, NOS|2019
5-9|~|~|~|~|Incidence|9886447|Corpus and Uterus, NOS|2019
5-9|~|~|~|~|Mortality|20221753|Esophagus|2019
5-9|~|~|~|~|Incidence|20221753|Esophagus|2019
5-9|~|~|~|~|Mortality|9886447|Female Breast|2019
5-9|~|~|~|~|Incidence|9886447|Female Breast|2019
5-9|~|~|~|~|Incidence|9886447|Female Breast, <i>in situ</i>|2019
5-9|~|~|~|~|Mortality|20221753|Hodgkin Lymphoma|2019
5-9|0.3|0.4|0.4|72|Incidence|20221753|Hodgkin Lymphoma|2019
5-9|.|.|.|.|Mortality|20221753|Kaposi Sarcoma|2019
5-9|~|~|~|~|Incidence|20221753|Kaposi Sarcoma|2019
5-9|~|~|~|~|Mortality|20221753|Kidney and Renal Pelvis|2019
5-9|0.4|0.6|0.5|101|Incidence|20221753|Kidney and Renal Pelvis|2019
5-9|~|~|~|~|Mortality|20221753|Larynx|2019
5-9|~|~|~|~|Incidence|20221753|Larynx|2019
5-9|0.3|0.5|0.4|80|Mortality|20221753|Leukemias|2019
5-9|3.8|4.4|4.1|827|Incidence|20221753|Leukemias|2019
5-9|~|~|~|~|Mortality|20221753|Liver and Intrahepatic Bile Duct|2019
5-9|0.1|0.2|0.1|27|Incidence|20221753|Liver and Intrahepatic Bile Duct|2019
5-9|~|~|~|~|Mortality|20221753|Lung and Bronchus|2019
5-9|~|~|~|~|Incidence|20221753|Lung and Bronchus|2019
5-9|~|~|~|~|Mortality|9886447|Male and Female Breast|2019
5-9|~|~|~|~|Incidence|9886447|Male and Female Breast|2019
5-9|~|~|~|~|Incidence|9886447|Male and Female Breast, <i>in situ</i>|2019
5-9|~|~|~|~|Mortality|20221753|Melanomas of the Skin|2019
5-9|0.1|0.2|0.1|21|Incidence|20221753|Melanomas of the Skin|2019
5-9|~|~|~|~|Mortality|20221753|Mesothelioma|2019
5-9|~|~|~|~|Incidence|20221753|Mesothelioma|2019
5-9|~|~|~|~|Mortality|20221753|Myeloma|2019
5-9|~|~|~|~|Incidence|20221753|Myeloma|2019
5-9|~|~|~|~|Mortality|20221753|Non-Hodgkin Lymphoma|2019
5-9|0.8|1.1|1.0|193|Incidence|20221753|Non-Hodgkin Lymphoma|2019
5-9|~|~|~|~|Mortality|20221753|Oral Cavity and Pharynx|2019
5-9|0.1|0.1|0.1|19|Incidence|20221753|Oral Cavity and Pharynx|2019
5-9|~|~|~|~|Mortality|9886447|Ovary|2019
5-9|0.2|0.5|0.3|34|Incidence|9886447|Ovary|2019
5-9|~|~|~|~|Mortality|20221753|Pancreas|2019
5-9|~|~|~|~|Incidence|20221753|Pancreas|2019
5-9|~|~|~|~|Mortality|10335306|Prostate|2019
5-9|~|~|~|~|Incidence|10335306|Prostate|2019
5-9|~|~|~|~|Mortality|20221753|Stomach|2019
5-9|~|~|~|~|Incidence|20221753|Stomach|2019
5-9|~|~|~|~|Mortality|10335306|Testis|2019
5-9|~|~|~|~|Incidence|10335306|Testis|2019
5-9|~|~|~|~|Mortality|20221753|Thyroid|2019
5-9|0.1|0.2|0.2|36|Incidence|20221753|Thyroid|2019
5-9|~|~|~|~|Mortality|20221753|Urinary Bladder|2019
5-9|~|~|~|~|Incidence|20221753|Urinary Bladder|2019
<1|1.1|1.9|1.5|55|Mortality|3762227|All Cancer Sites Combined|2019
<1|24.3|27.6|25.9|976|Incidence|3762227|All Cancer Sites Combined|2019
<1|0.3|0.7|0.5|17|Mortality|3762227|Brain and Other Nervous System|2019
<1|2.6|3.8|3.2|119|Incidence|3762227|Brain and Other Nervous System|2019
<1|~|~|~|~|Mortality|1841226|Cervix|2019
<1|~|~|~|~|Incidence|1841226|Cervix|2019
<1|~|~|~|~|Mortality|3762227|Colon and Rectum|2019
<1|~|~|~|~|Incidence|3762227|Colon and Rectum|2019
<1|~|~|~|~|Mortality|1841226|Corpus and Uterus, NOS|2019
<1|~|~|~|~|Incidence|1841226|Corpus and Uterus, NOS|2019
<1|~|~|~|~|Mortality|3762227|Esophagus|2019
<1|~|~|~|~|Incidence|3762227|Esophagus|2019
<1|~|~|~|~|Mortality|1841226|Female Breast|2019
<1|~|~|~|~|Incidence|1841226|Female Breast|2019
<1|~|~|~|~|Incidence|1841226|Female Breast, <i>in situ</i>|2019
<1|~|~|~|~|Mortality|3762227|Hodgkin Lymphoma|2019
<1|~|~|~|~|Incidence|3762227|Hodgkin Lymphoma|2019
<1|.|.|.|.|Mortality|3762227|Kaposi Sarcoma|2019
<1|~|~|~|~|Incidence|3762227|Kaposi Sarcoma|2019
<1|~|~|~|~|Mortality|3762227|Kidney and Renal Pelvis|2019
<1|1.1|2.0|1.5|57|Incidence|3762227|Kidney and Renal Pelvis|2019
<1|~|~|~|~|Mortality|3762227|Larynx|2019
<1|~|~|~|~|Incidence|3762227|Larynx|2019
<1|~|~|~|~|Mortality|3762227|Leukemias|2019
<1|3.3|4.6|3.9|146|Incidence|3762227|Leukemias|2019
<1|~|~|~|~|Mortality|3762227|Liver and Intrahepatic Bile Duct|2019
<1|1.2|2.1|1.6|60|Incidence|3762227|Liver and Intrahepatic Bile Duct|2019
<1|~|~|~|~|Mortality|3762227|Lung and Bronchus|2019
<1|~|~|~|~|Incidence|3762227|Lung and Bronchus|2019
<1|~|~|~|~|Mortality|1841226|Male and Female Breast|2019
<1|~|~|~|~|Incidence|1841226|Male and Female Breast|2019
<1|~|~|~|~|Incidence|1841226|Male and Female Breast, <i>in situ</i>|2019
<1|~|~|~|~|Mortality|3762227|Melanomas of the Skin|2019
<1|~|~|~|~|Incidence|3762227|Melanomas of the Skin|2019
<1|~|~|~|~|Mortality|3762227|Mesothelioma|2019
<1|~|~|~|~|Incidence|3762227|Mesothelioma|2019
<1|~|~|~|~|Mortality|3762227|Myeloma|2019
<1|~|~|~|~|Incidence|3762227|Myeloma|2019
<1|~|~|~|~|Mortality|3762227|Non-Hodgkin Lymphoma|2019
<1|~|~|~|~|Incidence|3762227|Non-Hodgkin Lymphoma|2019
<1|~|~|~|~|Mortality|3762227|Oral Cavity and Pharynx|2019
<1|~|~|~|~|Incidence|3762227|Oral Cavity and Pharynx|2019
<1|~|~|~|~|Mortality|1841226|Ovary|2019
<1|~|~|~|~|Incidence|1841226|Ovary|2019
<1|~|~|~|~|Mortality|3762227|Pancreas|2019
<1|~|~|~|~|Incidence|3762227|Pancreas|2019
<1|~|~|~|~|Mortality|1921001|Prostate|2019
<1|~|~|~|~|Incidence|1921001|Prostate|2019
<1|~|~|~|~|Mortality|3762227|Stomach|2019
<1|~|~|~|~|Incidence|3762227|Stomach|2019
<1|~|~|~|~|Mortality|1921001|Testis|2019
<1|~|~|~|~|Incidence|1921001|Testis|2019
<1|~|~|~|~|Mortality|3762227|Thyroid|2019
<1|~|~|~|~|Incidence|3762227|Thyroid|2019
<1|~|~|~|~|Mortality|3762227|Urinary Bladder|2019
<1|~|~|~|~|Incidence|3762227|Urinary Bladder|2019
1-4|1.8|2.2|2.0|307|Mortality|15566282|All Cancer Sites Combined|2020
1-4|20.2|21.7|20.9|3157|Incidence|15082362|All Cancer Sites Combined|2020
1-4|0.4|0.6|0.5|73|Mortality|15566282|Brain and Other Nervous System|2020
1-4|3.2|3.8|3.5|528|Incidence|15082362|Brain and Other Nervous System|2020
1-4|~|~|~|~|Mortality|7613266|Cervix|2020
1-4|~|~|~|~|Incidence|7377169|Cervix|2020
1-4|~|~|~|~|Mortality|15566282|Colon and Rectum|2020
1-4|~|~|~|~|Incidence|15082362|Colon and Rectum|2020
1-4|~|~|~|~|Mortality|7613266|Corpus and Uterus, NOS|2020
1-4|~|~|~|~|Incidence|7377169|Corpus and Uterus, NOS|2020
1-4|~|~|~|~|Mortality|15566282|Esophagus|2020
1-4|~|~|~|~|Incidence|15082362|Esophagus|2020
1-4|~|~|~|~|Mortality|7613266|Female Breast|2020
1-4|~|~|~|~|Incidence|7377169|Female Breast|2020
1-4|~|~|~|~|Incidence|7377169|Female Breast, <i>in situ</i>|2020
1-4|~|~|~|~|Mortality|15566282|Hodgkin Lymphoma|2020
1-4|~|~|~|~|Incidence|15082362|Hodgkin Lymphoma|2020
1-4|.|.|.|.|Mortality|15566282|Kaposi Sarcoma|2020
1-4|~|~|~|~|Incidence|15082362|Kaposi Sarcoma|2020
1-4|~|~|~|~|Mortality|15566282|Kidney and Renal Pelvis|2020
1-4|1.9|2.3|2.1|316|Incidence|15082362|Kidney and Renal Pelvis|2020
1-4|~|~|~|~|Mortality|15566282|Larynx|2020
1-4|~|~|~|~|Incidence|15082362|Larynx|2020
1-4|0.4|0.7|0.5|85|Mortality|15566282|Leukemias|2020
1-4|7.9|8.9|8.4|1265|Incidence|15082362|Leukemias|2020
1-4|~|~|~|~|Mortality|15566282|Liver and Intrahepatic Bile Duct|2020
1-4|0.6|0.9|0.7|106|Incidence|15082362|Liver and Intrahepatic Bile Duct|2020
1-4|~|~|~|~|Mortality|15566282|Lung and Bronchus|2020
1-4|~|~|~|~|Incidence|15082362|Lung and Bronchus|2020
1-4|~|~|~|~|Mortality|7613266|Male and Female Breast|2020
1-4|~|~|~|~|Incidence|7377169|Male and Female Breast|2020
1-4|~|~|~|~|Incidence|7377169|Male and Female Breast, <i>in situ</i>|2020
1-4|~|~|~|~|Mortality|15566282|Melanomas of the Skin|2020
1-4|~|~|~|~|Incidence|15082362|Melanomas of the Skin|2020
1-4|~|~|~|~|Mortality|15566282|Mesothelioma|2020
1-4|~|~|~|~|Incidence|15082362|Mesothelioma|2020
1-4|~|~|~|~|Mortality|15566282|Myeloma|2020
1-4|~|~|~|~|Incidence|15082362|Myeloma|2020
1-4|~|~|~|~|Mortality|15566282|Non-Hodgkin Lymphoma|2020
1-4|0.6|0.9|0.7|113|Incidence|15082362|Non-Hodgkin Lymphoma|2020
1-4|~|~|~|~|Mortality|15566282|Oral Cavity and Pharynx|2020
1-4|~|~|~|~|Incidence|15082362|Oral Cavity and Pharynx|2020
1-4|~|~|~|~|Mortality|7613266|Ovary|2020
1-4|~|~|~|~|Incidence|7377169|Ovary|2020
1-4|~|~|~|~|Mortality|15566282|Pancreas|2020
1-4|~|~|~|~|Incidence|15082362|Pancreas|2020
1-4|~|~|~|~|Mortality|7953016|Prostate|2020
1-4|~|~|~|~|Incidence|7705193|Prostate|2020
1-4|~|~|~|~|Mortality|15566282|Stomach|2020
1-4|~|~|~|~|Incidence|15082362|Stomach|2020
1-4|~|~|~|~|Mortality|7953016|Testis|2020
1-4|0.2|0.5|0.4|27|Incidence|7705193|Testis|2020
1-4|~|~|~|~|Mortality|15566282|Thyroid|2020
1-4|~|~|~|~|Incidence|15082362|Thyroid|2020
1-4|~|~|~|~|Mortality|15566282|Urinary Bladder|2020
1-4|~|~|~|~|Incidence|15082362|Urinary Bladder|2020
10-14|1.8|2.2|2.0|410|Mortality|20754423|All Cancer Sites Combined|2020
10-14|13.7|14.7|14.2|2857|Incidence|20107666|All Cancer Sites Combined|2020
10-14|0.5|0.7|0.6|121|Mortality|20754423|Brain and Other Nervous System|2020
10-14|2.3|2.8|2.5|509|Incidence|20107666|Brain and Other Nervous System|2020
10-14|~|~|~|~|Mortality|10159455|Cervix|2020
10-14|~|~|~|~|Incidence|9842471|Cervix|2020
10-14|~|~|~|~|Mortality|20754423|Colon and Rectum|2020
10-14|0.5|0.8|0.6|130|Incidence|20107666|Colon and Rectum|2020
10-14|~|~|~|~|Mortality|10159455|Corpus and Uterus, NOS|2020
10-14|~|~|~|~|Incidence|9842471|Corpus and Uterus, NOS|2020
10-14|~|~|~|~|Mortality|20754423|Esophagus|2020
10-14|~|~|~|~|Incidence|20107666|Esophagus|2020
10-14|~|~|~|~|Mortality|10159455|Female Breast|2020
10-14|~|~|~|~|Incidence|9842471|Female Breast|2020
10-14|~|~|~|~|Incidence|9842471|Female Breast, <i>in situ</i>|2020
10-14|~|~|~|~|Mortality|20754423|Hodgkin Lymphoma|2020
10-14|1.0|1.3|1.2|236|Incidence|20107666|Hodgkin Lymphoma|2020
10-14|.|.|.|.|Mortality|20754423|Kaposi Sarcoma|2020
10-14|~|~|~|~|Incidence|20107666|Kaposi Sarcoma|2020
10-14|~|~|~|~|Mortality|20754423|Kidney and Renal Pelvis|2020
10-14|0.1|0.2|0.2|36|Incidence|20107666|Kidney and Renal Pelvis|2020
10-14|~|~|~|~|Mortality|20754423|Larynx|2020
10-14|~|~|~|~|Incidence|20107666|Larynx|2020
10-14|0.4|0.6|0.5|98|Mortality|20754423|Leukemias|2020
10-14|3.0|3.5|3.3|660|Incidence|20107666|Leukemias|2020
10-14|~|~|~|~|Mortality|20754423|Liver and Intrahepatic Bile Duct|2020
10-14|0.1|0.2|0.1|22|Incidence|20107666|Liver and Intrahepatic Bile Duct|2020
10-14|~|~|~|~|Mortality|20754423|Lung and Bronchus|2020
10-14|~|~|~|~|Incidence|20107666|Lung and Bronchus|2020
10-14|~|~|~|~|Mortality|10159455|Male and Female Breast|2020
10-14|~|~|~|~|Incidence|9842471|Male and Female Breast|2020
10-14|~|~|~|~|Incidence|9842471|Male and Female Breast, <i>in situ</i>|2020
10-14|~|~|~|~|Mortality|20754423|Melanomas of the Skin|2020
10-14|0.1|0.3|0.2|37|Incidence|20107666|Melanomas of the Skin|2020
10-14|~|~|~|~|Mortality|20754423|Mesothelioma|2020
10-14|~|~|~|~|Incidence|20107666|Mesothelioma|2020
10-14|~|~|~|~|Mortality|20754423|Myeloma|2020
10-14|~|~|~|~|Incidence|20107666|Myeloma|2020
10-14|~|~|~|~|Mortality|20754423|Non-Hodgkin Lymphoma|2020
10-14|1.1|1.4|1.3|257|Incidence|20107666|Non-Hodgkin Lymphoma|2020
10-14|~|~|~|~|Mortality|20754423|Oral Cavity and Pharynx|2020
10-14|0.1|0.3|0.2|39|Incidence|20107666|Oral Cavity and Pharynx|2020
10-14|~|~|~|~|Mortality|10159455|Ovary|2020
10-14|0.8|1.2|1.0|94|Incidence|9842471|Ovary|2020
10-14|~|~|~|~|Mortality|20754423|Pancreas|2020
10-14|0.0|0.1|0.1|17|Incidence|20107666|Pancreas|2020
10-14|~|~|~|~|Mortality|10594968|Prostate|2020
10-14|~|~|~|~|Incidence|10265195|Prostate|2020
10-14|~|~|~|~|Mortality|20754423|Stomach|2020
10-14|~|~|~|~|Incidence|20107666|Stomach|2020
10-14|~|~|~|~|Mortality|10594968|Testis|2020
10-14|0.2|0.4|0.2|25|Incidence|10265195|Testis|2020
10-14|~|~|~|~|Mortality|20754423|Thyroid|2020
10-14|0.6|0.9|0.8|152|Incidence|20107666|Thyroid|2020
10-14|~|~|~|~|Mortality|20754423|Urinary Bladder|2020
10-14|~|~|~|~|Incidence|20107666|Urinary Bladder|2020
15-19|2.4|2.8|2.6|549|Mortality|20960929|All Cancer Sites Combined|2020
15-19|22.1|23.5|22.8|4632|Incidence|20322846|All Cancer Sites Combined|2020
15-19|0.5|0.7|0.6|129|Mortality|20960929|Brain and Other Nervous System|2020
15-19|2.1|2.5|2.3|466|Incidence|20322846|Brain and Other Nervous System|2020
15-19|~|~|~|~|Mortality|10266332|Cervix|2020
15-19|~|~|~|~|Incidence|9955751|Cervix|2020
15-19|~|~|~|~|Mortality|20960929|Colon and Rectum|2020
15-19|1.1|1.4|1.3|259|Incidence|20322846|Colon and Rectum|2020
15-19|~|~|~|~|Mortality|10266332|Corpus and Uterus, NOS|2020
15-19|~|~|~|~|Incidence|9955751|Corpus and Uterus, NOS|2020
15-19|~|~|~|~|Mortality|20960929|Esophagus|2020
15-19|~|~|~|~|Incidence|20322846|Esophagus|2020
15-19|~|~|~|~|Mortality|10266332|Female Breast|2020
15-19|~|~|~|~|Incidence|9955751|Female Breast|2020
15-19|~|~|~|~|Incidence|9955751|Female Breast, <i>in situ</i>|2020
15-19|~|~|~|~|Mortality|20960929|Hodgkin Lymphoma|2020
15-19|2.8|3.3|3.0|619|Incidence|20322846|Hodgkin Lymphoma|2020
15-19|.|.|.|.|Mortality|20960929|Kaposi Sarcoma|2020
15-19|~|~|~|~|Incidence|20322846|Kaposi Sarcoma|2020
15-19|~|~|~|~|Mortality|20960929|Kidney and Renal Pelvis|2020
15-19|0.2|0.3|0.2|44|Incidence|20322846|Kidney and Renal Pelvis|2020
15-19|~|~|~|~|Mortality|20960929|Larynx|2020
15-19|~|~|~|~|Incidence|20322846|Larynx|2020
15-19|0.5|0.7|0.6|116|Mortality|20960929|Leukemias|2020
15-19|2.7|3.2|3.0|603|Incidence|20322846|Leukemias|2020
15-19|~|~|~|~|Mortality|20960929|Liver and Intrahepatic Bile Duct|2020
15-19|0.1|0.2|0.2|32|Incidence|20322846|Liver and Intrahepatic Bile Duct|2020
15-19|~|~|~|~|Mortality|20960929|Lung and Bronchus|2020
15-19|0.1|0.2|0.1|28|Incidence|20322846|Lung and Bronchus|2020
15-19|~|~|~|~|Mortality|10266332|Male and Female Breast|2020
15-19|~|~|~|~|Incidence|9955751|Male and Female Breast|2020
15-19|~|~|~|~|Incidence|9955751|Male and Female Breast, <i>in situ</i>|2020
15-19|~|~|~|~|Mortality|20960929|Melanomas of the Skin|2020
15-19|0.5|0.8|0.6|130|Incidence|20322846|Melanomas of the Skin|2020
15-19|~|~|~|~|Mortality|20960929|Mesothelioma|2020
15-19|~|~|~|~|Incidence|20322846|Mesothelioma|2020
15-19|~|~|~|~|Mortality|20960929|Myeloma|2020
15-19|~|~|~|~|Incidence|20322846|Myeloma|2020
15-19|0.0|0.1|0.1|16|Mortality|20960929|Non-Hodgkin Lymphoma|2020
15-19|1.7|2.1|1.9|382|Incidence|20322846|Non-Hodgkin Lymphoma|2020
15-19|~|~|~|~|Mortality|20960929|Oral Cavity and Pharynx|2020
15-19|0.3|0.5|0.4|81|Incidence|20322846|Oral Cavity and Pharynx|2020
15-19|~|~|~|~|Mortality|10266332|Ovary|2020
15-19|1.1|1.5|1.3|128|Incidence|9955751|Ovary|2020
15-19|~|~|~|~|Mortality|20960929|Pancreas|2020
15-19|0.1|0.2|0.2|35|Incidence|20322846|Pancreas|2020
15-19|~|~|~|~|Mortality|10694597|Prostate|2020
15-19|~|~|~|~|Incidence|10367095|Prostate|2020
15-19|~|~|~|~|Mortality|20960929|Stomach|2020
15-19|0.1|0.2|0.1|22|Incidence|20322846|Stomach|2020
15-19|~|~|~|~|Mortality|10694597|Testis|2020
15-19|3.1|3.9|3.5|361|Incidence|10367095|Testis|2020
15-19|~|~|~|~|Mortality|20960929|Thyroid|2020
15-19|2.6|3.1|2.8|578|Incidence|20322846|Thyroid|2020
15-19|~|~|~|~|Mortality|20960929|Urinary Bladder|2020
15-19|0.1|0.1|0.1|19|Incidence|20322846|Urinary Bladder|2020
5-9|1.7|2.1|1.9|382|Mortality|20237711|All Cancer Sites Combined|2020
5-9|11.6|12.6|12.1|2379|Incidence|19608494|All Cancer Sites Combined|2020
5-9|0.8|1.1|0.9|189|Mortality|20237711|Brain and Other Nervous System|2020
5-9|2.8|3.3|3.0|594|Incidence|19608494|Brain and Other Nervous System|2020
5-9|~|~|~|~|Mortality|9890958|Cervix|2020
5-9|~|~|~|~|Incidence|9584236|Cervix|2020
5-9|~|~|~|~|Mortality|20237711|Colon and Rectum|2020
5-9|0.1|0.1|0.1|18|Incidence|19608494|Colon and Rectum|2020
5-9|~|~|~|~|Mortality|9890958|Corpus and Uterus, NOS|2020
5-9|~|~|~|~|Incidence|9584236|Corpus and Uterus, NOS|2020
5-9|~|~|~|~|Mortality|20237711|Esophagus|2020
5-9|~|~|~|~|Incidence|19608494|Esophagus|2020
5-9|~|~|~|~|Mortality|9890958|Female Breast|2020
5-9|~|~|~|~|Incidence|9584236|Female Breast|2020
5-9|~|~|~|~|Incidence|9584236|Female Breast, <i>in situ</i>|2020
5-9|~|~|~|~|Mortality|20237711|Hodgkin Lymphoma|2020
5-9|0.3|0.4|0.3|65|Incidence|19608494|Hodgkin Lymphoma|2020
5-9|.|.|.|.|Mortality|20237711|Kaposi Sarcoma|2020
5-9|~|~|~|~|Incidence|19608494|Kaposi Sarcoma|2020
5-9|~|~|~|~|Mortality|20237711|Kidney and Renal Pelvis|2020
5-9|0.5|0.8|0.7|128|Incidence|19608494|Kidney and Renal Pelvis|2020
5-9|~|~|~|~|Mortality|20237711|Larynx|2020
5-9|~|~|~|~|Incidence|19608494|Larynx|2020
5-9|0.3|0.5|0.4|73|Mortality|20237711|Leukemias|2020
5-9|4.0|4.5|4.2|832|Incidence|19608494|Leukemias|2020
5-9|~|~|~|~|Mortality|20237711|Liver and Intrahepatic Bile Duct|2020
5-9|0.1|0.2|0.1|25|Incidence|19608494|Liver and Intrahepatic Bile Duct|2020
5-9|~|~|~|~|Mortality|20237711|Lung and Bronchus|2020
5-9|~|~|~|~|Incidence|19608494|Lung and Bronchus|2020
5-9|~|~|~|~|Mortality|9890958|Male and Female Breast|2020
5-9|~|~|~|~|Incidence|9584236|Male and Female Breast|2020
5-9|~|~|~|~|Incidence|9584236|Male and Female Breast, <i>in situ</i>|2020
5-9|~|~|~|~|Mortality|20237711|Melanomas of the Skin|2020
5-9|~|~|~|~|Incidence|19608494|Melanomas of the Skin|2020
5-9|~|~|~|~|Mortality|20237711|Mesothelioma|2020
5-9|~|~|~|~|Incidence|19608494|Mesothelioma|2020
5-9|~|~|~|~|Mortality|20237711|Myeloma|2020
5-9|~|~|~|~|Incidence|19608494|Myeloma|2020
5-9|~|~|~|~|Mortality|20237711|Non-Hodgkin Lymphoma|2020
5-9|0.9|1.1|1.0|195|Incidence|19608494|Non-Hodgkin Lymphoma|2020
5-9|~|~|~|~|Mortality|20237711|Oral Cavity and Pharynx|2020
5-9|0.1|0.2|0.1|21|Incidence|19608494|Oral Cavity and Pharynx|2020
5-9|~|~|~|~|Mortality|9890958|Ovary|2020
5-9|0.1|0.3|0.2|16|Incidence|9584236|Ovary|2020
5-9|~|~|~|~|Mortality|20237711|Pancreas|2020
5-9|~|~|~|~|Incidence|19608494|Pancreas|2020
5-9|~|~|~|~|Mortality|10346753|Prostate|2020
5-9|~|~|~|~|Incidence|10024258|Prostate|2020
5-9|~|~|~|~|Mortality|20237711|Stomach|2020
5-9|~|~|~|~|Incidence|19608494|Stomach|2020
5-9|~|~|~|~|Mortality|10346753|Testis|2020
5-9|~|~|~|~|Incidence|10024258|Testis|2020
5-9|~|~|~|~|Mortality|20237711|Thyroid|2020
5-9|~|~|~|~|Incidence|19608494|Thyroid|2020
5-9|~|~|~|~|Mortality|20237711|Urinary Bladder|2020
5-9|~|~|~|~|Incidence|19608494|Urinary Bladder|2020
<1|1.1|1.9|1.4|54|Mortality|3735010|All Cancer Sites Combined|2020
<1|23.5|26.8|25.1|908|Incidence|3618856|All Cancer Sites Combined|2020
<1|~|~|~|~|Mortality|3735010|Brain and Other Nervous System|2020
<1|3.1|4.4|3.7|135|Incidence|3618856|Brain and Other Nervous System|2020
<1|~|~|~|~|Mortality|1826869|Cervix|2020
<1|~|~|~|~|Incidence|1770114|Cervix|2020
<1|~|~|~|~|Mortality|3735010|Colon and Rectum|2020
<1|~|~|~|~|Incidence|3618856|Colon and Rectum|2020
<1|~|~|~|~|Mortality|1826869|Corpus and Uterus, NOS|2020
<1|~|~|~|~|Incidence|1770114|Corpus and Uterus, NOS|2020
<1|~|~|~|~|Mortality|3735010|Esophagus|2020
<1|~|~|~|~|Incidence|3618856|Esophagus|2020
<1|~|~|~|~|Mortality|1826869|Female Breast|2020
<1|~|~|~|~|Incidence|1770114|Female Breast|2020
<1|~|~|~|~|Incidence|1770114|Female Breast, <i>in situ</i>|2020
<1|~|~|~|~|Mortality|3735010|Hodgkin Lymphoma|2020
<1|~|~|~|~|Incidence|3618856|Hodgkin Lymphoma|2020
<1|.|.|.|.|Mortality|3735010|Kaposi Sarcoma|2020
<1|~|~|~|~|Incidence|3618856|Kaposi Sarcoma|2020
<1|~|~|~|~|Mortality|3735010|Kidney and Renal Pelvis|2020
<1|1.1|1.9|1.5|53|Incidence|3618856|Kidney and Renal Pelvis|2020
<1|~|~|~|~|Mortality|3735010|Larynx|2020
<1|~|~|~|~|Incidence|3618856|Larynx|2020
<1|0.3|0.8|0.5|20|Mortality|3735010|Leukemias|2020
<1|3.2|4.5|3.8|138|Incidence|3618856|Leukemias|2020
<1|~|~|~|~|Mortality|3735010|Liver and Intrahepatic Bile Duct|2020
<1|1.0|1.8|1.4|50|Incidence|3618856|Liver and Intrahepatic Bile Duct|2020
<1|~|~|~|~|Mortality|3735010|Lung and Bronchus|2020
<1|~|~|~|~|Incidence|3618856|Lung and Bronchus|2020
<1|~|~|~|~|Mortality|1826869|Male and Female Breast|2020
<1|~|~|~|~|Incidence|1770114|Male and Female Breast|2020
<1|~|~|~|~|Incidence|1770114|Male and Female Breast, <i>in situ</i>|2020
<1|~|~|~|~|Mortality|3735010|Melanomas of the Skin|2020
<1|~|~|~|~|Incidence|3618856|Melanomas of the Skin|2020
<1|~|~|~|~|Mortality|3735010|Mesothelioma|2020
<1|~|~|~|~|Incidence|3618856|Mesothelioma|2020
<1|~|~|~|~|Mortality|3735010|Myeloma|2020
<1|~|~|~|~|Incidence|3618856|Myeloma|2020
<1|~|~|~|~|Mortality|3735010|Non-Hodgkin Lymphoma|2020
<1|~|~|~|~|Incidence|3618856|Non-Hodgkin Lymphoma|2020
<1|~|~|~|~|Mortality|3735010|Oral Cavity and Pharynx|2020
<1|~|~|~|~|Incidence|3618856|Oral Cavity and Pharynx|2020
<1|~|~|~|~|Mortality|1826869|Ovary|2020
<1|~|~|~|~|Incidence|1770114|Ovary|2020
<1|~|~|~|~|Mortality|3735010|Pancreas|2020
<1|~|~|~|~|Incidence|3618856|Pancreas|2020
<1|~|~|~|~|Mortality|1908141|Prostate|2020
<1|~|~|~|~|Incidence|1848742|Prostate|2020
<1|~|~|~|~|Mortality|3735010|Stomach|2020
<1|~|~|~|~|Incidence|3618856|Stomach|2020
<1|~|~|~|~|Mortality|1908141|Testis|2020
<1|~|~|~|~|Incidence|1848742|Testis|2020
<1|~|~|~|~|Mortality|3735010|Thyroid|2020
<1|~|~|~|~|Incidence|3618856|Thyroid|2020
<1|~|~|~|~|Mortality|3735010|Urinary Bladder|2020
<1|~|~|~|~|Incidence|3618856|Urinary Bladder|2020
1-4|0.2|0.4|0.3|44|Mortality|15339782|Acute Lymphocytic|1999
1-4|6.2|7.0|6.6|999|Incidence|15136428|Acute Lymphocytic|1999
1-4|0.2|0.4|0.3|50|Mortality|15339782|Acute Myeloid|1999
1-4|0.8|1.1|1.0|146|Incidence|15136428|Acute Myeloid|1999
1-4|~|~|~|~|Mortality|15339782|Bones and Joints|1999
1-4|0.1|0.3|0.2|32|Incidence|15136428|Bones and Joints|1999
1-4|0.6|0.9|0.8|119|Mortality|15339782|Leukemia|1999
1-4|7.5|8.4|7.9|1201|Incidence|15136428|Leukemia|1999
1-4|0.7|1.0|0.8|129|Mortality|15339782|Other|1999
1-4|3.7|4.4|4.0|611|Incidence|15136428|Other|1999
1-4|0.1|0.2|0.1|18|Mortality|15339782|Soft Tissue|1999
1-4|0.8|1.1|0.9|142|Incidence|15136428|Soft Tissue|1999
10-14|0.3|0.5|0.4|75|Mortality|20213364|Acute Lymphocytic|1999
10-14|1.8|2.2|2.0|394|Incidence|19935660|Acute Lymphocytic|1999
10-14|0.2|0.3|0.3|54|Mortality|20213364|Acute Myeloid|1999
10-14|0.5|0.7|0.6|117|Incidence|19935660|Acute Myeloid|1999
10-14|0.2|0.4|0.3|55|Mortality|20213364|Bones and Joints|1999
10-14|1.2|1.6|1.4|281|Incidence|19935660|Bones and Joints|1999
10-14|0.7|1.0|0.9|175|Mortality|20213364|Leukemia|1999
10-14|2.6|3.1|2.8|566|Incidence|19935660|Leukemia|1999
10-14|0.3|0.4|0.3|68|Mortality|20213364|Other|1999
10-14|2.2|2.6|2.4|474|Incidence|19935660|Other|1999
10-14|0.1|0.3|0.2|37|Mortality|20213364|Soft Tissue|1999
10-14|0.6|0.8|0.7|136|Incidence|19935660|Soft Tissue|1999
15-19|0.4|0.6|0.5|91|Mortality|20084602|Acute Lymphocytic|1999
15-19|1.2|1.5|1.3|265|Incidence|19785979|Acute Lymphocytic|1999
15-19|0.3|0.4|0.3|66|Mortality|20084602|Acute Myeloid|1999
15-19|0.7|1.0|0.9|171|Incidence|19785979|Acute Myeloid|1999
15-19|0.5|0.8|0.6|127|Mortality|20084602|Bones and Joints|1999
15-19|1.2|1.6|1.4|275|Incidence|19785979|Bones and Joints|1999
15-19|1.0|1.3|1.1|221|Mortality|20084602|Leukemia|1999
15-19|2.4|2.9|2.7|526|Incidence|19785979|Leukemia|1999
15-19|0.5|0.8|0.6|127|Mortality|20084602|Other|1999
15-19|7.4|8.2|7.8|1544|Incidence|19785979|Other|1999
15-19|0.2|0.4|0.3|65|Mortality|20084602|Soft Tissue|1999
15-19|0.9|1.1|1.0|197|Incidence|19785979|Soft Tissue|1999
5-9|0.2|0.4|0.3|65|Mortality|20606460|Acute Lymphocytic|1999
5-9|2.7|3.2|3.0|600|Incidence|20334315|Acute Lymphocytic|1999
5-9|0.1|0.2|0.1|29|Mortality|20606460|Acute Myeloid|1999
5-9|0.4|0.6|0.5|92|Incidence|20334315|Acute Myeloid|1999
5-9|0.1|0.2|0.1|24|Mortality|20606460|Bones and Joints|1999
5-9|0.5|0.7|0.6|118|Incidence|20334315|Bones and Joints|1999
5-9|0.5|0.7|0.6|130|Mortality|20606460|Leukemia|1999
5-9|3.3|3.9|3.6|731|Incidence|20334315|Leukemia|1999
5-9|0.4|0.6|0.5|108|Mortality|20606460|Other|1999
5-9|1.0|1.3|1.2|235|Incidence|20334315|Other|1999
5-9|0.1|0.2|0.1|28|Mortality|20606460|Soft Tissue|1999
5-9|0.5|0.7|0.6|112|Incidence|20334315|Soft Tissue|1999
<1|~|~|~|~|Mortality|3795762|Acute Lymphocytic|1999
<1|1.7|2.7|2.2|81|Incidence|3744604|Acute Lymphocytic|1999
<1|~|~|~|~|Mortality|3795762|Acute Myeloid|1999
<1|0.9|1.6|1.2|44|Incidence|3744604|Acute Myeloid|1999
<1|~|~|~|~|Mortality|3795762|Bones and Joints|1999
<1|~|~|~|~|Incidence|3744604|Bones and Joints|1999
<1|0.5|1.0|0.7|27|Mortality|3795762|Leukemia|1999
<1|3.7|5.1|4.4|163|Incidence|3744604|Leukemia|1999
<1|0.4|0.9|0.6|23|Mortality|3795762|Other|1999
<1|9.6|11.7|10.6|397|Incidence|3744604|Other|1999
<1|~|~|~|~|Mortality|3795762|Soft Tissue|1999
<1|2.3|3.4|2.8|104|Incidence|3744604|Soft Tissue|1999
1-4|0.2|0.4|0.3|48|Mortality|15322337|Acute Lymphocytic|2000
1-4|6.8|7.7|7.2|1090|Incidence|15119430|Acute Lymphocytic|2000
1-4|0.3|0.5|0.4|56|Mortality|15322337|Acute Myeloid|2000
1-4|0.7|1.0|0.8|123|Incidence|15119430|Acute Myeloid|2000
1-4|~|~|~|~|Mortality|15322337|Bones and Joints|2000
1-4|0.1|0.2|0.2|23|Incidence|15119430|Bones and Joints|2000
1-4|0.8|1.1|0.9|137|Mortality|15322337|Leukemia|2000
1-4|8.0|8.9|8.4|1274|Incidence|15119430|Leukemia|2000
1-4|0.7|1.0|0.9|135|Mortality|15322337|Other|2000
1-4|3.7|4.3|4.0|600|Incidence|15119430|Other|2000
1-4|0.1|0.2|0.1|20|Mortality|15322337|Soft Tissue|2000
1-4|0.9|1.2|1.1|159|Incidence|15119430|Soft Tissue|2000
10-14|0.4|0.5|0.4|92|Mortality|20637696|Acute Lymphocytic|2000
10-14|1.6|1.9|1.7|356|Incidence|20358437|Acute Lymphocytic|2000
10-14|0.2|0.3|0.2|47|Mortality|20637696|Acute Myeloid|2000
10-14|0.4|0.6|0.5|99|Incidence|20358437|Acute Myeloid|2000
10-14|0.2|0.4|0.3|62|Mortality|20637696|Bones and Joints|2000
10-14|1.2|1.5|1.3|270|Incidence|20358437|Bones and Joints|2000
10-14|0.7|1.0|0.8|173|Mortality|20637696|Leukemia|2000
10-14|2.3|2.7|2.5|511|Incidence|20358437|Leukemia|2000
10-14|0.3|0.5|0.4|76|Mortality|20637696|Other|2000
10-14|2.3|2.7|2.5|501|Incidence|20358437|Other|2000
10-14|0.1|0.2|0.1|27|Mortality|20637696|Soft Tissue|2000
10-14|0.7|1.0|0.9|175|Incidence|20358437|Soft Tissue|2000
15-19|0.4|0.6|0.5|98|Mortality|20294955|Acute Lymphocytic|2000
15-19|1.4|1.8|1.6|319|Incidence|19998739|Acute Lymphocytic|2000
15-19|0.3|0.5|0.4|77|Mortality|20294955|Acute Myeloid|2000
15-19|0.7|1.0|0.8|168|Incidence|19998739|Acute Myeloid|2000
15-19|0.4|0.6|0.5|98|Mortality|20294955|Bones and Joints|2000
15-19|1.2|1.5|1.4|275|Incidence|19998739|Bones and Joints|2000
15-19|1.0|1.4|1.2|242|Mortality|20294955|Leukemia|2000
15-19|2.5|3.0|2.7|548|Incidence|19998739|Leukemia|2000
15-19|0.6|0.8|0.7|138|Mortality|20294955|Other|2000
15-19|7.5|8.3|7.9|1584|Incidence|19998739|Other|2000
15-19|0.3|0.5|0.4|73|Mortality|20294955|Soft Tissue|2000
15-19|1.1|1.4|1.2|249|Incidence|19998739|Soft Tissue|2000
5-9|0.3|0.5|0.4|78|Mortality|20463852|Acute Lymphocytic|2000
5-9|2.9|3.4|3.1|631|Incidence|20194272|Acute Lymphocytic|2000
5-9|0.1|0.2|0.2|33|Mortality|20463852|Acute Myeloid|2000
5-9|0.3|0.5|0.4|81|Incidence|20194272|Acute Myeloid|2000
5-9|0.1|0.1|0.1|19|Mortality|20463852|Bones and Joints|2000
5-9|0.4|0.6|0.5|104|Incidence|20194272|Bones and Joints|2000
5-9|0.6|0.8|0.7|142|Mortality|20463852|Leukemia|2000
5-9|3.5|4.0|3.8|758|Incidence|20194272|Leukemia|2000
5-9|0.4|0.6|0.5|98|Mortality|20463852|Other|2000
5-9|1.0|1.3|1.2|239|Incidence|20194272|Other|2000
5-9|0.0|0.1|0.1|17|Mortality|20463852|Soft Tissue|2000
5-9|0.5|0.7|0.6|115|Incidence|20194272|Soft Tissue|2000
<1|0.2|0.7|0.4|16|Mortality|3855956|Acute Lymphocytic|2000
<1|1.9|2.9|2.3|89|Incidence|3804065|Acute Lymphocytic|2000
<1|~|~|~|~|Mortality|3855956|Acute Myeloid|2000
<1|1.0|1.8|1.4|52|Incidence|3804065|Acute Myeloid|2000
<1|~|~|~|~|Mortality|3855956|Bones and Joints|2000
<1|~|~|~|~|Incidence|3804065|Bones and Joints|2000
<1|0.7|1.4|1.0|38|Mortality|3855956|Leukemia|2000
<1|4.0|5.4|4.7|178|Incidence|3804065|Leukemia|2000
<1|0.4|0.9|0.6|24|Mortality|3855956|Other|2000
<1|9.0|11.0|10.0|380|Incidence|3804065|Other|2000
<1|~|~|~|~|Mortality|3855956|Soft Tissue|2000
<1|2.5|3.7|3.1|117|Incidence|3804065|Soft Tissue|2000
1-4|0.2|0.4|0.3|41|Mortality|15285559|Acute Lymphocytic|2001
1-4|7.1|8.0|7.6|1144|Incidence|15123657|Acute Lymphocytic|2001
1-4|0.4|0.6|0.5|73|Mortality|15285559|Acute Myeloid|2001
1-4|0.7|1.0|0.8|125|Incidence|15123657|Acute Myeloid|2001
1-4|~|~|~|~|Mortality|15285559|Bones and Joints|2001
1-4|0.1|0.2|0.1|22|Incidence|15123657|Bones and Joints|2001
1-4|0.9|1.2|1.0|155|Mortality|15285559|Leukemia|2001
1-4|8.5|9.4|9.0|1355|Incidence|15123657|Leukemia|2001
1-4|0.7|1.0|0.8|122|Mortality|15285559|Other|2001
1-4|4.2|4.9|4.5|688|Incidence|15123657|Other|2001
1-4|0.1|0.2|0.1|18|Mortality|15285559|Soft Tissue|2001
1-4|1.0|1.4|1.2|180|Incidence|15123657|Soft Tissue|2001
10-14|0.3|0.5|0.4|78|Mortality|20978678|Acute Lymphocytic|2001
10-14|1.8|2.2|2.0|419|Incidence|20758808|Acute Lymphocytic|2001
10-14|0.2|0.3|0.2|46|Mortality|20978678|Acute Myeloid|2001
10-14|0.5|0.8|0.7|136|Incidence|20758808|Acute Myeloid|2001
10-14|0.3|0.4|0.3|72|Mortality|20978678|Bones and Joints|2001
10-14|1.2|1.6|1.4|291|Incidence|20758808|Bones and Joints|2001
10-14|0.7|0.9|0.8|170|Mortality|20978678|Leukemia|2001
10-14|2.7|3.2|3.0|618|Incidence|20758808|Leukemia|2001
10-14|0.3|0.4|0.3|70|Mortality|20978678|Other|2001
10-14|2.5|2.9|2.7|556|Incidence|20758808|Other|2001
10-14|0.1|0.2|0.2|36|Mortality|20978678|Soft Tissue|2001
10-14|0.7|1.0|0.9|177|Incidence|20758808|Soft Tissue|2001
15-19|0.4|0.6|0.5|105|Mortality|20456284|Acute Lymphocytic|2001
15-19|1.4|1.7|1.5|307|Incidence|20227701|Acute Lymphocytic|2001
15-19|0.3|0.4|0.3|70|Mortality|20456284|Acute Myeloid|2001
15-19|0.7|1.0|0.9|173|Incidence|20227701|Acute Myeloid|2001
15-19|0.4|0.6|0.5|101|Mortality|20456284|Bones and Joints|2001
15-19|1.5|1.9|1.7|346|Incidence|20227701|Bones and Joints|2001
15-19|1.0|1.3|1.1|225|Mortality|20456284|Leukemia|2001
15-19|2.6|3.1|2.9|578|Incidence|20227701|Leukemia|2001
15-19|0.6|0.8|0.7|147|Mortality|20456284|Other|2001
15-19|7.9|8.7|8.3|1681|Incidence|20227701|Other|2001
15-19|0.2|0.4|0.3|61|Mortality|20456284|Soft Tissue|2001
15-19|1.0|1.3|1.1|224|Incidence|20227701|Soft Tissue|2001
5-9|0.3|0.5|0.4|84|Mortality|20173362|Acute Lymphocytic|2001
5-9|2.8|3.3|3.1|616|Incidence|19962452|Acute Lymphocytic|2001
5-9|0.1|0.2|0.2|31|Mortality|20173362|Acute Myeloid|2001
5-9|0.3|0.5|0.4|84|Incidence|19962452|Acute Myeloid|2001
5-9|~|~|~|~|Mortality|20173362|Bones and Joints|2001
5-9|0.5|0.7|0.6|114|Incidence|19962452|Bones and Joints|2001
5-9|0.6|0.9|0.8|153|Mortality|20173362|Leukemia|2001
5-9|3.5|4.0|3.8|750|Incidence|19962452|Leukemia|2001
5-9|0.3|0.5|0.4|88|Mortality|20173362|Other|2001
5-9|1.3|1.7|1.5|298|Incidence|19962452|Other|2001
5-9|0.1|0.2|0.1|26|Mortality|20173362|Soft Tissue|2001
5-9|0.4|0.6|0.5|95|Incidence|19962452|Soft Tissue|2001
<1|~|~|~|~|Mortality|4012658|Acute Lymphocytic|2001
<1|1.5|2.4|1.9|75|Incidence|3970113|Acute Lymphocytic|2001
<1|~|~|~|~|Mortality|4012658|Acute Myeloid|2001
<1|1.0|1.7|1.3|52|Incidence|3970113|Acute Myeloid|2001
<1|~|~|~|~|Mortality|4012658|Bones and Joints|2001
<1|~|~|~|~|Incidence|3970113|Bones and Joints|2001
<1|0.4|0.9|0.6|25|Mortality|4012658|Leukemia|2001
<1|3.5|4.7|4.1|161|Incidence|3970113|Leukemia|2001
<1|0.2|0.7|0.4|17|Mortality|4012658|Other|2001
<1|10.4|12.5|11.4|454|Incidence|3970113|Other|2001
<1|~|~|~|~|Mortality|4012658|Soft Tissue|2001
<1|2.8|3.9|3.3|132|Incidence|3970113|Soft Tissue|2001
1-4|0.2|0.3|0.2|34|Mortality|15477731|Acute Lymphocytic|2002
1-4|6.8|7.6|7.2|1099|Incidence|15313864|Acute Lymphocytic|2002
1-4|0.2|0.4|0.3|46|Mortality|15477731|Acute Myeloid|2002
1-4|0.7|1.0|0.9|133|Incidence|15313864|Acute Myeloid|2002
1-4|~|~|~|~|Mortality|15477731|Bones and Joints|2002
1-4|0.1|0.2|0.2|26|Incidence|15313864|Bones and Joints|2002
1-4|0.5|0.8|0.7|104|Mortality|15477731|Leukemia|2002
1-4|8.1|9.1|8.6|1315|Incidence|15313864|Leukemia|2002
1-4|0.7|1.0|0.9|136|Mortality|15477731|Other|2002
1-4|3.8|4.4|4.1|629|Incidence|15313864|Other|2002
1-4|0.1|0.2|0.1|23|Mortality|15477731|Soft Tissue|2002
1-4|1.0|1.4|1.2|182|Incidence|15313864|Soft Tissue|2002
10-14|0.3|0.5|0.4|91|Mortality|21261421|Acute Lymphocytic|2002
10-14|1.6|2.0|1.8|382|Incidence|21040663|Acute Lymphocytic|2002
10-14|0.2|0.3|0.2|44|Mortality|21261421|Acute Myeloid|2002
10-14|0.6|0.8|0.7|139|Incidence|21040663|Acute Myeloid|2002
10-14|0.2|0.4|0.3|61|Mortality|21261421|Bones and Joints|2002
10-14|1.2|1.5|1.3|277|Incidence|21040663|Bones and Joints|2002
10-14|0.7|0.9|0.8|168|Mortality|21261421|Leukemia|2002
10-14|2.6|3.0|2.8|583|Incidence|21040663|Leukemia|2002
10-14|0.3|0.5|0.4|78|Mortality|21261421|Other|2002
10-14|2.4|2.9|2.7|559|Incidence|21040663|Other|2002
10-14|0.1|0.3|0.2|41|Mortality|21261421|Soft Tissue|2002
10-14|0.7|0.9|0.8|171|Incidence|21040663|Soft Tissue|2002
15-19|0.4|0.6|0.5|106|Mortality|20610370|Acute Lymphocytic|2002
15-19|1.4|1.8|1.6|329|Incidence|20386049|Acute Lymphocytic|2002
15-19|0.3|0.5|0.4|78|Mortality|20610370|Acute Myeloid|2002
15-19|0.7|1.0|0.8|167|Incidence|20386049|Acute Myeloid|2002
15-19|0.4|0.6|0.5|94|Mortality|20610370|Bones and Joints|2002
15-19|1.4|1.8|1.6|328|Incidence|20386049|Bones and Joints|2002
15-19|1.0|1.3|1.1|237|Mortality|20610370|Leukemia|2002
15-19|2.6|3.1|2.8|576|Incidence|20386049|Leukemia|2002
15-19|0.6|0.8|0.7|148|Mortality|20610370|Other|2002
15-19|8.4|9.2|8.8|1786|Incidence|20386049|Other|2002
15-19|0.2|0.4|0.3|58|Mortality|20610370|Soft Tissue|2002
15-19|0.9|1.2|1.1|218|Incidence|20386049|Soft Tissue|2002
5-9|0.3|0.5|0.4|82|Mortality|19872417|Acute Lymphocytic|2002
5-9|2.9|3.4|3.1|615|Incidence|19665950|Acute Lymphocytic|2002
5-9|0.1|0.2|0.2|34|Mortality|19872417|Acute Myeloid|2002
5-9|0.3|0.5|0.4|84|Incidence|19665950|Acute Myeloid|2002
5-9|0.1|0.2|0.1|21|Mortality|19872417|Bones and Joints|2002
5-9|0.5|0.7|0.6|122|Incidence|19665950|Bones and Joints|2002
5-9|0.6|0.9|0.7|148|Mortality|19872417|Leukemia|2002
5-9|3.6|4.2|3.9|763|Incidence|19665950|Leukemia|2002
5-9|0.4|0.6|0.5|97|Mortality|19872417|Other|2002
5-9|1.4|1.8|1.6|310|Incidence|19665950|Other|2002
5-9|0.1|0.2|0.1|28|Mortality|19872417|Soft Tissue|2002
5-9|0.5|0.8|0.6|125|Incidence|19665950|Soft Tissue|2002
<1|~|~|~|~|Mortality|3951461|Acute Lymphocytic|2002
<1|1.5|2.4|1.9|74|Incidence|3910837|Acute Lymphocytic|2002
<1|~|~|~|~|Mortality|3951461|Acute Myeloid|2002
<1|1.0|1.7|1.3|51|Incidence|3910837|Acute Myeloid|2002
<1|~|~|~|~|Mortality|3951461|Bones and Joints|2002
<1|~|~|~|~|Incidence|3910837|Bones and Joints|2002
<1|0.3|0.8|0.5|21|Mortality|3951461|Leukemia|2002
<1|3.6|5.0|4.3|167|Incidence|3910837|Leukemia|2002
<1|0.5|1.1|0.8|31|Mortality|3951461|Other|2002
<1|10.0|12.1|11.0|431|Incidence|3910837|Other|2002
<1|~|~|~|~|Mortality|3951461|Soft Tissue|2002
<1|2.7|3.8|3.2|125|Incidence|3910837|Soft Tissue|2002
1-4|0.3|0.5|0.4|61|Mortality|15616575|Acute Lymphocytic|2003
1-4|6.4|7.2|6.8|1063|Incidence|15616575|Acute Lymphocytic|2003
1-4|0.2|0.3|0.2|38|Mortality|15616575|Acute Myeloid|2003
1-4|0.7|1.0|0.9|134|Incidence|15616575|Acute Myeloid|2003
1-4|~|~|~|~|Mortality|15616575|Bones and Joints|2003
1-4|0.2|0.3|0.2|36|Incidence|15616575|Bones and Joints|2003
1-4|0.7|1.0|0.9|133|Mortality|15616575|Leukemia|2003
1-4|7.7|8.6|8.1|1266|Incidence|15616575|Leukemia|2003
1-4|0.6|0.9|0.8|118|Mortality|15616575|Other|2003
1-4|4.0|4.7|4.3|679|Incidence|15616575|Other|2003
1-4|~|~|~|~|Mortality|15616575|Soft Tissue|2003
1-4|0.9|1.2|1.1|165|Incidence|15616575|Soft Tissue|2003
10-14|0.3|0.5|0.4|87|Mortality|21415353|Acute Lymphocytic|2003
10-14|1.6|1.9|1.7|370|Incidence|21415353|Acute Lymphocytic|2003
10-14|0.2|0.3|0.3|55|Mortality|21415353|Acute Myeloid|2003
10-14|0.5|0.7|0.6|132|Incidence|21415353|Acute Myeloid|2003
10-14|0.2|0.4|0.3|64|Mortality|21415353|Bones and Joints|2003
10-14|1.2|1.5|1.3|285|Incidence|21415353|Bones and Joints|2003
10-14|0.7|1.0|0.9|186|Mortality|21415353|Leukemia|2003
10-14|2.3|2.8|2.6|548|Incidence|21415353|Leukemia|2003
10-14|0.3|0.4|0.3|69|Mortality|21415353|Other|2003
10-14|2.7|3.2|2.9|630|Incidence|21415353|Other|2003
10-14|0.1|0.2|0.2|36|Mortality|21415353|Soft Tissue|2003
10-14|0.7|1.0|0.9|186|Incidence|21415353|Soft Tissue|2003
15-19|0.3|0.5|0.4|82|Mortality|20797166|Acute Lymphocytic|2003
15-19|1.3|1.6|1.4|301|Incidence|20797166|Acute Lymphocytic|2003
15-19|0.2|0.4|0.3|65|Mortality|20797166|Acute Myeloid|2003
15-19|0.7|0.9|0.8|168|Incidence|20797166|Acute Myeloid|2003
15-19|0.4|0.6|0.5|104|Mortality|20797166|Bones and Joints|2003
15-19|1.3|1.7|1.5|312|Incidence|20797166|Bones and Joints|2003
15-19|0.8|1.0|0.9|183|Mortality|20797166|Leukemia|2003
15-19|2.5|3.0|2.7|568|Incidence|20797166|Leukemia|2003
15-19|0.5|0.8|0.7|136|Mortality|20797166|Other|2003
15-19|8.4|9.2|8.8|1822|Incidence|20797166|Other|2003
15-19|0.3|0.4|0.3|68|Mortality|20797166|Soft Tissue|2003
15-19|1.1|1.4|1.2|252|Incidence|20797166|Soft Tissue|2003
5-9|0.4|0.5|0.4|87|Mortality|19620851|Acute Lymphocytic|2003
5-9|3.0|3.5|3.3|638|Incidence|19620851|Acute Lymphocytic|2003
5-9|0.1|0.3|0.2|39|Mortality|19620851|Acute Myeloid|2003
5-9|0.3|0.5|0.4|76|Incidence|19620851|Acute Myeloid|2003
5-9|~|~|~|~|Mortality|19620851|Bones and Joints|2003
5-9|0.4|0.6|0.5|91|Incidence|19620851|Bones and Joints|2003
5-9|0.7|0.9|0.8|156|Mortality|19620851|Leukemia|2003
5-9|3.6|4.1|3.9|757|Incidence|19620851|Leukemia|2003
5-9|0.4|0.6|0.5|101|Mortality|19620851|Other|2003
5-9|1.2|1.5|1.3|258|Incidence|19620851|Other|2003
5-9|0.1|0.2|0.1|26|Mortality|19620851|Soft Tissue|2003
5-9|0.4|0.7|0.5|107|Incidence|19620851|Soft Tissue|2003
<1|~|~|~|~|Mortality|3975871|Acute Lymphocytic|2003
<1|1.5|2.4|1.9|77|Incidence|3975871|Acute Lymphocytic|2003
<1|~|~|~|~|Mortality|3975871|Acute Myeloid|2003
<1|1.0|1.8|1.4|55|Incidence|3975871|Acute Myeloid|2003
<1|~|~|~|~|Mortality|3975871|Bones and Joints|2003
<1|~|~|~|~|Incidence|3975871|Bones and Joints|2003
<1|0.5|1.1|0.8|30|Mortality|3975871|Leukemia|2003
<1|3.8|5.1|4.4|176|Incidence|3975871|Leukemia|2003
<1|0.4|0.9|0.6|23|Mortality|3975871|Other|2003
<1|10.5|12.7|11.6|460|Incidence|3975871|Other|2003
<1|~|~|~|~|Mortality|3975871|Soft Tissue|2003
<1|2.6|3.7|3.1|124|Incidence|3975871|Soft Tissue|2003
1-4|0.2|0.4|0.3|42|Mortality|15771627|Acute Lymphocytic|2004
1-4|7.3|8.2|7.7|1216|Incidence|15771627|Acute Lymphocytic|2004
1-4|0.3|0.5|0.3|55|Mortality|15771627|Acute Myeloid|2004
1-4|0.8|1.1|0.9|141|Incidence|15771627|Acute Myeloid|2004
1-4|~|~|~|~|Mortality|15771627|Bones and Joints|2004
1-4|0.1|0.3|0.2|30|Incidence|15771627|Bones and Joints|2004
1-4|0.6|0.9|0.8|120|Mortality|15771627|Leukemia|2004
1-4|8.7|9.7|9.2|1446|Incidence|15771627|Leukemia|2004
1-4|0.7|1.0|0.8|130|Mortality|15771627|Other|2004
1-4|4.1|4.8|4.5|702|Incidence|15771627|Other|2004
1-4|0.1|0.2|0.2|24|Mortality|15771627|Soft Tissue|2004
1-4|0.9|1.3|1.1|172|Incidence|15771627|Soft Tissue|2004
10-14|0.3|0.4|0.3|72|Mortality|21411680|Acute Lymphocytic|2004
10-14|1.7|2.1|1.9|400|Incidence|21411680|Acute Lymphocytic|2004
10-14|0.2|0.3|0.2|50|Mortality|21411680|Acute Myeloid|2004
10-14|0.5|0.7|0.6|135|Incidence|21411680|Acute Myeloid|2004
10-14|0.2|0.3|0.3|57|Mortality|21411680|Bones and Joints|2004
10-14|1.3|1.6|1.4|307|Incidence|21411680|Bones and Joints|2004
10-14|0.6|0.9|0.7|156|Mortality|21411680|Leukemia|2004
10-14|2.6|3.1|2.8|604|Incidence|21411680|Leukemia|2004
10-14|0.3|0.4|0.3|69|Mortality|21411680|Other|2004
10-14|2.6|3.1|2.9|611|Incidence|21411680|Other|2004
10-14|0.1|0.3|0.2|42|Mortality|21411680|Soft Tissue|2004
10-14|0.8|1.1|1.0|206|Incidence|21411680|Soft Tissue|2004
15-19|0.4|0.5|0.4|93|Mortality|21102552|Acute Lymphocytic|2004
15-19|1.5|1.8|1.6|344|Incidence|21102552|Acute Lymphocytic|2004
15-19|0.2|0.4|0.3|64|Mortality|21102552|Acute Myeloid|2004
15-19|0.7|1.0|0.8|175|Incidence|21102552|Acute Myeloid|2004
15-19|0.4|0.6|0.5|114|Mortality|21102552|Bones and Joints|2004
15-19|1.3|1.7|1.5|318|Incidence|21102552|Bones and Joints|2004
15-19|0.9|1.1|1.0|210|Mortality|21102552|Leukemia|2004
15-19|2.6|3.1|2.9|606|Incidence|21102552|Leukemia|2004
15-19|0.6|0.8|0.7|151|Mortality|21102552|Other|2004
15-19|8.4|9.3|8.8|1866|Incidence|21102552|Other|2004
15-19|0.2|0.4|0.3|66|Mortality|21102552|Soft Tissue|2004
15-19|1.0|1.3|1.2|250|Incidence|21102552|Soft Tissue|2004
5-9|0.3|0.5|0.4|83|Mortality|19454237|Acute Lymphocytic|2004
5-9|3.0|3.5|3.3|637|Incidence|19454237|Acute Lymphocytic|2004
5-9|0.1|0.3|0.2|35|Mortality|19454237|Acute Myeloid|2004
5-9|0.4|0.6|0.4|87|Incidence|19454237|Acute Myeloid|2004
5-9|~|~|~|~|Mortality|19454237|Bones and Joints|2004
5-9|0.5|0.7|0.6|109|Incidence|19454237|Bones and Joints|2004
5-9|0.7|0.9|0.8|156|Mortality|19454237|Leukemia|2004
5-9|3.7|4.3|4.0|772|Incidence|19454237|Leukemia|2004
5-9|0.4|0.6|0.5|98|Mortality|19454237|Other|2004
5-9|1.4|1.8|1.6|307|Incidence|19454237|Other|2004
5-9|0.1|0.2|0.1|28|Mortality|19454237|Soft Tissue|2004
5-9|0.4|0.6|0.5|100|Incidence|19454237|Soft Tissue|2004
<1|~|~|~|~|Mortality|4014258|Acute Lymphocytic|2004
<1|1.6|2.5|2.0|79|Incidence|4014258|Acute Lymphocytic|2004
<1|~|~|~|~|Mortality|4014258|Acute Myeloid|2004
<1|1.2|2.0|1.5|61|Incidence|4014258|Acute Myeloid|2004
<1|~|~|~|~|Mortality|4014258|Bones and Joints|2004
<1|~|~|~|~|Incidence|4014258|Bones and Joints|2004
<1|0.4|0.9|0.6|23|Mortality|4014258|Leukemia|2004
<1|3.8|5.1|4.4|178|Incidence|4014258|Leukemia|2004
<1|0.3|0.8|0.5|20|Mortality|4014258|Other|2004
<1|10.8|13.0|11.9|477|Incidence|4014258|Other|2004
<1|~|~|~|~|Mortality|4014258|Soft Tissue|2004
<1|2.7|3.8|3.2|130|Incidence|4014258|Soft Tissue|2004
1-4|0.2|0.3|0.3|41|Mortality|15913007|Acute Lymphocytic|2005
1-4|6.9|7.8|7.4|1170|Incidence|15913007|Acute Lymphocytic|2005
1-4|0.3|0.5|0.4|60|Mortality|15913007|Acute Myeloid|2005
1-4|0.7|1.0|0.9|137|Incidence|15913007|Acute Myeloid|2005
1-4|~|~|~|~|Mortality|15913007|Bones and Joints|2005
1-4|0.1|0.3|0.2|32|Incidence|15913007|Bones and Joints|2005
1-4|0.6|0.9|0.8|120|Mortality|15913007|Leukemia|2005
1-4|8.2|9.1|8.7|1379|Incidence|15913007|Leukemia|2005
1-4|0.7|0.9|0.8|127|Mortality|15913007|Other|2005
1-4|4.2|4.8|4.5|714|Incidence|15913007|Other|2005
1-4|0.1|0.2|0.1|21|Mortality|15913007|Soft Tissue|2005
1-4|0.9|1.2|1.0|167|Incidence|15913007|Soft Tissue|2005
10-14|0.3|0.5|0.4|79|Mortality|21212579|Acute Lymphocytic|2005
10-14|1.7|2.1|1.9|397|Incidence|21212579|Acute Lymphocytic|2005
10-14|0.2|0.3|0.2|44|Mortality|21212579|Acute Myeloid|2005
10-14|0.5|0.7|0.6|125|Incidence|21212579|Acute Myeloid|2005
10-14|0.2|0.4|0.3|67|Mortality|21212579|Bones and Joints|2005
10-14|1.1|1.4|1.3|268|Incidence|21212579|Bones and Joints|2005
10-14|0.6|0.8|0.7|150|Mortality|21212579|Leukemia|2005
10-14|2.6|3.1|2.8|603|Incidence|21212579|Leukemia|2005
10-14|0.3|0.5|0.4|82|Mortality|21212579|Other|2005
10-14|2.7|3.1|2.9|610|Incidence|21212579|Other|2005
10-14|0.1|0.2|0.2|35|Mortality|21212579|Soft Tissue|2005
10-14|0.7|0.9|0.8|164|Incidence|21212579|Soft Tissue|2005
15-19|0.3|0.5|0.4|79|Mortality|21486214|Acute Lymphocytic|2005
15-19|1.4|1.7|1.5|331|Incidence|21486214|Acute Lymphocytic|2005
15-19|0.3|0.4|0.3|75|Mortality|21486214|Acute Myeloid|2005
15-19|0.6|0.8|0.7|153|Incidence|21486214|Acute Myeloid|2005
15-19|0.5|0.7|0.6|124|Mortality|21486214|Bones and Joints|2005
15-19|1.4|1.7|1.5|328|Incidence|21486214|Bones and Joints|2005
15-19|0.9|1.2|1.0|223|Mortality|21486214|Leukemia|2005
15-19|2.6|3.0|2.8|595|Incidence|21486214|Leukemia|2005
15-19|0.5|0.7|0.6|120|Mortality|21486214|Other|2005
15-19|8.7|9.5|9.1|1948|Incidence|21486214|Other|2005
15-19|0.3|0.5|0.4|80|Mortality|21486214|Soft Tissue|2005
15-19|1.0|1.3|1.2|248|Incidence|21486214|Soft Tissue|2005
5-9|0.3|0.4|0.3|64|Mortality|19389067|Acute Lymphocytic|2005
5-9|2.9|3.4|3.1|610|Incidence|19389067|Acute Lymphocytic|2005
5-9|0.1|0.2|0.1|29|Mortality|19389067|Acute Myeloid|2005
5-9|0.3|0.5|0.4|75|Incidence|19389067|Acute Myeloid|2005
5-9|0.1|0.1|0.1|17|Mortality|19389067|Bones and Joints|2005
5-9|0.5|0.7|0.6|114|Incidence|19389067|Bones and Joints|2005
5-9|0.5|0.8|0.6|125|Mortality|19389067|Leukemia|2005
5-9|3.5|4.0|3.8|730|Incidence|19389067|Leukemia|2005
5-9|0.4|0.6|0.5|90|Mortality|19389067|Other|2005
5-9|1.4|1.8|1.6|311|Incidence|19389067|Other|2005
5-9|0.1|0.2|0.1|21|Mortality|19389067|Soft Tissue|2005
5-9|0.5|0.8|0.6|126|Incidence|19389067|Soft Tissue|2005
<1|~|~|~|~|Mortality|4004393|Acute Lymphocytic|2005
<1|1.5|2.4|1.9|78|Incidence|4004393|Acute Lymphocytic|2005
<1|~|~|~|~|Mortality|4004393|Acute Myeloid|2005
<1|1.0|1.7|1.3|52|Incidence|4004393|Acute Myeloid|2005
<1|~|~|~|~|Mortality|4004393|Bones and Joints|2005
<1|~|~|~|~|Incidence|4004393|Bones and Joints|2005
<1|0.3|0.8|0.5|22|Mortality|4004393|Leukemia|2005
<1|3.7|5.0|4.3|173|Incidence|4004393|Leukemia|2005
<1|0.3|0.7|0.5|19|Mortality|4004393|Other|2005
<1|9.9|12.0|10.9|438|Incidence|4004393|Other|2005
<1|~|~|~|~|Mortality|4004393|Soft Tissue|2005
<1|3.1|4.4|3.7|149|Incidence|4004393|Soft Tissue|2005
1-4|0.2|0.4|0.3|44|Mortality|15897145|Acute Lymphocytic|2006
1-4|6.9|7.8|7.3|1167|Incidence|15897145|Acute Lymphocytic|2006
1-4|0.3|0.4|0.3|54|Mortality|15897145|Acute Myeloid|2006
1-4|0.8|1.1|0.9|147|Incidence|15897145|Acute Myeloid|2006
1-4|~|~|~|~|Mortality|15897145|Bones and Joints|2006
1-4|0.1|0.2|0.2|25|Incidence|15897145|Bones and Joints|2006
1-4|0.6|0.9|0.8|124|Mortality|15897145|Leukemia|2006
1-4|8.2|9.2|8.7|1381|Incidence|15897145|Leukemia|2006
1-4|0.6|0.8|0.7|108|Mortality|15897145|Other|2006
1-4|3.7|4.3|4.0|637|Incidence|15897145|Other|2006
1-4|0.1|0.2|0.1|23|Mortality|15897145|Soft Tissue|2006
1-4|1.0|1.3|1.1|181|Incidence|15897145|Soft Tissue|2006
10-14|0.3|0.4|0.3|69|Mortality|21033138|Acute Lymphocytic|2006
10-14|2.0|2.4|2.2|463|Incidence|21033138|Acute Lymphocytic|2006
10-14|0.1|0.3|0.2|42|Mortality|21033138|Acute Myeloid|2006
10-14|0.6|0.8|0.7|142|Incidence|21033138|Acute Myeloid|2006
10-14|0.1|0.2|0.2|37|Mortality|21033138|Bones and Joints|2006
10-14|1.1|1.4|1.3|269|Incidence|21033138|Bones and Joints|2006
10-14|0.6|0.8|0.7|152|Mortality|21033138|Leukemia|2006
10-14|3.0|3.5|3.2|677|Incidence|21033138|Leukemia|2006
10-14|0.3|0.4|0.3|68|Mortality|21033138|Other|2006
10-14|2.6|3.1|2.8|598|Incidence|21033138|Other|2006
10-14|0.1|0.2|0.1|25|Mortality|21033138|Soft Tissue|2006
10-14|0.7|1.0|0.9|181|Incidence|21033138|Soft Tissue|2006
15-19|0.3|0.5|0.4|92|Mortality|21807709|Acute Lymphocytic|2006
15-19|1.5|1.8|1.6|359|Incidence|21807709|Acute Lymphocytic|2006
15-19|0.3|0.4|0.3|71|Mortality|21807709|Acute Myeloid|2006
15-19|0.7|0.9|0.8|177|Incidence|21807709|Acute Myeloid|2006
15-19|0.4|0.6|0.5|115|Mortality|21807709|Bones and Joints|2006
15-19|1.5|1.8|1.6|356|Incidence|21807709|Bones and Joints|2006
15-19|0.8|1.1|0.9|207|Mortality|21807709|Leukemia|2006
15-19|2.8|3.2|3.0|656|Incidence|21807709|Leukemia|2006
15-19|0.4|0.6|0.5|117|Mortality|21807709|Other|2006
15-19|8.0|8.8|8.4|1828|Incidence|21807709|Other|2006
15-19|0.2|0.4|0.3|60|Mortality|21807709|Soft Tissue|2006
15-19|0.9|1.2|1.1|231|Incidence|21807709|Soft Tissue|2006
5-9|0.2|0.3|0.3|52|Mortality|19544688|Acute Lymphocytic|2006
5-9|3.0|3.5|3.2|627|Incidence|19544688|Acute Lymphocytic|2006
5-9|0.1|0.1|0.1|17|Mortality|19544688|Acute Myeloid|2006
5-9|0.3|0.5|0.4|81|Incidence|19544688|Acute Myeloid|2006
5-9|0.1|0.1|0.1|18|Mortality|19544688|Bones and Joints|2006
5-9|0.6|0.8|0.7|137|Incidence|19544688|Bones and Joints|2006
5-9|0.4|0.6|0.5|104|Mortality|19544688|Leukemia|2006
5-9|3.6|4.2|3.9|756|Incidence|19544688|Leukemia|2006
5-9|0.4|0.6|0.5|96|Mortality|19544688|Other|2006
5-9|1.5|1.9|1.7|328|Incidence|19544688|Other|2006
5-9|0.1|0.2|0.2|31|Mortality|19544688|Soft Tissue|2006
5-9|0.5|0.7|0.6|115|Incidence|19544688|Soft Tissue|2006
<1|~|~|~|~|Mortality|4041738|Acute Lymphocytic|2006
<1|1.9|2.8|2.3|93|Incidence|4041738|Acute Lymphocytic|2006
<1|~|~|~|~|Mortality|4041738|Acute Myeloid|2006
<1|0.9|1.7|1.3|51|Incidence|4041738|Acute Myeloid|2006
<1|~|~|~|~|Mortality|4041738|Bones and Joints|2006
<1|~|~|~|~|Incidence|4041738|Bones and Joints|2006
<1|0.5|1.1|0.8|31|Mortality|4041738|Leukemia|2006
<1|4.2|5.6|4.8|195|Incidence|4041738|Leukemia|2006
<1|0.4|0.9|0.6|24|Mortality|4041738|Other|2006
<1|11.3|13.5|12.3|499|Incidence|4041738|Other|2006
<1|~|~|~|~|Mortality|4041738|Soft Tissue|2006
<1|2.5|3.6|3.0|120|Incidence|4041738|Soft Tissue|2006
1-4|0.2|0.3|0.2|38|Mortality|15977965|Acute Lymphocytic|2007
1-4|7.6|8.5|8.1|1288|Incidence|15977965|Acute Lymphocytic|2007
1-4|0.2|0.4|0.3|47|Mortality|15977965|Acute Myeloid|2007
1-4|0.7|1.0|0.8|130|Incidence|15977965|Acute Myeloid|2007
1-4|~|~|~|~|Mortality|15977965|Bones and Joints|2007
1-4|0.1|0.3|0.2|33|Incidence|15977965|Bones and Joints|2007
1-4|0.5|0.8|0.7|106|Mortality|15977965|Leukemia|2007
1-4|8.8|9.8|9.3|1482|Incidence|15977965|Leukemia|2007
1-4|0.6|0.9|0.7|115|Mortality|15977965|Other|2007
1-4|4.4|5.1|4.7|752|Incidence|15977965|Other|2007
1-4|0.1|0.2|0.1|17|Mortality|15977965|Soft Tissue|2007
1-4|1.0|1.4|1.2|188|Incidence|15977965|Soft Tissue|2007
10-14|0.3|0.5|0.4|80|Mortality|20841042|Acute Lymphocytic|2007
10-14|1.7|2.1|1.9|395|Incidence|20841042|Acute Lymphocytic|2007
10-14|0.2|0.3|0.2|52|Mortality|20841042|Acute Myeloid|2007
10-14|0.6|0.8|0.7|137|Incidence|20841042|Acute Myeloid|2007
10-14|0.2|0.3|0.2|48|Mortality|20841042|Bones and Joints|2007
10-14|1.2|1.5|1.3|275|Incidence|20841042|Bones and Joints|2007
10-14|0.7|1.0|0.8|175|Mortality|20841042|Leukemia|2007
10-14|2.7|3.1|2.9|606|Incidence|20841042|Leukemia|2007
10-14|0.2|0.4|0.3|62|Mortality|20841042|Other|2007
10-14|2.5|2.9|2.7|556|Incidence|20841042|Other|2007
10-14|0.1|0.2|0.2|35|Mortality|20841042|Soft Tissue|2007
10-14|0.7|1.0|0.8|171|Incidence|20841042|Soft Tissue|2007
15-19|0.3|0.5|0.4|82|Mortality|22067816|Acute Lymphocytic|2007
15-19|1.5|1.9|1.7|371|Incidence|22067816|Acute Lymphocytic|2007
15-19|0.2|0.4|0.3|66|Mortality|22067816|Acute Myeloid|2007
15-19|0.7|0.9|0.8|170|Incidence|22067816|Acute Myeloid|2007
15-19|0.4|0.6|0.5|111|Mortality|22067816|Bones and Joints|2007
15-19|1.3|1.6|1.5|325|Incidence|22067816|Bones and Joints|2007
15-19|0.8|1.1|0.9|202|Mortality|22067816|Leukemia|2007
15-19|2.7|3.2|3.0|654|Incidence|22067816|Leukemia|2007
15-19|0.5|0.7|0.6|133|Mortality|22067816|Other|2007
15-19|8.7|9.5|9.1|2014|Incidence|22067816|Other|2007
15-19|0.2|0.3|0.3|58|Mortality|22067816|Soft Tissue|2007
15-19|1.1|1.4|1.2|270|Incidence|22067816|Soft Tissue|2007
5-9|0.3|0.5|0.4|85|Mortality|19714611|Acute Lymphocytic|2007
5-9|3.1|3.6|3.4|666|Incidence|19714611|Acute Lymphocytic|2007
5-9|0.1|0.2|0.1|27|Mortality|19714611|Acute Myeloid|2007
5-9|0.3|0.5|0.4|86|Incidence|19714611|Acute Myeloid|2007
5-9|~|~|~|~|Mortality|19714611|Bones and Joints|2007
5-9|0.5|0.7|0.6|113|Incidence|19714611|Bones and Joints|2007
5-9|0.6|0.8|0.7|139|Mortality|19714611|Leukemia|2007
5-9|3.8|4.3|4.0|798|Incidence|19714611|Leukemia|2007
5-9|0.4|0.6|0.5|103|Mortality|19714611|Other|2007
5-9|1.3|1.6|1.5|289|Incidence|19714611|Other|2007
5-9|0.1|0.2|0.1|24|Mortality|19714611|Soft Tissue|2007
5-9|0.6|0.9|0.8|148|Incidence|19714611|Soft Tissue|2007
<1|~|~|~|~|Mortality|4147997|Acute Lymphocytic|2007
<1|1.4|2.3|1.8|76|Incidence|4147997|Acute Lymphocytic|2007
<1|~|~|~|~|Mortality|4147997|Acute Myeloid|2007
<1|1.1|1.8|1.4|59|Incidence|4147997|Acute Myeloid|2007
<1|~|~|~|~|Mortality|4147997|Bones and Joints|2007
<1|~|~|~|~|Incidence|4147997|Bones and Joints|2007
<1|0.3|0.8|0.5|21|Mortality|4147997|Leukemia|2007
<1|3.7|5.0|4.3|179|Incidence|4147997|Leukemia|2007
<1|0.4|0.9|0.6|26|Mortality|4147997|Other|2007
<1|10.9|13.1|12.0|496|Incidence|4147997|Other|2007
<1|~|~|~|~|Mortality|4147997|Soft Tissue|2007
<1|2.9|4.1|3.5|145|Incidence|4147997|Soft Tissue|2007
1-4|0.2|0.4|0.3|42|Mortality|16138392|Acute Lymphocytic|2008
1-4|7.4|8.3|7.8|1265|Incidence|16138392|Acute Lymphocytic|2008
1-4|0.3|0.4|0.3|54|Mortality|16138392|Acute Myeloid|2008
1-4|0.8|1.1|0.9|150|Incidence|16138392|Acute Myeloid|2008
1-4|~|~|~|~|Mortality|16138392|Bones and Joints|2008
1-4|0.1|0.2|0.2|25|Incidence|16138392|Bones and Joints|2008
1-4|0.6|0.9|0.8|123|Mortality|16138392|Leukemia|2008
1-4|8.8|9.7|9.2|1488|Incidence|16138392|Leukemia|2008
1-4|0.6|0.8|0.7|112|Mortality|16138392|Other|2008
1-4|4.0|4.6|4.3|688|Incidence|16138392|Other|2008
1-4|0.1|0.2|0.1|22|Mortality|16138392|Soft Tissue|2008
1-4|1.2|1.5|1.4|219|Incidence|16138392|Soft Tissue|2008
10-14|0.2|0.4|0.3|65|Mortality|20706655|Acute Lymphocytic|2008
10-14|2.0|2.4|2.2|450|Incidence|20706655|Acute Lymphocytic|2008
10-14|0.1|0.3|0.2|41|Mortality|20706655|Acute Myeloid|2008
10-14|0.5|0.8|0.7|135|Incidence|20706655|Acute Myeloid|2008
10-14|0.2|0.3|0.2|45|Mortality|20706655|Bones and Joints|2008
10-14|1.2|1.5|1.3|270|Incidence|20706655|Bones and Joints|2008
10-14|0.6|0.9|0.7|152|Mortality|20706655|Leukemia|2008
10-14|2.9|3.4|3.2|657|Incidence|20706655|Leukemia|2008
10-14|0.2|0.4|0.3|60|Mortality|20706655|Other|2008
10-14|2.5|3.0|2.8|571|Incidence|20706655|Other|2008
10-14|0.1|0.2|0.1|29|Mortality|20706655|Soft Tissue|2008
10-14|0.7|1.0|0.8|171|Incidence|20706655|Soft Tissue|2008
15-19|0.3|0.4|0.3|77|Mortality|22210880|Acute Lymphocytic|2008
15-19|1.5|1.9|1.7|377|Incidence|22210880|Acute Lymphocytic|2008
15-19|0.2|0.3|0.3|56|Mortality|22210880|Acute Myeloid|2008
15-19|0.8|1.0|0.9|193|Incidence|22210880|Acute Myeloid|2008
15-19|0.4|0.6|0.5|120|Mortality|22210880|Bones and Joints|2008
15-19|1.3|1.6|1.5|325|Incidence|22210880|Bones and Joints|2008
15-19|0.8|1.0|0.9|196|Mortality|22210880|Leukemia|2008
15-19|2.8|3.3|3.1|683|Incidence|22210880|Leukemia|2008
15-19|0.5|0.7|0.5|121|Mortality|22210880|Other|2008
15-19|8.6|9.4|9.0|1998|Incidence|22210880|Other|2008
15-19|0.2|0.4|0.3|71|Mortality|22210880|Soft Tissue|2008
15-19|1.0|1.3|1.1|247|Incidence|22210880|Soft Tissue|2008
5-9|0.2|0.4|0.3|57|Mortality|19929602|Acute Lymphocytic|2008
5-9|3.3|3.8|3.6|708|Incidence|19929602|Acute Lymphocytic|2008
5-9|0.1|0.2|0.1|26|Mortality|19929602|Acute Myeloid|2008
5-9|0.3|0.5|0.4|86|Incidence|19929602|Acute Myeloid|2008
5-9|~|~|~|~|Mortality|19929602|Bones and Joints|2008
5-9|0.5|0.7|0.6|122|Incidence|19929602|Bones and Joints|2008
5-9|0.4|0.6|0.5|100|Mortality|19929602|Leukemia|2008
5-9|3.9|4.5|4.2|834|Incidence|19929602|Leukemia|2008
5-9|0.4|0.5|0.4|89|Mortality|19929602|Other|2008
5-9|1.4|1.8|1.6|320|Incidence|19929602|Other|2008
5-9|0.1|0.2|0.2|35|Mortality|19929602|Soft Tissue|2008
5-9|0.6|0.8|0.7|143|Incidence|19929602|Soft Tissue|2008
<1|~|~|~|~|Mortality|4132735|Acute Lymphocytic|2008
<1|1.6|2.5|2.0|83|Incidence|4132735|Acute Lymphocytic|2008
<1|~|~|~|~|Mortality|4132735|Acute Myeloid|2008
<1|1.2|2.0|1.6|65|Incidence|4132735|Acute Myeloid|2008
<1|~|~|~|~|Mortality|4132735|Bones and Joints|2008
<1|~|~|~|~|Incidence|4132735|Bones and Joints|2008
<1|0.4|1.0|0.7|27|Mortality|4132735|Leukemia|2008
<1|3.9|5.2|4.5|188|Incidence|4132735|Leukemia|2008
<1|0.4|0.9|0.6|25|Mortality|4132735|Other|2008
<1|11.5|13.7|12.5|518|Incidence|4132735|Other|2008
<1|~|~|~|~|Mortality|4132735|Soft Tissue|2008
<1|2.7|3.9|3.3|135|Incidence|4132735|Soft Tissue|2008
1-4|0.1|0.3|0.2|34|Mortality|16240931|Acute Lymphocytic|2009
1-4|7.4|8.3|7.8|1273|Incidence|16240931|Acute Lymphocytic|2009
1-4|0.2|0.4|0.3|45|Mortality|16240931|Acute Myeloid|2009
1-4|0.8|1.1|0.9|151|Incidence|16240931|Acute Myeloid|2009
1-4|~|~|~|~|Mortality|16240931|Bones and Joints|2009
1-4|0.1|0.2|0.1|24|Incidence|16240931|Bones and Joints|2009
1-4|0.6|0.9|0.7|118|Mortality|16240931|Leukemia|2009
1-4|8.8|9.7|9.2|1498|Incidence|16240931|Leukemia|2009
1-4|0.5|0.8|0.6|104|Mortality|16240931|Other|2009
1-4|4.0|4.6|4.3|701|Incidence|16240931|Other|2009
1-4|0.1|0.2|0.1|22|Mortality|16240931|Soft Tissue|2009
1-4|1.0|1.4|1.2|193|Incidence|16240931|Soft Tissue|2009
10-14|0.3|0.4|0.3|69|Mortality|20660564|Acute Lymphocytic|2009
10-14|2.0|2.4|2.2|450|Incidence|20660564|Acute Lymphocytic|2009
10-14|0.1|0.2|0.2|33|Mortality|20660564|Acute Myeloid|2009
10-14|0.5|0.7|0.6|121|Incidence|20660564|Acute Myeloid|2009
10-14|0.2|0.3|0.3|55|Mortality|20660564|Bones and Joints|2009
10-14|1.2|1.6|1.4|290|Incidence|20660564|Bones and Joints|2009
10-14|0.5|0.7|0.6|127|Mortality|20660564|Leukemia|2009
10-14|2.8|3.3|3.1|635|Incidence|20660564|Leukemia|2009
10-14|0.2|0.3|0.2|50|Mortality|20660564|Other|2009
10-14|2.7|3.2|2.9|604|Incidence|20660564|Other|2009
10-14|0.1|0.3|0.2|40|Mortality|20660564|Soft Tissue|2009
10-14|0.8|1.0|0.9|183|Incidence|20660564|Soft Tissue|2009
15-19|0.2|0.4|0.3|66|Mortality|22192810|Acute Lymphocytic|2009
15-19|1.4|1.8|1.6|350|Incidence|22192810|Acute Lymphocytic|2009
15-19|0.2|0.4|0.3|63|Mortality|22192810|Acute Myeloid|2009
15-19|0.7|0.9|0.8|179|Incidence|22192810|Acute Myeloid|2009
15-19|0.4|0.6|0.5|102|Mortality|22192810|Bones and Joints|2009
15-19|1.3|1.7|1.5|331|Incidence|22192810|Bones and Joints|2009
15-19|0.7|0.9|0.8|172|Mortality|22192810|Leukemia|2009
15-19|2.6|3.1|2.8|628|Incidence|22192810|Leukemia|2009
15-19|0.5|0.7|0.6|125|Mortality|22192810|Other|2009
15-19|8.9|9.7|9.2|2052|Incidence|22192810|Other|2009
15-19|0.2|0.4|0.3|66|Mortality|22192810|Soft Tissue|2009
15-19|1.1|1.4|1.2|275|Incidence|22192810|Soft Tissue|2009
5-9|0.2|0.4|0.3|62|Mortality|20182499|Acute Lymphocytic|2009
5-9|3.3|3.8|3.6|718|Incidence|20182499|Acute Lymphocytic|2009
5-9|0.1|0.2|0.1|30|Mortality|20182499|Acute Myeloid|2009
5-9|0.3|0.5|0.4|79|Incidence|20182499|Acute Myeloid|2009
5-9|0.1|0.1|0.1|18|Mortality|20182499|Bones and Joints|2009
5-9|0.5|0.7|0.6|113|Incidence|20182499|Bones and Joints|2009
5-9|0.5|0.7|0.6|117|Mortality|20182499|Leukemia|2009
5-9|3.9|4.5|4.2|840|Incidence|20182499|Leukemia|2009
5-9|0.3|0.5|0.4|84|Mortality|20182499|Other|2009
5-9|1.4|1.8|1.6|319|Incidence|20182499|Other|2009
5-9|0.1|0.2|0.2|34|Mortality|20182499|Soft Tissue|2009
5-9|0.5|0.7|0.6|126|Incidence|20182499|Soft Tissue|2009
<1|~|~|~|~|Mortality|4003587|Acute Lymphocytic|2009
<1|1.5|2.4|1.9|78|Incidence|4003587|Acute Lymphocytic|2009
<1|~|~|~|~|Mortality|4003587|Acute Myeloid|2009
<1|0.9|1.6|1.2|48|Incidence|4003587|Acute Myeloid|2009
<1|~|~|~|~|Mortality|4003587|Bones and Joints|2009
<1|~|~|~|~|Incidence|4003587|Bones and Joints|2009
<1|0.4|1.0|0.7|27|Mortality|4003587|Leukemia|2009
<1|3.4|4.7|4.0|162|Incidence|4003587|Leukemia|2009
<1|0.6|1.2|0.8|33|Mortality|4003587|Other|2009
<1|10.9|13.1|12.0|479|Incidence|4003587|Other|2009
<1|~|~|~|~|Mortality|4003587|Soft Tissue|2009
<1|3.0|4.2|3.6|143|Incidence|4003587|Soft Tissue|2009
1-4|0.2|0.3|0.2|37|Mortality|16238083|Acute Lymphocytic|2010
1-4|7.2|8.1|7.6|1242|Incidence|16238083|Acute Lymphocytic|2010
1-4|0.2|0.4|0.3|46|Mortality|16238083|Acute Myeloid|2010
1-4|0.8|1.1|0.9|151|Incidence|16238083|Acute Myeloid|2010
1-4|~|~|~|~|Mortality|16238083|Bones and Joints|2010
1-4|0.1|0.3|0.2|29|Incidence|16238083|Bones and Joints|2010
1-4|0.6|0.8|0.7|112|Mortality|16238083|Leukemia|2010
1-4|8.5|9.5|9.0|1458|Incidence|16238083|Leukemia|2010
1-4|0.5|0.7|0.6|97|Mortality|16238083|Other|2010
1-4|5.1|5.8|5.4|880|Incidence|16238083|Other|2010
1-4|~|~|~|~|Mortality|16238083|Soft Tissue|2010
1-4|1.0|1.3|1.2|190|Incidence|16238083|Soft Tissue|2010
10-14|0.2|0.4|0.3|59|Mortality|20681024|Acute Lymphocytic|2010
10-14|2.0|2.4|2.2|459|Incidence|20681024|Acute Lymphocytic|2010
10-14|0.2|0.3|0.2|50|Mortality|20681024|Acute Myeloid|2010
10-14|0.6|0.8|0.7|138|Incidence|20681024|Acute Myeloid|2010
10-14|0.2|0.3|0.3|53|Mortality|20681024|Bones and Joints|2010
10-14|1.2|1.5|1.3|276|Incidence|20681024|Bones and Joints|2010
10-14|0.6|0.8|0.7|142|Mortality|20681024|Leukemia|2010
10-14|3.0|3.5|3.2|667|Incidence|20681024|Leukemia|2010
10-14|0.3|0.5|0.4|88|Mortality|20681024|Other|2010
10-14|3.1|3.6|3.3|684|Incidence|20681024|Other|2010
10-14|0.1|0.2|0.2|32|Mortality|20681024|Soft Tissue|2010
10-14|0.9|1.1|1.0|204|Incidence|20681024|Soft Tissue|2010
15-19|0.2|0.4|0.3|66|Mortality|21981869|Acute Lymphocytic|2010
15-19|1.4|1.7|1.5|335|Incidence|21981869|Acute Lymphocytic|2010
15-19|0.2|0.4|0.3|67|Mortality|21981869|Acute Myeloid|2010
15-19|0.8|1.0|0.9|201|Incidence|21981869|Acute Myeloid|2010
15-19|0.3|0.5|0.4|91|Mortality|21981869|Bones and Joints|2010
15-19|1.2|1.5|1.3|292|Incidence|21981869|Bones and Joints|2010
15-19|0.6|0.9|0.7|163|Mortality|21981869|Leukemia|2010
15-19|2.7|3.2|2.9|645|Incidence|21981869|Leukemia|2010
15-19|0.5|0.7|0.6|133|Mortality|21981869|Other|2010
15-19|8.8|9.6|9.2|2020|Incidence|21981869|Other|2010
15-19|0.2|0.4|0.3|67|Mortality|21981869|Soft Tissue|2010
15-19|1.0|1.3|1.1|249|Incidence|21981869|Soft Tissue|2010
5-9|0.2|0.4|0.3|61|Mortality|20331821|Acute Lymphocytic|2010
5-9|3.4|4.0|3.7|751|Incidence|20331821|Acute Lymphocytic|2010
5-9|0.1|0.2|0.1|29|Mortality|20331821|Acute Myeloid|2010
5-9|0.3|0.5|0.4|74|Incidence|20331821|Acute Myeloid|2010
5-9|0.1|0.2|0.1|20|Mortality|20331821|Bones and Joints|2010
5-9|0.5|0.7|0.6|113|Incidence|20331821|Bones and Joints|2010
5-9|0.4|0.7|0.5|111|Mortality|20331821|Leukemia|2010
5-9|4.0|4.6|4.3|866|Incidence|20331821|Leukemia|2010
5-9|0.3|0.5|0.4|83|Mortality|20331821|Other|2010
5-9|1.8|2.2|2.0|411|Incidence|20331821|Other|2010
5-9|0.1|0.2|0.1|28|Mortality|20331821|Soft Tissue|2010
5-9|0.5|0.8|0.7|133|Incidence|20331821|Soft Tissue|2010
<1|~|~|~|~|Mortality|3951495|Acute Lymphocytic|2010
<1|1.2|2.0|1.5|61|Incidence|3951495|Acute Lymphocytic|2010
<1|~|~|~|~|Mortality|3951495|Acute Myeloid|2010
<1|1.4|2.2|1.7|69|Incidence|3951495|Acute Myeloid|2010
<1|~|~|~|~|Mortality|3951495|Bones and Joints|2010
<1|~|~|~|~|Incidence|3951495|Bones and Joints|2010
<1|0.4|0.9|0.6|25|Mortality|3951495|Leukemia|2010
<1|3.7|5.0|4.3|169|Incidence|3951495|Leukemia|2010
<1|0.3|0.7|0.5|18|Mortality|3951495|Other|2010
<1|12.0|14.2|13.1|516|Incidence|3951495|Other|2010
<1|~|~|~|~|Mortality|3951495|Soft Tissue|2010
<1|2.8|4.0|3.4|133|Incidence|3951495|Soft Tissue|2010
1-4|0.1|0.3|0.2|31|Mortality|16162947|Acute Lymphocytic|2011
1-4|7.5|8.3|7.9|1275|Incidence|16162947|Acute Lymphocytic|2011
1-4|0.2|0.4|0.3|46|Mortality|16162947|Acute Myeloid|2011
1-4|0.8|1.1|1.0|156|Incidence|16162947|Acute Myeloid|2011
1-4|~|~|~|~|Mortality|16162947|Bones and Joints|2011
1-4|0.2|0.3|0.2|40|Incidence|16162947|Bones and Joints|2011
1-4|0.5|0.7|0.6|95|Mortality|16162947|Leukemia|2011
1-4|8.7|9.6|9.2|1482|Incidence|16162947|Leukemia|2011
1-4|0.6|0.8|0.7|110|Mortality|16162947|Other|2011
1-4|4.9|5.6|5.3|851|Incidence|16162947|Other|2011
1-4|0.1|0.2|0.1|23|Mortality|16162947|Soft Tissue|2011
1-4|1.0|1.4|1.2|191|Incidence|16162947|Soft Tissue|2011
10-14|0.3|0.5|0.4|76|Mortality|20715026|Acute Lymphocytic|2011
10-14|2.0|2.4|2.2|452|Incidence|20715026|Acute Lymphocytic|2011
10-14|0.1|0.2|0.2|32|Mortality|20715026|Acute Myeloid|2011
10-14|0.5|0.8|0.6|131|Incidence|20715026|Acute Myeloid|2011
10-14|0.2|0.3|0.2|51|Mortality|20715026|Bones and Joints|2011
10-14|1.3|1.6|1.4|295|Incidence|20715026|Bones and Joints|2011
10-14|0.5|0.7|0.6|127|Mortality|20715026|Leukemia|2011
10-14|2.9|3.4|3.1|647|Incidence|20715026|Leukemia|2011
10-14|0.2|0.4|0.3|62|Mortality|20715026|Other|2011
10-14|3.2|3.7|3.5|722|Incidence|20715026|Other|2011
10-14|0.1|0.3|0.2|38|Mortality|20715026|Soft Tissue|2011
10-14|0.7|0.9|0.8|164|Incidence|20715026|Soft Tissue|2011
15-19|0.3|0.4|0.3|70|Mortality|21661743|Acute Lymphocytic|2011
15-19|1.5|1.9|1.7|372|Incidence|21661743|Acute Lymphocytic|2011
15-19|0.2|0.3|0.3|57|Mortality|21661743|Acute Myeloid|2011
15-19|0.8|1.1|1.0|206|Incidence|21661743|Acute Myeloid|2011
15-19|0.4|0.6|0.5|101|Mortality|21661743|Bones and Joints|2011
15-19|1.2|1.5|1.4|295|Incidence|21661743|Bones and Joints|2011
15-19|0.7|0.9|0.8|177|Mortality|21661743|Leukemia|2011
15-19|2.9|3.4|3.1|680|Incidence|21661743|Leukemia|2011
15-19|0.5|0.7|0.6|132|Mortality|21661743|Other|2011
15-19|8.9|9.7|9.3|2021|Incidence|21661743|Other|2011
15-19|0.2|0.4|0.3|64|Mortality|21661743|Soft Tissue|2011
15-19|0.9|1.2|1.1|230|Incidence|21661743|Soft Tissue|2011
5-9|0.1|0.3|0.2|42|Mortality|20335489|Acute Lymphocytic|2011
5-9|3.5|4.0|3.8|766|Incidence|20335489|Acute Lymphocytic|2011
5-9|0.1|0.2|0.1|28|Mortality|20335489|Acute Myeloid|2011
5-9|0.3|0.5|0.4|86|Incidence|20335489|Acute Myeloid|2011
5-9|0.0|0.1|0.1|16|Mortality|20335489|Bones and Joints|2011
5-9|0.5|0.7|0.6|126|Incidence|20335489|Bones and Joints|2011
5-9|0.4|0.6|0.5|98|Mortality|20335489|Leukemia|2011
5-9|4.2|4.8|4.5|906|Incidence|20335489|Leukemia|2011
5-9|0.3|0.5|0.4|74|Mortality|20335489|Other|2011
5-9|1.9|2.3|2.1|420|Incidence|20335489|Other|2011
5-9|0.1|0.2|0.1|21|Mortality|20335489|Soft Tissue|2011
5-9|0.5|0.8|0.6|131|Incidence|20335489|Soft Tissue|2011
<1|~|~|~|~|Mortality|3963264|Acute Lymphocytic|2011
<1|1.5|2.4|1.9|77|Incidence|3963264|Acute Lymphocytic|2011
<1|~|~|~|~|Mortality|3963264|Acute Myeloid|2011
<1|1.0|1.8|1.4|54|Incidence|3963264|Acute Myeloid|2011
<1|~|~|~|~|Mortality|3963264|Bones and Joints|2011
<1|~|~|~|~|Incidence|3963264|Bones and Joints|2011
<1|0.3|0.8|0.6|22|Mortality|3963264|Leukemia|2011
<1|3.6|4.9|4.2|167|Incidence|3963264|Leukemia|2011
<1|0.4|1.0|0.7|27|Mortality|3963264|Other|2011
<1|11.1|13.4|12.2|484|Incidence|3963264|Other|2011
<1|~|~|~|~|Mortality|3963264|Soft Tissue|2011
<1|2.8|3.9|3.3|132|Incidence|3963264|Soft Tissue|2011
1-4|0.2|0.4|0.3|42|Mortality|16054205|Acute Lymphocytic|2012
1-4|7.3|8.2|7.7|1239|Incidence|16054205|Acute Lymphocytic|2012
1-4|0.3|0.6|0.4|71|Mortality|16054205|Acute Myeloid|2012
1-4|0.8|1.1|0.9|150|Incidence|16054205|Acute Myeloid|2012
1-4|~|~|~|~|Mortality|16054205|Bones and Joints|2012
1-4|0.1|0.3|0.2|28|Incidence|16054205|Bones and Joints|2012
1-4|0.7|1.0|0.8|136|Mortality|16054205|Leukemia|2012
1-4|8.6|9.5|9.0|1452|Incidence|16054205|Leukemia|2012
1-4|0.6|0.8|0.7|111|Mortality|16054205|Other|2012
1-4|5.2|5.9|5.5|889|Incidence|16054205|Other|2012
1-4|0.1|0.2|0.1|19|Mortality|16054205|Soft Tissue|2012
1-4|1.0|1.3|1.2|187|Incidence|16054205|Soft Tissue|2012
10-14|0.2|0.4|0.3|63|Mortality|20673843|Acute Lymphocytic|2012
10-14|1.9|2.3|2.1|440|Incidence|20673843|Acute Lymphocytic|2012
10-14|0.1|0.2|0.2|36|Mortality|20673843|Acute Myeloid|2012
10-14|0.5|0.7|0.6|114|Incidence|20673843|Acute Myeloid|2012
10-14|0.2|0.3|0.2|48|Mortality|20673843|Bones and Joints|2012
10-14|1.3|1.7|1.5|311|Incidence|20673843|Bones and Joints|2012
10-14|0.5|0.7|0.6|126|Mortality|20673843|Leukemia|2012
10-14|2.7|3.2|3.0|614|Incidence|20673843|Leukemia|2012
10-14|0.3|0.4|0.4|73|Mortality|20673843|Other|2012
10-14|3.1|3.6|3.3|690|Incidence|20673843|Other|2012
10-14|0.2|0.3|0.2|48|Mortality|20673843|Soft Tissue|2012
10-14|0.8|1.1|0.9|189|Incidence|20673843|Soft Tissue|2012
15-19|0.2|0.4|0.3|67|Mortality|21374020|Acute Lymphocytic|2012
15-19|1.4|1.7|1.5|329|Incidence|21374020|Acute Lymphocytic|2012
15-19|0.2|0.3|0.3|56|Mortality|21374020|Acute Myeloid|2012
15-19|0.8|1.1|0.9|198|Incidence|21374020|Acute Myeloid|2012
15-19|0.4|0.6|0.5|110|Mortality|21374020|Bones and Joints|2012
15-19|1.3|1.6|1.5|314|Incidence|21374020|Bones and Joints|2012
15-19|0.6|0.9|0.7|156|Mortality|21374020|Leukemia|2012
15-19|2.8|3.2|3.0|641|Incidence|21374020|Leukemia|2012
15-19|0.5|0.7|0.6|129|Mortality|21374020|Other|2012
15-19|9.6|10.4|10.0|2140|Incidence|21374020|Other|2012
15-19|0.3|0.4|0.4|76|Mortality|21374020|Soft Tissue|2012
15-19|0.8|1.1|1.0|209|Incidence|21374020|Soft Tissue|2012
5-9|0.2|0.3|0.2|43|Mortality|20472679|Acute Lymphocytic|2012
5-9|3.2|3.7|3.4|699|Incidence|20472679|Acute Lymphocytic|2012
5-9|0.1|0.2|0.1|27|Mortality|20472679|Acute Myeloid|2012
5-9|0.3|0.5|0.4|84|Incidence|20472679|Acute Myeloid|2012
5-9|0.0|0.1|0.1|17|Mortality|20472679|Bones and Joints|2012
5-9|0.5|0.7|0.6|113|Incidence|20472679|Bones and Joints|2012
5-9|0.4|0.6|0.5|97|Mortality|20472679|Leukemia|2012
5-9|3.8|4.3|4.0|823|Incidence|20472679|Leukemia|2012
5-9|0.3|0.5|0.4|89|Mortality|20472679|Other|2012
5-9|1.9|2.3|2.1|422|Incidence|20472679|Other|2012
5-9|0.1|0.2|0.1|26|Mortality|20472679|Soft Tissue|2012
5-9|0.5|0.7|0.6|126|Incidence|20472679|Soft Tissue|2012
<1|~|~|~|~|Mortality|3926731|Acute Lymphocytic|2012
<1|1.6|2.5|2.0|79|Incidence|3926731|Acute Lymphocytic|2012
<1|~|~|~|~|Mortality|3926731|Acute Myeloid|2012
<1|0.9|1.6|1.2|48|Incidence|3926731|Acute Myeloid|2012
<1|~|~|~|~|Mortality|3926731|Bones and Joints|2012
<1|~|~|~|~|Incidence|3926731|Bones and Joints|2012
<1|0.3|0.8|0.5|19|Mortality|3926731|Leukemia|2012
<1|3.5|4.8|4.1|162|Incidence|3926731|Leukemia|2012
<1|0.3|0.8|0.5|19|Mortality|3926731|Other|2012
<1|12.1|14.4|13.2|518|Incidence|3926731|Other|2012
<1|~|~|~|~|Mortality|3926731|Soft Tissue|2012
<1|3.0|4.2|3.5|138|Incidence|3926731|Soft Tissue|2012
1-4|0.1|0.3|0.2|33|Mortality|15923773|Acute Lymphocytic|2013
1-4|6.7|7.6|7.1|1136|Incidence|15923773|Acute Lymphocytic|2013
1-4|0.2|0.4|0.3|45|Mortality|15923773|Acute Myeloid|2013
1-4|0.8|1.1|0.9|144|Incidence|15923773|Acute Myeloid|2013
1-4|~|~|~|~|Mortality|15923773|Bones and Joints|2013
1-4|0.2|0.4|0.3|47|Incidence|15923773|Bones and Joints|2013
1-4|0.5|0.7|0.6|96|Mortality|15923773|Leukemia|2013
1-4|8.0|8.9|8.4|1344|Incidence|15923773|Leukemia|2013
1-4|0.4|0.7|0.6|89|Mortality|15923773|Other|2013
1-4|4.8|5.6|5.2|826|Incidence|15923773|Other|2013
1-4|0.1|0.2|0.2|24|Mortality|15923773|Soft Tissue|2013
1-4|1.1|1.5|1.3|209|Incidence|15923773|Soft Tissue|2013
10-14|0.2|0.4|0.3|63|Mortality|20656987|Acute Lymphocytic|2013
10-14|1.8|2.2|2.0|417|Incidence|20656987|Acute Lymphocytic|2013
10-14|0.2|0.3|0.2|43|Mortality|20656987|Acute Myeloid|2013
10-14|0.6|0.8|0.7|141|Incidence|20656987|Acute Myeloid|2013
10-14|0.2|0.3|0.2|51|Mortality|20656987|Bones and Joints|2013
10-14|1.2|1.5|1.4|285|Incidence|20656987|Bones and Joints|2013
10-14|0.6|0.8|0.7|139|Mortality|20656987|Leukemia|2013
10-14|2.8|3.3|3.0|629|Incidence|20656987|Leukemia|2013
10-14|0.2|0.4|0.3|62|Mortality|20656987|Other|2013
10-14|3.5|4.0|3.7|767|Incidence|20656987|Other|2013
10-14|0.1|0.3|0.2|41|Mortality|20656987|Soft Tissue|2013
10-14|0.8|1.0|0.9|183|Incidence|20656987|Soft Tissue|2013
15-19|0.2|0.3|0.3|56|Mortality|21183476|Acute Lymphocytic|2013
15-19|1.4|1.8|1.6|335|Incidence|21183476|Acute Lymphocytic|2013
15-19|0.2|0.4|0.3|59|Mortality|21183476|Acute Myeloid|2013
15-19|0.8|1.0|0.9|192|Incidence|21183476|Acute Myeloid|2013
15-19|0.4|0.6|0.5|108|Mortality|21183476|Bones and Joints|2013
15-19|1.3|1.7|1.5|314|Incidence|21183476|Bones and Joints|2013
15-19|0.6|0.9|0.8|159|Mortality|21183476|Leukemia|2013
15-19|2.8|3.3|3.0|645|Incidence|21183476|Leukemia|2013
15-19|0.4|0.6|0.5|113|Mortality|21183476|Other|2013
15-19|9.0|9.8|9.4|1991|Incidence|21183476|Other|2013
15-19|0.3|0.5|0.4|82|Mortality|21183476|Soft Tissue|2013
15-19|0.9|1.2|1.0|220|Incidence|21183476|Soft Tissue|2013
5-9|0.1|0.3|0.2|42|Mortality|20575591|Acute Lymphocytic|2013
5-9|3.1|3.6|3.4|697|Incidence|20575591|Acute Lymphocytic|2013
5-9|0.1|0.2|0.1|30|Mortality|20575591|Acute Myeloid|2013
5-9|0.4|0.6|0.5|94|Incidence|20575591|Acute Myeloid|2013
5-9|~|~|~|~|Mortality|20575591|Bones and Joints|2013
5-9|0.5|0.7|0.6|128|Incidence|20575591|Bones and Joints|2013
5-9|0.4|0.6|0.5|94|Mortality|20575591|Leukemia|2013
5-9|3.9|4.4|4.1|849|Incidence|20575591|Leukemia|2013
5-9|0.4|0.5|0.4|92|Mortality|20575591|Other|2013
5-9|2.0|2.4|2.2|449|Incidence|20575591|Other|2013
5-9|0.1|0.2|0.1|29|Mortality|20575591|Soft Tissue|2013
5-9|0.5|0.7|0.6|128|Incidence|20575591|Soft Tissue|2013
<1|~|~|~|~|Mortality|3931411|Acute Lymphocytic|2013
<1|1.2|2.1|1.6|63|Incidence|3931411|Acute Lymphocytic|2013
<1|~|~|~|~|Mortality|3931411|Acute Myeloid|2013
<1|1.1|1.9|1.5|59|Incidence|3931411|Acute Myeloid|2013
<1|~|~|~|~|Mortality|3931411|Bones and Joints|2013
<1|~|~|~|~|Incidence|3931411|Bones and Joints|2013
<1|0.3|0.8|0.5|21|Mortality|3931411|Leukemia|2013
<1|3.7|5.1|4.3|171|Incidence|3931411|Leukemia|2013
<1|~|~|~|~|Mortality|3931411|Other|2013
<1|13.3|15.7|14.4|568|Incidence|3931411|Other|2013
<1|~|~|~|~|Mortality|3931411|Soft Tissue|2013
<1|3.1|4.3|3.7|145|Incidence|3931411|Soft Tissue|2013
1-4|0.2|0.3|0.2|36|Mortality|15923833|Acute Lymphocytic|2014
1-4|6.9|7.7|7.3|1164|Incidence|15923833|Acute Lymphocytic|2014
1-4|0.2|0.4|0.3|43|Mortality|15923833|Acute Myeloid|2014
1-4|0.8|1.1|1.0|155|Incidence|15923833|Acute Myeloid|2014
1-4|~|~|~|~|Mortality|15923833|Bones and Joints|2014
1-4|0.1|0.3|0.2|33|Incidence|15923833|Bones and Joints|2014
1-4|0.5|0.8|0.6|101|Mortality|15923833|Leukemia|2014
1-4|8.3|9.3|8.8|1399|Incidence|15923833|Leukemia|2014
1-4|0.5|0.8|0.6|102|Mortality|15923833|Other|2014
1-4|4.8|5.5|5.1|814|Incidence|15923833|Other|2014
1-4|~|~|~|~|Mortality|15923833|Soft Tissue|2014
1-4|1.1|1.4|1.3|200|Incidence|15923833|Soft Tissue|2014
10-14|0.2|0.3|0.3|55|Mortality|20673760|Acute Lymphocytic|2014
10-14|1.9|2.3|2.1|434|Incidence|20673760|Acute Lymphocytic|2014
10-14|0.1|0.2|0.1|22|Mortality|20673760|Acute Myeloid|2014
10-14|0.5|0.8|0.6|133|Incidence|20673760|Acute Myeloid|2014
10-14|0.2|0.4|0.3|63|Mortality|20673760|Bones and Joints|2014
10-14|1.4|1.7|1.5|317|Incidence|20673760|Bones and Joints|2014
10-14|0.4|0.6|0.5|97|Mortality|20673760|Leukemia|2014
10-14|2.8|3.3|3.1|633|Incidence|20673760|Leukemia|2014
10-14|0.3|0.4|0.3|69|Mortality|20673760|Other|2014
10-14|3.6|4.1|3.8|792|Incidence|20673760|Other|2014
10-14|0.1|0.2|0.1|30|Mortality|20673760|Soft Tissue|2014
10-14|0.8|1.1|1.0|198|Incidence|20673760|Soft Tissue|2014
15-19|0.2|0.4|0.3|66|Mortality|21060362|Acute Lymphocytic|2014
15-19|1.5|1.9|1.7|353|Incidence|21060362|Acute Lymphocytic|2014
15-19|0.2|0.3|0.3|54|Mortality|21060362|Acute Myeloid|2014
15-19|0.9|1.1|1.0|211|Incidence|21060362|Acute Myeloid|2014
15-19|0.4|0.6|0.5|96|Mortality|21060362|Bones and Joints|2014
15-19|1.3|1.6|1.4|297|Incidence|21060362|Bones and Joints|2014
15-19|0.6|0.9|0.8|160|Mortality|21060362|Leukemia|2014
15-19|3.0|3.5|3.2|679|Incidence|21060362|Leukemia|2014
15-19|0.4|0.6|0.5|104|Mortality|21060362|Other|2014
15-19|9.5|10.3|9.9|2083|Incidence|21060362|Other|2014
15-19|0.2|0.4|0.3|67|Mortality|21060362|Soft Tissue|2014
15-19|1.0|1.3|1.1|242|Incidence|21060362|Soft Tissue|2014
5-9|0.2|0.3|0.2|50|Mortality|20526270|Acute Lymphocytic|2014
5-9|3.2|3.7|3.5|712|Incidence|20526270|Acute Lymphocytic|2014
5-9|0.1|0.2|0.1|21|Mortality|20526270|Acute Myeloid|2014
5-9|0.4|0.5|0.4|91|Incidence|20526270|Acute Myeloid|2014
5-9|0.1|0.2|0.1|20|Mortality|20526270|Bones and Joints|2014
5-9|0.6|0.8|0.7|138|Incidence|20526270|Bones and Joints|2014
5-9|0.3|0.5|0.4|87|Mortality|20526270|Leukemia|2014
5-9|3.9|4.5|4.2|858|Incidence|20526270|Leukemia|2014
5-9|0.4|0.6|0.5|94|Mortality|20526270|Other|2014
5-9|2.1|2.6|2.3|480|Incidence|20526270|Other|2014
5-9|0.1|0.2|0.1|25|Mortality|20526270|Soft Tissue|2014
5-9|0.6|0.8|0.7|140|Incidence|20526270|Soft Tissue|2014
<1|~|~|~|~|Mortality|3954973|Acute Lymphocytic|2014
<1|1.1|1.9|1.4|57|Incidence|3954973|Acute Lymphocytic|2014
<1|~|~|~|~|Mortality|3954973|Acute Myeloid|2014
<1|1.4|2.2|1.7|69|Incidence|3954973|Acute Myeloid|2014
<1|~|~|~|~|Mortality|3954973|Bones and Joints|2014
<1|~|~|~|~|Incidence|3954973|Bones and Joints|2014
<1|~|~|~|~|Mortality|3954973|Leukemia|2014
<1|3.3|4.6|3.9|155|Incidence|3954973|Leukemia|2014
<1|0.3|0.8|0.5|20|Mortality|3954973|Other|2014
<1|13.8|16.2|15.0|592|Incidence|3954973|Other|2014
<1|~|~|~|~|Mortality|3954973|Soft Tissue|2014
<1|2.5|3.6|3.0|118|Incidence|3954973|Soft Tissue|2014
1-4|0.2|0.4|0.3|44|Mortality|15940562|Acute Lymphocytic|2015
1-4|7.5|8.4|7.9|1265|Incidence|15940562|Acute Lymphocytic|2015
1-4|0.2|0.4|0.3|45|Mortality|15940562|Acute Myeloid|2015
1-4|0.8|1.2|1.0|158|Incidence|15940562|Acute Myeloid|2015
1-4|~|~|~|~|Mortality|15940562|Bones and Joints|2015
1-4|0.1|0.3|0.2|32|Incidence|15940562|Bones and Joints|2015
1-4|0.6|0.9|0.7|115|Mortality|15940562|Leukemia|2015
1-4|8.9|9.8|9.4|1491|Incidence|15940562|Leukemia|2015
1-4|0.5|0.8|0.6|101|Mortality|15940562|Other|2015
1-4|5.1|5.8|5.4|864|Incidence|15940562|Other|2015
1-4|0.1|0.3|0.2|29|Mortality|15940562|Soft Tissue|2015
1-4|1.1|1.4|1.3|201|Incidence|15940562|Soft Tissue|2015
10-14|0.2|0.3|0.3|52|Mortality|20614613|Acute Lymphocytic|2015
10-14|2.0|2.4|2.2|448|Incidence|20614613|Acute Lymphocytic|2015
10-14|0.2|0.3|0.2|44|Mortality|20614613|Acute Myeloid|2015
10-14|0.5|0.8|0.6|133|Incidence|20614613|Acute Myeloid|2015
10-14|0.2|0.4|0.3|65|Mortality|20614613|Bones and Joints|2015
10-14|1.3|1.6|1.5|302|Incidence|20614613|Bones and Joints|2015
10-14|0.5|0.7|0.6|115|Mortality|20614613|Leukemia|2015
10-14|2.9|3.4|3.1|646|Incidence|20614613|Leukemia|2015
10-14|0.2|0.3|0.2|46|Mortality|20614613|Other|2015
10-14|4.0|4.6|4.3|879|Incidence|20614613|Other|2015
10-14|0.1|0.3|0.2|38|Mortality|20614613|Soft Tissue|2015
10-14|0.8|1.1|0.9|193|Incidence|20614613|Soft Tissue|2015
15-19|0.2|0.4|0.3|60|Mortality|21090272|Acute Lymphocytic|2015
15-19|1.7|2.0|1.9|391|Incidence|21090272|Acute Lymphocytic|2015
15-19|0.2|0.3|0.3|56|Mortality|21090272|Acute Myeloid|2015
15-19|0.8|1.0|0.9|190|Incidence|21090272|Acute Myeloid|2015
15-19|0.4|0.6|0.5|113|Mortality|21090272|Bones and Joints|2015
15-19|1.3|1.6|1.4|304|Incidence|21090272|Bones and Joints|2015
15-19|0.6|0.8|0.7|147|Mortality|21090272|Leukemia|2015
15-19|3.1|3.6|3.3|700|Incidence|21090272|Leukemia|2015
15-19|0.5|0.7|0.5|115|Mortality|21090272|Other|2015
15-19|10.5|11.4|11.0|2316|Incidence|21090272|Other|2015
15-19|0.2|0.3|0.3|53|Mortality|21090272|Soft Tissue|2015
15-19|1.1|1.4|1.3|269|Incidence|21090272|Soft Tissue|2015
5-9|0.2|0.3|0.2|44|Mortality|20490819|Acute Lymphocytic|2015
5-9|3.3|3.9|3.6|736|Incidence|20490819|Acute Lymphocytic|2015
5-9|0.1|0.2|0.1|20|Mortality|20490819|Acute Myeloid|2015
5-9|0.3|0.5|0.4|88|Incidence|20490819|Acute Myeloid|2015
5-9|0.1|0.1|0.1|18|Mortality|20490819|Bones and Joints|2015
5-9|0.6|0.8|0.7|136|Incidence|20490819|Bones and Joints|2015
5-9|0.4|0.5|0.4|91|Mortality|20490819|Leukemia|2015
5-9|4.0|4.5|4.2|867|Incidence|20490819|Leukemia|2015
5-9|0.3|0.4|0.4|72|Mortality|20490819|Other|2015
5-9|2.1|2.5|2.3|466|Incidence|20490819|Other|2015
5-9|0.1|0.2|0.2|37|Mortality|20490819|Soft Tissue|2015
5-9|0.5|0.7|0.6|124|Incidence|20490819|Soft Tissue|2015
<1|~|~|~|~|Mortality|3984144|Acute Lymphocytic|2015
<1|1.3|2.2|1.7|68|Incidence|3984144|Acute Lymphocytic|2015
<1|~|~|~|~|Mortality|3984144|Acute Myeloid|2015
<1|1.3|2.1|1.7|67|Incidence|3984144|Acute Myeloid|2015
<1|~|~|~|~|Mortality|3984144|Bones and Joints|2015
<1|~|~|~|~|Incidence|3984144|Bones and Joints|2015
<1|0.3|0.8|0.6|22|Mortality|3984144|Leukemia|2015
<1|3.8|5.1|4.4|177|Incidence|3984144|Leukemia|2015
<1|0.2|0.7|0.4|16|Mortality|3984144|Other|2015
<1|13.8|16.2|14.9|595|Incidence|3984144|Other|2015
<1|~|~|~|~|Mortality|3984144|Soft Tissue|2015
<1|3.1|4.3|3.6|145|Incidence|3984144|Soft Tissue|2015
1-4|0.1|0.3|0.2|33|Mortality|15973469|Acute Lymphocytic|2016
1-4|7.1|7.9|7.5|1197|Incidence|15973469|Acute Lymphocytic|2016
1-4|0.3|0.5|0.4|59|Mortality|15973469|Acute Myeloid|2016
1-4|0.9|1.2|1.1|171|Incidence|15973469|Acute Myeloid|2016
1-4|~|~|~|~|Mortality|15973469|Bones and Joints|2016
1-4|0.1|0.3|0.2|32|Incidence|15973469|Bones and Joints|2016
1-4|0.6|0.8|0.7|108|Mortality|15973469|Leukemia|2016
1-4|8.4|9.4|8.9|1422|Incidence|15973469|Leukemia|2016
1-4|0.6|0.8|0.7|111|Mortality|15973469|Other|2016
1-4|4.7|5.5|5.1|813|Incidence|15973469|Other|2016
1-4|0.1|0.3|0.2|32|Mortality|15973469|Soft Tissue|2016
1-4|1.0|1.4|1.2|193|Incidence|15973469|Soft Tissue|2016
10-14|0.2|0.3|0.2|51|Mortality|20634000|Acute Lymphocytic|2016
10-14|2.3|2.7|2.5|518|Incidence|20634000|Acute Lymphocytic|2016
10-14|0.1|0.2|0.2|37|Mortality|20634000|Acute Myeloid|2016
10-14|0.7|0.9|0.8|160|Incidence|20634000|Acute Myeloid|2016
10-14|0.2|0.4|0.3|56|Mortality|20634000|Bones and Joints|2016
10-14|1.4|1.7|1.6|322|Incidence|20634000|Bones and Joints|2016
10-14|0.4|0.6|0.5|108|Mortality|20634000|Leukemia|2016
10-14|3.4|3.9|3.6|747|Incidence|20634000|Leukemia|2016
10-14|0.3|0.4|0.3|67|Mortality|20634000|Other|2016
10-14|3.8|4.3|4.1|836|Incidence|20634000|Other|2016
10-14|0.1|0.2|0.1|30|Mortality|20634000|Soft Tissue|2016
10-14|0.7|1.0|0.9|179|Incidence|20634000|Soft Tissue|2016
15-19|0.3|0.4|0.3|72|Mortality|21140143|Acute Lymphocytic|2016
15-19|1.6|2.0|1.8|384|Incidence|21140143|Acute Lymphocytic|2016
15-19|0.2|0.3|0.2|46|Mortality|21140143|Acute Myeloid|2016
15-19|0.8|1.1|0.9|195|Incidence|21140143|Acute Myeloid|2016
15-19|0.5|0.7|0.6|118|Mortality|21140143|Bones and Joints|2016
15-19|1.4|1.7|1.5|325|Incidence|21140143|Bones and Joints|2016
15-19|0.6|0.8|0.7|148|Mortality|21140143|Leukemia|2016
15-19|3.0|3.5|3.2|681|Incidence|21140143|Leukemia|2016
15-19|0.5|0.7|0.5|116|Mortality|21140143|Other|2016
15-19|10.7|11.6|11.1|2347|Incidence|21140143|Other|2016
15-19|0.2|0.4|0.3|60|Mortality|21140143|Soft Tissue|2016
15-19|1.1|1.4|1.2|259|Incidence|21140143|Soft Tissue|2016
5-9|0.2|0.4|0.3|55|Mortality|20450557|Acute Lymphocytic|2016
5-9|3.4|3.9|3.6|744|Incidence|20450557|Acute Lymphocytic|2016
5-9|0.1|0.2|0.1|29|Mortality|20450557|Acute Myeloid|2016
5-9|0.3|0.5|0.4|81|Incidence|20450557|Acute Myeloid|2016
5-9|0.1|0.2|0.1|22|Mortality|20450557|Bones and Joints|2016
5-9|0.6|0.8|0.7|142|Incidence|20450557|Bones and Joints|2016
5-9|0.4|0.6|0.5|106|Mortality|20450557|Leukemia|2016
5-9|4.0|4.6|4.3|882|Incidence|20450557|Leukemia|2016
5-9|0.3|0.4|0.3|71|Mortality|20450557|Other|2016
5-9|2.1|2.5|2.3|469|Incidence|20450557|Other|2016
5-9|0.1|0.3|0.2|41|Mortality|20450557|Soft Tissue|2016
5-9|0.6|0.8|0.7|138|Incidence|20450557|Soft Tissue|2016
<1|~|~|~|~|Mortality|3963268|Acute Lymphocytic|2016
<1|1.5|2.4|1.9|76|Incidence|3963268|Acute Lymphocytic|2016
<1|~|~|~|~|Mortality|3963268|Acute Myeloid|2016
<1|1.0|1.7|1.3|52|Incidence|3963268|Acute Myeloid|2016
<1|~|~|~|~|Mortality|3963268|Bones and Joints|2016
<1|~|~|~|~|Incidence|3963268|Bones and Joints|2016
<1|0.5|1.1|0.7|29|Mortality|3963268|Leukemia|2016
<1|3.7|5.0|4.3|170|Incidence|3963268|Leukemia|2016
<1|0.3|0.8|0.5|20|Mortality|3963268|Other|2016
<1|12.7|15.0|13.8|548|Incidence|3963268|Other|2016
<1|~|~|~|~|Mortality|3963268|Soft Tissue|2016
<1|2.8|4.0|3.4|134|Incidence|3963268|Soft Tissue|2016
1-4|0.2|0.2|0.2|163|Mortality|79313061|Acute Lymphocytic|2016-2020
1-4|7.2|7.6|7.4|5685|Incidence|76880096|Acute Lymphocytic|2016-2020
1-4|0.3|0.4|0.3|251|Mortality|79313061|Acute Myeloid|2016-2020
1-4|0.9|1.0|0.9|712|Incidence|76880096|Acute Myeloid|2016-2020
1-4|0.0|0.0|0.0|20|Mortality|79313061|Bones and Joints|2016-2020
1-4|0.2|0.2|0.2|149|Incidence|76880096|Bones and Joints|2016-2020
1-4|0.6|0.7|0.6|499|Mortality|79313061|Leukemia|2016-2020
1-4|8.5|8.9|8.7|6668|Incidence|76880096|Leukemia|2016-2020
1-4|0.6|0.7|0.6|488|Mortality|79313061|Other|2016-2020
1-4|4.9|5.2|5.1|3893|Incidence|76880096|Other|2016-2020
1-4|0.1|0.2|0.2|134|Mortality|79313061|Soft Tissue|2016-2020
1-4|1.1|1.2|1.2|886|Incidence|76880096|Soft Tissue|2016-2020
10-14|0.2|0.3|0.2|252|Mortality|103879774|Acute Lymphocytic|2016-2020
10-14|2.3|2.5|2.4|2370|Incidence|100666137|Acute Lymphocytic|2016-2020
10-14|0.2|0.2|0.2|187|Mortality|103879774|Acute Myeloid|2016-2020
10-14|0.7|0.8|0.7|721|Incidence|100666137|Acute Myeloid|2016-2020
10-14|0.3|0.3|0.3|304|Mortality|103879774|Bones and Joints|2016-2020
10-14|1.4|1.6|1.5|1495|Incidence|100666137|Bones and Joints|2016-2020
10-14|0.5|0.6|0.5|534|Mortality|103879774|Leukemia|2016-2020
10-14|3.3|3.5|3.4|3400|Incidence|100666137|Leukemia|2016-2020
10-14|0.3|0.3|0.3|299|Mortality|103879774|Other|2016-2020
10-14|3.9|4.2|4.0|4055|Incidence|100666137|Other|2016-2020
10-14|0.2|0.2|0.2|191|Mortality|103879774|Soft Tissue|2016-2020
10-14|0.8|0.9|0.9|893|Incidence|100666137|Soft Tissue|2016-2020
15-19|0.3|0.3|0.3|322|Mortality|105350147|Acute Lymphocytic|2016-2020
15-19|1.7|1.9|1.8|1850|Incidence|102161808|Acute Lymphocytic|2016-2020
15-19|0.2|0.2|0.2|216|Mortality|105350147|Acute Myeloid|2016-2020
15-19|0.8|0.9|0.8|861|Incidence|102161808|Acute Myeloid|2016-2020
15-19|0.5|0.6|0.5|544|Mortality|105350147|Bones and Joints|2016-2020
15-19|1.4|1.6|1.5|1538|Incidence|102161808|Bones and Joints|2016-2020
15-19|0.6|0.7|0.6|684|Mortality|105350147|Leukemia|2016-2020
15-19|3.0|3.2|3.1|3198|Incidence|102161808|Leukemia|2016-2020
15-19|0.5|0.6|0.5|551|Mortality|105350147|Other|2016-2020
15-19|10.4|10.9|10.6|10879|Incidence|102161808|Other|2016-2020
15-19|0.3|0.3|0.3|324|Mortality|105350147|Soft Tissue|2016-2020
15-19|1.1|1.3|1.2|1212|Incidence|102161808|Soft Tissue|2016-2020
5-9|0.2|0.2|0.2|198|Mortality|101453285|Acute Lymphocytic|2016-2020
5-9|3.4|3.7|3.5|3475|Incidence|98323876|Acute Lymphocytic|2016-2020
5-9|0.1|0.1|0.1|126|Mortality|101453285|Acute Myeloid|2016-2020
5-9|0.4|0.4|0.4|397|Incidence|98323876|Acute Myeloid|2016-2020
5-9|0.1|0.1|0.1|84|Mortality|101453285|Bones and Joints|2016-2020
5-9|0.6|0.7|0.6|612|Incidence|98323876|Bones and Joints|2016-2020
5-9|0.4|0.4|0.4|402|Mortality|101453285|Leukemia|2016-2020
5-9|4.0|4.3|4.2|4084|Incidence|98323876|Leukemia|2016-2020
5-9|0.3|0.4|0.4|356|Mortality|101453285|Other|2016-2020
5-9|2.0|2.2|2.1|2032|Incidence|98323876|Other|2016-2020
5-9|0.1|0.2|0.1|150|Mortality|101453285|Soft Tissue|2016-2020
5-9|0.6|0.7|0.6|635|Incidence|98323876|Soft Tissue|2016-2020
<1|0.1|0.2|0.1|27|Mortality|19169850|Acute Lymphocytic|2016-2020
<1|1.6|1.9|1.7|324|Incidence|18583091|Acute Lymphocytic|2016-2020
<1|0.1|0.3|0.2|36|Mortality|19169850|Acute Myeloid|2016-2020
<1|1.3|1.6|1.5|271|Incidence|18583091|Acute Myeloid|2016-2020
<1|~|~|~|~|Mortality|19169850|Bones and Joints|2016-2020
<1|0.2|0.3|0.2|44|Incidence|18583091|Bones and Joints|2016-2020
<1|0.4|0.6|0.5|96|Mortality|19169850|Leukemia|2016-2020
<1|3.8|4.4|4.1|760|Incidence|18583091|Leukemia|2016-2020
<1|0.4|0.6|0.5|95|Mortality|19169850|Other|2016-2020
<1|13.0|14.1|13.6|2520|Incidence|18583091|Other|2016-2020
<1|~|~|~|~|Mortality|19169850|Soft Tissue|2016-2020
<1|2.9|3.4|3.2|588|Incidence|18583091|Soft Tissue|2016-2020
1-4|0.2|0.3|0.2|37|Mortality|16012579|Acute Lymphocytic|2017
1-4|6.9|7.8|7.4|1179|Incidence|16012579|Acute Lymphocytic|2017
1-4|0.3|0.4|0.3|54|Mortality|16012579|Acute Myeloid|2017
1-4|0.8|1.1|1.0|157|Incidence|16012579|Acute Myeloid|2017
1-4|~|~|~|~|Mortality|16012579|Bones and Joints|2017
1-4|0.2|0.3|0.2|39|Incidence|16012579|Bones and Joints|2017
1-4|0.6|0.8|0.7|110|Mortality|16012579|Leukemia|2017
1-4|8.3|9.2|8.7|1400|Incidence|16012579|Leukemia|2017
1-4|0.5|0.7|0.6|90|Mortality|16012579|Other|2017
1-4|4.9|5.6|5.2|836|Incidence|16012579|Other|2017
1-4|0.1|0.3|0.2|28|Mortality|16012579|Soft Tissue|2017
1-4|1.0|1.4|1.2|194|Incidence|16012579|Soft Tissue|2017
10-14|0.1|0.3|0.2|43|Mortality|20783456|Acute Lymphocytic|2017
10-14|2.2|2.6|2.4|496|Incidence|20783456|Acute Lymphocytic|2017
10-14|0.2|0.3|0.2|45|Mortality|20783456|Acute Myeloid|2017
10-14|0.5|0.7|0.6|130|Incidence|20783456|Acute Myeloid|2017
10-14|0.2|0.3|0.2|50|Mortality|20783456|Bones and Joints|2017
10-14|1.4|1.7|1.5|315|Incidence|20783456|Bones and Joints|2017
10-14|0.4|0.6|0.5|109|Mortality|20783456|Leukemia|2017
10-14|3.1|3.6|3.3|687|Incidence|20783456|Leukemia|2017
10-14|0.3|0.4|0.3|69|Mortality|20783456|Other|2017
10-14|3.7|4.2|3.9|816|Incidence|20783456|Other|2017
10-14|0.1|0.3|0.2|41|Mortality|20783456|Soft Tissue|2017
10-14|0.7|1.0|0.8|173|Incidence|20783456|Soft Tissue|2017
15-19|0.2|0.4|0.3|59|Mortality|21105586|Acute Lymphocytic|2017
15-19|1.5|1.8|1.6|348|Incidence|21105586|Acute Lymphocytic|2017
15-19|0.2|0.4|0.3|59|Mortality|21105586|Acute Myeloid|2017
15-19|0.7|1.0|0.8|173|Incidence|21105586|Acute Myeloid|2017
15-19|0.4|0.6|0.5|104|Mortality|21105586|Bones and Joints|2017
15-19|1.4|1.7|1.5|325|Incidence|21105586|Bones and Joints|2017
15-19|0.6|0.8|0.7|145|Mortality|21105586|Leukemia|2017
15-19|2.8|3.3|3.0|635|Incidence|21105586|Leukemia|2017
15-19|0.4|0.6|0.5|110|Mortality|21105586|Other|2017
15-19|9.7|10.6|10.1|2140|Incidence|21105586|Other|2017
15-19|0.2|0.4|0.3|62|Mortality|21105586|Soft Tissue|2017
15-19|1.1|1.4|1.3|268|Incidence|21105586|Soft Tissue|2017
5-9|0.1|0.3|0.2|39|Mortality|20330306|Acute Lymphocytic|2017
5-9|3.0|3.5|3.2|659|Incidence|20330306|Acute Lymphocytic|2017
5-9|0.1|0.1|0.1|18|Mortality|20330306|Acute Myeloid|2017
5-9|0.3|0.5|0.4|80|Incidence|20330306|Acute Myeloid|2017
5-9|~|~|~|~|Mortality|20330306|Bones and Joints|2017
5-9|0.4|0.7|0.5|111|Incidence|20330306|Bones and Joints|2017
5-9|0.3|0.5|0.4|77|Mortality|20330306|Leukemia|2017
5-9|3.6|4.2|3.9|787|Incidence|20330306|Leukemia|2017
5-9|0.3|0.5|0.4|82|Mortality|20330306|Other|2017
5-9|2.0|2.4|2.2|438|Incidence|20330306|Other|2017
5-9|0.1|0.2|0.1|29|Mortality|20330306|Soft Tissue|2017
5-9|0.5|0.8|0.7|133|Incidence|20330306|Soft Tissue|2017
<1|~|~|~|~|Mortality|3882437|Acute Lymphocytic|2017
<1|1.3|2.1|1.7|65|Incidence|3882437|Acute Lymphocytic|2017
<1|~|~|~|~|Mortality|3882437|Acute Myeloid|2017
<1|1.2|2.0|1.5|59|Incidence|3882437|Acute Myeloid|2017
<1|~|~|~|~|Mortality|3882437|Bones and Joints|2017
<1|~|~|~|~|Incidence|3882437|Bones and Joints|2017
<1|0.3|0.8|0.5|19|Mortality|3882437|Leukemia|2017
<1|3.6|4.9|4.2|162|Incidence|3882437|Leukemia|2017
<1|0.3|0.7|0.4|17|Mortality|3882437|Other|2017
<1|12.1|14.4|13.2|513|Incidence|3882437|Other|2017
<1|~|~|~|~|Mortality|3882437|Soft Tissue|2017
<1|2.6|3.8|3.1|122|Incidence|3882437|Soft Tissue|2017
1-4|0.1|0.3|0.2|30|Mortality|15951619|Acute Lymphocytic|2018
1-4|7.5|8.4|7.9|1264|Incidence|15951619|Acute Lymphocytic|2018
1-4|0.3|0.5|0.4|56|Mortality|15951619|Acute Myeloid|2018
1-4|0.7|1.0|0.9|139|Incidence|15951619|Acute Myeloid|2018
1-4|~|~|~|~|Mortality|15951619|Bones and Joints|2018
1-4|0.1|0.3|0.2|30|Incidence|15951619|Bones and Joints|2018
1-4|0.5|0.8|0.7|106|Mortality|15951619|Leukemia|2018
1-4|8.7|9.7|9.2|1467|Incidence|15951619|Leukemia|2018
1-4|0.5|0.8|0.7|105|Mortality|15951619|Other|2018
1-4|4.5|5.2|4.9|777|Incidence|15951619|Other|2018
1-4|0.1|0.3|0.2|28|Mortality|15951619|Soft Tissue|2018
1-4|0.9|1.2|1.0|160|Incidence|15951619|Soft Tissue|2018
10-14|0.2|0.3|0.3|56|Mortality|20887842|Acute Lymphocytic|2018
10-14|2.0|2.4|2.2|455|Incidence|20887842|Acute Lymphocytic|2018
10-14|0.1|0.2|0.2|36|Mortality|20887842|Acute Myeloid|2018
10-14|0.6|0.8|0.7|145|Incidence|20887842|Acute Myeloid|2018
10-14|0.3|0.4|0.3|71|Mortality|20887842|Bones and Joints|2018
10-14|1.4|1.8|1.6|330|Incidence|20887842|Bones and Joints|2018
10-14|0.4|0.6|0.5|110|Mortality|20887842|Leukemia|2018
10-14|3.0|3.5|3.3|683|Incidence|20887842|Leukemia|2018
10-14|0.2|0.3|0.2|49|Mortality|20887842|Other|2018
10-14|4.1|4.7|4.4|916|Incidence|20887842|Other|2018
10-14|0.2|0.3|0.2|51|Mortality|20887842|Soft Tissue|2018
10-14|0.8|1.1|0.9|192|Incidence|20887842|Soft Tissue|2018
15-19|0.3|0.5|0.4|78|Mortality|21077066|Acute Lymphocytic|2018
15-19|1.8|2.2|2.0|427|Incidence|21077066|Acute Lymphocytic|2018
15-19|0.2|0.3|0.2|51|Mortality|21077066|Acute Myeloid|2018
15-19|0.7|0.9|0.8|171|Incidence|21077066|Acute Myeloid|2018
15-19|0.4|0.6|0.5|98|Mortality|21077066|Bones and Joints|2018
15-19|1.4|1.7|1.5|320|Incidence|21077066|Bones and Joints|2018
15-19|0.7|0.9|0.8|162|Mortality|21077066|Leukemia|2018
15-19|3.1|3.6|3.3|705|Incidence|21077066|Leukemia|2018
15-19|0.4|0.6|0.5|113|Mortality|21077066|Other|2018
15-19|10.5|11.4|10.9|2307|Incidence|21077066|Other|2018
15-19|0.3|0.5|0.4|81|Mortality|21077066|Soft Tissue|2018
15-19|0.9|1.2|1.1|228|Incidence|21077066|Soft Tissue|2018
5-9|0.1|0.2|0.1|28|Mortality|20212958|Acute Lymphocytic|2018
5-9|3.3|3.8|3.6|722|Incidence|20212958|Acute Lymphocytic|2018
5-9|0.1|0.2|0.1|29|Mortality|20212958|Acute Myeloid|2018
5-9|0.3|0.5|0.4|81|Incidence|20212958|Acute Myeloid|2018
5-9|0.1|0.2|0.1|25|Mortality|20212958|Bones and Joints|2018
5-9|0.6|0.8|0.7|136|Incidence|20212958|Bones and Joints|2018
5-9|0.3|0.4|0.3|66|Mortality|20212958|Leukemia|2018
5-9|3.9|4.5|4.2|847|Incidence|20212958|Leukemia|2018
5-9|0.2|0.4|0.3|61|Mortality|20212958|Other|2018
5-9|1.8|2.2|2.0|411|Incidence|20212958|Other|2018
5-9|0.1|0.2|0.2|31|Mortality|20212958|Soft Tissue|2018
5-9|0.5|0.8|0.7|132|Incidence|20212958|Soft Tissue|2018
<1|~|~|~|~|Mortality|3826908|Acute Lymphocytic|2018
<1|1.3|2.2|1.7|65|Incidence|3826908|Acute Lymphocytic|2018
<1|~|~|~|~|Mortality|3826908|Acute Myeloid|2018
<1|1.2|2.0|1.6|61|Incidence|3826908|Acute Myeloid|2018
<1|~|~|~|~|Mortality|3826908|Bones and Joints|2018
<1|~|~|~|~|Incidence|3826908|Bones and Joints|2018
<1|~|~|~|~|Mortality|3826908|Leukemia|2018
<1|3.7|5.1|4.3|166|Incidence|3826908|Leukemia|2018
<1|0.3|0.7|0.5|18|Mortality|3826908|Other|2018
<1|13.3|15.8|14.5|556|Incidence|3826908|Other|2018
<1|~|~|~|~|Mortality|3826908|Soft Tissue|2018
<1|2.4|3.5|2.9|110|Incidence|3826908|Soft Tissue|2018
1-4|0.1|0.3|0.2|32|Mortality|15809112|Acute Lymphocytic|2019
1-4|6.5|7.3|6.9|1093|Incidence|15809112|Acute Lymphocytic|2019
1-4|0.2|0.3|0.2|39|Mortality|15809112|Acute Myeloid|2019
1-4|0.8|1.1|0.9|145|Incidence|15809112|Acute Myeloid|2019
1-4|~|~|~|~|Mortality|15809112|Bones and Joints|2019
1-4|0.1|0.3|0.2|30|Incidence|15809112|Bones and Joints|2019
1-4|0.5|0.7|0.6|90|Mortality|15809112|Leukemia|2019
1-4|7.7|8.6|8.1|1284|Incidence|15809112|Leukemia|2019
1-4|0.4|0.7|0.5|83|Mortality|15809112|Other|2019
1-4|4.8|5.5|5.1|812|Incidence|15809112|Other|2019
1-4|0.1|0.2|0.1|20|Mortality|15809112|Soft Tissue|2019
1-4|1.1|1.5|1.3|205|Incidence|15809112|Soft Tissue|2019
10-14|0.2|0.4|0.3|57|Mortality|20820053|Acute Lymphocytic|2019
10-14|2.1|2.5|2.3|484|Incidence|20820053|Acute Lymphocytic|2019
10-14|0.1|0.3|0.2|38|Mortality|20820053|Acute Myeloid|2019
10-14|0.6|0.9|0.8|158|Incidence|20820053|Acute Myeloid|2019
10-14|0.2|0.3|0.3|55|Mortality|20820053|Bones and Joints|2019
10-14|1.4|1.7|1.5|321|Incidence|20820053|Bones and Joints|2019
10-14|0.4|0.6|0.5|109|Mortality|20820053|Leukemia|2019
10-14|3.2|3.7|3.4|707|Incidence|20820053|Leukemia|2019
10-14|0.2|0.3|0.3|53|Mortality|20820053|Other|2019
10-14|3.8|4.4|4.1|851|Incidence|20820053|Other|2019
10-14|0.1|0.2|0.1|28|Mortality|20820053|Soft Tissue|2019
10-14|0.8|1.1|0.9|195|Incidence|20820053|Soft Tissue|2019
15-19|0.2|0.3|0.3|53|Mortality|21066423|Acute Lymphocytic|2019
15-19|1.6|2.0|1.8|384|Incidence|21066423|Acute Lymphocytic|2019
15-19|0.1|0.2|0.1|28|Mortality|21066423|Acute Myeloid|2019
15-19|0.7|0.9|0.8|172|Incidence|21066423|Acute Myeloid|2019
15-19|0.5|0.7|0.6|118|Mortality|21066423|Bones and Joints|2019
15-19|1.2|1.6|1.4|293|Incidence|21066423|Bones and Joints|2019
15-19|0.4|0.6|0.5|113|Mortality|21066423|Leukemia|2019
15-19|2.9|3.4|3.1|656|Incidence|21066423|Leukemia|2019
15-19|0.4|0.6|0.5|108|Mortality|21066423|Other|2019
15-19|10.6|11.5|11.1|2329|Incidence|21066423|Other|2019
15-19|0.2|0.4|0.3|60|Mortality|21066423|Soft Tissue|2019
15-19|1.1|1.4|1.3|271|Incidence|21066423|Soft Tissue|2019
5-9|0.1|0.3|0.2|40|Mortality|20221753|Acute Lymphocytic|2019
5-9|3.2|3.7|3.5|703|Incidence|20221753|Acute Lymphocytic|2019
5-9|0.1|0.2|0.1|30|Mortality|20221753|Acute Myeloid|2019
5-9|0.3|0.5|0.4|81|Incidence|20221753|Acute Myeloid|2019
5-9|~|~|~|~|Mortality|20221753|Bones and Joints|2019
5-9|0.5|0.8|0.6|128|Incidence|20221753|Bones and Joints|2019
5-9|0.3|0.5|0.4|80|Mortality|20221753|Leukemia|2019
5-9|3.8|4.4|4.1|827|Incidence|20221753|Leukemia|2019
5-9|0.3|0.5|0.4|76|Mortality|20221753|Other|2019
5-9|1.8|2.2|2.0|411|Incidence|20221753|Other|2019
5-9|0.1|0.2|0.1|26|Mortality|20221753|Soft Tissue|2019
5-9|0.5|0.8|0.6|130|Incidence|20221753|Soft Tissue|2019
<1|~|~|~|~|Mortality|3762227|Acute Lymphocytic|2019
<1|1.4|2.3|1.8|69|Incidence|3762227|Acute Lymphocytic|2019
<1|~|~|~|~|Mortality|3762227|Acute Myeloid|2019
<1|1.1|1.9|1.4|54|Incidence|3762227|Acute Myeloid|2019
<1|~|~|~|~|Mortality|3762227|Bones and Joints|2019
<1|~|~|~|~|Incidence|3762227|Bones and Joints|2019
<1|~|~|~|~|Mortality|3762227|Leukemia|2019
<1|3.3|4.6|3.9|146|Incidence|3762227|Leukemia|2019
<1|0.4|0.9|0.6|22|Mortality|3762227|Other|2019
<1|12.3|14.7|13.5|507|Incidence|3762227|Other|2019
<1|~|~|~|~|Mortality|3762227|Soft Tissue|2019
<1|2.9|4.1|3.4|129|Incidence|3762227|Soft Tissue|2019
1-4|0.1|0.3|0.2|31|Mortality|15566282|Acute Lymphocytic|2020
1-4|6.8|7.6|7.2|1087|Incidence|15082362|Acute Lymphocytic|2020
1-4|0.2|0.4|0.3|43|Mortality|15566282|Acute Myeloid|2020
1-4|0.7|1.0|0.8|120|Incidence|15082362|Acute Myeloid|2020
1-4|~|~|~|~|Mortality|15566282|Bones and Joints|2020
1-4|0.1|0.2|0.2|23|Incidence|15082362|Bones and Joints|2020
1-4|0.4|0.7|0.5|85|Mortality|15566282|Leukemia|2020
1-4|7.9|8.9|8.4|1265|Incidence|15082362|Leukemia|2020
1-4|0.5|0.8|0.6|99|Mortality|15566282|Other|2020
1-4|4.6|5.3|4.9|745|Incidence|15082362|Other|2020
1-4|0.1|0.2|0.2|26|Mortality|15566282|Soft Tissue|2020
1-4|0.9|1.2|1.0|157|Incidence|15082362|Soft Tissue|2020
10-14|0.2|0.3|0.2|45|Mortality|20754423|Acute Lymphocytic|2020
10-14|2.2|2.6|2.4|476|Incidence|20107666|Acute Lymphocytic|2020
10-14|0.1|0.2|0.1|31|Mortality|20754423|Acute Myeloid|2020
10-14|0.6|0.8|0.7|142|Incidence|20107666|Acute Myeloid|2020
10-14|0.3|0.4|0.3|72|Mortality|20754423|Bones and Joints|2020
10-14|1.1|1.4|1.3|253|Incidence|20107666|Bones and Joints|2020
10-14|0.4|0.6|0.5|98|Mortality|20754423|Leukemia|2020
10-14|3.0|3.5|3.3|660|Incidence|20107666|Leukemia|2020
10-14|0.2|0.4|0.3|61|Mortality|20754423|Other|2020
10-14|3.4|3.9|3.6|726|Incidence|20107666|Other|2020
10-14|0.1|0.3|0.2|41|Mortality|20754423|Soft Tissue|2020
10-14|0.8|1.0|0.9|180|Incidence|20107666|Soft Tissue|2020
15-19|0.2|0.4|0.3|60|Mortality|20960929|Acute Lymphocytic|2020
15-19|1.6|1.9|1.8|357|Incidence|20322846|Acute Lymphocytic|2020
15-19|0.1|0.2|0.2|32|Mortality|20960929|Acute Myeloid|2020
15-19|0.7|1.0|0.8|167|Incidence|20322846|Acute Myeloid|2020
15-19|0.4|0.6|0.5|106|Mortality|20960929|Bones and Joints|2020
15-19|1.4|1.7|1.5|310|Incidence|20322846|Bones and Joints|2020
15-19|0.5|0.7|0.6|116|Mortality|20960929|Leukemia|2020
15-19|2.7|3.2|3.0|603|Incidence|20322846|Leukemia|2020
15-19|0.4|0.6|0.5|104|Mortality|20960929|Other|2020
15-19|9.4|10.3|9.8|1995|Incidence|20322846|Other|2020
15-19|0.2|0.4|0.3|61|Mortality|20960929|Soft Tissue|2020
15-19|0.9|1.2|1.0|213|Incidence|20322846|Soft Tissue|2020
5-9|0.1|0.2|0.2|36|Mortality|20237711|Acute Lymphocytic|2020
5-9|3.4|3.9|3.7|719|Incidence|19608494|Acute Lymphocytic|2020
5-9|0.1|0.2|0.1|20|Mortality|20237711|Acute Myeloid|2020
5-9|0.3|0.5|0.4|80|Incidence|19608494|Acute Myeloid|2020
5-9|~|~|~|~|Mortality|20237711|Bones and Joints|2020
5-9|0.5|0.7|0.6|108|Incidence|19608494|Bones and Joints|2020
5-9|0.3|0.5|0.4|73|Mortality|20237711|Leukemia|2020
5-9|4.0|4.5|4.2|832|Incidence|19608494|Leukemia|2020
5-9|0.3|0.4|0.3|66|Mortality|20237711|Other|2020
5-9|1.6|1.9|1.7|343|Incidence|19608494|Other|2020
5-9|0.1|0.2|0.1|23|Mortality|20237711|Soft Tissue|2020
5-9|0.5|0.7|0.6|114|Incidence|19608494|Soft Tissue|2020
<1|~|~|~|~|Mortality|3735010|Acute Lymphocytic|2020
<1|1.2|2.1|1.6|59|Incidence|3618856|Acute Lymphocytic|2020
<1|~|~|~|~|Mortality|3735010|Acute Myeloid|2020
<1|1.0|1.8|1.3|48|Incidence|3618856|Acute Myeloid|2020
<1|~|~|~|~|Mortality|3735010|Bones and Joints|2020
<1|~|~|~|~|Incidence|3618856|Bones and Joints|2020
<1|0.3|0.8|0.5|20|Mortality|3735010|Leukemia|2020
<1|3.2|4.5|3.8|138|Incidence|3618856|Leukemia|2020
<1|0.3|0.8|0.5|18|Mortality|3735010|Other|2020
<1|11.3|13.6|12.4|448|Incidence|3618856|Other|2020
<1|~|~|~|~|Mortality|3735010|Soft Tissue|2020
<1|2.5|3.7|3.1|112|Incidence|3618856|Soft Tissue|2020
